"Cancer","Gene","Known Var","Predicts","Drugs","Evidence","Ref","DBlevel","Origin Database","Original_Cancer_Type"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Imatinib,Nilotinib,Dasatinib","D","25686603",3,"CIVIC","Acute Lymphoblastic Leukemia"
"Leukemia","ABL1","BCR-ABL Y253H","Resistance","Dasatinib","C","16775234",2,"CIVIC","Acute Lymphoblastic Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Dasatinib","C","16775234",2,"CIVIC","Acute Lymphoblastic Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Ponatinib,Axitinib","D","25686603",3,"CIVIC","Acute Lymphoblastic Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Dasatinib","C","17264298",2,"CIVIC","Acute Lymphoblastic Leukemia"
"Leukemia","ABL1","BCR-ABL","Sensitivity/Response","Dasatinib","C","16775234",2,"CIVIC","Acute Lymphoblastic Leukemia"
"Leukemia","CSF1R","MEF2D-CSF1R","Sensitivity/Response","GW-2580,Imatinib","D","24186003",3,"CIVIC","Acute Lymphoblastic Leukemia"
"Leukemia","DNMT3A","R882","Resistance","Daunorubicin","B","22081665",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835V","Sensitivity/Response","Sunitinib","D","15304385",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835V","Sensitivity/Response","Sunitinib+Cytarabine","D","15304385",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835V","Sensitivity/Response","Sunitinib+Daunorubicin","D","15304385",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835V","Sensitivity/Response","Quizartinib","D","23497317",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","DNMT3A","Mutation","Sensitivity/Response","Decitabine","B","22124213",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","572_630ins","Sensitivity/Response","Crenolanib, Quizartinib, Sorafenib","3A","18230792, 22368270, 24227820, 29859851, 29875101",2,"OncoKB","Acute Myeloid Leukemia"
"Leukemia","DNMT3A","R882","Sensitivity/Response","Idarubicin","B","22081665",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","NTRK3","ETV6-NTRK3","Sensitivity/Response","Entrectinib","D","29237803",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","IDH2","Mutation","Sensitivity/Response","Enasidenib","A","28588020",1,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","Y842C","Resistance","Quizartinib","D","22858906",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","Mutation","Sensitivity/Response","Midostaurin","A","28546144",1,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835V","Sensitivity/Response","Tyrphostin AG 1296,AS602868","D","17330097",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","572_630ins","Sensitivity/Response","Gilteritinib","1","28516360, 28645776",1,"OncoKB","Acute Myeloid Leukemia"
"Leukemia","FLT3","Oncogenic Mutations","Sensitivity/Response","Midostaurin + High Dose Chemotherapy","1","28644114",1,"OncoKB","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835Y","Sensitivity/Response","Gilteritinib","D","27908881",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","IDH2","Oncogenic Mutations","Sensitivity/Response","Enasidenib","1","28588020",1,"OncoKB","Acute Myeloid Leukemia"
"Leukemia","FLT3","TKD MUTATION","Resistance","Sorafenib","B","22368270",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","TKD MUTATION","Resistance","Sorafenib","B","18230792",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","ITD","Sensitivity/Response","Lestaurtinib","B","14726387",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","ITD","Sensitivity/Response","Sorafenib","B","18230792",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","ITD","Sensitivity/Response","Tyrphostin AG 1296","D","12357354",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","WT1","EXON 7 MUTATION","Resistance","Cytarabine+Daunorubicin","B","18591546",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL","Sensitivity/Response","Imatinib","A","12476305",1,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","IDH1","R132C","Sensitivity/Response","GSK321","D","26436839",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","ITD","Sensitivity/Response","Gilteritinib","D","27908881",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","ITD","Sensitivity/Response","Gilteritinib","D","28516360",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835","Resistance","Sorafenib","B","22368270",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","Y842C","Resistance","FLT3/ABL/Aurora Kinase Inhibitor KW-2449","D","22858906",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","Y842C","Resistance","Sorafenib","D","22858906",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","Y842C","Resistance","Sunitinib","D","22858906",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","Y842C","Sensitivity/Response","Lestaurtinib","D","22858906",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","Mutation","Sensitivity/Response","Gilteritinib","B","31665578",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","F691L","Resistance","Lestaurtinib","D","22858906",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","F691L","Resistance","Midostaurin","D","22858906",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835I","Sensitivity/Response","Gilteritinib","D","27908881",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","SRSF2","Oncogenic Mutations","Sensitivity/Response","H3B-8800","4","29457796",3,"OncoKB","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835","Resistance","Ponatinib,Quizartinib","D","23430109",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835","Resistance","SU5614","D","19318574",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835","Resistance","Sorafenib,Quizartinib","B","22504184",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","IDH1","R132C","Sensitivity/Response","BPTES","D","24333121",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","ITD","Sensitivity/Response","Sorafenib","B","22368270",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","RUNX1","Mutation","Resistance","Cytarabine","B","21343560",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835H","Sensitivity/Response","Gilteritinib","D","27908881",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835V","Sensitivity/Response","Gilteritinib","D","27908881",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","ITD","Sensitivity/Response","Ponatinib","D","21482694",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FGFR1","Fusion","Sensitivity/Response","Sorafenib,Sunitinib","D","21482694",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","NPM1","EXON 12 MUTATION","Resistance","Tretinoin","B","19965647",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835H","Resistance","Sorafenib","C","23969938",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","CEBPA","Mutation","Sensitivity/Response","Tretinoin","B","19965647",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835H/Y","Resistance","Sorafenib","D","23969938",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","U2AF1","Oncogenic Mutations","Sensitivity/Response","H3B-8800","4","29457796",3,"OncoKB","Acute Myeloid Leukemia"
"Leukemia","IDH1","R132C","Sensitivity/Response","Ivosidenib","B","25583779",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","IDH1","Mutation","Sensitivity/Response","Ivosidenib","A","29860938",1,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","ITD","Resistance","Tretinoin","B","19965647",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","ITD","Resistance","Daunorubicin","D","15626738",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","ITD","Resistance","SU5614","D","15626738",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","NPM1","EXON 12 MUTATION","Sensitivity/Response","Valproic Acid","B","24797300",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","NPM1","EXON 12 MUTATION","Sensitivity/Response","Tretinoin+NSC348884","D","21719597",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","NPM1","EXON 12 MUTATION","Sensitivity/Response","Anti-CD33+Anti-CD123","E","24927407",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","NPM1","EXON 12 MUTATION","Sensitivity/Response","Anti-CD33","E","24927407",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","NPM1","W288FS","Sensitivity/Response","NSC348884","D","21719597",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FGFR1","FGFR1OP2-FGFR1","Sensitivity/Response","Ponatinib","D","21482694",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","ITD","Sensitivity/Response","Sorafenib","C","23969938",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","NPM1","EXON 12 MUTATION","Sensitivity/Response","Tretinoin","B","19059939",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","NPM1","EXON 12 MUTATION","Sensitivity/Response","Daunorubicin","B","22417203",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","IDH1","Oncogenic Mutations","Sensitivity/Response","Ivosidenib","1","23393090, 23558169, 29860938",1,"OncoKB","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835V","Sensitivity/Response","Sunitinib","C","15459012",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","KIT","RS3733542","Sensitivity/Response","Selumetinib","B","24178622",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","KIT","N822K","Sensitivity/Response","Sunitinib,Sorafenib","D","21482694",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","PDGFRA","FIP1L1-PDGFRA","Sensitivity/Response","Sorafenib,Sunitinib","D","21482694",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","IDH2","Mutation","Sensitivity/Response","Enasidenib","D","28193778",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","Mutation","Sensitivity/Response","Gilteritinib","B","28645776",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","ZRSR2","Oncogenic Mutations","Sensitivity/Response","H3B-8800","4","29457796",3,"OncoKB","Acute Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL","Resistance","Imatinib","D","12476305",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","NPM1","W288FS","Sensitivity/Response","Etoposide+Cytarabine+Daunorubicin","E","15659725",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","KIT","N822K","Sensitivity/Response","Ponatinib","D","21482694",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","CEBPA","N-TERMINAL FRAME SHIFT","Sensitivity/Response","OICR-9429","D","26167872",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","SF3B1","Oncogenic Mutations","Sensitivity/Response","H3B-8800","4","29457796",3,"OncoKB","Acute Myeloid Leukemia"
"Leukemia","FLT3","TKD MUTATION","Sensitivity/Response","Midostaurin","B","20733134",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","D835V","Resistance","Tandutinib","D","15256420",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","ITD","Resistance","Selumetinib","B","24178622",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FLT3","Y842C","Sensitivity/Response","Midostaurin","D","22858906",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","NTRK2","ETV6-NTRK2","Sensitivity/Response","Larotrectinib","C","29920189",2,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","FGF2","EXPRESSION","Resistance","Quizartinib","D","27671675",3,"CIVIC","Acute Myeloid Leukemia"
"Leukemia","PML","B2 DOMAIN MUTATION","Resistance","Tretinoin","B","23670176",2,"CIVIC","Acute Promyelocytic Leukemia"
"Leukemia","PML","PML-RARA A216V","Resistance","Tretinoin","C","21613260",2,"CIVIC","Acute Promyelocytic Leukemia"
"Leukemia","PML","PML-RARA","Sensitivity/Response","Tretinoin","B","8674046",2,"CIVIC","Acute Promyelocytic Leukemia"
"Leukemia","PML","PML-RARA","Sensitivity/Response","Tretinoin+Arsenic Trioxide","A","11704842",1,"CIVIC","Acute Promyelocytic Leukemia"
"Leukemia","FLT3","ITD","Resistance","Tretinoin+Anthracycline Antineoplastic Antibiotic","B","24981688",2,"CIVIC","Acute Promyelocytic Leukemia"
"Leukemia","PML","PML-RARA A216V","Resistance","Arsenic Trioxide","B","26537301",2,"CIVIC","Acute Promyelocytic Leukemia"
"Leukemia","PML","PML-RARA","Sensitivity/Response","Tretinoin","C","21505136",2,"CIVIC","Acute Promyelocytic Leukemia"
"Leukemia","PML","PML-RARA L218P","Resistance","Tretinoin","C","21613260",2,"CIVIC","Acute Promyelocytic Leukemia"
"Leukemia","ABL1","rearrangement(GoF) BCR-ABL1","response","dasatinib + venetoclax","preclinical","27582059",3,"GDKD","acute_lymphoblastic_leukemia"
"Leukemia","BCR","rearrangement(GoF) BCR-ABL1","response","dasatinib + venetoclax","preclinical","27582059",3,"GDKD","acute_lymphoblastic_leukemia"
"Leukemia","ABL1","T315A(GoF)","response","nilotinib, ponatinib","NCCN guidelines","NCCN",1,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","ABL1","T315I(GoF)","response","ponatinib","NCCN guidelines","NCCN",1,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","ABL1","T315I(GoF)","response","AURK inhibitors + BCR-ABL1 inhibitors","case report","22772060",2,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","ABL1","T315I(GoF)","response","axitinib","case report","25686603",2,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","ABL1","F317L/V/I/C(GoF)","response","nilotinib, ponatinib","NCCN guidelines","NCCN",1,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","ABL1","F359V/C/I(GoF)","response","dasatinib, ponatinib","NCCN guidelines","NCCN",1,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","ABL1","Y253H(GoF)","response","dasatinib, ponatinib","NCCN guidelines","NCCN",1,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","ABL1","E255K/V(GoF)","response","dasatinib, ponatinib","NCCN guidelines","NCCN",1,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","ABL1","V299L(GoF)","response","nilotinib, ponatinib","NCCN guidelines","NCCN",1,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","NOTCH1","PEST domain p.2245-2536(GoF)","sensitivity","Gamma secretase inhibitors + mTOR inhibitors","preclinical","19246562",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","NOTCH1","PEST domain p.2245-2536(GoF)","sensitivity","Gamma secretase inhibitors + CDK4 inhibitors","preclinical","19318552",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","NOTCH1","PEST domain p.2245-2536(GoF)","response","steroids early setting","late trials","20861909, 20861920, 20944675",2,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","NOTCH1","HD p.1529-1723(GoF)","response","Gamma secretase inhibitors","early trials","ASCO 2006 (abstr 6585)",2,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","NOTCH1","HD p.1529-1723(GoF)","sensitivity","Gamma secretase inhibitors","preclinical","15472075, 19778842, 22510873, 23001755",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","NOTCH1","HD p.1529-1723(GoF)","sensitivity","Gamma secretase inhibitors + mTOR inhibitors","preclinical","19246562",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","NOTCH1","HD p.1529-1723(GoF)","sensitivity","Gamma secretase inhibitors + CDK4 inhibitors","preclinical","19318552",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","NOTCH1","HD p.1529-1723(GoF)","response","steroids early setting","late trials","20861909, 20861920, 20944675",2,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","JAK2","rearrangement(GoF)","sensitivity","ruxolitinib","preclinical","22875628, 22899477",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","JAK2","R683(GoF)","sensitivity","ruxolitinib","preclinical","18805579, 22955920",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","BCR","rearrangement(GoF) BCR-JAK2","sensitivity","ruxolitinib","preclinical","22897847",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","NOTCH1","PEST domain p.2245-2536(GoF)","sensitivity","Gamma secretase inhibitors","preclinical","15472075, 19778842, 22510873, 23001755",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","NOTCH1","rearrangement(GoF)","sensitivity","Gamma secretase inhibitors","preclinical","16688224, 23033986",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","ALK","F856S(GoF)","sensitivity","crizotinib","preclinical","26032424",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","ALK","A348D(GoF)","sensitivity","crizotinib","preclinical","26032424",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","NRAS","any(GoF)","sensitivity","MEK inhibitors","preclinical","18701506",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","IL7R","237-255_indel or S185C(GoF)","sensitivity","ruxolitinib (in SH2B3 deleted)","preclinical","22897847, 22955920",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","ABL1","rearrangement(GoF) BCR-ABL1","response","imatinib, dasatinib, ponatinib","FDA-approved","FDA",1,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","ABL1","rearrangement(GoF) BCR-ABL1","response","nilotinib","NCCN guidelines","NCCN",1,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","NOTCH1","PEST domain p.2245-2536(GoF)","response","Gamma secretase inhibitors","early trials","ASCO 2006 (abstr 6585)",2,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","JAK2","rearrangement(GoF) BCR-JAK2","sensitivity","ruxolitinib","preclinical","22897847",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","FBXW7","any(LoF)","response","steroids in early setting","late trials","20861909",2,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","CRLF2","rearrangement(GoF)","sensitivity","BET inhibitors","preclinical","22904298",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","IL7R","237-255_indel or S185C(GoF)","sensitivity","mTOR inhibitors  (in SH2B3 deleted)","preclinical","22955920",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","CRLF2","rearrangement(GoF)","sensitivity","mTOR inhibitors","preclinical","22955920",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","JAK1","S646F(GoF)","sensitivity","ruxolitinib","preclinical","22955920",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","KRAS","G12(GoF)","sensitivity","MEK inhibitors","preclinical","18701506",3,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","BCR","rearrangement(GoF) BCR-ABL1","response","nilotinib","NCCN guidelines","NCCN",1,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","BCR","rearrangement(GoF) BCR-ABL1","response","imatinib, dasatinib, ponatinib","FDA-approved","FDA",1,"GDKD","acute_lymphocytic_leukemia"
"Leukemia","FLT3","N676(GoF)","sensitivity","crenolanib, PKC412","preclinical","24619500",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","IDH1","unknown","response","IDH1 inhibitor","early trials","ENA 2014 (abstr 1LBA)",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","TP53","mut(LoF)","response","decitabine","early trials","27959731",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","D835(GoF)","resistance","ponatinib","preclinical","23430109",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","MLL","rearrangement(GoF)","sensitivity","HDAC inhibitors","preclinical","22015773",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","IDH2","R172K","response","IDH2 inhibitor","early trials","AACR 2014 (abstr CT103)",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","Y842(GoF)","sensitivity","crenolanib, PKC412","preclinical","24619500",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","IDH2","R140Q","response","IDH2 inhibitor","early trials","AACR 2014 (abstr CT103)",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","Y842(GoF)","resistance","quizartinib","preclinical","22504184",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","SRSF2","any(LoF)","sensitivity","spliceosome inhibitor","preclinical","27135740",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","ITD (Y591-597), tyrosine kinase domain (p.610-p.946)(GoF)","response","midostaurin","late trials","ASH 2015",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","N676(GoF)","resistance","quizartinib","preclinical","23878140",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","ITD (Y591-597)(GoF)","response","quizartinib","early trials","ASH 2012 (abstr 673), ASH 2012 (abstr 48)",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","KRAS","any(GoF)","sensitivity","MEK inhibitors","preclinical","22507781",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","HRAS","any(GoF)","sensitivity","MEK inhibitors +/- mTOR inhibitors","preclinical","22399013, 22507781",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","KIT","N822K(GoF)","sensitivity","dasatinib","preclinical","23149070",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","ITD (Y591-597)(GoF)","response","sorafenib","early trials","19389879, 22368270",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","D835(GoF)","resistance","quizartinib","preclinical","22504184",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","D835(GoF)","response","lestaurtinib","case report","16857985",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","TP53","wild type(LoF)","response","HDM2 inhibitor","early trials","AACR 2017 (abstr CT152)",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","NPM1","any(LoF)","response","daunorubicin","FDA-approved","22417203",1,"GDKD","acute_myeloid_leukemia"
"Leukemia","DNMT3A","any(LoF)","response","daunorubicin","FDA-approved","22417203",1,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","D835(GoF)","response","midostaurin","case report","20733134",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","NPM1","any(LoF)","response","ATRA (non-FLT3 ITD AML)","late trials","19059939",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","ITD (Y591-597)(GoF)","response","FLT3 inhibitors","early trials","16857985",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","Y842(GoF)","resistance","ponatinib","preclinical","23430109",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","NPM1","any(LoF)","sensitivity","DOT1L inhibitors + MLL1 inhibitors","preclinical","27535106",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","NRAS","any(GoF)","sensitivity","MEK inhibitors","preclinical","22507781",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","D835(GoF)","resistance","sorafenib","case report","22368270",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","RARA","rearrangement(GoF) PML-RARA","response","ATRA + arsenic trioxide","FDA-approved","FDA",1,"GDKD","acute_myeloid_leukemia"
"Leukemia","JAK2","V617F(GoF)","response","ruxolitinib","early trials","22422826",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","IDH1","unknown","sensitivity","BCL2 inhibitors","preclinical","25599133",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","ITD (Y591-597)(GoF)","response","sorafenib + azacytidine","early trials","23613521",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","MLL","rearrangement(GoF)","sensitivity","BET inhibitors","preclinical","21964340",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","PML","rearrangement(GoF) PML-RARA","response","ATRA + arsenic trioxide","FDA-approved","FDA",1,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","F691(GoF)","sensitivity","novel FLT3 inhibitors","preclinical","25847190, 25847190",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","KIT","exon 8 p.416-422(GoF)","sensitivity","imatinib","preclinical","15618474",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","JAK2","V617F(GoF)","sensitivity","JAK inhibitors (alone or in combination)","preclinical","22829971",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","FLT3","F691(GoF)","resistance","quizartinib","preclinical","22504184",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","MLL","rearrangement(GoF)","sensitivity","DOT1L inhibitors","preclinical","21741596",3,"GDKD","acute_myeloid_leukemia"
"Leukemia","KIT","D816V(GoF)","response","dasatinib","case report","18986703",2,"GDKD","acute_myeloid_leukemia"
"Leukemia","MLL","rearrangement(GoF)","response","daunorubicin","FDA-approved","22417203",1,"GDKD","acute_myeloid_leukemia"
"Carcinoma","NOTCH1","PEST domain p.2245-2536(GoF)","response","NOTCH1 inhibitor","case report","27870570",2,"GDKD","adenoid_cystic_carcinoma"
"Lung Cancer","FGFR1","Amplification","Sensitivity/Response","Pazopanib","C","24302556",2,"CIVIC","Adenosquamous Lung Carcinoma"
"Kidney Cancer","FGFR3","Fusion","Sensitivity/Response","Erdafitinib","C","26324363",2,"CIVIC","Adrenal Carcinoma"
"General Cancer","MTOR","Oncogenic Mutations","Sensitivity/Response","Everolimus, Temsirolimus","4","24622468, 24631838, 26831717, 27482884, 30327302",3,"OncoKB","All Solid Tumors"
"General Cancer","CDK12","Truncating Mutations","Sensitivity/Response","Cemiplimab, Nivolumab, Pembrolizumab","4","29906450",3,"OncoKB","All Solid Tumors"
"General Cancer","NTRK3","Fusions","Sensitivity/Response","Larotrectinib","1","26216294, 29466156",1,"OncoKB","All Solid Tumors"
"General Cancer","FGFR3","Oncogenic Mutations","Sensitivity/Response","AZD4547, BGJ398, Debio1347, Erdafitinib","4","21119661, 23082000, 25169980, 26324363, 26438159, 27870574, 29848605, 30745300, 31088831, 31340094",3,"OncoKB","All Solid Tumors"
"General Cancer","CDKN2A","Oncogenic Mutations","Sensitivity/Response","Abemaciclib, Palbociclib, Ribociclib","4","19874578, 24495407, 25941111, 28283584, 29232554",3,"OncoKB","All Solid Tumors"
"General Cancer","PTEN","Oncogenic Mutations","Sensitivity/Response","AZD8186, GSK2636771","4","28645941",3,"OncoKB","All Solid Tumors"
"General Cancer","BRAF","L597","Sensitivity/Response","PLX8394","4","26466569, 28659148, 28783719, 30559419",3,"OncoKB","All Solid Tumors"
"General Cancer","NTRK1","Fusions","Sensitivity/Response","Entrectinib","3A","28183697",2,"OncoKB","All Solid Tumors"
"General Cancer","Other Biomarkers","MSI-H","Sensitivity/Response","Pembrolizumab","1","26028255, 28596308, 30589920",1,"OncoKB","All Solid Tumors"
"General Cancer","NTRK1","Fusions","Sensitivity/Response","Larotrectinib","1","26216294, 29466156",1,"OncoKB","All Solid Tumors"
"General Cancer","FGFR1","Oncogenic Mutations","Sensitivity/Response","AZD4547, BGJ398, Debio1347, Erdafitinib","4","23082000, 25169980, 26438159, 27870574, 30745300, 31088831, 31340094",3,"OncoKB","All Solid Tumors"
"General Cancer","KRAS","Oncogenic Mutations","Sensitivity/Response","Binimetinib, Cobimetinib, Trametinib","4","28783719, 29247021",3,"OncoKB","All Solid Tumors"
"General Cancer","NTRK2","Fusions","Sensitivity/Response","Entrectinib","3A","28183697",2,"OncoKB","All Solid Tumors"
"General Cancer","NTRK3","Fusions","Sensitivity/Response","Entrectinib","3A","28183697",2,"OncoKB","All Solid Tumors"
"General Cancer","BRAF","K601","Sensitivity/Response","PLX8394","4","26466569, 28659148, 28783719, 30559419",3,"OncoKB","All Solid Tumors"
"General Cancer","BRAF","G469A","Sensitivity/Response","PLX8394","4","26466569, 28659148, 28783719, 30559419",3,"OncoKB","All Solid Tumors"
"General Cancer","MET","Fusions","Sensitivity/Response","Crizotinib","4","29102694, 29284707, 29527595",3,"OncoKB","All Solid Tumors"
"General Cancer","NF1","Oncogenic Mutations","Sensitivity/Response","Cobimetinib, Trametinib","4","24535670, 24576830, 26936308",3,"OncoKB","All Solid Tumors"
"General Cancer","NTRK1","G595R","Resistance","Larotrectinib","R2","29466156",4,"OncoKB","All Solid Tumors"
"General Cancer","ATM","Oncogenic Mutations","Sensitivity/Response","Olaparib","4","26510020",3,"OncoKB","All Solid Tumors"
"General Cancer","BRAF","G469R","Sensitivity/Response","PLX8394","4","26466569, 28659148, 28783719, 30559419",3,"OncoKB","All Solid Tumors"
"General Cancer","BRAF","G469V","Sensitivity/Response","PLX8394","4","26466569, 28659148, 28783719, 30559419",3,"OncoKB","All Solid Tumors"
"General Cancer","NTRK2","Fusions","Sensitivity/Response","Larotrectinib","1","26216294, 29466156",1,"OncoKB","All Solid Tumors"
"General Cancer","FGFR2","Oncogenic Mutations","Sensitivity/Response","AZD4547, BGJ398, Debio1347, Erdafitinib","4","23082000, 25169980, 26438159, 27870574, 30745300, 31088831, 31340094",3,"OncoKB","All Solid Tumors"
"General Cancer","BRAF","G464","Sensitivity/Response","PLX8394","4","26466569, 28659148, 28783719, 30559419",3,"OncoKB","All Solid Tumors"
"General Cancer","NTRK3","G623R","Resistance","Larotrectinib","R2","28578312, 29466156",4,"OncoKB","All Solid Tumors"
"General Cancer","SMARCB1","Oncogenic Mutations","Sensitivity/Response","Tazemetostat","4","20951942, 23620515, 27391784, 29650362",3,"OncoKB","All Tumors"
"Sarcoma","FOXO1","PAX3-FOXO1","Sensitivity/Response","BET Inhibitor","D","28446439",3,"CIVIC","Alveolar Rhabdomyosarcoma"
"Lymphoma","ALK","NPM-ALK","Sensitivity/Response","Crizotinib","D","18089725",3,"CIVIC","Anaplastic Large Cell Lymphoma"
"Lymphoma","ALK","Fusion","Sensitivity/Response","Crizotinib","C","21345110",2,"CIVIC","Anaplastic Large Cell Lymphoma"
"Lymphoma","ALK","NPM-ALK","Sensitivity/Response","Crizotinib","B","23598171",2,"CIVIC","Anaplastic Large Cell Lymphoma"
"Thyroid Cancer","BRAF","V600E","Sensitivity/Response","Dabrafenib + Trametinib","1","29072975",1,"OncoKB","Anaplastic Thyroid Cancer"
"Kidney Cancerr","TSC2","any(LoF)","response","mTOR inhibitors","early trials","23312829, 21525172, 20048174",2,"GDKD","angiomyolipoma"
"Kidney Cancerr","TSC1","any(LoF)","response","mTOR inhibitors","early trials","23312829, 21525172, 20048174",2,"GDKD","angiomyolipoma"
"Sarcoma","MTOR","I1973F(GoF)","response","everolimus","case report","ASCO 2015 (abstr 11010)",2,"GDKD","angiosarcoma"
"Sarcoma","MTOR","K1771R(GoF)","response","everolimus","case report","26859683",2,"GDKD","angiosarcoma"
"Sarcoma","KDR","D717V","Sensitivity/Response","Sunitinib,Sorafenib","D","19723655",3,"CIVIC","Angiosarcoma"
"Sarcoma","KDR","A1065T","Sensitivity/Response","Sunitinib,Sorafenib","D","19723655",3,"CIVIC","Angiosarcoma"
"Sarcoma","PTPRB","LOSS-OF-FUNCTION","Sensitivity/Response","Sunitinib","D","24633157",3,"CIVIC","Angiosarcoma"
"Leukemia","CSF3R","Y752X(GoF)","sensitivity","dasatinib","preclinical","23656643",3,"GDKD","atypical_chronic_myeloid_leukemia"
"Leukemia","CSF3R","D771fs(GoF)","sensitivity","dasatinib","preclinical","23656643",3,"GDKD","atypical_chronic_myeloid_leukemia"
"Leukemia","CSF3R","T615A(GoF)","sensitivity","ruxolitinib","preclinical","23656643",3,"GDKD","atypical_chronic_myeloid_leukemia"
"Leukemia","CSF3R","S783fs(GoF)","sensitivity","dasatinib","preclinical","23656643",3,"GDKD","atypical_chronic_myeloid_leukemia"
"Leukemia","CSF3R","W791X(GoF)","sensitivity","dasatinib","preclinical","23656643",3,"GDKD","atypical_chronic_myeloid_leukemia"
"Leukemia","CSF3R","Q741X(GoF)","sensitivity","dasatinib","preclinical","23656643",3,"GDKD","atypical_chronic_myeloid_leukemia"
"Leukemia","CSF3R","T618I(GoF)","response","ruxolitinib","case report","23656643",2,"GDKD","atypical_chronic_myeloid_leukemia"
"Leukemia","PDGFRA","BCR-PDGFRA","Sensitivity/Response","Imatinib","C","12944919",2,"CIVIC","B-cell Acute Lymphoblastic Leukemia"
"Leukemia","FLT3","Overexpression","Sensitivity/Response","Sunitinib","C","27181063",2,"CIVIC","B-cell Adult Acute Lymphocytic Leukemia"
"Leukemia","ABL1","SFPQ-ABL1","Sensitivity/Response","Dasatinib>Imatinib","C","32306475",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","SFPQ-ABL1","Sensitivity/Response","Dasatinib>Imatinib","C","32306475",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","RCSD1-ABL1","Reduced Sensitivity","Dasatinib","C","21863287",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","RCSD1-ABL1","Reduced Sensitivity","Dasatinib","C","21863287",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","RCSD1-ABL1","Sensitivity/Response","Imatinib","C","27125982",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","RCSD1-ABL1","Sensitivity/Response","Imatinib","C","27125982",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","JAK2","GOLGA5-JAK2","Sensitivity/Response","Ruxolitinib","C","29773603",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","JAK2","GOLGA5-JAK2","Sensitivity/Response","Ruxolitinib","C","29773603",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib","C","31905241",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib","C","31905241",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","RCSD1-ABL1","Sensitivity/Response","Dasatinib","C","28057740",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","RCSD1-ABL1","Sensitivity/Response","Dasatinib","C","28057740",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","RANBP2-ABL1","Sensitivity/Response","Dasatinib","C","31434701",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","RANBP2-ABL1","Sensitivity/Response","Dasatinib","C","31434701",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","RCSD1-ABL1","Sensitivity/Response","Dasatinib","C","19794096",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","RCSD1-ABL1","Sensitivity/Response","Dasatinib","C","19794096",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","ETV6-ABL1","Sensitivity/Response","Imatinib","C","30028819",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","ETV6-ABL1","Sensitivity/Response","Imatinib","C","30028819",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib+Methotrexate+Etoposide","C","31725893",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib+Methotrexate+Etoposide","C","31725893",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","NUP214-ABL1","Sensitivity/Response","Dasatinib+Vincristine+Dexamethasone","C","26681761",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","NUP214-ABL1","Sensitivity/Response","Dasatinib+Vincristine+Dexamethasone","C","26681761",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","RCSD1-ABL1","Sensitivity/Response","Dasatinib","D","25207766",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","RCSD1-ABL1","Sensitivity/Response","Dasatinib","D","25207766",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","ETV6-ABL1","Sensitivity/Response","Dasatinib","C","25207766",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","ETV6-ABL1","Sensitivity/Response","Dasatinib","C","25207766",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","SNX2-ABL1","Resistance","Dasatinib","C","24215620",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","SNX2-ABL1","Resistance","Dasatinib","C","24215620",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","RCSD1-ABL1","Sensitivity/Response","Tyrosine Kinase Inhibitor","C","27855558",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","RCSD1-ABL1","Sensitivity/Response","Tyrosine Kinase Inhibitor","C","27855558",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","NUP214-ABL1","Sensitivity/Response","Ponatinib,Imatinib,Dasatinib,Nilotinib","D","23175662",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","NUP214-ABL1","Sensitivity/Response","Ponatinib,Imatinib,Dasatinib,Nilotinib","D","23175662",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","JAK2","SSBP2-JAK2","Sensitivity/Response","Ruxolitinib","C","25207766",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","JAK2","SSBP2-JAK2","Sensitivity/Response","Ruxolitinib","C","25207766",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","PDGFRB","EBF1-PDGFRB","Sensitivity/Response","Imatinib+Chemotherapy","C","32068648",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","PDGFRB","EBF1-PDGFRB","Sensitivity/Response","Imatinib+Chemotherapy","C","32068648",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","SNX2-ABL1","Reduced Sensitivity","Imatinib","C","21391972",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","SNX2-ABL1","Reduced Sensitivity","Imatinib","C","21391972",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","FOXP1-ABL1","Sensitivity/Response","Dasatinib","C","30938769",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","FOXP1-ABL1","Sensitivity/Response","Dasatinib","C","30938769",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib","D","29880614",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib","D","29880614",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib","D","31725893",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib","D","31725893",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","RCSD1-ABL1","Sensitivity/Response","Dasatinib","C","26600955",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","RCSD1-ABL1","Sensitivity/Response","Dasatinib","C","26600955",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","RCSD1-ABL1","Sensitivity/Response","Ponatinib","D","25768406",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","RCSD1-ABL1","Sensitivity/Response","Ponatinib","D","25768406",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","SNX2-ABL1","Resistance","Imatinib,Dasatinib","D","24367893",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","SNX2-ABL1","Resistance","Imatinib,Dasatinib","D","24367893",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","RCSD1-ABL1","Sensitivity/Response","Ponatinib","C","25768406",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","RCSD1-ABL1","Sensitivity/Response","Ponatinib","C","25768406",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","RCSD1-ABL1","Sensitivity/Response","Imatinib","C","25207766",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL1","RCSD1-ABL1","Sensitivity/Response","Imatinib","C","25207766",2,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL2","Fusion","Sensitivity/Response","Dasatinib","D","25207766",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Lymphoma","ABL2","Fusion","Sensitivity/Response","Dasatinib","D","25207766",3,"CIVIC","B-lymphoblastic Leukemia/lymphoma"
"Leukemia","ABL1","T315A","Sensitivity/Response","Bosutinib, Nilotinib","2A","15071128, 19075254",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","T315A","Sensitivity/Response","Bosutinib, Nilotinib","2A","15071128, 19075254",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","Y253H","Sensitivity/Response","Bosutinib, Dasatinib","2A","19075254, 25368968",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","Y253H","Sensitivity/Response","Bosutinib, Dasatinib","2A","19075254, 25368968",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","V299L","Sensitivity/Response","Nilotinib","2A","15071128",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","V299L","Sensitivity/Response","Nilotinib","2A","15071128",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","F317I","Sensitivity/Response","Bosutinib, Nilotinib","2A","15071128, 19075254",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","F317I","Sensitivity/Response","Bosutinib, Nilotinib","2A","15071128, 19075254",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","E255V","Sensitivity/Response","Bosutinib, Dasatinib","2A","19075254, 25368968",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","E255V","Sensitivity/Response","Bosutinib, Dasatinib","2A","19075254, 25368968",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","E255K","Sensitivity/Response","Bosutinib, Dasatinib","2A","19075254, 25368968",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","E255K","Sensitivity/Response","Bosutinib, Dasatinib","2A","19075254, 25368968",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","T315I","Resistance","Bosutinib, Dasatinib, Imatinib, Nilotinib","R1","17768119, 18403620",4,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","T315I","Resistance","Bosutinib, Dasatinib, Imatinib, Nilotinib","R1","17768119, 18403620",4,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","BCR-ABL1 Fusion","Sensitivity/Response","Bosutinib, Nilotinib","2A","15071128, 19075254",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","BCR-ABL1 Fusion","Sensitivity/Response","Bosutinib, Nilotinib","2A","15071128, 19075254",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","F359I","Sensitivity/Response","Bosutinib, Dasatinib","2A","19075254, 25368968",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","F359I","Sensitivity/Response","Bosutinib, Dasatinib","2A","19075254, 25368968",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","F359V","Sensitivity/Response","Bosutinib, Dasatinib","2A","19075254, 25368968",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","F359V","Sensitivity/Response","Bosutinib, Dasatinib","2A","19075254, 25368968",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","F317V","Sensitivity/Response","Bosutinib, Nilotinib","2A","15071128, 19075254",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","F317V","Sensitivity/Response","Bosutinib, Nilotinib","2A","15071128, 19075254",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","F317L","Sensitivity/Response","Bosutinib, Nilotinib","2A","15071128, 19075254",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","F317L","Sensitivity/Response","Bosutinib, Nilotinib","2A","15071128, 19075254",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","F359C","Sensitivity/Response","Bosutinib, Dasatinib","2A","19075254, 25368968",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","F359C","Sensitivity/Response","Bosutinib, Dasatinib","2A","19075254, 25368968",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","F317C","Sensitivity/Response","Bosutinib, Nilotinib","2A","15071128, 19075254",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","F317C","Sensitivity/Response","Bosutinib, Nilotinib","2A","15071128, 19075254",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","T315I","Sensitivity/Response","Ponatinib","1","19075254, 23044928",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","T315I","Sensitivity/Response","Ponatinib","1","19075254, 23044928",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Leukemia","ABL1","BCR-ABL1 Fusion","Sensitivity/Response","Dasatinib, Imatinib, Ponatinib","1","11287973, 12200353, 17496201, 20131302, 21931113, 24180494, 24441288",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Lymphoma","ABL1","BCR-ABL1 Fusion","Sensitivity/Response","Dasatinib, Imatinib, Ponatinib","1","11287973, 12200353, 17496201, 20131302, 21931113, 24180494, 24441288",1,"OncoKB","B-Lymphoblastic Leukemia/Lymphoma"
"Skin Cancer","SMO","L412F","Resistance","Vismodegib","C","26822128",2,"CIVIC","Basal Cell Carcinoma"
"Skin Cancer","SMO","D473H","Resistance","Vismodegib","D","25759020",3,"CIVIC","Basal Cell Carcinoma"
"Skin Cancer","SMO","Mutation","Sensitivity/Response","PSI,Arsenic Trioxide","D","25759020",3,"CIVIC","Basal Cell Carcinoma"
"Skin Cancer","SMO","Mutation","Resistance","Sonidegib>Vismodegib","B","26546616",2,"CIVIC","Basal Cell Carcinoma"
"Skin Cancer","SMO","L412F","Resistance","Vismodegib","D","25759020",3,"CIVIC","Basal Cell Carcinoma"
"Skin Cancer","SMO","Mutation","Resistance","Vismodegib","B","25759020",2,"CIVIC","Basal Cell Carcinoma"
"Skin Cancer","PTCH1","any(LoF)","response","vismodegib","FDA-approved","19726763",2,"GDKD","basal_cell_carcinoma"
"Skin Cancer","CD274","amplification(GoF)","response","PD1 blockade","case report","27942391",2,"GDKD","basal_cell_carcinoma"
"Skin Cancer","SMO","G497W, D473Y(GoF)","resistance","vismodegib","case report","25306392",2,"GDKD","basal_cell_carcinoma"
"Blood Cancer","PDGFRB","EBF1-PDGFRB","Sensitivity/Response","Imatinib+Chemotherapy","C","32068648",2,"CIVIC","BCR-ABL1-like"
"Blood Cancer","JAK2","SSBP2-JAK2","Sensitivity/Response","Ruxolitinib","C","25207766",2,"CIVIC","BCR-ABL1-like"
"Blood Cancer","ABL1","RANBP2-ABL1","Sensitivity/Response","Dasatinib","C","31434701",2,"CIVIC","BCR-ABL1-like"
"Blood Cancer","ABL2","Fusion","Sensitivity/Response","Dasatinib","D","25207766",3,"CIVIC","BCR-ABL1-like"
"Blood Cancer","ABL1","NUP214-ABL1","Sensitivity/Response","Dasatinib+Vincristine+Dexamethasone","C","26681761",2,"CIVIC","BCR-ABL1-like"
"Blood Cancer","ABL1","RCSD1-ABL1","Sensitivity/Response","Tyrosine Kinase Inhibitor","C","27855558",2,"CIVIC","BCR-ABL1-like"
"Blood Cancer","ABL1","RCSD1-ABL1","Sensitivity/Response","Imatinib","C","25207766",2,"CIVIC","BCR-ABL1-like"
"Blood Cancer","ABL1","RCSD1-ABL1","Sensitivity/Response","Dasatinib","D","25207766",3,"CIVIC","BCR-ABL1-like"
"Blood Cancer","JAK2","GOLGA5-JAK2","Sensitivity/Response","Ruxolitinib","C","29773603",2,"CIVIC","BCR-ABL1-like"
"Biliary Cancer","MAGEH1","EXPRESSION","Resistance","Gemcitabine","D","20088962",3,"CIVIC","Bile Duct Adenocarcinoma"
"Biliary Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab+Pertuzumab","B","29320312",2,"CIVIC","Biliary Tract Cancer"
"Biliary Cancer","KRAS","any(GoF)","response","MEK inhibitors","early trials","23391555",2,"GDKD","biliary_tract"
"Biliary Cancer","FGFR2","rearrangement(GoF)","response","FGFR inhibitors","early trials","ASCO 2016 (abstr 109)",2,"GDKD","biliary_tract"
"Biliary Cancer","ERBB2","amplification(GoF)","response","trastuzumab, lapatinib, pertuzumab","early trials","26022204",2,"GDKD","biliary_tract"
"Biliary Cancer","FGFR2","rearrangement(GoF)","sensitivity","FGFR inhibitors","preclinical","23558953",3,"GDKD","biliary_tract"
"Biliary Cancer","FGFR2","mut(GoF)","resistance","FGFR inhibitors","early trials","ASCO 2017 (abstr 2500)",2,"GDKD","biliary_tract"
"Biliary Cancer","FGFR2","multiple(GoF)","resistance","FGFR inhibitors","early trials","28034880",2,"GDKD","biliary_tract"
"Biliary Cancer","BRAF","L485W(GoF)","response","ERK inhibitors","case report","ASCO 2017 (abstr 2508)",2,"GDKD","biliary_tract"
"Biliary Cancer","IDH2","R172(GoF)","sensitivity","dasatinib","preclinical","27231123",3,"GDKD","biliary_tract"
"Biliary Cancer","IDH1","R132(GoF)","sensitivity","dasatinib","preclinical","27231123",3,"GDKD","biliary_tract"
"Bladder Cancer","TP53","mut(LoF)","sensitivity","mitomycin C, gemcitabine, doxorubicin","preclinical","27397505",3,"GDKD","bladder"
"Bladder Cancer","MTOR","E2014K(GoF)","response","everolimus","case report","24625776",2,"GDKD","bladder"
"Bladder Cancer","PIK3CA","any(GoF)","response","PI3K pathway inhibitors","case report","ASCO 2015 (abstr 2516)",2,"GDKD","bladder"
"Bladder Cancer","FGFR3","rearrangement(GoF)","response","FGFR inhibitors","case report","26324363, ASCO 2017 (abstr 2500)",2,"GDKD","bladder"
"Bladder Cancer","ERCC2","any(LoF)","response","cisplatin","early trials","25096233",2,"GDKD","bladder"
"Bladder Cancer","ERBB3","R103G(GoF)","response","afatinib","case report","ASCO 2015 (abstr e15516)",2,"GDKD","bladder"
"Bladder Cancer","ERBB3","G284R(GoF)","response","afatinib","case report","ASCO 2015 (abstr e15516)",2,"GDKD","bladder"
"Bladder Cancer","ERBB2","amplification(GoF)","response","afatinib","case report","27044931",2,"GDKD","bladder"
"Bladder Cancer","ATM","any(LoF)","response","cisplatin","early trials","26238431",2,"GDKD","bladder"
"Bladder Cancer","TSC1","any(LoF)","response","everolimus","early trials","22923433",2,"GDKD","bladder"
"Bladder Cancer","FGFR3","any(GoF)","response","FGFR inhibitors","early trials","27870574",2,"GDKD","bladder"
"Bladder Cancer","RB1","any(LoF)","response","cisplatin","early trials","26238431",2,"GDKD","bladder"
"Bladder Cancer","MTOR","E2419K(GoF)","response","everolimus","case report","24625776",2,"GDKD","bladder"
"Bladder Cancer","ERBB3","G284R, V104M, R103G(GoF)","response","afatinib","case report","27044931",2,"GDKD","bladder"
"Bladder Cancer","FANCC","any(LoF)","response","cisplatin","early trials","26238431",2,"GDKD","bladder"
"Bladder Cancer","MTOR","N1421D(GoF)","response","everolimus","case report","ASCO 2015 (abstr 11010)",2,"GDKD","bladder"
"Bladder Cancer","KDM6A","Oncogenic Mutations","Sensitivity/Response","Tazemetostat","4","24123378, 28228601, 29045832, 29059780",3,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR2","Fusions","Sensitivity/Response","AZD4547, BGJ398, Debio1347","3A","24122810, 27870574, 30745300",2,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","G380R","Sensitivity/Response","AZD4547, BGJ398, Debio1347, Erdafitinib","3A","21119661, 26324363, 27870574, 29848605, 30745300, 31088831",2,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","K650","Sensitivity/Response","AZD4547, BGJ398, Debio1347, Erdafitinib","3A","21119661, 26324363, 27870574, 29848605, 30745300, 31088831",2,"OncoKB","Bladder Cancer"
"Bladder Cancer","MTOR","E2014K","Sensitivity/Response","Everolimus","3A","23551593, 24625776",2,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","Y373C","Sensitivity/Response","Erdafitinib","1","26324363, 31340094",1,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","G370C","Sensitivity/Response","Erdafitinib","1","26324363, 31340094",1,"OncoKB","Bladder Cancer"
"Bladder Cancer","MTOR","E2419K","Sensitivity/Response","Everolimus","3A","23551593, 24625776",2,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","R248C","Sensitivity/Response","Erdafitinib","1","26324363, 31340094",1,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","S249C","Sensitivity/Response","Erdafitinib","1","26324363, 31340094",1,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","Fusions","Sensitivity/Response","AZD4547, BGJ398, Debio1347","3A","22837387, 29848605, 30745300",2,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR2","Fusions","Sensitivity/Response","Erdafitinib","1","26324363, 31340094",1,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","G370C","Sensitivity/Response","AZD4547, BGJ398, Debio1347","3A","21119661, 27870574, 29848605, 30745300",2,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","Fusions","Sensitivity/Response","Erdafitinib","1","26324363, 31340094",1,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","R248C","Sensitivity/Response","AZD4547, BGJ398, Debio1347","3A","21119661, 27870574, 29848605, 30745300",2,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","S371C","Sensitivity/Response","AZD4547, BGJ398, Debio1347, Erdafitinib","3A","21119661, 26324363, 27870574, 29848605, 30745300, 31088831",2,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","Y373C","Sensitivity/Response","AZD4547, BGJ398, Debio1347","3A","21119661, 27870574, 29848605, 30745300",2,"OncoKB","Bladder Cancer"
"Bladder Cancer","ERCC2","Oncogenic Mutations","Sensitivity/Response","Cisplatin","3A","12208738, 25096233, 27310333, 29980530",2,"OncoKB","Bladder Cancer"
"Bladder Cancer","FGFR3","S249C","Sensitivity/Response","AZD4547, BGJ398, Debio1347","3A","21119661, 27870574, 29848605, 30745300",2,"OncoKB","Bladder Cancer"
"Bladder Cancer","ERCC1","EXPRESSION","Sensitivity/Response","Cisplatin","B","26162296",2,"CIVIC","Bladder Carcinoma"
"Bladder Cancer","ERBB2","Mutation","Sensitivity/Response","Platinum Compound","C","25636205",2,"CIVIC","Bladder Carcinoma"
"Bladder Cancer","FGFR1","Amplification","Sensitivity/Response","Infigratinib","C","27870574",2,"CIVIC","Bladder Carcinoma"
"Bladder Cancer","PTEN","Loss","Resistance","Everolimus","B","23989949",2,"CIVIC","Bladder Carcinoma"
"Bladder Cancer","MTOR","MUTATION","Sensitivity/Response","Pazopanib+Everolimus","C","24625776",2,"CIVIC","Bladder Carcinoma"
"Bladder Cancer","ERBB2","Amplification","Sensitivity/Response","Pertuzumab+Trastuzumab","B","29320312",2,"CIVIC","Bladder Carcinoma"
"Bladder Cancer","FGFR3","FGFR3-BAIAP2L1","Sensitivity/Response","PD173074","D","23558953",3,"CIVIC","Bladder Carcinoma"
"Bladder Cancer","FGFR3","Overexpression","Sensitivity/Response","Dovitinib,Tyrosine Kinase Inhibitor SU5402,PD173074","D","21119661",3,"CIVIC","Bladder Carcinoma"
"Bladder Cancer","FGFR1","Expression","Sensitivity/Response","Dovitinib,PD173074","D","21119661",3,"CIVIC","Bladder Carcinoma"
"Bladder Cancer","FGFR3","Mutation","Sensitivity/Response","Infigratinib","B","27870574",2,"CIVIC","Bladder Carcinoma"
"Bladder Cancer","TSC1","LOSS-OF-FUNCTION","Sensitivity/Response","Everolimus","B","22923433",2,"CIVIC","Bladder Carcinoma"
"Glioma","IDH1","Mutation","Sensitivity/Response","Olaparib","D","28148839",3,"CIVIC","Brain Glioma"
"Glioma","IDH1","R132C","Sensitivity/Response","Temozolomide","B","20975057",2,"CIVIC","Brain Glioma"
"Glioma","MMP2","SERUM LEVELS","Sensitivity/Response","Bevacizumab","B","24327581",2,"CIVIC","Brain Glioma"
"Glioma","EGFR","VIII","Sensitivity/Response","Nimotuzumab","D","26778701",3,"CIVIC","Brain Glioma"
"Breast Cancer","NOTCH2","rearrangement(GoF)","sensitivity","Gamma secretase inhibitors","preclinical","22101766",3,"GDKD","breast"
"Breast Cancer","NOTCH2","PEST domain p.2010-2472(GoF)","sensitivity","Gamma secretase inhibitors","preclinical","25564152",3,"GDKD","breast"
"Breast Cancer","ERBB2","V659E(GoF)","response","lapatinib","case report","23950206",2,"GDKD","breast"
"Breast Cancer","JAK2","amplification(GoF)","sensitivity","JAK inhibitors","preclinical","27075627",3,"GDKD","breast"
"Breast Cancer","NTRK3","rearrangement(GoF)","sensitivity","midostaurin, IGF1R inhibitors, PI3K pathway inhibitors","preclinical","21148487, 23131561",3,"GDKD","breast"
"Breast Cancer","ESR1","L536(GoF)","resistance","anti-estrogens","early trials","24185512, 24185510",2,"GDKD","breast"
"Breast Cancer","FGF4","amplification(GoF)","response","dovitinib","early trials","23658459",2,"GDKD","breast"
"Breast Cancer","ESR1","P535H(GoF)","resistance","anti-estrogens","early trials","24185512",2,"GDKD","breast"
"Breast Cancer","ESR1","any(GoF)","response","fulvestrant","late trials","27269946",2,"GDKD","breast"
"Breast Cancer","AKT3","rearrangement(GoF)","sensitivity","ATP-competitive AKT inhibitors","preclinical","22722202",3,"GDKD","breast"
"Breast Cancer","ESR1","Y537S(GoF)","reduced sensitivity","fulvestrant","preclinical","27986707",3,"GDKD","breast"
"Breast Cancer","BRCA1","any(LoF)","response","veliparib + cisplatin","early trials","26801247",2,"GDKD","breast"
"Breast Cancer","ESR1","codons 537, 538(GoF)","resistance","anti-estrogens","early trials","24185512, 24185510, 24398047",2,"GDKD","breast"
"Breast Cancer","ERBB2","amplification(GoF)","response","neratinib, afatinib","late trials","20142587, 22418700, 23632474",2,"GDKD","breast"
"Breast Cancer","ERBB2","amplification(GoF)","response","trastuzumab + HSP90 inhibitors","early trials","21558407",2,"GDKD","breast"
"Breast Cancer","ESR1","ERS1-YAP1 rearrangement(GoF)","resistance","anti-estrogens","preclinical","24055055",3,"GDKD","breast"
"Breast Cancer","ERBB2","amplification(GoF)","response","trastuzumab, lapatinib, pertuzumab, ado-trastuzumab emtansine","FDA-approved","FDA",1,"GDKD","breast"
"Breast Cancer","GATA3","any(GoF)","sensitivity","aromatase inhhibitors","preclinical","24758297",3,"GDKD","breast"
"Breast Cancer","NF2","any(LoF)","response","tensirolimus plus chemotherapy","case report","25878190",2,"GDKD","breast"
"Breast Cancer","NOTCH1","PEST domain p.2245-2536(GoF)","sensitivity","Gamma secretase inhibitors","preclinical","25564152",3,"GDKD","breast"
"Breast Cancer","ERBB2","amplification(GoF)","sensitivity","HER2 inhibitors + CDK4/6 inhibitors","preclinical","26977878",3,"GDKD","breast"
"Breast Cancer","ESR1","E380Q(GoF)","resistance","anti-estrogens","early trials","24185512, 24185510, 24398047",2,"GDKD","breast"
"Breast Cancer","ESR1","codons 537, 538(GoF)","response","novel estrogen receptor degrader","early trials","AACR 2015 (abstr CT231)",2,"GDKD","breast"
"Breast Cancer","HGF","amplification(GoF)","resistance","trastuzumab in HER2-ampl","early trials","22850551",2,"GDKD","breast"
"Breast Cancer","ERBB2","D769Y(GoF)","sensitivity","trastuzumab, lapatinib, neratinib","preclinical","23220880",3,"GDKD","breast"
"Breast Cancer","ERBB2","K753E(GoF)","resistance","lapatinib","preclinical","27697991",3,"GDKD","breast"
"Breast Cancer","PDPK1","amplification(GoF)","sensitivity","PI3K pathway inhibitors","preclinical","19602588",3,"GDKD","breast"
"Breast Cancer","PIK3CA","any(GoF)","response","PI3K aplha inhibitors","early trials","28331003",2,"GDKD","breast"
"Breast Cancer","FGF3","amplification(GoF)","response","dovitinib","early trials","23658459",2,"GDKD","breast"
"Breast Cancer","PIK3CA","amplification(GoF)","resistance","PI3K pathway inhibitors","preclinical","24366379",3,"GDKD","breast"
"Breast Cancer","BRCA1","any(LoF)","response","platinum agents","early trials","25847936",2,"GDKD","breast"
"Breast Cancer","TOP2A","amplification(GoF)","response","anthracyclines","late trials","22864769",2,"GDKD","breast"
"Breast Cancer","MET","amplification(GoF)","resistance","trastuzumab in HER2-amplified","early trials","22850551",2,"GDKD","breast"
"Breast Cancer","PIK3CB","D1067Y(GoF)","sensitivity","AKT inhibitor, mTORC1/2 inhibitors","preclinical","26759240",3,"GDKD","breast"
"Breast Cancer","ERBB2","D769H(GoF)","sensitivity","trastuzumab, lapatinib, neratinib","preclinical","23220880",3,"GDKD","breast"
"Breast Cancer","PTEN","any/deletion(LoF)","sensitivity","PI3K pathway inhibitors","preclinical","23085766, 22932669",3,"GDKD","breast"
"Breast Cancer","TP53","mut(LoF)","resistance","CDK4/CDK6 inhibitor abemaciclib","early trials","27217383",2,"GDKD","breast"
"Breast Cancer","NOTCH1","rearrangement(GoF)","sensitivity","Gamma secretase inhibitors","preclinical","22101766",3,"GDKD","breast"
"Breast Cancer","ERBB2","P780_Y781insGSP(GoF)","sensitivity","neratinib","preclinical","23220880",3,"GDKD","breast"
"Breast Cancer","FGFR1","amplification(GoF)","response","FGFR inhibitors","early trials","25193991",2,"GDKD","breast"
"Breast Cancer","ESR1","codons 537, 538(GoF)","sensitivity","novel estrogen receptor degrader","preclinical","27020862",3,"GDKD","breast"
"Breast Cancer","BRCA2","any(LoF)","response","platinum agents","early trials","25847936",2,"GDKD","breast"
"Breast Cancer","PIK3CA","any(GoF)","response","everolimus + trastuzumab + chemotherapy (HER2 ampl)","late trials","27091708",2,"GDKD","breast"
"Breast Cancer","PIK3CA","any(GoF)","response","AKT inhibitors","early trials","ASCO 2015 (abstr 2500)",2,"GDKD","breast"
"Breast Cancer","ESR1","any(GoF)","resistance","exemestane","late trials","27269946",2,"GDKD","breast"
"Breast Cancer","BRCA2","any(LoF)","response","PARP inhibitors","early trials","20609467",2,"GDKD","breast"
"Breast Cancer","FGFR2","amplification(GoF)","response","FGFR inhibitors","case report","25193991",2,"GDKD","breast"
"Breast Cancer","ERBB2","755-759del(GoF)","sensitivity","neratinib","preclinical","23220880",3,"GDKD","breast"
"Breast Cancer","CDH1","mut(LoF)","sensitivity","bicalutamide","preclinical","27397505",3,"GDKD","breast"
"Breast Cancer","ERBB2","T798I(GoF)","resistance","neratinib","case report","28274957",2,"GDKD","breast"
"Breast Cancer","ERBB2","R896C(GoF)","sensitivity","trastuzumab, lapatinib, neratinib","preclinical","23220880",3,"GDKD","breast"
"Breast Cancer","PTEN","any/deletion(LoF)","resistance","PI3K aplha inhibitors","early trials, case report","25409150",2,"GDKD","breast"
"Breast Cancer","ERBB2","V842I(GoF)","sensitivity","lapatinib, neratinib","preclinical","23220880",3,"GDKD","breast"
"Breast Cancer","INPP4B","any/deletion(LoF)","sensitivity","PI3K pathway inhibitors","preclinical","23551093",3,"GDKD","breast"
"Breast Cancer","ERBB2","K753E(GoF)","sensitivity","neratinib","preclinical","27697991",3,"GDKD","breast"
"Breast Cancer","PIK3CA","any(GoF)","response","PI3K pathway inhibitors","early trials","22271473",2,"GDKD","breast"
"Breast Cancer","ERBB2","amplification(GoF)","response","trastuzumab + everolimus + chemotherapy","early trials","21107682, 20975068",2,"GDKD","breast"
"Breast Cancer","PTEN","any/deletion(LoF)","response","everolimus + trastuzumab + chemotherapy (HER2 ampl)","late trials","27091708",2,"GDKD","breast"
"Breast Cancer","ERBB2","L755S(GoF)","sensitivity","neratinib","preclinical","23220880",3,"GDKD","breast"
"Breast Cancer","ERBB4","H809G(GoF)","resistance","lapatinib","case report","26530965",2,"GDKD","breast"
"Breast Cancer","PIK3CB","D1067Y(GoF)","resistance","PI3K pathway inhibitors","case report","26759240",2,"GDKD","breast"
"Breast Cancer","BRCA1","any(LoF)","response","PARP inhibitors","early trials","20609467, 25366685",2,"GDKD","breast"
"Breast Cancer","ERBB2","G309A(GoF)","sensitivity","lapatinib, neratinib","preclinical","23220880",3,"GDKD","breast"
"Breast Cancer","BRCA2","any(LoF)","response","veliparib + cisplatin","early trials","26801247",2,"GDKD","breast"
"Breast Cancer","ERBB2","V777L(GoF)","sensitivity","lapatinib, neratinib","preclinical","23220880",3,"GDKD","breast"
"Breast Cancer","ERBB2","T798I(GoF)","sensitivity","afatinib","preclinical","28274957",3,"GDKD","breast"
"Breast Cancer","AKT1","E17K(GoF)","sensitivity","allosteric AKT inhibitors","preclinical","21464312, 17611497",3,"GDKD","breast"
"Breast Cancer","PTEN","any/deletion(LoF)","sensitivity","ATM inhibitor","preclinical","27397505",3,"GDKD","breast"
"Breast Cancer","ERBB2","L869R(GoF)","response","neratinib","case report","28274957",2,"GDKD","breast"
"Breast Cancer","ARID1A","any/deletion(LoF)","resistance","trastuzumab (ANXA1 high)","early trials","27172896",2,"GDKD","breast cancer"
"Breast Cancer","AKT2","EXPRESSION","Sensitivity/Response","Trastuzumab","B","22842582",2,"CIVIC","Breast Cancer"
"Breast Cancer","BRCA1","Loss-of-function","Sensitivity/Response","Quarfloxin,Pidnarulex","D","28211448",3,"CIVIC","Breast Cancer"
"Breast Cancer","TP53","R249","Sensitivity/Response","Doxorubicin","B","9569050",2,"CIVIC","Breast Cancer"
"Breast Cancer","TP53","R175H","Sensitivity/Response","Doxorubicin","D","22698404",3,"CIVIC","Breast Cancer"
"Breast Cancer","AKT1","E17K","Sensitivity/Response","Capivasertib","C","26351323",2,"CIVIC","Breast Cancer"
"Breast Cancer","FCGR3A","F212V","Sensitivity/Response","Trastuzumab","B","24989892",2,"CIVIC","Breast Cancer"
"Breast Cancer","TP53","Mutation","Sensitivity/Response","Doxorubicin","D","22698404",3,"CIVIC","Breast Cancer"
"Breast Cancer","KRAS","G13D","Resistance","Pictilisib","D","20453058",3,"CIVIC","Breast Cancer"
"Breast Cancer","NF2","K159fs","Sensitivity/Response","Temsirolimus","C","25878190",2,"CIVIC","Breast Cancer"
"Breast Cancer","PTEN","Loss","Resistance","Trastuzumab","B","24387334",2,"CIVIC","Breast Cancer"
"Breast Cancer","CCND1","Amplification","Sensitivity/Response","Palbociclib","D","19874578",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","V842I","Sensitivity/Response","Neratinib","D","23220880",3,"CIVIC","Breast Cancer"
"Breast Cancer","PTEN","Loss","Resistance","Trastuzumab","B","21594665",2,"CIVIC","Breast Cancer"
"Breast Cancer","AGR2","EXPRESSION","Resistance","Tamoxifen","B","24167368",2,"CIVIC","Breast Cancer"
"Breast Cancer","AKT3","OVEREXPRESSION","Resistance","Akt Inhibitor MK2206","D","27297869",3,"CIVIC","Breast Cancer"
"Breast Cancer","FGFR1","Amplification","Resistance","Afimoxifene","D","20179196",3,"CIVIC","Breast Cancer"
"Breast Cancer","BRCA2","Loss-of-function","Sensitivity/Response","Quarfloxin,Pidnarulex","D","28211448",3,"CIVIC","Breast Cancer"
"Breast Cancer","SGK1","Overexpression","Resistance","Alpelisib","D","27451907",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","L755_T759del","Sensitivity/Response","Neratinib,Lapatinib","D","23220880",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","L755W","Sensitivity/Response","Neratinib","D","23220880",3,"CIVIC","Breast Cancer"
"Breast Cancer","AR","OVEREXPRESSION","Sensitivity/Response","Dactolisib","D","24356815",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","V777L","Sensitivity/Response","Neratinib","D","23220880",3,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","D538G","Sensitivity/Response","Letrozole+Palbociclib","B","27556863",2,"CIVIC","Breast Cancer"
"Breast Cancer","AKT1","E17K","Sensitivity/Response","Akt Inhibitor MK2206","D","23888070",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","SERUM LEVELS","Sensitivity/Response","Lapatinib","B","26811533",2,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","Oncogenic Mutations","Sensitivity/Response","Alpelisib + Fulvestrant","1","25877889, 30543347, 31091374",1,"OncoKB","Breast Cancer"
"Breast Cancer","PIK3CA","Oncogenic Mutations","Sensitivity/Response","Alpelisib, Buparlisib, Buparlisib + Fulvestrant, Copanlisib, GDC-0077, Serabelisib, Taselisib, Taselisib + Fulvestrant","3A","22049316, 22188813, 23662903, 24608574, 24652201, 25172762, 25877889, 27672108, 28490463, 29401002, 29793946, 30715997",2,"OncoKB","Breast Cancer"
"Breast Cancer","ERBB2","Oncogenic Mutations","Sensitivity/Response","Neratinib","3A","23220880, 29420467",2,"OncoKB","Breast Cancer"
"Breast Cancer","FOXP3","EXPRESSION","Sensitivity/Response","Epirubicin","B","22431701",2,"CIVIC","Breast Cancer"
"Breast Cancer","RET","Overexpression","Sensitivity/Response","Vandetanib","D","26686064",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","D769H","Sensitivity/Response","Lapatinib,Neratinib","D","23220880",3,"CIVIC","Breast Cancer"
"Breast Cancer","FGFR1","Amplification","Sensitivity/Response","FGFR Inhibitor AZD4547","C","27179038",2,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","N857S","Sensitivity/Response","Lapatinib","D","22046346",3,"CIVIC","Breast Cancer"
"Breast Cancer","TFF3","EXPRESSION","Sensitivity/Response","Aminoglutethimide,Tamoxifen","B","25900183",2,"CIVIC","Breast Cancer"
"Breast Cancer","BRCA2","Loss-of-function","Sensitivity/Response","Talazoparib","B","28242752",2,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","R896C","Sensitivity/Response","Neratinib","D","23220880",3,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","E542K","Sensitivity/Response","Pictilisib","D","20453058",3,"CIVIC","Breast Cancer"
"Breast Cancer","PTEN","R233*","Sensitivity/Response","MTOR Inhibitor","D","20085938",3,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","Oncogenic Mutations","Sensitivity/Response","AZD9496, Fulvestrant","3A","27269946, 27986707",2,"OncoKB","Breast Cancer"
"Breast Cancer","PIK3CA","E542K","Sensitivity/Response","Sirolimus","D","15647370",3,"CIVIC","Breast Cancer"
"Breast Cancer","RSF1","AMPLIFICATION","Resistance","Tamoxifen","B","24367492",2,"CIVIC","Breast Cancer"
"Breast Cancer","BRCA1","Loss-of-function","Sensitivity/Response","Talazoparib","B","28242752",2,"CIVIC","Breast Cancer"
"Breast Cancer","TIMP1","OVEREXPRESSION","Resistance","Fulvestrant","D","23881388",3,"CIVIC","Breast Cancer"
"Breast Cancer","FGFR1","Amplification","Sensitivity/Response","Dovitinib","B","23658459",2,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","V773A","Sensitivity/Response","Lapatinib","D","22046346",3,"CIVIC","Breast Cancer"
"Breast Cancer","FCGR2A","H167R","Sensitivity/Response","Trastuzumab","B","24989892",2,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","L755S","Sensitivity/Response","Neratinib","D","23220880",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB4","EXPRESSION","Resistance","Trastuzumab","D","25153719",3,"CIVIC","Breast Cancer"
"Breast Cancer","PTEN","Loss","Resistance","Alpelisib","D","25409150",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","T798I","Sensitivity/Response","Osimertinib","D","28274957",3,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","E545K","Sensitivity/Response","Pictilisib","D","20453058",3,"CIVIC","Breast Cancer"
"Breast Cancer","RB1","LOSS-OF-FUNCTION","Resistance","Palbociclib","D","20473330",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","AKTi-1/2","D","18725974",3,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","H1047R","Sensitivity/Response","PI3K-alpha Inhibitor MEN1611","D","21558396",3,"CIVIC","Breast Cancer"
"Breast Cancer","BRCA2","Mutation","Sensitivity/Response","Olaparib","B","28792849",2,"CIVIC","Breast Cancer"
"Breast Cancer","NTRK3","ETV6-NTRK3 G623R","Resistance","Entrectinib","C","26884591",2,"CIVIC","Breast Cancer"
"Breast Cancer","MTOR","M2327I","Resistance","Sirolimus,RapaLink-1","D","27279227",3,"CIVIC","Breast Cancer"
"Breast Cancer","PGR","Expression","Sensitivity/Response","Tamoxifen","B","23280579",2,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","H1047R","Sensitivity/Response","Pictilisib","D","20453058",3,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","Y537N","Sensitivity/Response","Tamoxifen,Fulvestrant","D","24185510",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","D769Y","Sensitivity/Response","Neratinib","D","23220880",3,"CIVIC","Breast Cancer"
"Breast Cancer","SGK1","Overexpression","Sensitivity/Response","Alpelisib+SGK1-Inh","D","27451907",3,"CIVIC","Breast Cancer"
"Breast Cancer","CDKN1B","CYTOPLASMIC MISLOCALIZATION","Resistance","Lapatinib","D","25587029",3,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Resistance","Paclitaxel+Doxorubicin+Cyclophosphamide+Fluorouracil+Epirubicin","B","18371219",2,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Ado-Trastuzumab Emtansine, Lapatinib, Lapatinib + Trastuzumab, Neratinib, Pertuzumab + Trastuzumab, Trastuzumab","1","16091755, 16236738, 17192538, 19060928, 19786658, 22149875, 22153890, 22257673, 23020162, 23602601, 26874901, 29146401, 29320312, 30274983, 30516102, 30860945",1,"OncoKB","Breast Cancer"
"Breast Cancer","PIK3CA","E542K","Sensitivity/Response","PI3K-alpha Inhibitor MEN1611","D","21558396",3,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","E545K","Sensitivity/Response","Pictilisib,Akt Inhibitor MK2206","D","23888070",3,"CIVIC","Breast Cancer"
"Breast Cancer","PTEN","Loss","Sensitivity/Response","PI3Kbeta Inhibitor AZD8186","D","25398829",3,"CIVIC","Breast Cancer"
"Breast Cancer","SGK1","Overexpression","Resistance","Alpelisib","B","27451907",2,"CIVIC","Breast Cancer"
"Breast Cancer","PTEN","Loss","Sensitivity/Response","MTOR Kinase Inhibitor PP242,Everolimus","D","21358673",3,"CIVIC","Breast Cancer"
"Breast Cancer","TLK2","AMPLIFICATION","Sensitivity/Response","GF109203X,Go6983","D","27694828",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Lapatinib+Trastuzumab","D","16091755",3,"CIVIC","Breast Cancer"
"Breast Cancer","MTOR","A2034V","Resistance","RapaLink-1,MTOR Kinase Inhibitor AZD8055","D","27279227",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB4","EXPRESSION","Resistance","Lapatinib","D","25590338",3,"CIVIC","Breast Cancer"
"Breast Cancer","SF3B1","K700E","Sensitivity/Response","Spliceostatin A","D","25424858",3,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Sensitivity/Response","Palbociclib+Phosphatidylinositide 3-Kinase Inhibitor","D","25002028",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","P780INS","Sensitivity/Response","Neratinib","D","23220880",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","L755S","Resistance","Lapatinib","D","23220880",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","G309A","Sensitivity/Response","Neratinib","D","23220880",3,"CIVIC","Breast Cancer"
"Breast Cancer","FGFR1","Amplification","Resistance","Infigratinib","B","27870574",2,"CIVIC","Breast Cancer"
"Breast Cancer","TIMP1","OVEREXPRESSION","Resistance","Paclitaxel","B","22544540",2,"CIVIC","Breast Cancer"
"Breast Cancer","BRCA2","Oncogenic Mutations","Sensitivity/Response","Olaparib, Talazoparib","2A","28578601, 30110579, 30563931",1,"OncoKB","Breast Cancer"
"Breast Cancer","TOP2A","EXPRESSION","Sensitivity/Response","Doxorubicin","B","15486187",2,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","Y537S","Resistance","Hormone Therapy","D","24185512",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","Mutation","Sensitivity/Response","Neratinib","B","28679771",2,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","Y537S","Sensitivity/Response","Tamoxifen,Fulvestrant","D","24185510",3,"CIVIC","Breast Cancer"
"Breast Cancer","ABCC3","AMPLIFICATION","Resistance","Paclitaxel,Monomethyl Auristatin E","D","18593940",3,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","D538G","Sensitivity/Response","Fulvestrant,Tamoxifen","D","24185510",3,"CIVIC","Breast Cancer"
"Breast Cancer","SF3B1","K666N","Sensitivity/Response","Spliceostatin A","D","25424858",3,"CIVIC","Breast Cancer"
"Breast Cancer","AKT1","E17K","Sensitivity/Response","AZD5363","3A","22294718, 23394218, 26351323, 28489509",2,"OncoKB","Breast Cancer"
"Breast Cancer","BRCA1","Oncogenic Mutations","Sensitivity/Response","Olaparib, Talazoparib","2A","28578601, 30110579, 30563931",1,"OncoKB","Breast Cancer"
"Breast Cancer","ALK","Fusion","Sensitivity/Response","Crizotinib","E","19737969",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB4","NUCLEAR TRANSLOCATION","Resistance","Trastuzumab","D","25153719",3,"CIVIC","Breast Cancer"
"Breast Cancer","MYD88","OVEREXPRESSION","Resistance","Paclitaxel","D","26596839",3,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3R1","MUTATION","Sensitivity/Response","MTOR Kinase Inhibitor PP242","D","21358673",3,"CIVIC","Breast Cancer"
"Breast Cancer","FGFR1","Amplification","Sensitivity/Response","Pazopanib","C","29223982",2,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","Overexpression","Sensitivity/Response","Palbociclib+Letrozole","B","25524798",2,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Sensitivity/Response","Alpelisib+Fulvestrant","A","31091374",1,"CIVIC","Breast Cancer"
"Breast Cancer","MTOR","A2034V","Resistance","Sirolimus","D","27279227",3,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","H1047L","Sensitivity/Response","Pictilisib","D","20453058",3,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","Y537C","Sensitivity/Response","Tamoxifen,Fulvestrant","D","24185510",3,"CIVIC","Breast Cancer"
"Breast Cancer","PTEN","Expression","Sensitivity/Response","Trastuzumab","B","16404430",2,"CIVIC","Breast Cancer"
"Breast Cancer","CCND1","Amplification","Resistance","Tamoxifen","B","24367492",2,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","MTOR Kinase Inhibitor PP242","D","21358673",3,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Pictilisib","D","20453058",3,"CIVIC","Breast Cancer"
"Breast Cancer","PTEN","Loss","Sensitivity/Response","Pictilisib","D","20453058",3,"CIVIC","Breast Cancer"
"Breast Cancer","TUBB3","EXPRESSION","Sensitivity/Response","Taxane Compound","B","23218766",2,"CIVIC","Breast Cancer"
"Breast Cancer","MTOR","M2327I","Resistance","MTOR Kinase Inhibitor AZD8055","D","27279227",3,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","L536Q","Resistance","Hormone Therapy","D","24185512",3,"CIVIC","Breast Cancer"
"Breast Cancer","TP53","DNA Binding Domain Mutation","Resistance","Tamoxifen","B","10786679",2,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Resistance","Trastuzumab","B","21594665",2,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","D538G","Resistance","Hormone Therapy","D","24185512",3,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","Y537N","Resistance","Hormone Therapy","D","24185512",3,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","Y537C","Resistance","Hormone Therapy","D","24185512",3,"CIVIC","Breast Cancer"
"Breast Cancer","RB1","PHOSPHORYLATION","Resistance","Alpelisib","B","25002028",2,"CIVIC","Breast Cancer"
"Breast Cancer","ESR1","L536Q","Sensitivity/Response","Tamoxifen,Fulvestrant","D","24185510",3,"CIVIC","Breast Cancer"
"Breast Cancer","MTOR","F2108L","Resistance","Sirolimus","D","27279227",3,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Sensitivity/Response","Everolimus,MTOR Kinase Inhibitor PP242","D","21358673",3,"CIVIC","Breast Cancer"
"Breast Cancer","TP53","Mutation","Resistance","Tamoxifen","C","10786679",2,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Sensitivity/Response","Phosphatidylinositide 3-Kinase Inhibitor+Ribociclib","D","25002028",3,"CIVIC","Breast Cancer"
"Breast Cancer","PIK3CA","E542K","Sensitivity/Response","Fulvestrant+Alpelisib","A","31091374",1,"CIVIC","Breast Cancer"
"Breast Cancer","PGR","Expression","Sensitivity/Response","Exemestane,Tamoxifen","B","21422407",2,"CIVIC","Breast Cancer"
"Breast Cancer","FGF3","AMPLIFICATION","Sensitivity/Response","Dovitinib","B","23658459",2,"CIVIC","Breast Cancer"
"Breast Cancer","ERBB2","R678Q","Sensitivity/Response","Neratinib,Lapatinib","D","23220880",3,"CIVIC","Breast Cancer"
"Breast Cancer","MTAP","Underexpression","Sensitivity/Response","Pyrimidine Antagonist","D","26751376",3,"CIVIC","Breast Cancer"
"Breast Cancer","FGFR2","Amplification","Sensitivity/Response","Dovitinib","B","23658459",2,"CIVIC","Breast Cancer"
"Breast Cancer","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib","C","29623306",2,"CIVIC","Breast Secretory Carcinoma"
"Lung Cancer","ROS1","REARRANGEMENT","Sensitivity/Response","Crizotinib","C","22215748",2,"CIVIC","Bronchiolo-alveolar Adenocarcinoma"
"Lung Cancer","EGFR","E746_A750del","Sensitivity/Response","Erlotinib","C","15329413",2,"CIVIC","Bronchiolo-alveolar Adenocarcinoma"
"General Cancer","TP53","R280K","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","TP53","R273C","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","TP53","Y220C","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","EGFR","L858R","Sensitivity/Response","Gefitinib,Multikinase Inhibitor AEE788,Erlotinib","D","19147750",3,"CIVIC","Cancer"
"General Cancer","PDGFRA","D842V","Resistance","Sunitinib","D","18955458",3,"CIVIC","Cancer"
"General Cancer","TP53","R273H","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","KIT","W557_K558del","Resistance","Imatinib","D","14645423",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL F317L","Resistance","Imatinib,Dasatinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","SMO","Mutation","Sensitivity/Response","Vismodegib","B","29320312",2,"CIVIC","Cancer"
"General Cancer","TP53","P47S","Resistance","Cisplatin","E","27034505",3,"CIVIC","Cancer"
"General Cancer","BRAF","MACF1-BRAF","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","HRAS","MUTATION","Sensitivity/Response","Binimetinib,MTOR Kinase Inhibitor AZD8055,Selumetinib,Everolimus,Mirdametinib","D","26544513",3,"CIVIC","Cancer"
"General Cancer","KIT","S628N","Sensitivity/Response","Imatinib,Dasatinib","D","25317746",3,"CIVIC","Cancer"
"General Cancer","TP53","R158H","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL Y253F","Resistance","Imatinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","ECSCR","EXPRESSION","Sensitivity/Response","Angiogenesis Inhibitor","B","26956051",2,"CIVIC","Cancer"
"General Cancer","NTRK1","Fusion","Sensitivity/Response","Larotrectinib","B","29466156",2,"CIVIC","Cancer"
"General Cancer","TP53","V157F","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","PIK3CA","Mutation","Sensitivity/Response","Pictilisib,Tanespimycin","D","25855885",3,"CIVIC","Cancer"
"General Cancer","TP53","R248W","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","BRAF","N581S","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL F317V","Resistance","Dasatinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","FGFR3","FGFR3-TACC3","Sensitivity/Response","Erdafitinib","B","26324363",2,"CIVIC","Cancer"
"General Cancer","BRAF","G464V","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","CD274","Expression","Sensitivity/Response","Nivolumab","B","22658127",2,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL Y253F","Resistance","Dasatinib,Bafetinib,Nilotinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","ROBO4","EXPRESSION","Sensitivity/Response","Angiogenesis Inhibitor","B","26956051",2,"CIVIC","Cancer"
"General Cancer","EGFR","L858R","Sensitivity/Response","Erlotinib","D","17877814",3,"CIVIC","Cancer"
"General Cancer","ALK","ALK Fusion G1269A","Resistance","Alectinib","D","25727400",3,"CIVIC","Cancer"
"General Cancer","KIT","Y503_F504insAY","Resistance","Imatinib","D","14645423",3,"CIVIC","Cancer"
"General Cancer","FGFR2","Fusion","Sensitivity/Response","Erdafitinib","B","26324363",2,"CIVIC","Cancer"
"General Cancer","TP53","G245S","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","CBLC","EXPRESSION","Resistance","Olaparib","D","25883215",3,"CIVIC","Cancer"
"General Cancer","TP53","R280T","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","BRAF","intron 10 rearrangement","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","TP53","R175H","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL G250E","Sensitivity/Response","Dasatinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","BRAF","G466V","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","BRAF","G469A","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","BRAF","D594G","Sensitivity/Response","Trametinib","D","28783719",3,"CIVIC","Cancer"
"General Cancer","PTEN","Loss","Sensitivity/Response","Everolimus","B","28330462",2,"CIVIC","Cancer"
"General Cancer","ERBB3","EXPRESSION","Sensitivity/Response","Anti-ErbB3 Monoclonal Antibody AV-203","D","25542901",3,"CIVIC","Cancer"
"General Cancer","KIT","N822H","Resistance","Imatinib","D","14645423",3,"CIVIC","Cancer"
"General Cancer","NRG1","Expression","Sensitivity/Response","Anti-ErbB3 Monoclonal Antibody AV-203","D","25542901",3,"CIVIC","Cancer"
"General Cancer","PDGFRA","V561D","Resistance","Sunitinib","D","18955458",3,"CIVIC","Cancer"
"General Cancer","TP53","R249S","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","ALK","EML4-ALK e20-e20","Sensitivity/Response","Crizotinib","C","25408655",2,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL G250E","Resistance","Imatinib,Bafetinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","ALK","ALK Fusion G1269A","Sensitivity/Response","Ceritinib","D","25727400",3,"CIVIC","Cancer"
"General Cancer","KIT","K642E","Resistance","Imatinib","D","14645423",3,"CIVIC","Cancer"
"General Cancer","ALK","NPM-ALK","Sensitivity/Response","Crizotinib","D","25727400",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL T315A","Resistance","Nilotinib,Bafetinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL F317L","Resistance","Bafetinib,Nilotinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","PTEN","Loss","Sensitivity/Response","Buparlisib+Carboplatin+Paclitaxel","B","25672916",2,"CIVIC","Cancer"
"General Cancer","BRAF","G496A","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL T315I","Resistance","Dasatinib,Imatinib,Bafetinib,Nilotinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","TP53","Wildtype","Sensitivity/Response","Nutlin-3a","D","17671205",3,"CIVIC","Cancer"
"General Cancer","BRAF","G606E","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","DPYD","DPYD*2A HOMOZYGOSITY","Adverse Response","Capecitabine,Fluorouracil,Tegafur","A","23988873",1,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL H396P","Resistance","Imatinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","KIT","V560G","Resistance","Imatinib","D","14645423",3,"CIVIC","Cancer"
"General Cancer","ALK","ALK Fusion G1269A","Sensitivity/Response","Brigatinib","D","25727400",3,"CIVIC","Cancer"
"General Cancer","PTCH1","MUTATION","Sensitivity/Response","Vismodegib","B","29320312",2,"CIVIC","Cancer"
"General Cancer","PIK3CA","Mutation","Sensitivity/Response","Capivasertib","D","22294718",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL M351T","Resistance","Imatinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","BRCA2","Mutation","Sensitivity/Response","Olaparib","A","19553641",1,"CIVIC","Cancer"
"General Cancer","FBXW7","MUTATION","Sensitivity/Response","MTOR Inhibitor","B","24586741",2,"CIVIC","Cancer"
"General Cancer","BRAF","DEL 485-490","Sensitivity/Response","Pan-RAF Inhibitor LY3009120","D","26732095",3,"CIVIC","Cancer"
"General Cancer","KRAS","G12C","Sensitivity/Response","Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor+ARS-853","D","26739882",3,"CIVIC","Cancer"
"General Cancer","FBXW7","LOSS-OF-FUNCTION","Sensitivity/Response","Sirolimus","D","18787170",3,"CIVIC","Cancer"
"General Cancer","BRAF","G596R","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","KIT","V559D","Sensitivity/Response","Sunitinib,PD-180970,Tandutinib,Imatinib,Dasatinib","D","16046538",3,"CIVIC","Cancer"
"General Cancer","BRAF","intron 9 rearrangement","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","EGFR","T790M","Resistance","Gefitinib,Erlotinib,Multikinase Inhibitor AEE788","D","19147750",3,"CIVIC","Cancer"
"General Cancer","BRAF","Mutation","Sensitivity/Response","Trametinib","D","22169769",3,"CIVIC","Cancer"
"General Cancer","PIK3CA","Mutation","Sensitivity/Response","Alpelisib","D","24608574",3,"CIVIC","Cancer"
"General Cancer","DNMT3A","Mutation","Resistance","Nivolumab,Pembrolizumab,Atezolizumab","B","28351930",2,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL H396P","Sensitivity/Response","Dasatinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL F317V","Resistance","Imatinib,Nilotinib,Bafetinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL M244V","Resistance","Imatinib,Bafetinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","PDGFRA","V561D","Resistance","Imatinib","D","14645423",3,"CIVIC","Cancer"
"General Cancer","TP53","Wildtype","Sensitivity/Response","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","PDGFRA","D842_H845DELDIMH","Resistance","Imatinib","D","14645423",3,"CIVIC","Cancer"
"General Cancer","KIT","D816V","Resistance","Dasatinib,Imatinib","C","25317746",2,"CIVIC","Cancer"
"General Cancer","DPYD","DPYD*13 HOMOZYGOSITY","Adverse Response","Fluorouracil,Capecitabine,Tegafur","A","23988873",1,"CIVIC","Cancer"
"General Cancer","NTRK1","Fusion","Sensitivity/Response","Entrectinib","B","28183697",2,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL Q252H","Resistance","Nilotinib,Dasatinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","ERBB3","Overexpression","Resistance","HER2 Inhibitor CP-724,714,Selumetinib,Gefitinib","D","24685132",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL T315A","Resistance","Imatinib,Dasatinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","TP53","Deleterious Mutation","Resistance","Nutlin-3a","D","17671205",3,"CIVIC","Cancer"
"General Cancer","MET","EXON 14 SKIPPING MUTATION","Sensitivity/Response","Crizotinib","D","26547802",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL G250E","Resistance","Nilotinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","PDGFRA","D842V","Resistance","Imatinib Mesylate","D","18955458",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL Q252H","Resistance","Imatinib,Bafetinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","EGFR","L858R","Sensitivity/Response","Erlotinib","D","21132006",3,"CIVIC","Cancer"
"General Cancer","TP53","R158L","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","ATM","Underexpression","Sensitivity/Response","KU-0060648,NU7441","D","23761041",3,"CIVIC","Cancer"
"General Cancer","KIT","D816V","Resistance","Imatinib","D","14645423",3,"CIVIC","Cancer"
"General Cancer","KIT","V560D","Sensitivity/Response","Imatinib Mesylate","D","18955458",3,"CIVIC","Cancer"
"General Cancer","BRAF","WASFL-BRAF","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","KRAS","Mutation","Sensitivity/Response","Trametinib","D","22169769",3,"CIVIC","Cancer"
"General Cancer","ERBB3","Overexpression","Sensitivity/Response","Selumetinib+Afatinib","D","24685132",3,"CIVIC","Cancer"
"General Cancer","BRAF","P731T","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","PTEN","Loss","Sensitivity/Response","Capivasertib","D","22294718",3,"CIVIC","Cancer"
"General Cancer","KRAS","Mutation","Sensitivity/Response","G-573,MEK Inhibitor GDC-0623","D","23934108",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL M244V","Sensitivity/Response","Imatinib","D","15930265",3,"CIVIC","Cancer"
"General Cancer","NTRK3","Amplification","Sensitivity/Response","Entrectinib","B","28183697",2,"CIVIC","Cancer"
"General Cancer","NAPRT","PROMOTER HYPERMETHYLATION","Sensitivity/Response","GNE-617","D","24097869",3,"CIVIC","Cancer"
"General Cancer","UGT1A1","UGT1A1*28","Adverse Response","Belinostat","A","26313268",1,"CIVIC","Cancer"
"General Cancer","KIT","N822K","Sensitivity/Response","Imatinib","D","14645423",3,"CIVIC","Cancer"
"General Cancer","CD44","CD44s Expression","Sensitivity/Response","RG7356","D","25762343",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL M351T","Resistance","Dasatinib,Bafetinib,Nilotinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","KIT","V560D","Resistance","Sunitinib","D","18955458",3,"CIVIC","Cancer"
"General Cancer","TYMS","RS34743033","Adverse Response","Methotrexate","B","23652803",2,"CIVIC","Cancer"
"General Cancer","DUSP6","EXPRESSION","Sensitivity/Response","Trametinib","D","22169769",3,"CIVIC","Cancer"
"General Cancer","SLCO1B1","RS4149056","Adverse Response","Methotrexate","B","23652803",2,"CIVIC","Cancer"
"General Cancer","SLCO1B1","N130D","Adverse Response","Methotrexate","B","23652803",2,"CIVIC","Cancer"
"General Cancer","NTRK3","Fusion","Sensitivity/Response","Entrectinib","B","28183697",2,"CIVIC","Cancer"
"General Cancer","EGFR","S768I","Sensitivity/Response","Gefitinib,Erlotinib","D","19147750",3,"CIVIC","Cancer"
"General Cancer","BRCA1","Mutation","Sensitivity/Response","Olaparib","A","19553641",1,"CIVIC","Cancer"
"General Cancer","ALK","EML4-ALK S1206Y","Sensitivity/Response","Ceritinib","D","24675041",3,"CIVIC","Cancer"
"General Cancer","NRAS","Mutation","Sensitivity/Response","Metformin+Trametinib","D","25504439",3,"CIVIC","Cancer"
"General Cancer","KRAS","G12V","Resistance","Crizotinib","C","25232318",2,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL M244V","Resistance","Nilotinib,Dasatinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","BRAF","V600E","Sensitivity/Response","Cobimetinib","D","23934108",3,"CIVIC","Cancer"
"General Cancer","KIT","L576P","Sensitivity/Response","Dasatinib,Imatinib","D","25317746",3,"CIVIC","Cancer"
"General Cancer","ABL1","BCR-ABL H396P","Resistance","Nilotinib,Bafetinib","D","18191450",3,"CIVIC","Cancer"
"General Cancer","ALK","ALK Fusion G1202R","Resistance","Alectinib","D","25727400",3,"CIVIC","Cancer"
"General Cancer","TUBB3","EXPRESSION","Resistance","Paclitaxel","D","21576762",3,"CIVIC","Cancer"
"General Cancer","TP53","Deleterious Mutation","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","ALK","Fusion","Sensitivity/Response","Entrectinib","B","28183697",2,"CIVIC","Cancer"
"General Cancer","PTEN","Mutation","Sensitivity/Response","Ipatasertib","D","23287563",3,"CIVIC","Cancer"
"General Cancer","PRKAA2","T172 PHOSPHORYLATION","Sensitivity/Response","ACLY SiRNA","E","23506848",3,"CIVIC","Cancer"
"General Cancer","NTRK1","Fusion","Sensitivity/Response","Larotrectinib","C","26603524",2,"CIVIC","Cancer"
"General Cancer","PIK3CA","E545K","Sensitivity/Response","Apitolisib","C","26787751",2,"CIVIC","Cancer"
"General Cancer","DPYD","RS67376798 HOMOZYGOSITY","Adverse Response","Fluorouracil,Tegafur,Capecitabine","A","23988873",1,"CIVIC","Cancer"
"General Cancer","MET","Amplification","Sensitivity/Response","Crizotinib","C","25232318",2,"CIVIC","Cancer"
"General Cancer","BRAF","D594G","Sensitivity/Response","Vemurafenib","D","28783719",3,"CIVIC","Cancer"
"General Cancer","ALK","ALK Fusion F1245C","Resistance","Crizotinib","D","22034911",3,"CIVIC","Cancer"
"General Cancer","KIT","A502_Y503insAY","Resistance","Sunitinib","D","18955458",3,"CIVIC","Cancer"
"General Cancer","BRAF","L597Q","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Cancer"
"General Cancer","PDGFRA","D842V","Resistance","Imatinib","D","14645423",3,"CIVIC","Cancer"
"General Cancer","UGT1A1","UGT1A1*60","Adverse Response","Belinostat","B","26313268",2,"CIVIC","Cancer"
"General Cancer","AKT1","E17K","Sensitivity/Response","Capivasertib","B","28489509",2,"CIVIC","Cancer"
"General Cancer","TP53","R248Q","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Cancer"
"General Cancer","MET","EXON 14 SKIPPING MUTATION","Sensitivity/Response","Capmatinib","D","25971938",3,"CIVIC","Cancer"
"General Cancer","KRAS","Mutation","Sensitivity/Response","AZD5438","D","26881434",3,"CIVIC","Cancer"
"General Cancer","ROS1","REARRANGEMENT","Sensitivity/Response","Entrectinib","B","28183697",2,"CIVIC","Cancer"
"General Cancer","NTRK1","Amplification","Sensitivity/Response","Entrectinib","B","28183697",2,"CIVIC","Cancer"
"General Cancer","ALK","ALK Fusion G1202R","Resistance","Brigatinib","D","25727400",3,"CIVIC","Cancer"
"General Cancer","PDGFRA","V561D","Resistance","Imatinib Mesylate","D","18955458",3,"CIVIC","Cancer"
"General Cancer","PIK3CA","Mutation","Sensitivity/Response","Capivasertib","B","28489509",2,"CIVIC","Cancer"
"General Cancer","FLT3","D835Y","Sensitivity/Response","Gilteritinib","D","28516360",3,"CIVIC","Cancer"
"Unspecified Cancer","SF3B1","K700E, K666N(GoF)","sensitivity","spliceosome inhibitor","preclinical","ENA 2014 (abstr 456), ENA 2014 (abstr 575), 25424858",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","SETD2","any/deletion(LoF)","sensitivity","WEE1 inhibitors","preclinical","ENA 2014 (abstr 211)",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","ERBB2","S310, L755, V777, P780_Y781insGSP, A775_G776insYVMA(GoF)","response","neratinib","early trials","AACR 2017 (abstr CT001)",2,"GDKD","cancer_unspecified"
"Unspecified Cancer","CDKN2C","any/deletion(LoF)","sensitivity","CDK2 inhibitors","preclinical","22471707, 22997239",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","TP53","R248Q, R175H(GoF)","sensitivity","HSP90 inhibitors","preclinical","26009011",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","AKT2","amplification(GoF)","sensitivity","allosteric AKT inhibitors","preclinical","ENA 2014 (abstr 373)",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","SUZ12","any/deletion(LoF)","sensitivity","BET inhibitors","preclinical","25119042",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","PTEN","any/deletion(LoF)","response","sirolimus","early trials","ASCO 2013 (abstr 2532)",2,"GDKD","cancer_unspecified"
"Unspecified Cancer","CDK6","amplification(GoF)","sensitivity","CDK6 inhibitors","preclinical","22471707",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MSH3","any(LoF)","sensitivity","DNA-PKcs inhibitors","preclinical","24556366",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","CDKN2B","any/deletion(LoF)","sensitivity","CDK4/6 inhibitors","preclinical","22471707",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","CDKN1A","any/deletion(LoF)","sensitivity","CDK2/4 inhibitors","preclinical","22471707, 22997239",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","CDKN2A","any/deletion(LoF)","sensitivity","CDK4/6 inhibitors","preclinical","22471707",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","FBXW7","any/deletion(LoF)","resistance","anti-tubulin agents","preclinical","21368834",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MET","exon 14 skipping(GoF)","response","crizotinib","early trials","ASCO 2016 (abstr 108), ASCO 2017 (abstr 8511)",2,"GDKD","cancer_unspecified"
"Unspecified Cancer","TRKC","G623R(GoF)","resistance","larotrectinib","preclinical","28578312",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","ERBB2","G309E(GoF)","sensitivity","ERBB2 TKIs, trastuzumab","preclinical","22908275",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","EPHA2","amplification(GoF)","sensitivity","dasatinib","preclinical","18047674, 19010823, 19861960",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","CDKN1B","any/deletion(LoF)","sensitivity","CDK2/4 inhibitors","preclinical","22471707",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","F129L(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","F129L(GoF)","sensitivity","ERK inhibitors","preclinical","23614898",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MET","exon 14 skipping(GoF)","response","crizotinib, cabozantinib","case report","25971938, 26215952",2,"GDKD","cancer_unspecified"
"Unspecified Cancer","BRCA1","any(LoF)","response","WEE1 inhibitors","case report","25964244",2,"GDKD","cancer_unspecified"
"Unspecified Cancer","CCND1","amplification(GoF)","sensitivity","CDK4/6 inhibitors","preclinical","22471707",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","BRAF","L485-P490(GoF)","resistance","vemurafenib","preclinical","26732095",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","ARID1A","any(LoF)","sensitivity","ATR inhibitors","preclinical","27958275",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","ARID1A","mut(LoF)","sensitivity","PARP inhibitors","preclinical","26069190",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","CCND3","amplification(GoF)","sensitivity","CDK4/6 inhibitors","preclinical","22471707",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MET","H1112R(GoF)","sensitivity","crizotinib","preclinical","17483355",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MCL1","amplification(GoF)","resistance","anti-tubulin agents","preclinical","21368834",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","CD274","amplification(GoF)","sensitivity","PD1 blockade","preclinical","25079317",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","G128D(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","ERBB2","S310Y(GoF)","sensitivity","ERBB2 TKIs, trastuzumab","preclinical","22908275",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","KDR","A1065T(GoF)","sensitivity","VEGFR inhibitors","preclinical","24569783",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","ERBB2","E321G(GoF)","sensitivity","ERBB2 TKIs","preclinical","22908275",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","ERBB2","C334S(GoF)","sensitivity","ERBB2 TKIs","preclinical","22908275",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","AKT1","E17K(GoF)","response","non-allosteric AKT inhibitors, allosteric AKT inhibitor","early trials","ENA 2015 (abstract B109), 28489509",2,"GDKD","cancer_unspecified"
"Unspecified Cancer","GNAS","R201(GoF)","sensitivity","JAK inhibitors","preclinical","21835143",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","D67N(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","NRAS","G12C(GoF)","sensitivity","ERK inhibitors","preclinical","23614898",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","CCND2","amplification(GoF)","sensitivity","CDK4/6 inhibitors","preclinical","22471707",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","I103N(GoF)","sensitivity","ERK inhibitors","preclinical","23614898",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","HRAS","any(GoF)","sensitivity","tipifarnib","early trials","NCT02383927",2,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","L115(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","CCNE1","amplification(GoF)","sensitivity","CDK2 inhibitors","preclinical","22471707",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MET","Y1230C(GoF)","reduced sensitivity","crizotinib","preclinical","17483355",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MET","Y1235D(GoF)","reduced sensitivity","crizotinib","preclinical","17483355",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MET","H1112L(GoF)","sensitivity","MET inhibitors","preclinical","AACR 2012 (abstr 1786)",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","SMARCA1","any/deletion(LoF)","sensitivity","EZH2 inhibitor in RAS wt","preclinical","26552009",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","AKT1","E17K(GoF)","sensitivity","AKT inhibitors","preclinical","21464312, 17611497, 23134728",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MTOR","S2215Y(GoF)","sensitivity","rapamycin","preclinical","24631838",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","EPHA3","amplification(GoF)","sensitivity","EPHA3 inhibitors","preclinical","25125683",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","PTEN","any/deletion(LoF)","sensitivity","PI3K pathway inhibitors","preclinical","21673091, 23287563, 21998291",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MET","V1110I(GoF)","sensitivity","crizotinib","preclinical","17483355",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","I103N(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","K104N(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","TRKA","G595R(GoF)","resistance","larotrectinib","preclinical","28578312",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","TRKC","G623R(GoF)","response","novel TRK inhibitors","case report","28578312",2,"GDKD","cancer_unspecified"
"Unspecified Cancer","ERBB2","S310F(GoF)","sensitivity","ERBB2 TKIs, trastuzumab","preclinical","22908275",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MET","T1010I(GoF)","sensitivity","crizotinib","preclinical","17483355",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","ERBB2","C311R(GoF)","sensitivity","ERBB2 TKIs, trastuzumab","preclinical","22908275",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","P124(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","ARID1A","mut(LoF)","sensitivity","EZH2 inhibitors in RAS wt","preclinical","26552009",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","BAP1","any/deletion(LoF)","sensitivity","PARP inhibitors","preclinical","22683710",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","NTRK1","rearrangement(GoF)","response","pan-TRK inhibitor","early trials","28183697, ASCO 2017 (LBA2501)",2,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","L215P(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MTOR","L1460P(GoF)","sensitivity","rapamycin","preclinical","24631838",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","IDH1","R132(GoF)","sensitivity","PARP inhibitors","preclinical","28148839",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MET","R988C(GoF)","sensitivity","crizotinib","preclinical","17483355",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MTOR","R2505P(GoF)","sensitivity","rapamycin","preclinical","24631838",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","STK11","any/deletion(LoF)","sensitivity","mTOR inhibitors","preclinical","19541609",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","I99T(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","V211D(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","AURKA","amplification(GoF)","sensitivity","AURK inhibitors","preclinical","22302096",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","F133L(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","Q56P(GoF)","sensitivity","trametinib","preclinical","26582713",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","PBRM1","any/deletion(LoF)","sensitivity","EZH2 inhibitor in RAS wt","preclinical","26552009",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MTOR","F2108L(GoF)","sensitivity","mTOR kinase inhibitors","preclinical","25295501",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","P124(GoF)","sensitivity","ERK inhibitors","preclinical","23614898",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MTOR","F2108L(GoF)","resistance","everolimus","case report","25295501",2,"GDKD","cancer_unspecified"
"Unspecified Cancer","ERBB3","P262H(GoF)","sensitivity","trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors","preclinical","23680147",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","BRAF","L485-P490(GoF)","response","pan-RAF inhibitor","preclinical","26732095",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","L215P(GoF)","sensitivity","ERK inhibitors","preclinical","23614898",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","U2AF1","mut(LoF)","sensitivity","FLT3 inhibitors","preclinical","27397505",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","H119P(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MET","M1250I(GoF)","sensitivity","crizotinib","preclinical","17483355",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","ATR","any/deletion(LoF)","sensitivity","PARP inhibitors","preclinical","23548269",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","E120D(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","MAP2K1","I111N(GoF)","resistance","MEK inhibitors","preclinical","19915144",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","ERBB3","G284R(GoF)","sensitivity","trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors","preclinical","23680147",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","ERBB3","Q809R(GoF)","sensitivity","trastuzumab, lapatinib, PI3K pathway inhibitors + MEK inhibitors","preclinical","23680147",3,"GDKD","cancer_unspecified"
"Unspecified Cancer","RAD50","L1237F(LoF)","response","irinotecan plus CHK1/2 inhibitor in ATM deficient tumor","case report","24934408",2,"GDKD","cancer_unspecified"
"Cervical Cancer","KRAS","any(GoF)","sensitivity","CDK4/6 inhibitors + MEK inhibitors","preclinical","27167191",3,"GDKD","cervical"
"Cervical Cancer","PIK3CA","any(GoF)","response","PI3K pathway inhibitors","early trials","22271473, ASCO 2013 (abstr 2531)",2,"GDKD","cervical"
"Cervical Cancer","HRAS","any(GoF)","sensitivity","mTOR inhibitors","preclinical","22345164",3,"GDKD","cervical"
"Cervical Cancer","HRAS","any(GoF)","sensitivity","PI3K pathway inhibitors + MEK inhibitors","preclinical","15950068",3,"GDKD","cervical"
"Cervical Cancer","KRAS","any(GoF)","sensitivity","MEK inhibitors","preclinical","22169769",3,"GDKD","cervical"
"Cervical Cancer","AURKA","Overexpression","Resistance","Paclitaxel","D","12559175",3,"CIVIC","Cervical Adenocarcinoma"
"Cervical Cancer","PIK3CA","E545K","Resistance","Cisplatin>Radiation Ionizing Radiotherapy","D","27489350",3,"CIVIC","Cervical Cancer"
"Cervical Cancer","XRCC1","Q399R","Sensitivity/Response","Carboplatin,Cisplatin","B","16875718",2,"CIVIC","Cervical Cancer"
"Cervical Cancer","PIK3CA","E545K","Sensitivity/Response","Pictilisib+Cisplatin","D","27489350",3,"CIVIC","Cervix Carcinoma"
"Cervical Cancer","PIK3CA","E545K","Resistance","Cisplatin","D","27489350",3,"CIVIC","Cervix Carcinoma"
"Leukemia","NT5C2","R367Q","Resistance","Doxorubicin,Gemcitabine,Cytarabine,Prednisolone","D","23377183",3,"CIVIC","Childhood Acute Lymphocytic Leukemia"
"Leukemia","NT5C2","R367Q","Resistance","Thioguanine,Mercaptopurine","C","23377183",2,"CIVIC","Childhood Acute Lymphocytic Leukemia"
"Leukemia","NT5C2","S445F","Resistance","Mercaptopurine,Thioguanine","D","23377183",3,"CIVIC","Childhood Acute Lymphocytic Leukemia"
"Leukemia","NT5C2","R367Q","Resistance","Thioguanine,Mercaptopurine","D","23377183",3,"CIVIC","Childhood Acute Lymphocytic Leukemia"
"Leukemia","NT5C2","R238W","Resistance","Gemcitabine,Prednisolone,Doxorubicin,Cytarabine","D","23377183",3,"CIVIC","Childhood Acute Lymphocytic Leukemia"
"Leukemia","NT5C2","R238W","Resistance","Mercaptopurine,Thioguanine","D","23377183",3,"CIVIC","Childhood Acute Lymphocytic Leukemia"
"Leukemia","NT5C2","S445F","Resistance","Prednisolone,Doxorubicin,Gemcitabine,Cytarabine","D","23377183",3,"CIVIC","Childhood Acute Lymphocytic Leukemia"
"Leukemia","PRPS1","N144S","Sensitivity/Response","Cytarabine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","L191F","Resistance","Mercaptopurine,Thioguanine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","T303S","Resistance","Thioguanine,Mercaptopurine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PDGFRB","EBF1-PDGFRB","Sensitivity/Response","Imatinib,Dasatinib","C","25207766",2,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","K176N","Resistance","Thioguanine,Mercaptopurine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","I72V","Resistance","Thioguanine,Mercaptopurine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","C77S","Resistance","Thioguanine,Mercaptopurine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","CDK4","EXPRESSION","Sensitivity/Response","Dexamethasone+Ribociclib","D","29408328",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","A190T","Sensitivity/Response","Mercaptopurine+Lometrexol","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PDGFRB","EBF1-PDGFRB","Sensitivity/Response","Imatinib","C","24186319",2,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","D139G","Resistance","Thioguanine,Mercaptopurine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","N144S","Resistance","Thioguanine,Mercaptopurine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","K176N","Resistance","Daunorubicin,Asparaginase,Methotrexate,Cytarabine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","S103I","Resistance","Mercaptopurine,Thioguanine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PDGFRB","EBF1-PDGFRB","Sensitivity/Response","Imatinib","C","26872634",2,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","A87T","Resistance","Thioguanine,Mercaptopurine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","CDK6","EXPRESSION","Sensitivity/Response","Ribociclib+Dexamethasone","D","29408328",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","L191F","Sensitivity/Response","Cytarabine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","D183E","Resistance","Thioguanine,Mercaptopurine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","A190T","Resistance","Methotrexate,Daunorubicin,Cytarabine,Asparaginase","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","S103T","Resistance","Cytarabine,Daunorubicin,Asparaginase,Methotrexate","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","V53A","Resistance","Thioguanine,Mercaptopurine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","A190T","Resistance","Thioguanine,Mercaptopurine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","S103N","Resistance","Methotrexate,Asparaginase,Cytarabine,Daunorubicin","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","L191F","Resistance","Asparaginase,Daunorubicin,Methotrexate","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PDGFRB","EBF1-PDGFRB","Sensitivity/Response","Imatinib","C","23835704",2,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","S103N","Resistance","Thioguanine,Mercaptopurine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","T303S","Resistance","Methotrexate,Asparaginase,Daunorubicin,Cytarabine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","N144S","Resistance","Daunorubicin,Asparaginase,Methotrexate","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","JAK2","JAK2 F694L","Sensitivity/Response","Ruxolitinib","C","27860260",2,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","S103T","Resistance","Thioguanine,Mercaptopurine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","M115T","Resistance","Mercaptopurine,Thioguanine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Leukemia","PRPS1","D183E","Resistance","Methotrexate,Daunorubicin,Asparaginase,Cytarabine","D","25962120",3,"CIVIC","Childhood B-cell Acute Lymphoblastic Leukemia"
"Glioma","BRAF","KIAA1549-BRAF","Sensitivity/Response","Everolimus+Trametinib","D","29156677",3,"CIVIC","Childhood Low-grade Glioma"
"Glioma","NF1","Mutation","Sensitivity/Response","Selumetinib","B","31151904",2,"CIVIC","Childhood Low-grade Glioma"
"Glioma","BRAF","V600E","Sensitivity/Response","Vemurafenib","C","25524464",2,"CIVIC","Childhood Pilocytic Astrocytoma"
"Glioma","BRAF","KIAA1549-BRAF","Sensitivity/Response","Trametinib","D","28002790",3,"CIVIC","Childhood Pilocytic Astrocytoma"
"Glioma","BRAF","KIAA1549-BRAF","Sensitivity/Response","Selumetinib","D","28002790",3,"CIVIC","Childhood Pilocytic Astrocytoma"
"Glioma","BRAF","KIAA1549-BRAF","Resistance","Vemurafenib,Sorafenib","D","28002790",3,"CIVIC","Childhood Pilocytic Astrocytoma"
"Biliary Cancer","FGFR2","Mutation","Sensitivity/Response","Infigratinib","C","27870574",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","FGFR2","Mutation","Sensitivity/Response","Infigratinib","B","29182496",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","FGFR2","FGFR2-BICC1","Sensitivity/Response","PD173074,Infigratinib","D","24122810",3,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","FGFR2","FGFR2-AHCYL1","Sensitivity/Response","Infigratinib,PD173074","D","24122810",3,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","IDH1","Mutation","Sensitivity/Response","Ivosidenib","B","31300360",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","CDKN2A","Mutation","Sensitivity/Response","Palbociclib","B","158598",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","BRAF","V600","Sensitivity/Response","Vemurafenib","B","26287849",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","BRAF","V600E","Sensitivity/Response","Irinotecan+Panitumumab+Vemurafenib","C","26687137",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","FGFR2","Fusion","Sensitivity/Response","Infigratinib","C","27870574",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab+Pertuzumab","C","31453370",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","FGFR2","Fusion","Sensitivity/Response","Infigratinib","B","29182496",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","FGFR2","Fusions","Sensitivity/Response","AZD4547, BGJ398, Debio1347, Erdafitinib","3A","24122810, 29182496, 30745300, 31088831",2,"OncoKB","Cholangiocarcinoma"
"Biliary Cancer","NRG1","ATP1B1-NRG1","Sensitivity/Response","Afatinib","C","28950338",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","ERRFI1","E384*","Sensitivity/Response","Erlotinib","C","24550739",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","FGFR2","FGFR2-MGEA5","Sensitivity/Response","Ponatinib","C","24550739",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","FGFR2","FGFR2-TACC3","Sensitivity/Response","Pazopanib>Ponatinib","C","24550739",2,"CIVIC","Cholangiocarcinoma"
"Biliary Cancer","BRAF","V600E","Sensitivity/Response","Trametinib+Dabrafenib","C","28480077",2,"CIVIC","Cholangiocarcinoma"
"Bone Cancer","EGFR","Expression","Sensitivity/Response","Lapatinib","B","23559153",2,"CIVIC","Chordoma"
"Leukemia","JAK2","PCM1-JAK2 Fusion","Sensitivity/Response","Ruxolitinib","3A","22875628, 22899477, 23400675, 23630205, 25207766, 25260694, 25515960, 26202607",2,"OncoKB","Chronic Eosinophilic Leukemia"
"Leukemia","PDGFRA","FIP1L1-PDGFRA Fusion","Sensitivity/Response","Imatinib","1","18950453",1,"OncoKB","Chronic Eosinophilic Leukemia"
"Leukemia","KIT","M541L","Sensitivity/Response","Imatinib","C","25015329",2,"CIVIC","Chronic Leukemia"
"Leukemia","ATM","L2427P","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","BCL2","G101V","Resistance","Venetoclax","D","31160589",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","E2187*","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","K468FS","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","R3008C","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","A2062V","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","TP53","Mutation","Sensitivity/Response","Alemtuzumab","B","14726385",2,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","F2732V","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","F1025L","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","D1682H","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","BTK","C481S","Resistance","Ibrutinib","B","24869598",2,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","K293*","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","c.7089+1del","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","D1930V","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","BTK","C481S","Resistance","Ibrutinib","B","26182309",2,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","BTK","T316A","Resistance","Ibrutinib","C","27626698",2,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","C2488Y","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","Mutation","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","c.7515+1_2del","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","c.902-1G>T","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ATM","T2666A","Resistance","Doxorubicin","D","23585524",3,"CIVIC","Chronic Lymphocytic Leukemia"
"Leukemia","ABL1","E255V","Sensitivity/Response","Bosutinib, Dasatinib","2A","15930265, 19075254, 19779040, 28599428",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","T315A","Sensitivity/Response","Bosutinib, Nilotinib","2A","15930265, 19075254, 28599428",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","BCR-ABL1 Fusion","Sensitivity/Response","Asciminib","3A","",2,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","T315I","Resistance","Bosutinib, Dasatinib, Imatinib, Nilotinib","R1","17768119, 18403620",4,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","E255K","Sensitivity/Response","Bosutinib, Dasatinib","2A","15930265, 19075254, 19779040, 28599428",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","F317V","Sensitivity/Response","Bosutinib, Nilotinib","2A","15930265, 19075254, 28599428",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","F317C","Sensitivity/Response","Bosutinib, Nilotinib","2A","15930265, 19075254, 28599428",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","BCR-ABL1 Fusion","Sensitivity/Response","Bosutinib, Dasatinib, Imatinib, Nilotinib","1","11287972, 11287973, 12637609, 20525993, 20525995, 23502220, 27217448, 28095277, 28218239, 29091516",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","Y253H","Sensitivity/Response","Bosutinib, Dasatinib","2A","15930265, 19075254, 19779040, 28599428",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","V299L","Sensitivity/Response","Nilotinib","2A","15930265, 19075254",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","F359V","Sensitivity/Response","Bosutinib, Dasatinib","2A","15930265, 19075254, 19779040, 28599428",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","T315I","Sensitivity/Response","Ponatinib","1","19878872, 23190221, 24180494",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","F317I","Sensitivity/Response","Bosutinib, Nilotinib","2A","15930265, 19075254, 28599428",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","F359I","Sensitivity/Response","Bosutinib, Dasatinib","2A","15930265, 19075254, 19779040, 28599428",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","F317L","Sensitivity/Response","Bosutinib, Nilotinib","2A","15930265, 19075254, 28599428",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","F359C","Sensitivity/Response","Bosutinib, Dasatinib","2A","15930265, 19075254, 19779040, 28599428",1,"OncoKB","Chronic Myelogenous Leukemia"
"Leukemia","ABL1","BCR-ABL L248R","Resistance","Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V299L","Sensitivity/Response","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317R","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253H","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Imatinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M351T","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L248R F359I","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M244V","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L384M","Resistance","Imatinib Mesylate,Nilotinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253H","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Reduced Sensitivity","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E292V","Resistance","Nilotinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Nilotinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317C","Resistance","Dasatinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253H","Resistance","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255V","Resistance","Nilotinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL D276G","Resistance","Imatinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F311L","Resistance","Imatinib Mesylate+Nilotinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M244V","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L248V","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M244V","Resistance","Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E450Q","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Reduced Sensitivity","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Resistance","Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E355G","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V299L","Resistance","Dasatinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253H","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359C","Resistance","Nilotinib+Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Imatinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Imatinib","D","15930265",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253F","Resistance","Imatinib","C","15930265",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L387F","Resistance","Nilotinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E355G","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Nilotinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396P","Resistance","Nilotinib+Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315V","Sensitivity/Response","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L248V","Resistance","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E355G","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359C","Resistance","Imatinib Mesylate,Nilotinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","TKD MUTATION","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E459K","Resistance","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M244V","Resistance","Imatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L364I","Resistance","Imatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317V","Resistance","Dasatinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M244V","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M244V","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","Non-P-Loop Mutation","Resistance","Bosutinib","B","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M351T","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253H","Resistance","Nilotinib+Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V299L","Resistance","Dasatinib+Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","C475V","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396R","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL D276G","Resistance","Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255V","Resistance","Imatinib Mesylate,Nilotinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V379I","Resistance","Imatinib Mesylate","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","TKD MUTATION","Resistance","Bosutinib","B","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M351T","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317I","Resistance","Dasatinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Resistance","Imatinib","C","15930265",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L248V","Resistance","Nilotinib+Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M351T","Reduced Sensitivity","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Imatinib","C","15930265",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Resistance","Dasatinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M244V","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L384M","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E459K","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E292L","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E279K","Sensitivity/Response","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253F","Resistance","Imatinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E98G","Resistance","Imatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Sensitivity/Response","Axitinib","C","25686603",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M351T","Resistance","Imatinib Mesylate","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E355G","Resistance","Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL","Sensitivity/Response","Dasatinib,Nilotinib,Bafetinib","D","18191450",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G398R","Sensitivity/Response","Nilotinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL D276G","Resistance","Dasatinib","C","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M244V and L364I","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315A","Sensitivity/Response","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Imatinib","D","15194504",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255V","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","P-Loop Mutation","Resistance","Bosutinib","B","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Imatinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Q252H","Resistance","Dasatinib","C","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL D363G","Resistance","Imatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Imatinib Mesylate,Dasatinib","D","15705718",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Resistance","Nilotinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V299L","Sensitivity/Response","Nilotinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315A","Resistance","Dasatinib","D","15705718",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L248V","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Resistance","Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359I","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Dasatinib+Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359C","Resistance","Dasatinib","C","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359I","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253H","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M343T","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317V","Resistance","Dasatinib","D","15705718",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359C","Resistance","Imatinib Mesylate","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Q300R","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396R","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Q252H","Resistance","Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Nilotinib+Dasatinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396R","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253H","Resistance","Nilotinib,Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Reduced Sensitivity","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359C","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255V","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL D276G","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359I","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Resistance","Dasatinib","D","15705718",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E355G","Resistance","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396R","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E355G","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M244V","Resistance","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Q252H","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253F","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Resistance","Imatinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253H","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Q252H","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L387F","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L364I","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Imatinib Mesylate","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253H","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359C","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L248V","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396R","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359I","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L364P","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E459K","Resistance","Imatinib Mesylate","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Reduced Sensitivity","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Sensitivity/Response","Ponatinib","B","23190221",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317V","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL","Sensitivity/Response","Imatinib","A","20537386",1,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M351T","Resistance","Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L387M","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F486S","Sensitivity/Response","Nilotinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359C","Resistance","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL D276G","Sensitivity/Response","Nilotinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Q252H","Sensitivity/Response","Imatinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M351T","Reduced Sensitivity","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Reduced Sensitivity","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Imatinib","D","15930265",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396P","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V299L","Resistance","Dasatinib","D","15705718",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255V","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K V299L","Sensitivity/Response","Dasatinib,Ponatinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L387M","Resistance","Dasatinib","C","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359C","Resistance","Nilotinib,Imatinib Mesylate","C","19652056",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V298I","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396P","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L248R","Resistance","Dasatinib,Imatinib Mesylate","D","15705718",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Resistance","Imatinib Mesylate","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL D276G","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Nilotinib,Imatinib Mesylate","C","19652056",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","C475V","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL A397P","Resistance","Imatinib Mesylate","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E453Q","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL N331S","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Imatinib","B","20537386",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Resistance","Imatinib","C","15930265",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M244V","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Resistance","Nilotinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Reduced Sensitivity","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M351T","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","P-Loop Mutation","Resistance","Bosutinib","B","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M351T","Sensitivity/Response","Nilotinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Imatinib","D","15194504",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL D421G","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F486S","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L248R","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Nilotinib,Imatinib Mesylate","C","19652056",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Q252H","Resistance","Dasatinib","D","15705718",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL N146S","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Resistance","Dasatinib","B","18818391",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Sensitivity/Response","Ponatinib","B","25349473",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G398R","Sensitivity/Response","Dasatinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F486S","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","Non-P-Loop Mutation","Resistance","Bosutinib","B","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","P-Loop Mutation","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359I","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359I","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Resistance","Imatinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL N336S","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M351T","Sensitivity/Response","Imatinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E98G","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Nilotinib,Dasatinib,Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359C","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL A397P","Resistance","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V299L","Resistance","Imatinib Mesylate","B","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Nilotinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","Double Ph","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255V","Resistance","Nilotinib,Imatinib Mesylate","C","19652056",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Resistance","Imatinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317I","Resistance","Dasatinib","D","15705718",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL P480A","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L387F","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255V","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F486S","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L248V","Resistance","Imatinib Mesylate","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L248V","Resistance","Imatinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L384M","Resistance","Dasatinib","C","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Q300R","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M351T","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","LYN","OVEREXPRESSION","Resistance","Dasatinib,Bafetinib","D","18191450",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL S417Y","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Imatinib Mesylate+Dasatinib","D","15705718",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317L","Sensitivity/Response","Ponatinib","D","24236021",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL","Sensitivity/Response","Dasatinib,Nilotinib","A","20537386",1,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E450V","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Imatinib,Nilotinib,Dasatinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F311L","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F359V","Resistance","Imatinib Mesylate","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253H","Resistance","Nilotinib,Imatinib Mesylate","C","19652056",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M388L","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL S438C","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396R","Resistance","Imatinib","C","15930265",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L248V","Resistance","Nilotinib,Dasatinib,Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL N336S","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V379I","Resistance","Dasatinib","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABCB1","Overexpression","Resistance","Dasatinib,Bafetinib","D","18191450",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Ponatinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","BCL2L11","DELETION POLYMORPHISM","Resistance","Imatinib","B","22426421",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F311I","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Dasatinib+Imatinib Mesylate","D","15705718",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E355G","Resistance","Imatinib Mesylate","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M244V","Resistance","Imatinib Mesylate","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","TKD MUTATION","Resistance","Bosutinib","B","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E453A","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E453A","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","LYN","OVEREXPRESSION","Resistance","Nilotinib","D","18191450",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F486S","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Q252H","Resistance","Dasatinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","TKD MUTATION","Resistance","Nilotinib","B","19652056",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255V","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL T315I","Resistance","Nilotinib+Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E453K","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255V","Resistance","Dasatinib","B","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255V","Reduced Sensitivity","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396R","Resistance","Imatinib Mesylate","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL","Sensitivity/Response","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F486S","Resistance","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396R","Resistance","Imatinib","D","19075254",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL G250E","Resistance","Imatinib Mesylate","B","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V379I","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396R","Resistance","Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253H","Resistance","Imatinib Mesylate","B","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E459K","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M351T","Sensitivity/Response","Imatinib","C","15930265",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","L298V","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL M244V","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253F","Resistance","Bosutinib","C","21865346",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Imatinib Mesylate","C","17264298",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E255K","Resistance","Dasatinib,Imatinib Mesylate,Nilotinib","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL F317S","Resistance","Dasatinib","D","15705718",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL D363G","Resistance","Dasatinib","C","16775234",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V299L","Resistance","Dasatinib","C","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V379I","Resistance","Imatinib Mesylate","D","16772610",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL H396R","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL E279K","Resistance","Dasatinib","C","19779040",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL L248V","Resistance","Imatinib","C","12623848",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL V299L","Reduced Sensitivity","Bosutinib","C","22371878",2,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ABL1","BCR-ABL Y253F","Resistance","Axitinib","D","25686603",3,"CIVIC","Chronic Myeloid Leukemia"
"Leukemia","ZRSR2","Oncogenic Mutations","Sensitivity/Response","H3B-8800","4","29457796",3,"OncoKB","Chronic Myelomonocytic Leukemia"
"Leukemia","U2AF1","Oncogenic Mutations","Sensitivity/Response","H3B-8800","4","29457796",3,"OncoKB","Chronic Myelomonocytic Leukemia"
"Leukemia","SRSF2","Oncogenic Mutations","Sensitivity/Response","H3B-8800","4","29457796",3,"OncoKB","Chronic Myelomonocytic Leukemia"
"Leukemia","SF3B1","Oncogenic Mutations","Sensitivity/Response","H3B-8800","4","29457796",3,"OncoKB","Chronic Myelomonocytic Leukemia"
"Leukemia","CSF3R","T618I","Sensitivity/Response","Ruxolitinib","D","24081659",3,"CIVIC","Chronic Neutrophilic Leukemia"
"Leukemia","CSF3R","T618I","Sensitivity/Response","Ruxolitinib","C","25180155",2,"CIVIC","Chronic Neutrophilic Leukemia"
"Leukemia","SYK","amplification(GoF)","sensitivity","SYK inhibitors","preclinical","16409295, 19549911",3,"GDKD","chronic_lymphocytic_leukemia"
"Leukemia","BTK","C481S(GoF)","resistance","ibrutinib","early trials","24869598, 27199251",2,"GDKD","chronic_lymphocytic_leukemia"
"Leukemia","PLCG2","R665W, L845F(GoF)","resistance","ibrutinib","early trials","24869598",2,"GDKD","chronic_lymphocytic_leukemia"
"Leukemia","ABL1","F359V/C/I(GoF)","response","dasatinib, bosutinib, ponatinib","NCCN guidelines","21562040",1,"GDKD","chronic_myeloid_leukemia"
"Leukemia","ABL1","T315I(GoF)","response","ponatinib","NCCN guidelines","21562040",1,"GDKD","chronic_myeloid_leukemia"
"Leukemia","ABL1","rearrangement(GoF) BCR-ABL1","response","imatinib, dasatinib, nilotinib, bosutinib, ponatinib","FDA-approved","FDA",1,"GDKD","chronic_myeloid_leukemia"
"Leukemia","PRKCH","amplification(GoF)","sensitivity","trametinib (plus imatinib in BCR-ABL)","preclinical","25186176",3,"GDKD","chronic_myeloid_leukemia"
"Leukemia","BCR","rearrangement(GoF) BCR-ABL1","response","imatinib, dasatinib, nilotinib, bosutinib, ponatinib","FDA-approved","FDA",1,"GDKD","chronic_myeloid_leukemia"
"Leukemia","ABL1","T315A(GoF)","response","nilotinib, bosutinib, ponatinib","NCCN guidelines","21562040",1,"GDKD","chronic_myeloid_leukemia"
"Leukemia","ABL1","Y253H(GoF)","response","dasatinib, bosutinib, ponatinib","NCCN guidelines","21562040",1,"GDKD","chronic_myeloid_leukemia"
"Leukemia","ABL1","F317L/V/I/C(GoF)","response","nilotinib, bosutinib, ponatinib","NCCN guidelines","21562040",1,"GDKD","chronic_myeloid_leukemia"
"Leukemia","ABL1","V299L(GoF)","response","nilotinib, ponatinib","NCCN guidelines","21562040",1,"GDKD","chronic_myeloid_leukemia"
"Leukemia","ABL1","E255K/V(GoF)","response","dasatinib, bosutinib, ponatinib","NCCN guidelines","21562040",1,"GDKD","chronic_myeloid_leukemia"
"Blood Disorder","VHL","R200W (c.598C>T)","Sensitivity/Response","Ruxolitinib","C","27518686",2,"CIVIC","Chuvash Polycythemia"
"Kidney Cancer","MTOR","E1799K","Sensitivity/Response","Sirolimus","D","24631838",3,"CIVIC","Clear Cell Renal Cell Carcinoma"
"Brain Tumor","TSC1","Oncogenic Mutations","Sensitivity/Response","Everolimus","1","23158522",1,"OncoKB","CNS Cancer"
"Brain Tumor","TSC2","Oncogenic Mutations","Sensitivity/Response","Everolimus","1","23158522",1,"OncoKB","CNS Cancer"
"Colon and Rectal Cancer","ALK","STRN-ALK","Sensitivity/Response","Ceritinib","C","26933125",2,"CIVIC","Colon Adenocarcinoma"
"Colon and Rectal Cancer","FOS","OVEREXPRESSION","Sensitivity/Response","Irbesartan","C","27022066",2,"CIVIC","Colon Adenocarcinoma"
"Colon and Rectal Cancer","ERBB2","V842I","Sensitivity/Response","Trastuzumab+Neratinib+Lapatinib","D","26243863",3,"CIVIC","Colon Cancer"
"Colon and Rectal Cancer","ERBB2","L866M","Sensitivity/Response","Trastuzumab+Neratinib+Lapatinib","D","26243863",3,"CIVIC","Colon Cancer"
"Colon and Rectal Cancer","POU5F1","EXPRESSION","Resistance","Oxaliplatin","D","26398480",3,"CIVIC","Colon Cancer"
"Colon and Rectal Cancer","ERBB2","L755S","Sensitivity/Response","Lapatinib+Neratinib+Trastuzumab","D","26243863",3,"CIVIC","Colon Cancer"
"Colon and Rectal Cancer","ERBB2","V777L","Sensitivity/Response","Trastuzumab+Lapatinib+Neratinib","D","26243863",3,"CIVIC","Colon Cancer"
"Colon and Rectal Cancer","ERBB2","S310F/Y","Sensitivity/Response","Trastuzumab+Lapatinib+Neratinib","D","26243863",3,"CIVIC","Colon Cancer"
"Colon and Rectal Cancer","BIRC7","AMPLIFICATION","Resistance","Cisplatin","D","23188704",3,"CIVIC","Colon Cancer"
"Colon and Rectal Cancer","APC","MUTATION","Sensitivity/Response","JW55","D","22440753",3,"CIVIC","Colon Carcinoma"
"Colon and Rectal Cancer","KRAS","Q22*","Resistance","Panitumumab","C","19661358",2,"CIVIC","Colon Mucinous Adenocarcinoma"
"Colon and Rectal Cancer","ARAF","unknown(GoF)","resistance","BRAF inhibitor + MEK inhibitor/anti-EGFR mAb","case report","ENA 2014 (abstr 428)",2,"GDKD","colorectal"
"Colon and Rectal Cancer","EGFR","amplification(GoF)","response","anti-EGFR mAbs","late trials","18794099, 17664472",2,"GDKD","colorectal"
"Colon and Rectal Cancer","MET","amplification(GoF)","resistance","anti-EGFR mAbs","early trials","23729478",2,"GDKD","colorectal"
"Colon and Rectal Cancer","NRAS","any(GoF)","sensitivity","MEK inhibitors +/- PI3K pathway inhibitors","preclinical","23274911, 22392911",3,"GDKD","colorectal"
"Colon and Rectal Cancer","MET","amplification(GoF)","sensitivity","BCL2 inhibitors","preclinical","27397505",3,"GDKD","colorectal"
"Colon and Rectal Cancer","MET","amplification(GoF)","response","cabozantinib + panitumumab","case report","ENA 2015 (abstract A52)",2,"GDKD","colorectal"
"Colon and Rectal Cancer","PIK3CA","any(GoF)","response","aspirin in adjuvant setting","late trials","23094721",2,"GDKD","colorectal"
"Colon and Rectal Cancer","BRAF","V600(GoF)","response","irinotecan + vemurafenib + cetuximab","early trials","27729313",2,"GDKD","colorectal"
"Colon and Rectal Cancer","AREG","amplification(GoF)","response","anti-EGFR mAbs","early trials","19738126, 26341080",2,"GDKD","colorectal"
"Colon and Rectal Cancer","ERBB2","amplification(GoF)","resistance","anti-EGFR mAbs","early trials","22586653, 23348520",2,"GDKD","colorectal"
"Colon and Rectal Cancer","KRAS","any(GoF)","sensitivity","MEK inhibitors + PI3K pathway inhibitors","preclinical","22392911",3,"GDKD","colorectal"
"Colon and Rectal Cancer","EGFR","S492R(GoF)","response","panitumumab","case report","22270724",2,"GDKD","colorectal"
"Colon and Rectal Cancer","KRAS","G13D(GoF)","no response","cetuximab","late trials","27114605",2,"GDKD","colorectal"
"Colon and Rectal Cancer","PIK3CA","any(GoF)","sensitivity","PI3K pathway inhibitors (alone or in combination)","preclinical","23475782, 22392911",3,"GDKD","colorectal"
"Colon and Rectal Cancer","PIK3CA","any(GoF)","resistance","cetuximab","late trials","19223544, 20619739",2,"GDKD","colorectal"
"Colon and Rectal Cancer","KRAS","amplification(GoF)","resistance","BRAF inhibitor + MEK inhibitor/anti-EGFR mAb","case report","ENA 2014 (abstr 428)",2,"GDKD","colorectal"
"Colon and Rectal Cancer","FGFR2","rearrangement(GoF)","response","FGFR inhibitors","early trials","ASCO 2017 (abstr 2500)",2,"GDKD","colorectal"
"Colon and Rectal Cancer","EGFR","S492R(GoF)","response","novel anti-EGFR mAbs","early trials","25962717",2,"GDKD","colorectal"
"Colon and Rectal Cancer","EGFR","K467T(GoF)","sensitivity","panitumumab","preclinical","25623215",3,"GDKD","colorectal"
"Colon and Rectal Cancer","KRAS","any(GoF)","sensitivity","mTOR inhibitors + BH3 mimetics","preclinical","24163374",3,"GDKD","colorectal"
"Colon and Rectal Cancer","BRAF","V600(GoF)","response","dabrafenib + trametinib","early trials","26392102",2,"GDKD","colorectal"
"Colon and Rectal Cancer","NTRK1","G595R, G667C(GoF)","resistance","pan-TRK inhibitor","preclinical","26546295",3,"GDKD","colorectal"
"Colon and Rectal Cancer","BRAF","V600(GoF)","response","BRAF inhibitors + anti-EGFR mAbs +/- PI3K pathway inhibitors","early trials","28363909",2,"GDKD","colorectal"
"Colon and Rectal Cancer","NRAS","any(GoF)","resistance","cetuximab, panitumumab","NCCN guidelines","24024839, 20619739, 23325582",1,"GDKD","colorectal"
"Colon and Rectal Cancer","KRAS","any(GoF)","sensitivity","ERK inhibitors","preclinical","23614898",3,"GDKD","colorectal"
"Colon and Rectal Cancer","KRAS","any(GoF)","sensitivity","MEK inhibitors + IGF1R inhibitors","preclinical","24045180",3,"GDKD","colorectal"
"Colon and Rectal Cancer","APC","any(LoF)","sensitivity","tankyrase inhibitors","preclinical","22440753, 23539443",3,"GDKD","colorectal"
"Colon and Rectal Cancer","MET","amplification(GoF)","response","crizotinib and vemurafenib (in BRAF V600E mutated)","case report","27325282",2,"GDKD","colorectal"
"Colon and Rectal Cancer","BRAF","V600(GoF)","response","BRAF inhibitors + MEK inhibitors + anti-EGFR mAbs","early trials","ASCO 2014 (abstr 3515), ASCO 2015 (abstr 103)",2,"GDKD","colorectal"
"Colon and Rectal Cancer","KRAS","any(GoF)","resistance","cetuximab, panitumumab","FDA-rejected","FDA",1,"GDKD","colorectal"
"Colon and Rectal Cancer","ERBB2","amplification(GoF)","response","trastuzumab emtansine","case report","http://ascopubs.org/doi/full/10.1200/PO.16.00055",2,"GDKD","colorectal"
"Colon and Rectal Cancer","POLE","any(LoF)","response","PD1 blockade","case report","28188185",2,"GDKD","colorectal"
"Colon and Rectal Cancer","PTEN","any/deletion(LoF)","resistance","anti-EGFR mAbs","late trials","21163703, 19398573",2,"GDKD","colorectal"
"Colon and Rectal Cancer","JAK1","any(LoF)","resistance","PD1 blockade","case report","27903500",2,"GDKD","colorectal"
"Colon and Rectal Cancer","EGFR","G465R(GoF)","resistance","cetuximab, panitumumab","case report","26059438, 26888827",2,"GDKD","colorectal"
"Colon and Rectal Cancer","EGFR","K467T(GoF)","resistance","cetuximab","case report","25623215, 26888827",2,"GDKD","colorectal"
"Colon and Rectal Cancer","EREG","amplification(GoF)","response","anti-EGFR mAbs","early trials","19738126, 26341080",2,"GDKD","colorectal"
"Colon and Rectal Cancer","ATM","any/deletion(LoF)","response","ATR inhibitors","case report","ENA 2015 (abstract A48)",2,"GDKD","colorectal"
"Colon and Rectal Cancer","MET","amplification(GoF)","resistance","vemurafenib and panitumumab (in BRAF V600E mutated)","case report","27325282",2,"GDKD","colorectal"
"Colon and Rectal Cancer","KRAS","any(GoF)","sensitivity","MEK inhibitors + BCL-XL inhibitors","preclinical","23245996",3,"GDKD","colorectal"
"Colon and Rectal Cancer","KRAS","any(GoF)","sensitivity","anti-EGFR mAbs + MEK inhibitors","preclinical","24553387",3,"GDKD","colorectal"
"Colon and Rectal Cancer","ALK","rearrangement(GoF)","response","entrictinib, ceritinib","case report","26633560, 26933125",2,"GDKD","colorectal"
"Colon and Rectal Cancer","ZNRF3","any(GoF)","sensitivity","porcupine inhibitors","preclinical","26023187",3,"GDKD","colorectal"
"Colon and Rectal Cancer","MAP2K1","K57T(GoF)","response","panitumumab + trametinib","case report","26644315",2,"GDKD","colorectal"
"Colon and Rectal Cancer","FOXA1","amplification(GoF)","sensitivity","BCL2 inhibitors","preclinical","27397505",3,"GDKD","colorectal"
"Colon and Rectal Cancer","EGFR","S464L, G465R, I491M(GoF)","resistance","cetuximab","preclinical","25623215",3,"GDKD","colorectal"
"Colon and Rectal Cancer","EGFR","R451C(GoF)","resistance","cetuximab","case report","25623215",2,"GDKD","colorectal"
"Colon and Rectal Cancer","CTNNB1","any(GoF)","resistance","Tankyrase inhibitors","preclinical","23539443",3,"GDKD","colorectal"
"Colon and Rectal Cancer","MAP2K1","unknown(GoF)","resistance","anti-EGFR mAbs","case report","26030179",2,"GDKD","colorectal"
"Colon and Rectal Cancer","ERBB2","amplification(GoF)","response","trastuzumab + lapatinib (in KRAS wt)","early trials","27108243",2,"GDKD","colorectal"
"Colon and Rectal Cancer","ERBB3","amplification(GoF)","resistance","anti-EGFR mAbs","early trials","25520391",2,"GDKD","colorectal"
"Colon and Rectal Cancer","BRAF","V600(GoF)","resistance","cetuximab, panitumumab","late trials","20619739, 21163703, 23325582",2,"GDKD","colorectal"
"Colon and Rectal Cancer","NTRK1","rearrangement(GoF)","response","pan-TRK inhibitor","case report","26546295",2,"GDKD","colorectal"
"Colon and Rectal Cancer","BRAF","V600(GoF)","no response","vemurafenib","early trials","26460303",2,"GDKD","colorectal"
"Colon and Rectal Cancer","MYC","amplification(GoF)","sensitivity","temozolomide","preclinical","27397505",3,"GDKD","colorectal"
"Colon and Rectal Cancer","RNF43","any(GoF)","response","porcupine inhibitors","case report","ENA 2015 (abstract C45)",2,"GDKD","colorectal"
"Colon and Rectal Cancer","IGF2","amplification(GoF)","resistance","anti-EGFR mAbs","early trials","25632036",2,"GDKD","colorectal"
"Colon and Rectal Cancer","EGFR","S492R(GoF)","resistance","cetuximab","case report","22270724",2,"GDKD","colorectal"
"Colon and Rectal Cancer","KRAS","wild type","response","cetuximab, panitumumab","FDA-approved","FDA",1,"GDKD","colorectal"
"Colon and Rectal Cancer","ERBB2","L755S","Sensitivity/Response","Trastuzumab+Fluorouracil+Leucovorin","C","27626067",2,"CIVIC","Colorectal Adenocarcinoma"
"Colon and Rectal Cancer","KDR","R961W","Sensitivity/Response","Regorafenib","C","27004155",2,"CIVIC","Colorectal Adenocarcinoma"
"Colon and Rectal Cancer","ROS1","REARRANGEMENT","Sensitivity/Response","Crizotinib","E","24296758",3,"CIVIC","Colorectal Adenocarcinoma"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Panitumumab+Trametinib","B","29431699",2,"CIVIC","Colorectal Adenocarcinoma"
"Colon and Rectal Cancer","NTRK1","LMNA-NTRK1 e11-e10","Sensitivity/Response","Entrectinib","C","26546295",2,"CIVIC","Colorectal Adenocarcinoma"
"Colon and Rectal Cancer","ALK","Fusion","Sensitivity/Response","Crizotinib","E","19737969",3,"CIVIC","Colorectal Adenocarcinoma"
"Colon and Rectal Cancer","NTRK1","LMNA-NTRK1 G595R and G667C","Resistance","Entrectinib","C","26546295",2,"CIVIC","Colorectal Adenocarcinoma"
"Colon and Rectal Cancer","JUN","OVEREXPRESSION","Sensitivity/Response","Irbesartan","C","27022066",2,"CIVIC","Colorectal Adenocarcinoma"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Cetuximab+Vemurafenib+Irinotecan","D","22180495",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E and Amplification","Resistance","Selumetinib","E","21098728",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","HRAS","G13D","Resistance","Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor","C","26561417",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Sensitivity/Response","MEK Inhibitor RO4987655","B","24947927",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","ERBB2","Amplification","Resistance","Panitumumab,Cetuximab","B","23348520",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","FBXW7","MUTATION","Resistance","Panitumumab,Cetuximab","B","26508446",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","C420R","Resistance","Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","Mutation","Resistance","Cetuximab+Chemotherapy","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","H1047R","Resistance","Panitumumab,Cetuximab","C","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Panitumumab+Sorafenib","D","19001320",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Exon 2 Mutation","Resistance","Cetuximab","A","18946061",1,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab+Lapatinib","B","27108243",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12R","Resistance","Panitumumab","C","18316791",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Erlotinib+Vemurafenib","D","22180495",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Exon 2 Mutation","Sensitivity/Response","Vemurafenib","D","22180495",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Exon 2 Mutation","Sensitivity/Response","Regorafenib","B","24559322",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","A146V","Sensitivity/Response","Selumetinib+Dactolisib","D","22392911",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","S492R","Resistance","Cetuximab","C","22270724",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12V","Resistance","Panitumumab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Exon 2 Mutation","Resistance","Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor","B","27037411",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","MET","Amplification","Resistance","Anti-EGFR Monoclonal Antibody","D","23729478",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Resistance","Cetuximab","D","22586653",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","ERBB2","Amplification","Resistance","Oxaliplatin+Cetuximab+Capecitabine","B","24146218",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NTRK1","LMNA-NTRK1 e11-e10","Sensitivity/Response","Entrectinib","C","26563355",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Resistance","Ixazomib","D","26709701",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12V","Resistance","Panitumumab","C","18316791",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600","Resistance","Panitumumab","B","23325582",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Resistance","Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","D594G","Resistance","Cetuximab+Irinotecan","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","Mutation","Resistance","Cetuximab","D","22586653",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Pictilisib Bismesylate+PLX4720","D","23845441",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","E542K","Resistance","Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KDR","R1032Q","Sensitivity/Response","Cabozantinib,Dovitinib,Axitinib,Lenvatinib","D","29588308",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRG1","Expression","Resistance","Cetuximab","D","21900593",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Mutation","Resistance","Cetuximab","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","E545K","Resistance","Panitumumab,Cetuximab","C","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12S","Resistance","Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Trametinib+Dabrafenib+Panitumumab","B","29431699",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","FGFR1","Expression","Sensitivity/Response","Infigratinib","D","24135816",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","R88Q","Resistance","Irinotecan+Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12C","Resistance","Gefitinib,Erlotinib","B","23313110",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","RET","CCDC6-RET","Sensitivity/Response","Agerafenib","C","29538669",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PTP4A3","OVEREXPRESSION","Sensitivity/Response","Cetuximab","D","23867504",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","PLX4720+Nutlin-3","D","23812671",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Q546K","Resistance","Cetuximab+Irinotecan","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Q61K","Resistance","Cetuximab+Chemotherapy","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","H1047R","Sensitivity/Response","Vemurafenib+Akt Inhibitor MK2206","D","22180495",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12D","Resistance","Cetuximab,Panitumumab","C","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Resistance","Cetuximab","D","22722830",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","Q61","Resistance","Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Resistance","Cetuximab","B","26812186",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","HSPH1","T17 DELETION","Sensitivity/Response","Oxaliplatin+Fluorouracil","B","24512910",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12/G13","Resistance","Cetuximab","D","18202412",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","ALCAM","EXPRESSION","Resistance","Fluorouracil","B","24708484",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Cetuximab+Binimetinib+Encorafenib","B","168986",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Wildtype","Sensitivity/Response","Aspirin","B","23094721",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Mutation","Resistance","Cetuximab","D","22586653",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Sensitivity/Response","Trametinib+Afatinib","D","24685132",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","TOP1","AMPLIFICATION","Sensitivity/Response","Irinotecan","B","24256029",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Panitumumab+Vemurafenib","C","27325282",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","A146P","Resistance","Irinotecan+Cetuximab","C","19603018",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","Mutation","Sensitivity/Response","Panitumumab,Cetuximab","B","25673558",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Mutation","Resistance","Irinotecan","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Mutation","Resistance","Bevacizumab","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","MET","Amplification","Sensitivity/Response","Cetuximab+Crizotinib","D","23729478",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12S","Resistance","Panitumumab","C","18316791",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","HRAS","G13D","Resistance","Cetuximab","D","26561417",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Vemurafenib+Panitumumab","B","25589621",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","N345K","Resistance","Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NOTCH1","AMPLIFICATION","Sensitivity/Response","NOTCH1 Antibody (PF-06293622)","D","26152787",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","E542K","Resistance","Regorafenib","B","26184520",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","Q61K","Sensitivity/Response","Dactolisib+Selumetinib","D","22392911",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Exon 21 Mutation","Resistance","Chemotherapy+Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","Expression","Sensitivity/Response","Cetuximab","B","18003960",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab+Pertuzumab","B","29320312",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","ALK","CAD-ALK","Sensitivity/Response","Entrectinib","C","26633560",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Resistance","Cetuximab","B","26371285",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","ERBB2","Amplification","Resistance","Cetuximab","B","22586653",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12S","Resistance","Regorafenib","D","26161928",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","CDKN1A","EXPRESSION","Resistance","Fluorouracil","B","24708484",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","G596R","Sensitivity/Response","Vemurafenib","D","22180495",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12V","Resistance","Cetuximab","D","20978259",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","Mutation","Resistance","Cetuximab","D","22586653",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12D","Resistance","Panitumumab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12C","Resistance","Chemotherapy+Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EREG","EXPRESSION","Sensitivity/Response","Cetuximab","B","23374602",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Exon 2 Mutation","Sensitivity/Response","Irinotecan+Selumetinib","B","25322874",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Q61L","Resistance","Cetuximab+Chemotherapy","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","D594G","Resistance","Panitumumab,Cetuximab","C","27404270",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","ERBB3","Overexpression","Resistance","Cetuximab","B","25520391",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","G12C","Resistance","Cetuximab+Chemotherapy","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Resistance","Panitumumab,Cetuximab","B","25989278",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","V955I","Resistance","Cetuximab","C","28424201",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","Mutation","Resistance","Bevacizumab","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600","Sensitivity/Response","Dabrafenib+Trametinib","B","26392102",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","Q61R","Resistance","Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","TOP1","EXPRESSION","Sensitivity/Response","Irinotecan","B","19775480",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PPP1R15A","RS557806","Sensitivity/Response","FOLFIRI Regimen+Bevacizumab","B","27177629",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Resistance","Cetuximab","B","26623049",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Resistance","Oxaliplatin+Capecitabine+Bevacizumab","B","19571295",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12/G13","Resistance","Cetuximab","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Q61","Resistance","Cetuximab+Chemotherapy","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Mutation","Resistance","Oxaliplatin","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Vemurafenib","B","26460303",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Gefitinib+Cetuximab+Vemurafenib","D","22281684",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600","Resistance","Vemurafenib","B","26287849",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","G1049R","Resistance","Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Mutation","Sensitivity/Response","Cabozantinib","D","25242168",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","Amplification","Resistance","Dabrafenib+Panitumumab","C","25673644",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","Mutation","Resistance","Irinotecan","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Sensitivity/Response","Teprotumumab+Selumetinib","D","21985784",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","HSPA5","EXPRESSION","Sensitivity/Response","Fluorouracil","B","23456958",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","G719S","Sensitivity/Response","Cetuximab","D","24894453",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","Amplification","Sensitivity/Response","Panitumumab,Cetuximab","B","24653627",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","H1047L","Resistance","Irinotecan+Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12S","Resistance","Cetuximab,Panitumumab","C","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PTEN","Loss","Resistance","Cetuximab,Panitumumab","B","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","SMAD4","Deletion","Resistance","Fluorouracil","B","12237773",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12D","Resistance","Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NTRK1","Fusion","Sensitivity/Response","Larotrectinib","D","26716414",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12R","Resistance","Cetuximab","D","22722830",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12/G13","Resistance","Chemotherapy+Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Q61H","Resistance","Cetuximab","C","22722830",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12/G13","Resistance","Bevacizumab","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12C","Resistance","Panitumumab","C","18316791",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Sensitivity/Response","B-Raf/VEGFR-2 Inhibitor RAF265+Selumetinib","D","25199829",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","K467T","Sensitivity/Response","Panitumumab,Futuximab/Modotuximab Mixture","D","26888827",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Resistance","Irinotecan","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Resistance","Oxaliplatin","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Encorafenib + Binimetinib + Cetuximab, Panitumumab + Dabrafenib + Trametinib","2A","29431699",1,"OncoKB","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Resistance","Regorafenib","D","26161928",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Resistance","Cetuximab","B","25666295",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","Expression","Sensitivity/Response","Cetuximab","B","14993230",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Dactolisib+GDC-0879","D","23549875",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Resistance","Panitumumab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","Mutation","Resistance","Cetuximab","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","Amplification","Sensitivity/Response","Cetuximab","B","18794099",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","Q61L","Resistance","Cetuximab+Irinotecan","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Resistance","Panitumumab,Cetuximab","A","28275037",1,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","Q179X","Resistance","Cetuximab","B","25666295",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","D594K","Resistance","Oxaliplatin","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","Q61K","Resistance","Cetuximab+Chemotherapy","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","MET","Amplification","Sensitivity/Response","Crizotinib+Vemurafenib","C","27325282",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13V","Resistance","Cetuximab,Panitumumab","C","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Dabrafenib","B","22608338",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EPHB4","EXPRESSION","Resistance","Bevacizumab","B","23579861",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12R","Resistance","Regorafenib","D","26161928",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","UGT1A","EXPRESSION","Resistance","Ganetespib","D","25210794",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","GSTP1","I105V","Sensitivity/Response","FOLFOX Regimen","B","19922504",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12/G13","Resistance","Irinotecan","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","S492R","Resistance","Cetuximab","D","26888827",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12D","Resistance","Regorafenib","D","26161928",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","Mutation","Resistance","Cetuximab+Chemotherapy","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12/G13","Resistance","Cetuximab,Panitumumab","B","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Mutation","Resistance","Anti-EGFR Monoclonal Antibody","B","23435830",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BARD1","LOSS-OF-FUNCTION","Sensitivity/Response","Olaparib","D","27197561",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","V441F","Resistance","Cetuximab,Panitumumab","E","29196463",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","G465R","Sensitivity/Response","Futuximab/Modotuximab Mixture","C","26888827",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NT5E","OVEREXPRESSION","Sensitivity/Response","Cetuximab","B","25520391",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Resistance","Cetuximab,Panitumumab","C","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12C","Resistance","Regorafenib","D","26161928",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","Mutation","Resistance","Oxaliplatin","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","A146T","Resistance","Cetuximab+FOLFOX-4 Regimen","B","25666295",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EREG","EXPRESSION","Sensitivity/Response","Panitumumab","B","26867820",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","Oncogenic Mutations","Resistance","Cetuximab, Panitumumab","R1","20619739, 24024839, 24024844, 25110411",4,"OncoKB","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","R451C","Sensitivity/Response","Panitumumab,Futuximab/Modotuximab Mixture,Cetuximab","D","26888827",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","D594K","Resistance","Irinotecan","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12/G13","Resistance","Panitumumab","B","18316791",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Sensitivity/Response","Selumetinib+Dactolisib","D","22392911",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12A","Resistance","Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","HLA-C","COPY-NEUTRAL LOSS OF HETEROZYGOSITY","Resistance","Therapeutic Tumor Infiltrating Lymphocytes","C","27959684",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","A146T","Sensitivity/Response","Selumetinib+Dactolisib","D","22392911",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12V","Sensitivity/Response","Selumetinib+Dactolisib","D","22392911",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Exon 10 Mutation","Resistance","Chemotherapy+Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","APC","MUTATION","Sensitivity/Response","G007-LK","D","23539443",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12R","Resistance","Cetuximab+Chemotherapy","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Resistance","Chemotherapy+Bevacizumab","B","23828442",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","G724S","Sensitivity/Response","Cetuximab","D","24894453",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","AREG","Expression","Sensitivity/Response","Cetuximab","B","23374602",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","Q61","Resistance","Chemotherapy+Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","SLFN11","EXPRESSION","Sensitivity/Response","7-Ethyl-10-Hydroxycamptothecin","D","25089570",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Exon 2 Mutation","Resistance","Cetuximab","B","16618717",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Mutation","Sensitivity/Response","Aspirin","B","23094721",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","E81K","Resistance","Fluorouracil+Cetuximab+Oxaliplatin","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Q61R","Resistance","Irinotecan+Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","G13R","Resistance","Irinotecan+Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EIF4EBP1","PHOSPHORYLATION","Resistance","MTOR Kinase Inhibitor PP242,Dactolisib,WYE354","D","22262166",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab+Pertuzumab","B","30857956",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","G13R","Resistance","Panitumumab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","AREG","Expression","Sensitivity/Response","Panitumumab","B","26867820",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","S492R","Sensitivity/Response","Futuximab/Modotuximab Mixture,Panitumumab","D","26888827",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12V","Resistance","Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","A146","Resistance","Chemotherapy+Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","G12D","Resistance","Irinotecan+Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","S158L","Resistance","Cetuximab+Irinotecan","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Q61H","Resistance","Chemotherapy+Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","Mutation","Resistance","Panitumumab,Cetuximab","A","28275037",1,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","K467T","Resistance","Cetuximab","D","26888827",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Wildtype","Sensitivity/Response","Cetuximab, Panitumumab, Regorafenib","1","15677699, 19339720, 20921462, 20921465, 23177514, 24739896, 31268481",1,"OncoKB","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Vemurafenib","D","22180495",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","ERBB2","Amplification","Resistance","Cetuximab","B","28223103",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Resistance","Panitumumab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","E545Q","Resistance","Irinotecan+Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12V","Resistance","Regorafenib","D","26161928",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Mutation","Resistance","Chemotherapy+Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Resistance","Panitumumab,Cetuximab","C","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600","Sensitivity/Response","Cetuximab+Irinotecan+Vemurafenib","B","147167",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12D","Sensitivity/Response","Selumetinib+Dactolisib","D","22392911",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","E545K","Resistance","Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","Mutation","Resistance","Cetuximab,Panitumumab","B","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","G466V","Sensitivity/Response","Panitumumab+Irinotecan","D","28783719",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","DKK1","NUCLEAR EXPRESSION","Resistance","Levoleucovorin+Fluorouracil+Oxaliplatin+Irinotecan","B","25788273",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12A","Resistance","Regorafenib","D","26161928",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","D594G","Resistance","Cetuximab+Irinotecan","C","26989027",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Sensitivity/Response","Cetuximab+Selumetinib","B","26666244",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600","Sensitivity/Response","Cetuximab+Vemurafenib","B","26287849",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12C","Sensitivity/Response","Selumetinib+Dactolisib","D","22392911",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","SMAD4","MUTATION","Resistance","Panitumumab,Cetuximab","B","26508446",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PTEN","Loss","Resistance","Cetuximab","B","21163703",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Sensitivity/Response","Cetuximab","D","20978259",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","ARAF","S490T","Resistance","Irinotecan+Vemurafenib+Cetuximab","C","27729313",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12V","Resistance","Panitumumab,Cetuximab","C","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Sensitivity/Response","Refametinib","C","23434733",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","VEGFA","Decreased Peri-therapeutic Expression","Sensitivity/Response","Levoleucovorin+Irinotecan+Bevacizumab+Fluorouracil","B","25973082",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","G466V","Sensitivity/Response","Vemurafenib","D","28783719",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Capecitabine+Bevacizumab+Vemurafenib","D","22180495",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Sensitivity/Response","Immunomodulatory Oligonucleotide+Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor","D","21890455",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","TP53","Wildtype","Sensitivity/Response","Capecitabine+Cetuximab+Oxaliplatin","B","24957073",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","A146T","Resistance","Cetuximab","D","20570890",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Resistance","Cetuximab+FOLFOX-4 Regimen","B","25666295",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","H1047R","Resistance","Vemurafenib","D","22180495",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","S492R","Sensitivity/Response","Panitumumab","C","22270724",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Sensitivity/Response","Cetuximab+Dasatinib","D","20956938",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Sensitivity/Response","Cetuximab","B","20978259",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600","Sensitivity/Response","Cetuximab+Encorafenib","B","28363909",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","GNAS","R201C","Resistance","Irinotecan+Vemurafenib+Cetuximab","C","27729313",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600","Sensitivity/Response","Panitumumab + Dabrafenib + Trametinib, Vemurafenib + Panitumumab","3A","19001320, 19884556, 20619739, 22448344, 25589621, 29431699",2,"OncoKB","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","G12D","Resistance","Cetuximab","B","25666295",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Wildtype","Resistance","Regorafenib","D","26161928",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Resistance","Panitumumab,Cetuximab","B","19001320",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","Other Biomarkers","MSI-H","Sensitivity/Response","Nivolumab","1","28734759",1,"OncoKB","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600","Sensitivity/Response","Alpelisib+Cetuximab+Encorafenib","B","28363909",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","G465R","Resistance","Cetuximab,Panitumumab","C","26888827",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","EGFR","Expression","Sensitivity/Response","Panitumumab","B","17470858",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12/G13","Resistance","Oxaliplatin","B","19603024",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","H1047R","Resistance","Cetuximab+Irinotecan","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","TYMS","5' TANDEM REPEAT","Resistance","Fluorouracil+Irinotecan","B","20628391",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Sensitivity/Response","Binimetinib+Palbociclib","D","27167191",3,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Cetuximab+Irinotecan+Vemurafenib","B","27729313",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12A","Resistance","Cetuximab,Panitumumab","C","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Oncogenic Mutations","Resistance","Cetuximab, Panitumumab","R1","18316791, 20619739, 20921465, 21228335, 24024839",4,"OncoKB","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12D","Sensitivity/Response","Therapeutic Tumor Infiltrating Lymphocytes","C","27959684",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G12D","Resistance","Panitumumab","C","18316791",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","BRAF","V600E","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","NRAS","Q61H","Resistance","Irinotecan+Cetuximab","C","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","H1047R","Resistance","Panitumumab,Cetuximab","B","19223544",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","Mutation","Resistance","Cetuximab+Chemotherapy","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","KRAS","G13D","Resistance","Cetuximab","B","20619739",2,"CIVIC","Colorectal Cancer"
"Colon and Rectal Cancer","PIK3CA","R93W","Resistance","Cetuximab+Oxaliplatin+Fluorouracil","C","20619739",2,"CIVIC","Colorectal Cancer"
"Sarcoma","NTRK1","SQSTM1-NTRK1","Sensitivity/Response","Larotrectinib","C","30204247",2,"CIVIC","Congenital Fibrosarcoma"
"Sarcoma","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib","C","30204247",2,"CIVIC","Congenital Fibrosarcoma"
"Sarcoma","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib","C","27093299",2,"CIVIC","Congenital Fibrosarcoma"
"Sarcoma","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib","A","29606586",1,"CIVIC","Congenital Fibrosarcoma"
"Sarcoma","NTRK1","LMNA-NTRK1 e2-e10","Sensitivity/Response","Crizotinib","C","30709876",2,"CIVIC","Congenital Fibrosarcoma"
"Sarcoma","NTRK1","SQSTM1-NTRK1","Sensitivity/Response","Larotrectinib","C","29606586",2,"CIVIC","Congenital Fibrosarcoma"
"Sarcoma","CDK4","Amplification","Sensitivity/Response","Abemaciclib, Palbociclib","2A","23569312, 27124835",1,"OncoKB","Dedifferentiated Liposarcoma"
"Sarcoma","COL1A1","rearrangement(GoF) COL1A1-PDGFRB","response","imatinib","FDA-approved","FDA",1,"GDKD","dermatofibrosarcoma"
"Sarcoma","PDGFRB","rearrangement(GoF) COL1A1-PDGFRB","response","imatinib","FDA-approved","FDA",1,"GDKD","dermatofibrosarcoma"
"Sarcoma","PDGFB","COL1A1-PDGFB Fusion","Sensitivity/Response","Imatinib","1","15503291, 15681532, 15746584, 18451237, 19620561, 20439456, 21128251",1,"OncoKB","Dermatofibrosarcoma Protuberans"
"Sarcoma","PDGFRB","Overexpression","Sensitivity/Response","Sunitinib","C","29760553",2,"CIVIC","Dermatofibrosarcoma Protuberans"
"Sarcoma","CDKN2A","Loss","Sensitivity/Response","Palbociclib","D","25852058",3,"CIVIC","Dermatofibrosarcoma Protuberans"
"Sarcoma","PDGFB","COL1A1-PDGFB","Sensitivity/Response","Sunitinib","C","29760553",2,"CIVIC","Dermatofibrosarcoma Protuberans"
"Soft Tissue Sarcoma","CTNNB1","S45F","Sensitivity/Response","Meloxicam","C","24788118",2,"CIVIC","Desmoid Tumor"
"Lymphoma","ALK","CLTC-ALK","Sensitivity/Response","TAE684","D","21494621",3,"CIVIC","Diffuse Large B-cell Lymphoma"
"Lymphoma","EZH2","Y646H","Sensitivity/Response","Tazemetostat","C","29650362",2,"CIVIC","Diffuse Large B-cell Lymphoma"
"Lymphoma","ALK","Fusion","Sensitivity/Response","Crizotinib","C","24330038",2,"CIVIC","Diffuse Large B-cell Lymphoma"
"Lymphoma","ALK","CLTC-ALK","Sensitivity/Response","Crizotinib","C","26221234",2,"CIVIC","Diffuse Large B-cell Lymphoma"
"Pediatric Cancer","PTCH1","Truncating Mutations","Sensitivity/Response","Sonidegib","3A","24523439, 24900187",2,"OncoKB","Embryonal Tumor"
"Endometrial Cancer","PTEN","any/deletion(LoF)","no response","mTOR inhibitors","early trials","21788564, 23238879",2,"GDKD","endometrial"
"Endometrial Cancer","PIK3R2","N561D(LoF)","sensitivity","mTOR inhibitors","preclinical","21984976",3,"GDKD","endometrial"
"Endometrial Cancer","ERBB2","amplification(GoF)","sensitivity","trastuzumab + lapatinib","preclinical","25294905",3,"GDKD","endometrial"
"Endometrial Cancer","PIK3CA","any(GoF)","response","PI3K pathway inhibitors","early trials","22271473, 27672108",2,"GDKD","endometrial"
"Endometrial Cancer","AKT1","E17K(GoF)","response","tensirolimus","early trials","27016228",2,"GDKD","endometrial"
"Endometrial Cancer","PTEN","any/deletion(LoF)","response","PARP inhibitors","case report","21468130, 20944090",2,"GDKD","endometrial"
"Endometrial Cancer","EGFR","E690K(GoF)","response","lapatinib","case report","22885469",2,"GDKD","endometrial"
"Endometrial Cancer","ERBB2","amplification(GoF)","no response","trastuzumab alone","early trials","19840887",2,"GDKD","endometrial"
"Endometrial Cancer","POLE","exonuclease domain(GoF)","response","PD1 blockade","case report","27159395",2,"GDKD","endometrial"
"Endometrial Cancer","KRAS","any(GoF)","response","pan-RAF inhibitors","case report","AACR 2016 (abstr CT005), AACR 2017 (abstr CT002)",2,"GDKD","endometrial"
"Endometrial Cancer","FGFR2","N549K(GoF)","sensitivity","FGFR inhibitors","preclinical","18552176, 22238366, 23002168",3,"GDKD","endometrial"
"Endometrial Cancer","CTNNB1","H36Y, S37C, S37Y, D32V(GoF)","response","everolimus + letrozole","early trials","25624430",2,"GDKD","endometrial"
"Endometrial Cancer","FGFR2","S252W(GoF)","sensitivity","FGFR inhibitors","preclinical","18552176, 22238366, 23002168",3,"GDKD","endometrial"
"Endometrial Cancer","FGFR1","amplification(GoF)","sensitivity","FGFR inhibitors","case report","ASCO 2017 (abstr 2500)",2,"GDKD","endometrial"
"Endometrial Cancer","TSC1","any(GoF)","response","tensirolimus","case report","27016228",2,"GDKD","endometrial"
"Endometrial Cancer","PIK3R2","A171V(LoF)","sensitivity","mTOR inhibitors","preclinical","21984976, 19962665",3,"GDKD","endometrial"
"Endometrial Cancer","KRAS","any(GoF)","resistance","PI3K pathway inhibitors","preclinical","22662154",3,"GDKD","endometrial"
"Endometrial Cancer","KRAS","any(GoF)","sensitivity","PI3K pathway inhibitors + MEK inhibitors","preclinical","21984976, 22662154",3,"GDKD","endometrial"
"Endometrial Cancer","PTEN","any/deletion(LoF)","sensitivity","PI3K pathway inhibitors","preclinical","22662154",3,"GDKD","endometrial"
"Endometrial Cancer","FGFR2","M536I, M538I, I548V, N550, E566G, L618M, K660E(GoF)","sensitivity","ponatinib","preclinical","23908597",3,"GDKD","endometrial"
"Endometrial Cancer","FGFR2","M536I, M538I, I548V, N550, E566G, L618M, K660E(GoF)","resistance","dovitinib","preclinical","23908597",3,"GDKD","endometrial"
"Endometrial Cancer","TSC2","any(GoF)","response","tensirolimus","case report","27016228",2,"GDKD","endometrial"
"Endometrial Cancer","PIK3R1","any(LoF)","response","PI3K pathway inhibitors","case report","ASCO 2015 (abstr 11075)",2,"GDKD","endometrial"
"Endometrial Cancer","FGFR2","V565I(GoF)","resistance","dovitinib","preclinical","23908597",3,"GDKD","endometrial"
"Endometrial Cancer","FGFR2","V565I(GoF)","sensitivity","selective FGFR inhibitor","preclinical","ENA 2014 (abstr 381)",3,"GDKD","endometrial"
"Endometrial Cancer","FGFR2","V565I(GoF)","resistance","ponatinib","preclinical","23908597",3,"GDKD","endometrial"
"Endometrial Cancer","MTOR","S2215Y","Sensitivity/Response","Sirolimus","D","24631838",3,"CIVIC","Endometrial Adenocarcinoma"
"Endometrial Cancer","PTEN","Loss","Resistance","Temsirolimus,Ridaforolimus","B","24166148",2,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","PIK3CA","Mutation","Sensitivity/Response","Pictilisib","D","23674493",3,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","MRE11","LOSS","Sensitivity/Response","Talazoparib","D","24927325",3,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","FGFR2","N550K","Sensitivity/Response","PD173074","D","18757403",3,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab","B","19840887",2,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","KRAS","Mutation","Sensitivity/Response","Ridaforolimus,Temsirolimus","B","24166148",2,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","PIK3CA","Mutation","Sensitivity/Response","Temsirolimus,Ridaforolimus","B","24166148",2,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","AKT1","E17K","Sensitivity/Response","AZD5363","3A","22294718, 23394218, 26351323, 28489509",2,"OncoKB","Endometrial Cancer"
"Endometrial Cancer","KIT","EXPRESSION","Sensitivity/Response","Imatinib","C","16487996",2,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","PTEN","Loss","Sensitivity/Response","Temsirolimus","D","23674493",3,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","FGFR2","Mutation","Sensitivity/Response","Ponatinib","D","26574622",3,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","POLE","MUTATION","Sensitivity/Response","Pembrolizumab","C","27159395",2,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","FGFR2","FGFR2-BICC1","Sensitivity/Response","Erdafitinib","C","26324363",2,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","KIT","EXPRESSION","Sensitivity/Response","Imatinib","C","18607592",2,"CIVIC","Endometrial Cancer"
"Endometrial Cancer","STMN1","EXPRESSION","Resistance","Paclitaxel","B","24587245",2,"CIVIC","Endometrial Carcinoma"
"Endometrial Cancer","PTEN","Mutation","Sensitivity/Response","Everolimus","B","23238879",2,"CIVIC","Endometrial Carcinoma"
"Endometrial Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab","C","18555254",2,"CIVIC","Endometrial Serous Adenocarcinoma"
"Ovarian","BRCA1","W1815X","Sensitivity/Response","Olaparib","D","23415752",3,"CIVIC","Endometrioid Ovary Carcinoma"
"Ovarian Cancer","PIK3CA","Amplification","Sensitivity/Response","Pictilisib","C","25370471",2,"CIVIC","Epithelial Ovarian Cancer"
"Ovarian Cancer","EGFR","Exon 4 Deletion","Resistance","Cisplatin","D","23764753",3,"CIVIC","Epithelial Ovarian Cancer"
"Ovarian Cancer","KRAS","RS61764370","Resistance","Carboplatin,Paclitaxel","B","22139083",2,"CIVIC","Epithelial Ovarian Cancer"
"Sarcoma","ALK","Fusion","Sensitivity/Response","Crizotinib","C","25028698",2,"CIVIC","Epithelioid Inflammatory Myofibroblastic Sarcoma"
"Blood Disorder","BRAF","V600","Sensitivity/Response","Vemurafenib","1","26287849, 29188284",1,"OncoKB","Erdheim-Chester Disease"
"Esophageal","EGFR","amplification(GoF)","response","gefitinib","late trials","24950987",2,"GDKD","esophageal"
"Esophageal","GNAS","c.393T>C","Resistance","Fluorouracil+Cisplatin","B","19274060",2,"CIVIC","Esophageal Cancer"
"Esophageal","TP53","Wildtype","Sensitivity/Response","Chemotherapy","B","23515910",2,"CIVIC","Esophageal Carcinoma"
"Gastric Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab","1","20728210",1,"OncoKB","Esophagogastric Cancer"
"Esophageal","AURKA","AMPLIFICATION","Sensitivity/Response","Cisplatin+Alisertib","E","22302096",3,"CIVIC","Esophagus Adenocarcinoma"
"Esophageal","EGFR","Overexpression","Sensitivity/Response","Nimotuzumab","B","26459251",2,"CIVIC","Esophagus Squamous Cell Carcinoma"
"Esophageal","AURKA","EXPRESSION","Sensitivity/Response","Cisplatin+Fluorouracil","B","25924824",2,"CIVIC","Esophagus Squamous Cell Carcinoma"
"Breast Cancer","CDK6","OVEREXPRESSION","Resistance","Fulvestrant","B","27252418",2,"CIVIC","Estrogen-receptor Positive Breast Cancer"
"Breast Cancer","CDK4","EXPRESSION","Sensitivity/Response","Alpelisib","D","25002028",3,"CIVIC","Estrogen-receptor Positive Breast Cancer"
"Breast Cancer","CDK6","OVEREXPRESSION","Sensitivity/Response","Palbociclib+Fulvestrant","D","27252418",3,"CIVIC","Estrogen-receptor Positive Breast Cancer"
"Breast Cancer","FGFR1","Amplification","Sensitivity/Response","Ponatinib","D","22238366",3,"CIVIC","Estrogen-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Sensitivity/Response","Tamoxifen","B","17575221",2,"CIVIC","Estrogen-receptor Positive Breast Cancer"
"Breast Cancer","CCNE1","Amplification","Resistance","Palbociclib","D","27020857",3,"CIVIC","Estrogen-receptor Positive Breast Cancer"
"Breast Cancer","CCND1","Overexpression","Resistance","Tamoxifen","B","15138475",2,"CIVIC","Estrogen-receptor Positive Breast Cancer"
"Breast Cancer","ESR1","S463P","Resistance","Aromatase Inhibitor","D","24185512",3,"CIVIC","Estrogen-receptor Positive Breast Cancer"
"Breast Cancer","RB1","M695FS*26","Resistance","Palbociclib","D","27020857",3,"CIVIC","Estrogen-receptor Positive Breast Cancer"
"Sarcoma","CDKN2B","LOSS","Sensitivity/Response","Linsitinib,Palbociclib","D","27286459",3,"CIVIC","Ewing Sarcoma"
"Sarcoma","CDKN2A","Loss","Sensitivity/Response","Linsitinib,Palbociclib","D","27286459",3,"CIVIC","Ewing Sarcoma"
"Sarcoma","FLI1","EWSR1-FLI1 Fusion","Sensitivity/Response","TK216","4","19584866",3,"OncoKB","Ewing Sarcoma"
"Bone Cancer","FGFR1","Amplification","Sensitivity/Response","Ponatinib","D","26179511",3,"CIVIC","Ewing Sarcoma Of Bone"
"Bone Cancer","FGFR1","N546K","Sensitivity/Response","Ponatinib","E","26179511",3,"CIVIC","Ewing Sarcoma Of Bone"
"Bone Cancer","PTPRD","V253I","Sensitivity/Response","Teprotumumab,Cixutumumab","C","23800680",2,"CIVIC","Ewing Sarcoma Of Bone"
"Bone Cancer","CASP8","Overexpression","Sensitivity/Response","Conatumumab","D","26291055",3,"CIVIC","Ewing Sarcoma Of Bone"
"Sarcoma","FLI1","EWSR1-FLI1 Fusion","Sensitivity/Response","TK216","4","19584866",3,"OncoKB","Ewing Sarcoma of Soft Tissue"
"Soft Tissue Sarcoma","AKT1","H238Y(GoF)","response","everolimus","case report","ASCO 2015 (abstr 11010)",2,"GDKD","fibrous_histiocytoma"
"Lymphoma","EZH2","Oncogenic Mutations","Sensitivity/Response","Tazemetostat","3A","",2,"OncoKB","Follicular Lymphoma"
"Lymphoma","BCL2","F104I","Resistance","Venetoclax","D","31234236",3,"CIVIC","Follicular Lymphoma"
"Lymphoma","BCL2","F104I","Resistance","Venetoclax","C","31234236",2,"CIVIC","Follicular Lymphoma"
"Gastric Cancer","KRAS","any(GoF)","resistance","anti-EGFR mAbs","preclinical","22614881, 22290393",3,"GDKD","gastric"
"Gastric Cancer","ERBB2","amplification(GoF)","response","lapatinib (plus chemotherapy)","early trials","25694417, NCT02015169",2,"GDKD","gastric"
"Gastric Cancer","ERBB2","amplification(GoF)","response","pertuzumab","early trials","24960402",2,"GDKD","gastric"
"Gastric Cancer","MTOR","K1771R(GoF)","response","everolimus","case report","ASCO 2015 (abstr 11010)",2,"GDKD","gastric"
"Gastric Cancer","ERBB2","amplification(GoF)","response","trastuzumab","FDA-approved","FDA",1,"GDKD","gastric"
"Gastric Cancer","ATM","any/deletion(LoF)","response","PARP inhibitors","early trials","ENA 2014 (abstr 8LBA)",2,"GDKD","gastric"
"Gastric Cancer","MET","amplification(GoF)","sensitivity","MET inhibitors","preclinical","22729845, 23327903",3,"GDKD","gastric"
"Gastric Cancer","TSC2","any(LoF)","response","everolimus","case report","26859683",2,"GDKD","gastric"
"Gastric Cancer","ERBB2","amplification(GoF)","response","afatinib","case report","AACR 2014 (abstr CT228)",2,"GDKD","gastric"
"Gastric Cancer","PIK3CA","any(GoF)","response","PI3K alpha inhibitors","case report","ASCO 2015 (abstr 2501)",2,"GDKD","gastric"
"Gastric Cancer","BCOR","mut(LoF)","sensitivity","enzastaurin (PKCbeta inhibitor)","preclinical","27397505",3,"GDKD","gastric"
"Gastric Cancer","MTOR","N1421D(GoF)","response","everolimus","case report","26859683",2,"GDKD","gastric"
"Gastric Cancer","MET","amplification(GoF)","response","crizotinib + trastuzumab (in HER2 co-amplified)","case report","26432108",2,"GDKD","gastric"
"Gastric Cancer","FGFR2","amplification(GoF)","response","FGFR inhibitors","early trials","ASCO 2015 (abstr 2508)",2,"GDKD","gastric"
"Gastric Cancer","MET","amplification(GoF)","resistance","lapatinib in HER2-amplified","preclinical","22238368",3,"GDKD","gastric"
"Gastric Cancer","MET","amplification(GoF)","response","MET inhibitors","early trials","ASCO GI 2015 (abstr 1)",2,"GDKD","gastric"
"Gastric Cancer","TP53","Mutation","Sensitivity/Response","Chemotherapy","B","24740294",2,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","ATM","Underexpression","Sensitivity/Response","Olaparib","D","24841718",3,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","HSPH1","NUCLEAR EXPRESSION","Sensitivity/Response","Cisplatin,Fluorouracil","D","26943774",3,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","TYMS","Overexpression","Resistance","Raltitrexed","B","22422354",2,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab","B","20728210",2,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","ERBB2","Amplification","Sensitivity/Response","Lapatinib","B","24868024",2,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","PTEN","Loss","Resistance","Lapatinib,Trastuzumab","B","25300346",2,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","DNMT1","EXPRESSION","Resistance","Cisplatin","B","21458988",2,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab","A","20728210",1,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","MET","Amplification","Sensitivity/Response","Onartuzumab","C","22389872",2,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","FGFR1","Expression","Sensitivity/Response","Infigratinib","D","26637881",3,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","EIF4EBP1","PHOSPHORYLATION","Sensitivity/Response","Everolimus","D","23340172",3,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","CXCR4","EXPRESSION","Resistance","Docetaxel","B","20651371",2,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","RPS6","PHOSPHORYLATION","Sensitivity/Response","Everolimus","D","22343617",3,"CIVIC","Gastric Adenocarcinoma"
"Gastric Cancer","BRAF","V600E","Sensitivity/Response","Dabrafenib+Trametinib+Vemurafenib","C","27048246",2,"CIVIC","Gastrointestinal Neuroendocrine Tumor"
"Gastric Cancer","KIT","Exon 11 Mutation","Sensitivity/Response","Regorafenib","B","22614970",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V654A","Sensitivity/Response","Sunitinib","B","16638875",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","D816E","Resistance","Imatinib,Sunitinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 9 Mutation","Sensitivity/Response","Sunitinib","B","18955458",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","A502_Y503insAY","Sensitivity/Response","Ponatinib,Regorafenib,Imatinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 9 Mutation","Sensitivity/Response","Imatinib","B","16624552",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V654A","Sensitivity/Response","Regorafenib, Sunitinib","1","17046465, 23177515",1,"OncoKB","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V559D","Sensitivity/Response","Imatinib","C","22114577",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 9 Mutation","Reduced Sensitivity","Regorafenib","C","27371698",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","Exon 18 Mutation","Sensitivity/Response","Imatinib","C","18955451",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","I843DEL","Sensitivity/Response","Crenolanib","D","22745105",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","K558_V559del","Resistance","Sunitinib","C","18955458",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V555_V559DEL","Resistance","Sunitinib","C","18955458",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","W557_K558del","Sensitivity/Response","Sunitinib,Regorafenib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","I843DEL","Sensitivity/Response","Imatinib","D","14645423",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","T670I","Resistance","Ponatinib,Sunitinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","D579del","Resistance","Sunitinib","C","18955458",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842_I843delinsVM","Sensitivity/Response","Crenolanib","D","22745105",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 11 Mutation","Sensitivity/Response","Imatinib","B","14645423",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842V","Resistance","Imatinib","D","12949711",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842V","Sensitivity/Response","Crenolanib","D","22745105",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","T417_D419delinsY","Sensitivity/Response","Imatinib","C","18955451",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 11 Mutation","Sensitivity/Response","Regorafenib","B","27371698",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","K550_K559DEL","Resistance","Sunitinib","C","18955458",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","T670I","Resistance","Imatinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 9 Mutation","Sensitivity/Response","Regorafenib","B","23177515",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","N822K","Resistance","Ponatinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","MUTATION","Sensitivity/Response","Pictilisib+Imatinib","D","23231951",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842I","Sensitivity/Response","Crenolanib","D","22745105",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","Mutation","Sensitivity/Response","Imatinib","C","14645423",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842V","Resistance","Imatinib","R1","12949711, 15685537, 15928335, 17087936, 18794084, 18955458, 22718859, 22745105, 23752188, 24963404, 25905001",4,"OncoKB","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842V","Resistance","Imatinib","B","16954519",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V560_L576DEL","Sensitivity/Response","Regorafenib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842V","Resistance","Imatinib","B","15928335",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","W557_K558del","Sensitivity/Response","Imatinib,Ponatinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842V","Resistance","Imatinib","C","14645423",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","C809G","Resistance","Imatinib","C","16954519",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 9 Mutation","Sensitivity/Response","Sunitinib","B","22439647",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","A502_Y503insAY","Sensitivity/Response","Sunitinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","D820A","Resistance","Imatinib","C","16954519",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","C788_N828mut","Resistance","Imatinib, Sunitinib","R2","18955458, 22301675, 23840364, 25239608",4,"OncoKB","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","T670I","Resistance","Regorafenib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 11 Mutation","Resistance","Sunitinib","B","18955458",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","A829P","Resistance","Ponatinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","K550_K558del","Resistance","Sunitinib","C","18955458",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V654A","Resistance","Imatinib","D","16954519",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 9 Mutation","Reduced Sensitivity","Imatinib","B","18955451",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","EXPRESSION","Sensitivity/Response","Imatinib","B","18955451",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","L576P","Resistance","Sunitinib","C","18955458",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","V561A","Sensitivity/Response","Imatinib","D","12949711",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","C788_N828mut","Sensitivity/Response","Regorafenib","1","23177515",1,"OncoKB","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","W557_K558del","Resistance","Sunitinib","C","18955458",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","D816H","Resistance","Imatinib","C","16954519",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842Y","Sensitivity/Response","Crenolanib","D","22745105",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","BRAF","Exon 15 Mutation","Sensitivity/Response","Regorafenib","C","27371698",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","D820Y","Sensitivity/Response","Regorafenib","C","22614970",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","BRAF","Exon 15 Mutation","Resistance","Regorafenib","C","22614970",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V559D","Sensitivity/Response","Imatinib,Regorafenib,Ponatinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","A829P","Resistance","Imatinib,Sunitinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","P551_E554delPMYE","Sensitivity/Response","Ponatinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","F506_F508DUP","Sensitivity/Response","Imatinib","C","18955451",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Y823D","Resistance","Imatinib","C","16954519",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","T670I","Sensitivity/Response","Regorafenib, Sunitinib","1","17046465, 17699867, 23177515",1,"OncoKB","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","C788_N828mut","Sensitivity/Response","Sorafenib","2A","22270258, 23140824",1,"OncoKB","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","T670I","Resistance","Imatinib","C","16954519",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V560D","Resistance","Sunitinib","C","18955458",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","WILDTYPE","Sensitivity/Response","Regorafenib","B","27371698",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","D820G","Resistance","Imatinib","C","16954519",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 13 Mutation","Sensitivity/Response","Imatinib","C","14645423",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 11 Mutation","Sensitivity/Response","Regorafenib","B","23177515",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","T670I","Resistance","Imatinib","R2","16551858, 1675110, 16954519, 17545544, 17699867, 23840364",4,"OncoKB","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","V561D","Sensitivity/Response","Imatinib","C","18955451",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Oncogenic Mutations","Sensitivity/Response","Imatinib, Regorafenib, Sunitinib","1","12181401, 17046465, 18235122, 18955451, 23177515, 28196207",1,"OncoKB","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842V","Resistance","Sunitinib","C","18955458",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 9 Mutation","Reduced Sensitivity","Regorafenib","B","22614970",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V569_L576DEL","Sensitivity/Response","Sunitinib","B","26772734",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","N822K","Resistance","Regorafenib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842V","Sensitivity/Response","Dasatinib","2A","",1,"OncoKB","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 11 Mutation","Sensitivity/Response","Imatinib","B","18955451",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","N822K","Sensitivity/Response","Regorafenib","C","22614970",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","K484_G487DEL","Sensitivity/Response","Imatinib","C","18955451",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","D816E","Resistance","Ponatinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","P551_E554delPMYE","Sensitivity/Response","Sunitinib,Regorafenib,Imatinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842V","Resistance","Imatinib","B","26130666",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V560D","Sensitivity/Response","Imatinib,Ponatinib,Sunitinib,Regorafenib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","N822K","Resistance","Imatinib","C","16954519",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","K558NP","Sensitivity/Response","Ponatinib,Sunitinib,Imatinib,Regorafenib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","K550_W557del","Sensitivity/Response","Sunitinib,Imatinib,Regorafenib,Ponatinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","Oncogenic Mutations","Sensitivity/Response","Imatinib","2A","22718859",1,"OncoKB","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V654A","Resistance","Imatinib","R2","16551858, 16954519, 18955458, 23840364",4,"OncoKB","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","Exon 9 Mutation","Sensitivity/Response","Imatinib","B","14645423",2,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","N822K","Resistance","Imatinib,Sunitinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","K642E","Sensitivity/Response","Ponatinib,Sunitinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V560G","Sensitivity/Response","Imatinib,Regorafenib,Ponatinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","KIT","V560_L576DEL","Sensitivity/Response","Imatinib,Ponatinib","D","25239608",3,"CIVIC","Gastrointestinal Stromal Tumor"
"Gastric Cancer","PDGFRA","D842V(GoF)","sensitivity","HSP90 inhibitors","preclinical","18794084",3,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 17 p.788-828(GoF)","sensitivity","HSP90 inhibitors","preclinical","21737509",3,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","T670I(GoF)","resistance","imatinib","case report","24687822",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","wild type","sensitivity","dasatinib","preclinical","16397263",3,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 17 p.788-828(GoF)","sensitivity","sorafenib","preclinical","23840364",3,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","PDGFRA","wild type","response","sorafenib","early trials","ASCO 2011 (abstr 10009)",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","PDGFRA","wild type","response","sunitinib","late trials","18955458",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 9 p.449-514(GoF)","sensitivity","HSP90 inhibitors","preclinical","21737509",3,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","PDGFRA","D842V(GoF)","sensitivity","dasatinib","preclinical","18794084",3,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","PDGFRA","D842V(GoF)","response","crenolanib","early trials","ASCO 2016 (abstr 11010)",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","V559I, H687Y, T670, V654A, A829P, D816, N822, Y823D(GoF)","resistance","imatinib","preclinical","23582185, 21689725, 17259998",3,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","PDGFRA","D842V(GoF)","resistance","imatinib, sunitinib","late trials, preclinical","22718859, 16638875",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","PDGFRA","exon 18 p.814-854(GoF)","response","imatinib, sunitinib, regorafenib","NCCN guidelines","NCCN",1,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 17 p.788-828(GoF)","decreased sensitivity","imatinib, sunitinib","preclinical","23840364",3,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","PDGFRA","exon 14 p.631-668(GoF)","response","imatinib, sunitinib, regorafenib","NCCN guidelines","NCCN",1,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 11 p.550-592(GoF)","decreased sensitivity","sunitinib","late trials","18955458",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","NTRK3","rearrangement(GoF)","response","pan-TRK inhibitor","case report","AACR 2016 (abstr CT008)",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","BRAF","V600E(GoF)","response","dabrafenib","case report","23470635, 22608338",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","PDGFRA","wild type","sensitivity","dasatinib","preclinical","16397263",3,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 17 p.788-828(GoF)","response","nilotinib","early trials","22119758, 21456006",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","PDGFRA","wild type","decreased sensitivity","imatinib","late trials","14645423, 18955458",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 11 p.550-592(GoF)","response","imatinib, sunitinib, regorafenib","FDA-approved","FDA",1,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 9 p.449-514(GoF)","response","sorafenib","early trials","22270258",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","PDGFRA","exon 12 p.552-596(GoF)","response","imatinib, sunitinib, regorafenib","NCCN guidelines","NCCN",1,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","wild type","decreased sensitivity","imatinib","late trials","18955458",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 17 p.788-828(GoF)","response","imatinib, sunitinib, regorafenib","FDA-approved","FDA",1,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KRAS","G12(GoF)","resistance","imatinib","case report","24687822",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 14 p.664-714(GoF)","decreased sensitivity","imatinib","late trials","18955458",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","wild type","response","sorafenib","early trials","ASCO 2011 (abstr 10009)",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","wild type","response","sunitinib","late trials","18955458",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 14 p.664-714(GoF)","response","imatinib, sunitinib, regorafenib","FDA-approved","FDA",1,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 9 p.449-514(GoF)","response","imatinib, sunitinib, regorafenib","FDA-approved","FDA",1,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 9 p.449-514(GoF)","decreased sensitivity","imatinib (low dose)","late trials","18955458, 18955451, 16624552",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 13 p.627-664(GoF)","decreased sensitivity","imatinib","late trials","18955458",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 13 p.627-664(GoF)","response","imatinib, sunitinib, regorafenib","FDA-approved","FDA",1,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","A82P9, V654A, T670I(GoF)","sensitivity","ponatinib","preclinical","25239608",3,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","PDGFRA","R748G,Y894C(GoF)","response","imatinib, sunitinib, regorafenib","NCCN guidelines","NCCN",1,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 11 p.550-592(GoF)","response","ponatinib","early trials","25239608, ASCO 2015 (abstr 10535)",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 11 p.550-592(GoF)","response","HSP90 inhibitors","early trials","22898035",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 17 p.788-828, exon 18 p.829-860(GoF)","response","ponatinib","early trials","ASCO 2015 (abstr 10517)",2,"GDKD","gastrointestinal_stromal_tumor"
"Gastric Cancer","KIT","exon 11 p.550-592(GoF)","response","sorafenib","early trials","22270258",2,"GDKD","gastrointestinal_stromal_tumor"
"Germ Cell Tumor","MDM2","amplification(GoF)","resistance","cisplatin","early trials","27646943",2,"GDKD","germ-cell tumor"
"Germ Cell Tumor","TP53","mut(LoF)","resistance","cisplatin","early trials","27646943",2,"GDKD","germ-cell tumor"
"Blastoma","EGFR","VIII","Sensitivity/Response","Gefitinib,Erlotinib","B","16282176",2,"CIVIC","Glioblastoma"
"Blastoma","TP53","M237I","Resistance","AMGMDS3","D","25730903",3,"CIVIC","Glioblastoma"
"Blastoma","ROS1","GOPC-ROS1","Sensitivity/Response","Lorlatinib","D","30171048",3,"CIVIC","Glioblastoma"
"Blastoma","PTEN","Expression","Sensitivity/Response","Dacomitinib","D","25939761",3,"CIVIC","Glioblastoma"
"Blastoma","MGMT","Promoter Methylation","Sensitivity/Response","Temozolomide","A","15758010",1,"CIVIC","Glioblastoma"
"Blastoma","MGMT","Underexpression","Sensitivity/Response","Temozolomide","B","21331613",2,"CIVIC","Glioblastoma"
"Blastoma","PTEN","Expression","Sensitivity/Response","Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor","B","16282176",2,"CIVIC","Glioblastoma"
"Blastoma","MGMT","Promoter Methylation","Sensitivity/Response","Carmustine","B","11070098",2,"CIVIC","Glioblastoma"
"Blastoma","MET","Amplification","Sensitivity/Response","Crizotinib","C","22162573",2,"CIVIC","Glioblastoma"
"Blastoma","POLE","MUTATION","Sensitivity/Response","Pembrolizumab","C","27683556",2,"CIVIC","Glioblastoma"
"Blastoma","HGF","EXPRESSION","Sensitivity/Response","MET Tyrosine Kinase Inhibitor SGX523","D","22203985",3,"CIVIC","Glioblastoma"
"Blastoma","EGFR","VIII","Sensitivity/Response","Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor","B","16282176",2,"CIVIC","Glioblastoma"
"Blastoma","MGMT","RS16906252","Sensitivity/Response","Temozolomide","B","25910840",2,"CIVIC","Glioblastoma"
"Blastoma","PMS2","K706FS*19","Sensitivity/Response","Nivolumab","C","27001570",2,"CIVIC","Glioblastoma"
"Blastoma","MGMT","Underexpression","Sensitivity/Response","Temozolomide","B","17442989",2,"CIVIC","Glioblastoma"
"Blastoma","MGMT","Promoter Methylation","Sensitivity/Response","O6-Benzylguanine","E","11070098",3,"CIVIC","Glioblastoma"
"Blastoma","EGFR","VIII","Sensitivity/Response","Rindopepimut","B","25586468",2,"CIVIC","Glioblastoma"
"Blastoma","ATM","Mutation","Sensitivity/Response","Temozolomide","D","23960094",3,"CIVIC","Glioblastoma"
"Blastoma","BRCA2","K3226*","Sensitivity/Response","Temozolomide+Olaparib","C","32043779",2,"CIVIC","Glioblastoma"
"Blastoma","RB1","LOSS-OF-FUNCTION","Resistance","Palbociclib","D","20354191",3,"CIVIC","Glioblastoma"
"Blastoma","PTEN","Expression","Sensitivity/Response","Gefitinib,Erlotinib","B","16282176",2,"CIVIC","Glioblastoma"
"Blastoma","EGFR","VIII","Sensitivity/Response","Afatinib","C","26423602",2,"CIVIC","Glioblastoma"
"Blastoma","CDK6","OVEREXPRESSION","Sensitivity/Response","Palbociclib","D","28903422",3,"CIVIC","Glioblastoma Proneural Subtype"
"Glioma","IDH1","R132H","sensitivity","IDH1 inhibitor","preclinical","23558169",3,"GDKD","glioma"
"Glioma","ALK","R1192P(GoF)","sensitivity","crizotinib","preclinical","22072639",3,"GDKD","glioma"
"Glioma","ALK","I1171N(GoF)","sensitivity","crizotinib","preclinical","22072639",3,"GDKD","glioma"
"Glioma","CDKN2B","any/deletion(LoF)","sensitivity","CDK4/6 inhibitors","preclinical","22711607",3,"GDKD","glioma"
"Glioma","CDKN2C","any/deletion(LoF)","sensitivity","CDK4/6 inhibitors","preclinical","22711607",3,"GDKD","glioma"
"Glioma","ALK","F1174L(GoF)","reduced sensitivity","crizotinib","preclinical","22072639",3,"GDKD","glioma"
"Glioma","PTEN","any/deletion(LoF)","sensitivity","PI3K pathway inhibitors (alone or in combination)","preclinical","21325073, 21191045, 17804702",3,"GDKD","glioma"
"Glioma","EGFR","A289V(GoF)","sensitivity","erlotinib","preclinical","17177598",3,"GDKD","glioma"
"Glioma","EGFR","exon 2-7 p.30-336(GoF)","no response","EGFR TKIs","early trials","19204207",2,"GDKD","glioma"
"Glioma","MET","amplification(GoF)","response","crizotinib","case report","22162573",2,"GDKD","glioma"
"Glioma","ALK","R1275Q(GoF)","sensitivity","crizotinib","preclinical","22072639",3,"GDKD","glioma"
"Glioma","ATM","any(LoF)","sensitivity","temozolomide","preclinical","23960094",3,"GDKD","glioma"
"Glioma","ALK","G1128A(GoF)","sensitivity","crizotinib","preclinical","22072639",3,"GDKD","glioma"
"Glioma","EGFR","amplification(GoF)","no response","EGFR TKIs","early trials","16282176, 16278407",2,"GDKD","glioma"
"Glioma","STAG2","any(LoF)","sensitivity","PARP inhibitors","preclinical","24356817",3,"GDKD","glioma"
"Glioma","NF1","any/deletion(LoF)","sensitivity","mTOR inhibitors","preclinical","19573811",3,"GDKD","glioma"
"Glioma","EGFR","T263P(GoF)","sensitivity","erlotinib","preclinical","17177598",3,"GDKD","glioma"
"Glioma","EGFR","G598V(GoF)","sensitivity","erlotinib","preclinical","17177598",3,"GDKD","glioma"
"Glioma","CDKN2A","any/deletion(LoF)","sensitivity","CDK4/6 inhibitors","preclinical","22586120, 22711607",3,"GDKD","glioma"
"Glioma","PIK3R1","any(LoF)","sensitivity","AKT inhibitors","preclinical","23166678",3,"GDKD","glioma"
"Glioma","BRAF","V600E(GoF)","sensitivity","BRAF inhibitors","preclinical","22038996, 22586120",3,"GDKD","glioma"
"Glioma","PIK3CA","any(GoF)","sensitivity","PI3K pathway inhibitors","preclinical","19671762",3,"GDKD","glioma"
"Glioma","ALK","F1245C(GoF)","sensitivity","crizotinib","preclinical","22072639",3,"GDKD","glioma"
"Glioma","POLE","exonuclease domain(GoF)","response","PD1 blockade","case report","27001570, 27683556",2,"GDKD","glioma"
"Glioma","MET","rearrangement(GoF)","response","crizotinib","case report","27748748",2,"GDKD","glioma"
"Glioma","FGFR3","rearrangement(GoF)","response","FGFR inhibitors","early trials","26324363",2,"GDKD","glioma"
"Glioma","MGMT","any(methy/deletion)(LoF)","increased benefit","temozolomide","late trials","15758010",2,"GDKD","glioma"
"Glioma","EGFR","R108K(GoF)","sensitivity","erlotinib","preclinical","17177598",3,"GDKD","glioma"
"Glioma","PDGFRA","amplification(GoF)","no sensitivity","PDGFR inhibitors","preclinical","23544171",3,"GDKD","glioma"
"Glioma","ATR","any(LoF)","sensitivity","temozolomide","preclinical","23960094",3,"GDKD","glioma"
"Glioma","H3-3A","K27M","Sensitivity/Response","Akt/ERK Inhibitor ONC201","B","172409",2,"CIVIC","Glioma"
"Glioma","EGFR","T263P","Sensitivity/Response","Lapatinib","4","18334972, 20459769, 22588883",3,"OncoKB","Glioma"
"Glioma","EGFR","R108K","Sensitivity/Response","Lapatinib","4","18334972, 20459769, 22588883",3,"OncoKB","Glioma"
"Glioma","EGFR","A289V","Sensitivity/Response","Lapatinib","4","18334972, 20459769, 22588883",3,"OncoKB","Glioma"
"Glioma","EGFR","Amplification","Sensitivity/Response","Lapatinib","4","18334972, 20459769, 22588883",3,"OncoKB","Glioma"
"Leukemia","BRAF","V600E","Sensitivity/Response","Vemurafenib","B","26352686",2,"CIVIC","Hairy Cell Leukemia"
"Leukemia","KRAS","G12D","Resistance","Vemurafenib","C","26352686",2,"CIVIC","Hairy Cell Leukemia"
"Leukemia","BRAF","V600E","Sensitivity/Response","Vemurafenib","2A","26352686",1,"OncoKB","Hairy Cell Leukemia"
"Leukemia","BRAF","V600E(GoF)","response","vemurafenib","case report","22621641",2,"GDKD","hairy_cell_leukemia"
"Head & Neck","PIK3CA","Mutation","Sensitivity/Response","Pictilisib,Trametinib,Tanespimycin","D","25855885",3,"CIVIC","Head And Neck Cancer"
"Head & Neck","PIK3CA","Mutation","Sensitivity/Response","Dactolisib","D","23619167",3,"CIVIC","Head And Neck Cancer"
"Head & Neck","PIK3CA","H1047R","Sensitivity/Response","Cetuximab+Dactolisib","D","23619167",3,"CIVIC","Head And Neck Cancer"
"Head & Neck","PIK3CA","H1047R","Sensitivity/Response","Dactolisib","D","25855885",3,"CIVIC","Head And Neck Cancer"
"Head & Neck","PIK3CA","H1047R","Sensitivity/Response","Dactolisib","D","23619167",3,"CIVIC","Head And Neck Cancer"
"Head & Neck","MET","R1004G","Sensitivity/Response","Crizotinib","C","31391294",2,"CIVIC","Head And Neck Cancer"
"Head & Neck","PTEN","Mutation","Sensitivity/Response","Pictilisib,Tanespimycin","D","25855885",3,"CIVIC","Head And Neck Cancer"
"Head & Neck","PIK3CA","H1047R","Sensitivity/Response","Alpelisib","D","25550549",3,"CIVIC","Head And Neck Cancer"
"Head & Neck","PTPRD","MUTATION","Sensitivity/Response","JSI-124","D","26267899",3,"CIVIC","Head And Neck Carcinoma"
"Head & Neck","HRAS","Oncogenic Mutations","Sensitivity/Response","Tipifarnib","3A","12497061, 24240680",2,"OncoKB","Head and Neck Squamous Cell Carcinoma"
"Head & Neck","EGFR","Amplification","Sensitivity/Response","Fluorouracil+Platinum Compound+Cetuximab","B","21048039",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","PIK3CA","H1047R","Sensitivity/Response","Taselisib","D","26589432",3,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","CDKN1B","EXPRESSION","Sensitivity/Response","Cisplatin+Fluorouracil","B","24239278",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","CDKN2A","p16 Expression","Resistance","Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor","B","24577117",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","EGFR","Overexpression","Sensitivity/Response","Docetaxel+Cetuximab","B","21653686",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","PTPRT","PROMOTER HYPERMETHYLATION","Sensitivity/Response","JSI-124,Stattic","D","25982282",3,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","AREG","Expression","Resistance","Docetaxel+Cetuximab","B","21653686",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","CDKN2A","p16 Expression","Resistance","Afatinib","B","25892145",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","EGFR","VIII","Resistance","Docetaxel+Cetuximab","B","21653686",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","CDKN2A","p16 Expression","Resistance","Panitumumab","B","23746666",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","EGFR","Overexpression","Sensitivity/Response","Cetuximab","B","23265711",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","PIK3CA","Amplification","Sensitivity/Response","Taselisib","D","26589432",3,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","CDKN2A","p16 Expression","Sensitivity/Response","Panitumumab","B","23746666",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","CD274","Expression","Resistance","Radiation Therapy","B","28476872",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","CDKN2A","p16 Expression","Resistance","Cetuximab","B","24577089",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","SMAD4","UNDEREXPRESSION","Resistance","Cetuximab","D","26046389",3,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","MAPK1","E322K","Sensitivity/Response","Erlotinib","C","26181029",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","FGFR1","Expression","Sensitivity/Response","Infigratinib","D","26015511",3,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","NOTCH1","LOSS-OF-FUNCTION","Sensitivity/Response","Porcupine Inhibitor WNT974","D","24277854",3,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","ERBB2","Overexpression","Sensitivity/Response","Lapatinib","C","28061634",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","KRAS","RS61764370","Resistance","Cisplatin","B","25081901",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","PTEN","Mutation","Resistance","Taselisib","D","26589432",3,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","ALDH1A2","Underexpression","Sensitivity/Response","Tretinoin","D","26634247",3,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","PIK3CA","E542K","Sensitivity/Response","Apitolisib","C","26787751",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","DPYD","EXON 11-19 DELETION","Sensitivity/Response","Fluorouracil+Leucovorin","C","31871216",2,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","NRG1","Expression","Sensitivity/Response","Lapatinib","D","21840482",3,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","PIK3CA","Mutation","Sensitivity/Response","Taselisib+Radiation Therapy","D","26589432",3,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","EGF","EXPRESSION","Resistance","Cetuximab","D","25677871",3,"CIVIC","Head And Neck Squamous Cell Carcinoma"
"Head & Neck","FGFR1","amplification(GoF)","sensitivity","FGFR inhibitors","preclinical","23418312",3,"GDKD","head_neck"
"Head & Neck","AKT1","E17K(GoF)","response","PI3K pathway inhibitors","case report","26763254",2,"GDKD","head_neck"
"Head & Neck","NF1","D1644A(LoF)","response","everolimus","case report","26859683",2,"GDKD","head_neck"
"Head & Neck","FAT1","mut(LoF)","sensitivity","BET inhibitors","preclinical","27397505",3,"GDKD","head_neck"
"Head & Neck","ERBB2","amplification(GoF)","response","trastuzumab-based chemotherapy","case report","21380780",2,"GDKD","head_neck"
"Head & Neck","EGFR","amplification(GoF)","no response","gefitinib","early trials","21274259, 22261807",2,"GDKD","head_neck"
"Head & Neck","BRAF","G469A(GoF)","response","ERK inhibitors","case report","ASCO 2017 (abstr 2508)",2,"GDKD","head_neck"
"Head & Neck","FGFR2","P253R(GoF)","response","pazopanib","case report","23786770",2,"GDKD","head_neck"
"Head & Neck","TP53","any(LoF)","sensitivity","WEE1 inhibitors","preclinical","25125259",3,"GDKD","head_neck"
"Head & Neck","EGFR","amplification(GoF)","response","EGFR inhibitors","case report","26763254",2,"GDKD","head_neck"
"Head & Neck","EGFR","V843I(GoF)","no response","gefitinib","case report","21274259",2,"GDKD","head_neck"
"Head & Neck","PIK3CB","any(GoF)","sensitivity","AKT inhibitor, mTORC1/2 inhibitors","preclinical","23619167",3,"GDKD","head_neck"
"Head & Neck","PIK3CA","any(GoF)","response","PI3K pathway inhibitors","case report","26787751, 26763254",2,"GDKD","head_neck"
"Head & Neck","EGFR","delL747-P753insS(GoF)","no response","gefitinib","case report","21274259",2,"GDKD","head_neck"
"Head & Neck","EGFR","P546S(GoF)","response","cetuximab","case report","23578570",2,"GDKD","head_neck"
"Head & Neck","EGFR","P753S(GoF)","response","cetuximab + sirolimus","case report","24934779",2,"GDKD","head_neck"
"Blood Cancer","ATM","Mutation","Sensitivity/Response","Olaparib","D","20739657",3,"CIVIC","Hematologic Cancer"
"Liver Cancer","PROM1","EXPRESSION","Resistance","Sorafenib","B","22596232",2,"CIVIC","Hepatocellular Carcinoma"
"Liver Cancer","FGF19","Overexpression","Sensitivity/Response","Fisogatinib","B","31575541",2,"CIVIC","Hepatocellular Carcinoma"
"Liver Cancer","ERBB2","H878Y","Sensitivity/Response","Lapatinib","D","22046346",3,"CIVIC","Hepatocellular Carcinoma"
"Liver Cancer","KRAS","Mutation","Sensitivity/Response","Refametinib+Sorafenib","B","25294897",2,"CIVIC","Hepatocellular Carcinoma"
"Liver Cancer","JAK1","S703I","Sensitivity/Response","Ruxolitinib","D","26701727",3,"CIVIC","Hepatocellular Carcinoma"
"Liver Cancer","NF1","mut(LoF)","response","everolimus + pazopanib","case report","24931142",2,"GDKD","hepatocellular_carcinoma"
"Liver Cancer","KRAS","any(GoF)","response","sorafenib + MEK inhibitor","early trials, case report","25294897",2,"GDKD","hepatocellular_carcinoma"
"Liver Cancer","MET","amplification(GoF)","response","MET inhibitors","case report","ENA 2015 (abstract A55)",2,"GDKD","hepatocellular_carcinoma"
"Liver Cancer","NRAS","any(GoF)","response","sorafenib + MEK inhibitor","early trials, case report","25294897",2,"GDKD","hepatocellular_carcinoma"
"Liver Cancer","VEGFA","amplification(GoF)","response","sorafenib","early trials","24687604",2,"GDKD","hepatocellular_carcinoma"
"Breast Cancer","BRCA1","Loss-of-function","Sensitivity/Response","Olaparib","B","28578601",2,"CIVIC","Her2-receptor Negative Breast Cancer"
"Breast Cancer","BRCA2","Loss-of-function","Sensitivity/Response","Olaparib","B","28578601",2,"CIVIC","Her2-receptor Negative Breast Cancer"
"Breast Cancer","CDKN2A","Loss","Sensitivity/Response","Palbociclib+Letrozole","C","26715889",2,"CIVIC","Her2-receptor Negative Breast Cancer"
"Breast Cancer","BRCA1","Mutation","Sensitivity/Response","Olaparib","B","28792849",2,"CIVIC","Her2-receptor Negative Breast Cancer"
"Breast Cancer","PIK3CA","H1047R","Sensitivity/Response","Capivasertib+Trastuzumab","D","22294718",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Afatinib,Trastuzumab,Lapatinib","B","25537159",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab Emtansine","B","23020162",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab Emtansine","B","24793816",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Loss","Sensitivity/Response","PI3K/BET Inhibitor LY294002+Trastuzumab","D","15324695",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Loss","Sensitivity/Response","Everolimus","B","27091708",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","H1047R","Sensitivity/Response","Everolimus+Fulvestrant","C","27445490",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","BIRC5","OVEREXPRESSION","Resistance","Trastuzumab","B","23204226",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Resistance","Trastuzumab Emtansine","B","26920887",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Pilaralisib+Trastuzumab","D","23204226",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Sensitivity/Response","Everolimus","B","27091708",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab","B","11248153",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab","B","15911866",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Expression","Resistance","Fulvestrant+Everolimus","C","27445490",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Sensitivity/Response","Capivasertib","D","22294718",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","H1047R","Sensitivity/Response","Capivasertib+Lapatinib","D","22294718",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","A66","D","22802530",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Loss","Resistance","Lapatinib","D","19010894",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","E545K","Resistance","Trastuzumab Emtansine","D","26920887",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Loss","Resistance","Trastuzumab","B","21594665",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","E545K","Resistance","Dactolisib","D","19010894",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","H1047R","Resistance","Trastuzumab","D","26920887",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Loss","Resistance","Dactolisib+Lapatinib","D","19010894",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Overexpression","Sensitivity/Response","Trastuzumab Emtansine","B","28526536",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab Emtansine","B","21172893",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","E542K","Sensitivity/Response","Pictilisib","D","20453058",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","E542K","Sensitivity/Response","PI-103","D","20453058",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Capecitabine+Trastuzumab","B","19289619",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","E545K","Resistance","Trastuzumab","D","18829560",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","H1047R","Resistance","Trastuzumab Emtansine","D","26920887",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab+Afatinib","B","25370464",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Tgx 221","D","22802530",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","C420R","Sensitivity/Response","Pictilisib","D","20453058",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab>Neratinib","A","26874901",1,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Pertuzumab+Docetaxel+Trastuzumab","B","25693012",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","E545K","Resistance","Trastuzumab","D","26920887",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","C420R","Resistance","Trastuzumab","D","26920887",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Pictilisib","D","22802530",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Loss","Resistance","Dactolisib+Trastuzumab","D","19010894",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","I391M","Resistance","Trastuzumab Emtansine","D","26920887",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","Amplification","Sensitivity/Response","Lapatinib,Dactolisib","D","19010894",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab","A","16236737",1,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Neratinib","B","20142587",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","K111N","Resistance","Trastuzumab Emtansine","D","26920887",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Loss","Sensitivity/Response","Pictilisib","D","20453058",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Palbociclib+Trastuzumab","D","19874578",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","Amplification","Resistance","Trastuzumab","D","19010894",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Loss","Resistance","Dactolisib","D","19010894",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","K111N","Sensitivity/Response","Pictilisib","D","20453058",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","H1047R","Sensitivity/Response","Pictilisib","D","20453058",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Afatinib","B","26822398",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Lapatinib+Trastuzumab","B","22493419",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Afatinib","B","26596672",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","E545K","Sensitivity/Response","Pictilisib","D","20453058",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Loss","Resistance","Trastuzumab","D","19010894",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB3","Overexpression","Resistance","Trastuzumab Emtansine","B","26920887",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","H1047R","Resistance","Dactolisib","D","19010894",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab+Lapatinib","B","26255196",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Loss","Resistance","Trastuzumab Emtansine","B","26920887",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Capecitabine+Lapatinib","B","17192538",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab+Lapatinib","B","20124187",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab+Lapatinib","B","22257673",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","K111N","Resistance","Trastuzumab","D","26920887",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Resistance","Trastuzumab","B","17936563",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Afatinib","B","22418700",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Resistance","Capecitabine+Lapatinib","B","26920887",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","H1047R","Resistance","Trastuzumab+Lapatinib","D","19010894",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab Emtansine","B","23382472",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Loss","Resistance","Trastuzumab","D","17936563",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","E545K","Resistance","Lapatinib+Trastuzumab","D","19010894",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","Mutation","Resistance","Trastuzumab","B","21594665",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","K111N","Resistance","Lapatinib,Trastuzumab,Dactolisib","D","19010894",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","I391M","Resistance","Trastuzumab","D","26920887",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PTEN","Loss","Resistance","Trastuzumab","B","20813970",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","PIK3CA","C420R","Resistance","Trastuzumab Emtansine","D","26920887",3,"CIVIC","Her2-receptor Positive Breast Cancer"
"Breast Cancer","ERBB2","Amplification","Sensitivity/Response","Pertuzumab+Docetaxel+Trastuzumab","B","22149875",2,"CIVIC","Her2-receptor Positive Breast Cancer"
"Glioma","EGFR","L858R","Sensitivity/Response","Erlotinib","D","17177598",3,"CIVIC","High Grade Glioma"
"Glioma","EGFR","VIII","Sensitivity/Response","Erlotinib","D","17177598",3,"CIVIC","High Grade Glioma"
"Glioma","EGFR","R108K","Sensitivity/Response","Erlotinib","D","17177598",3,"CIVIC","High Grade Glioma"
"Glioma","IDH1","R132","Sensitivity/Response","Bevacizumab","B","22199315",2,"CIVIC","High Grade Glioma"
"Glioma","EGFR","T263P","Sensitivity/Response","Erlotinib","D","17177598",3,"CIVIC","High Grade Glioma"
"Glioma","EGFR","A289V","Sensitivity/Response","Erlotinib","D","17177598",3,"CIVIC","High Grade Glioma"
"Glioma","IDH1","R132C","Sensitivity/Response","AGI-5198","D","23558169",3,"CIVIC","High Grade Glioma"
"Glioma","MGMT","Underexpression","Sensitivity/Response","Temozolomide","B","21365007",2,"CIVIC","High Grade Glioma"
"Glioma","EGFR","L861Q","Sensitivity/Response","Erlotinib","D","17177598",3,"CIVIC","High Grade Glioma"
"Glioma","IDH1","R132","Sensitivity/Response","Bevacizumab,Sunitinib","B","22199315",2,"CIVIC","High Grade Glioma"
"Sarcoma","MET","EXON 14 SKIPPING MUTATION","Sensitivity/Response","Crizotinib","C","25971938",2,"CIVIC","Histiocytic And Dendritic Cell Cancer"
"Histiocytosis","ARAF","Oncogenic Mutations","Sensitivity/Response","Cobimetinib, Sorafenib","3A","24569458, 26566875, 29236635, 30867592",2,"OncoKB","Histiocytosis"
"Histiocytosis","MAP2K1","Oncogenic Mutations","Sensitivity/Response","Cobimetinib, Trametinib","3A","25351745, 25370473, 26324360, 26566875, 30867592",2,"OncoKB","Histiocytosis"
"Histiocytosis","NRAS","Oncogenic Mutations","Sensitivity/Response","Cobimetinib","3A","29236635, 30867592",2,"OncoKB","Histiocytosis"
"Histiocytosis","KRAS","Oncogenic Mutations","Sensitivity/Response","Cobimetinib","3A","29236635, 30867592",2,"OncoKB","Histiocytosis"
"Histiocytosis","MAP2K2","Oncogenic Mutations","Sensitivity/Response","Cobimetinib","3A","29236635, 30867592",2,"OncoKB","Histiocytosis"
"Histiocytosis","BRAF","Oncogenic Mutations","Sensitivity/Response","Cobimetinib","3A","29236635, 30867592",2,"OncoKB","Histiocytosis"
"Histiocytosis","RAF1","Oncogenic Mutations","Sensitivity/Response","Cobimetinib","3A","29236635, 30867592",2,"OncoKB","Histiocytosis"
"Blood Disorder","PDGFRA","rearrangement(GoF)","response","imatinib","FDA-approved","FDA",1,"GDKD","hypereosinophilic_syndrome"
"Blood Disorder","PDGFRA","T674I(GoF)","resistance","imatinib","case report","12660384",2,"GDKD","hypereosinophilic_syndrome"
"Breast Cancer","MMP9","SERUM LEVELS","Resistance","Bevacizumab","B","26921265",2,"CIVIC","Inflammatory Breast Carcinoma"
"Breast Cancer","MMP2","SERUM LEVELS","Sensitivity/Response","Bevacizumab","B","26921265",2,"CIVIC","Inflammatory Breast Carcinoma"
"Soft Tissue Sarcoma","ALK","F1174L","Resistance","Crizotinib","D","21030459",3,"CIVIC","Inflammatory Myofibroblastic Tumor"
"Soft Tissue Sarcoma","ALK","Fusions","Sensitivity/Response","Ceritinib, Crizotinib","2A","20979472, 23598171, 24670165, 26020125",1,"OncoKB","Inflammatory Myofibroblastic Tumor"
"Soft Tissue Sarcoma","ALK","Fusion","Sensitivity/Response","Crizotinib","B","23598171",2,"CIVIC","Inflammatory Myofibroblastic Tumor"
"Soft Tissue Sarcoma","ALK","RANBP2-ALK","Sensitivity/Response","Crizotinib","C","20979472",2,"CIVIC","Inflammatory Myofibroblastic Tumor"
"Soft Tissue Sarcoma","ROS1","TFG-ROS1","Sensitivity/Response","Crizotinib","C","24875859",2,"CIVIC","Inflammatory Myofibroblastic Tumor"
"Soft Tissue Sarcoma","ALK","rearrangement(GoF)","response","crizotinib","case report","20979472",2,"GDKD","inflammatory_myofibroblastic_tumor"
"Soft Tissue Sarcoma","ALK","rearrangement(GoF)","response","ceritinib","case report","27742657",2,"GDKD","inflammatory_myofibroblastic_tumor"
"Soft Tissue Sarcoma","ALK","G1128A(GoF)","resistance","crizotinib","case report","http://ascopubs.org/doi/full/10.1200/PO.17.00015",2,"GDKD","inflammatory_myofibroblastic_tumor"
"Soft Tissue Sarcoma","ROS1","rearrangement(GoF)","response","crizotinib","case report","24875859",2,"GDKD","inflammatory_myofibroblastic_tumor"
"Liver Cancer","BRAF","V600E","Sensitivity/Response","Trametinib+Dabrafenib","C","25435907",2,"CIVIC","Intrahepatic Cholangiocarcinoma"
"Liver Cancer","BRAF","V600E","Sensitivity/Response","Dabrafenib+Trametinib","C","28078132",2,"CIVIC","Intrahepatic Cholangiocarcinoma"
"Liver Cancer","IDH1","R132","Sensitivity/Response","Dasatinib","D","27231123",3,"CIVIC","Intrahepatic Cholangiocarcinoma"
"Bladder Cancer","TSC1","FRAMESHIFT TRUNCATION","Sensitivity/Response","Everolimus","B","22923433",2,"CIVIC","Invasive Bladder Transitional Cell Carcinoma"
"Histiocytosis","BRAF","V600","Sensitivity/Response","Vemurafenib","B","26287849",2,"CIVIC","Langerhans-cell Histiocytosis"
"Head & Neck","BRAF","V600E","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Laryngeal Squamous Cell Carcinoma"
"Leukemia","NF1","any/deletion(LoF)","sensitivity","MEK inhibitors","preclinical","23221341",3,"GDKD","leukemia"
"Leukemia","NF1","any/deletion(LoF)","sensitivity","mTOR inhibitors","preclinical","18483311, 20505189, 24509877",3,"GDKD","leukemia"
"Leukemia","NF1","any/deletion(LoF)","no response","everolimus + bevacizumab","early trials","ASCO 2016 (abstr 11053)",2,"GDKD","leukemia"
"Leukemia","NF1","any/deletion(LoF)","sensitivity","mTOR inhibitors + HSP90 inhibitors","preclinical","21907929",3,"GDKD","leukemia"
"Leukemia","FLT3","ITD","Sensitivity/Response","Sunitinib,Sorafenib","D","21482694",3,"CIVIC","Leukemia"
"Leukemia","TP53","Deleterious Mutation","Resistance","RG7112","B","26459177",2,"CIVIC","Leukemia"
"Leukemia","TP53","Wildtype","Sensitivity/Response","RG7112","B","26459177",2,"CIVIC","Leukemia"
"Sarcoma","CDK4","AMPLIFICATION","Sensitivity/Response","Palbociclib","B","23569312",2,"CIVIC","Liposarcoma"
"Sarcoma","MDM2","Amplification","Sensitivity/Response","Milademetan Tosylate, RO5045337","3A","23084521, 23400593",2,"OncoKB","Liposarcoma"
"Sarcoma","CDK4","AMPLIFICATION","Sensitivity/Response","Palbociclib","B","27124835",2,"CIVIC","Liposarcoma"
"Sarcoma","MDM2","amplification(GoF)","response","MDM2 inhibitors (tumors TP53 wt)","early trials","23084521, ASCO 2015 (abstr 10564)",2,"GDKD","liposarcomas"
"Sarcoma","FRS2","amplification(GoF)","sensitivity","FGFR inhibitors","preclinical","23393200",3,"GDKD","liposarcomas"
"Sarcoma","CDK4","amplification(GoF)","response","CDK4 inhibitors (tumors with RB expression)","early trials","23569312",2,"GDKD","liposarcomas"
"Ovarian Cancer","MAP2K1","Oncogenic Mutations","Sensitivity/Response","Cobimetinib, Trametinib","3A","25351745, 25370473, 26324360, 26566875, 30867592",2,"OncoKB","Low-Grade Serous Ovarian Cancer"
"Lung Cancer","KRAS","any(GoF)","response","PI3K pathway inhibitors + MEK inhibitors","early trials","25516890",2,"GDKD","lung"
"Lung Cancer","EGFR","exon 19 p.729-761(GoF)","response","irreversible EGFR TKIs","late trials","22753918",2,"GDKD","lung"
"Lung Cancer","EGFR","L747S(GoF)","sensitivity","MEK inhibitors (alone or in combination)","preclinical","23102728",3,"GDKD","lung"
"Lung Cancer","EGFR","S768I(GoF)","response","irreversible EGFR TKIs","late trials","22753918",2,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","sensitivity","FAK inhibitors","preclinical","23358651",3,"GDKD","lung"
"Lung Cancer","EGFR","L861Q(GoF)","response","irreversible EGFR TKIs","late trials","22753918",2,"GDKD","lung"
"Lung Cancer","EGFR","L718(GoF)","resistance","osimertinib","early trials","ASCO 2017 (abstr 2572)",2,"GDKD","lung"
"Lung Cancer","EGFR","exon 19 p.729-761(GoF)","response","erlotinib, afatinib","NCCN guidelines","22190593",1,"GDKD","lung"
"Lung Cancer","ERCC1","any/deletion(LoF)","sensitivity","cisplatin","preclinical","23275151, 23934192",3,"GDKD","lung"
"Lung Cancer","EGFR","G719A(GoF)","response","afatinib + cetuximab","early trials","ESMO 2012 (abstr 1289)",2,"GDKD","lung"
"Lung Cancer","EGFR","T790M(GoF)","resistance","erlotinib, afatinib","NCCN guidelines","NCCN",1,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","sensitivity","BET inhibitors in LKB1 wt","preclinical","23129625, 24045185",3,"GDKD","lung"
"Lung Cancer","EGFR","exon 19 p.729-761(GoF)","response","afatinib + cetuximab","early trials","ESMO 2012 (abstr 1289)",2,"GDKD","lung"
"Lung Cancer","EGFR","S720(GoF)","no response","erlotinib","case report","26773740",2,"GDKD","lung"
"Lung Cancer","EGFR","G719D(GoF)","response","irreversible EGFR TKIs","late trials","22753918",2,"GDKD","lung"
"Lung Cancer","EGFR","G719D(GoF)","response","erlotinib, afatinib","NCCN guidelines","NCCN",1,"GDKD","lung"
"Lung Cancer","EGFR","L861Q(GoF)","response","afatinib + cetuximab","early trials","ESMO 2012 (abstr 1289)",2,"GDKD","lung"
"Lung Cancer","EGFR","S768I(GoF)","response","erlotinib, afatinib","NCCN guidelines","NCCN",1,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","response","pan-RAF inhibitors","case report","AACR 2016 (abstr CT005)",2,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","response","fatty acid synthase inhibitors","case report","AACR 2016 (abstr LB214)",2,"GDKD","lung"
"Lung Cancer","EGFR","T790M(GoF)","response","irreversible EGFR T790M inhibitors","early trials","ASCO 2014 (abstr 8009), ENA 2014 (abstr 10LBA), ENA 2014 (abstr 9LBA), ASCO 2015 (abstr 8001)",2,"GDKD","lung"
"Lung Cancer","EGFR","G719A(GoF)","response","HSP90 inhibitors","early trials","ESMO 2012 (abstr 4380)",2,"GDKD","lung"
"Lung Cancer","EGFR","rearrangement(GoF) EGFR-RAD51","response","erlotinib","case report","27102076",2,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","sensitivity","JAK/TBK1/IKKε inhibitor","preclinical","24444711",3,"GDKD","lung"
"Lung Cancer","EGFR","L861R(GoF)","response","irreversible EGFR TKIs","late trials","22753918",2,"GDKD","lung"
"Lung Cancer","EGFR","G719C(GoF)","response","erlotinib, afatinib","NCCN guidelines","NCCN",1,"GDKD","lung"
"Lung Cancer","ERCC1","any/deletion(LoF)","sensitivity","PARP inhibitors","preclinical","23934192",3,"GDKD","lung"
"Lung Cancer","EGFR","L792(GoF)","resistance","osimertinib","early trials","ASCO 2017 (abstr 2572)",2,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","sensitivity","trametinib + ponatinib","preclinical","27338794",3,"GDKD","lung"
"Lung Cancer","EGFR","exon 20 p.762-823(GoF)","decreased sensitivity","first-generation and irreversible EGFR TKIs","late trials","21764376, 26773740,  26051236",2,"GDKD","lung"
"Lung Cancer","EGFR","G719D(GoF)","response","afatinib + cetuximab","early trials","ESMO 2012 (abstr 1289)",2,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","response","MEK inhibitors","early trials","23200175, 24947927, 25667274, 25722381",2,"GDKD","lung"
"Lung Cancer","EGFR","G719A(GoF)","sensitivity","MEK inhibitors (alone or in combination)","preclinical","23102728",3,"GDKD","lung"
"Lung Cancer","EGFR","exon 19 p.729-761(GoF)","response","HSP90 inhibitors","early trials","ESMO 2012 (abstr 4380)",2,"GDKD","lung"
"Lung Cancer","EGFR","V769_770insASV(GoF)","response","erlotinib","case report","26773740, 23328547",2,"GDKD","lung"
"Lung Cancer","ERBB2","A775_G776insYVMA, G776delinsVC, V659E, S310F(GoF)","response","ado-trastuzumab emtansine","early trials","ASCO 2017 (abstr 8510)",2,"GDKD","lung"
"Lung Cancer","EGFR","L861Q(GoF)","response","erlotinib, afatinib","NCCN guidelines","NCCN",1,"GDKD","lung"
"Lung Cancer","EGFR","G719S(GoF)","sensitivity","MEK inhibitors (alone or in combination)","preclinical","23102728",3,"GDKD","lung"
"Lung Cancer","EGFR","L747S(GoF)","response","HSP90 inhibitors","early trials","ESMO 2012 (abstr 4380)",2,"GDKD","lung"
"Lung Cancer","EGFR","T790M(GoF)","response","afatinib + cetuximab","early trials","25074459",2,"GDKD","lung"
"Lung Cancer","EGFR","L861Q(GoF)","sensitivity","MEK inhibitors (alone or in combination)","preclinical","23102728",3,"GDKD","lung"
"Lung Cancer","EGFR","G719A(GoF)","response","erlotinib, afatinib","NCCN guidelines","NCCN",1,"GDKD","lung"
"Lung Cancer","PTEN","any/deletion(LoF)","sensitivity","PI3K pathway inhibitors (alone or in combination)","preclinical","23136191",3,"GDKD","lung"
"Lung Cancer","CCND1","amplification(GoF)","no response","palbociclib","early trials","ASCO 2017 (abstr 9056)",2,"GDKD","lung"
"Lung Cancer","EGFR","S768I(GoF)","sensitivity","MEK inhibitors (alone or in combination)","preclinical","23102728",3,"GDKD","lung"
"Lung Cancer","EGFR","T790M(GoF)","sensitivity","MEK inhibitors (alone or in combination)","preclinical","23102728",3,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","no response","selumetinib","early trials","26802155",2,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","response","CDK4/CDK6 inhibitor abemaciclib","early trials","27217383",2,"GDKD","lung"
"Lung Cancer","EGFR","G719S(GoF)","response","afatinib + cetuximab","early trials","ESMO 2012 (abstr 1289)",2,"GDKD","lung"
"Lung Cancer","EGFR","G719S(GoF)","response","HSP90 inhibitors","early trials","ESMO 2012 (abstr 4380)",2,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","sensitivity","HSP90 inhibitors (in combination)","preclinical","23012248, 21907929",3,"GDKD","lung"
"Lung Cancer","EGFR","exon 19 p.729-761(GoF)","response","afatinib","late trials","22753918, 25589191",2,"GDKD","lung"
"Lung Cancer","EGFR","amplification(GoF)","no response","erlotinib","early trials","ASCO 2015 (abstr e19028)",2,"GDKD","lung"
"Lung Cancer","EGFR","L861Q(GoF)","response","HSP90 inhibitors","early trials","ESMO 2012 (abstr 4380)",2,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","sensitivity","dasatinib + notch inhibitor","preclinical","26855149",3,"GDKD","lung"
"Lung Cancer","EGFR","S768I(GoF)","response","afatinib + cetuximab","early trials","ESMO 2012 (abstr 1289)",2,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","resistance","EGFR TKIs","NCCN guidelines","20921461",1,"GDKD","lung"
"Lung Cancer","EGFR","G719C(GoF)","sensitivity","MEK inhibitors (alone or in combination)","preclinical","23102728",3,"GDKD","lung"
"Lung Cancer","EGFR","L858R(GoF)","response","erlotinib, afatinib, gefitinib","FDA-approved","FDA",1,"GDKD","lung"
"Lung Cancer","EGFR","L861P(GoF)","response","erlotinib, afatinib","NCCN guidelines","NCCN",1,"GDKD","lung"
"Lung Cancer","EGFR","L858R(GoF)","response","irreversible EGFR TKIs","late trials","22753918",2,"GDKD","lung"
"Lung Cancer","EGFR","L858R(GoF)","response","afatinib + cetuximab","early trials","ESMO 2012 (abstr 1289)",2,"GDKD","lung"
"Lung Cancer","EGFR","L858R(GoF)","response","HSP90 inhibitors","early trials","ESMO 2012 (abstr 4380)",2,"GDKD","lung"
"Lung Cancer","EGFR","L861R(GoF)","response","erlotinib, afatinib","NCCN guidelines","NCCN",1,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","response","pan-RAF inhibitor","early trials","AACR 2017 (abstr  CT002)",2,"GDKD","lung"
"Lung Cancer","KRAS","any(GoF)","response","CDK4/6 inhibitor + MEK inhibitor","early trials","AACR 2017 (CT046)",2,"GDKD","lung"
"Lung Cancer","EGFR","G719C(GoF)","response","irreversible EGFR TKIs","late trials","22753918",2,"GDKD","lung"
"Lung Cancer","EGFR","C797S(GoF)","resistance","osimertinib","early trials","25939061",2,"GDKD","lung"
"Lung Cancer","FGFR2","A266_S267ins(GoF)","sensitivity","FGFR inhibitors","preclinical","26048680",3,"GDKD","lung"
"Lung Cancer","EGFR","G719A(GoF)","response","irreversible EGFR TKIs","late trials","22753918",2,"GDKD","lung"
"Lung Cancer","SMO","P641A(GoF)","response","vismodegib","case report","ASCO 2017 (abstr 9062)",2,"GDKD","lung"
"Lung Cancer","EGFR","S768I(GoF)","response","HSP90 inhibitors","early trials","ESMO 2012 (abstr 4380)",2,"GDKD","lung"
"Lung Cancer","EGFR","exon 20 p.762-823(GoF)","response","HSP90 inhibitors","early trials","ASCO 2014 (abstr 8015)",2,"GDKD","lung"
"Lung Cancer","EGFR","exon 20 p.762-823(GoF)","sensitivity","osimertinib","preclinical","26515464",3,"GDKD","lung"
"Lung Cancer","EGFR","G719S(GoF)","response","erlotinib, afatinib","NCCN guidelines","NCCN",1,"GDKD","lung"
"Lung Cancer","EGFR","exon 19 p.729-761(GoF)","sensitivity","MEK inhibitors (alone or in combination)","preclinical","23102728",3,"GDKD","lung"
"Lung Cancer","EGFR","exon 19 p.729-761(GoF)","response","erlotinib, afatinib, gefitinib","FDA-approved","FDA",1,"GDKD","lung"
"Lung Cancer","EGFR","L858R(GoF)","sensitivity","MEK inhibitors (alone or in combination)","preclinical","23102728",3,"GDKD","lung"
"Lung Cancer","RAD51","rearrangement(GoF) EGFR-RAD51","response","erlotinib","case report","27102076",2,"GDKD","lung"
"Lung Cancer","EGFR","L747S(GoF)","response","afatinib + cetuximab","early trials","ESMO 2012 (abstr 1289)",2,"GDKD","lung"
"Lung Cancer","EGFR","T790M(GoF)","response","afatinib + nimotuzumab","early trials","26667485",2,"GDKD","lung"
"Lung Cancer","EGFR","T790M(GoF)","response","HSP90 inhibitors","early trials","ESMO 2012 (abstr 4380)",2,"GDKD","lung"
"Lung Cancer","EGFR","G719C(GoF)","response","HSP90 inhibitors","early trials","ESMO 2012 (abstr 4380)",2,"GDKD","lung"
"Lung Cancer","FGFR2","290_291WI>C(GoF)","sensitivity","FGFR inhibitors","preclinical","26048680",3,"GDKD","lung"
"Lung Cancer","EGFR","G719D(GoF)","sensitivity","MEK inhibitors (alone or in combination)","preclinical","23102728",3,"GDKD","lung"
"Lung Cancer","PIK3CA","any(GoF)","no response","PI3K pathway inhibitors","early trials","ASCO 2017 (abstr 9054)",2,"GDKD","lung"
"Lung Cancer","RICTOR","amplification(GoF)","response","mTORC1/2 inhibitors","case report","26370156",2,"GDKD","lung"
"Lung Cancer","EGFR","G719D(GoF)","response","HSP90 inhibitors","early trials","ESMO 2012 (abstr 4380)",2,"GDKD","lung"
"Lung Cancer","EGFR","L861P(GoF)","response","irreversible EGFR TKIs","late trials","22753918",2,"GDKD","lung"
"Lung Cancer","EGFR","L861R(GoF)","response","afatinib + cetuximab","early trials","ESMO 2012 (abstr 1289)",2,"GDKD","lung"
"Lung Cancer","EGFR","L861R(GoF)","response","HSP90 inhibitors","early trials","ESMO 2012 (abstr 4380)",2,"GDKD","lung"
"Lung Cancer","EGFR","L747S(GoF)","response","irreversible EGFR TKIs","late trials","22753918",2,"GDKD","lung"
"Lung Cancer","EGFR","L861P(GoF)","sensitivity","MEK inhibitors (alone or in combination)","preclinical","23102728",3,"GDKD","lung"
"Lung Cancer","EGFR","L861P(GoF)","response","afatinib + cetuximab","early trials","ESMO 2012 (abstr 1289)",2,"GDKD","lung"
"Lung Cancer","EGFR","L861P(GoF)","response","HSP90 inhibitors","early trials","ESMO 2012 (abstr 4380)",2,"GDKD","lung"
"Lung Cancer","EGFR","L861R(GoF)","sensitivity","MEK inhibitors (alone or in combination)","preclinical","23102728",3,"GDKD","lung"
"Lung Cancer","EGFR","G719C(GoF)","response","afatinib + cetuximab","early trials","ESMO 2012 (abstr 1289)",2,"GDKD","lung"
"Lung Cancer","EGFR","T790M(GoF)","response","osimertinib","FDA","FDA",1,"GDKD","lung"
"Lung Cancer","EGFR","L747S(GoF)","response","erlotinib, afatinib","NCCN guidelines","NCCN",1,"GDKD","lung"
"Lung Cancer","EGFR","G719S(GoF)","response","irreversible EGFR TKIs","late trials","22753918",2,"GDKD","lung"
"Lung Cancer","CDK4","amplification(GoF)","no response","palbociclib","early trials","ASCO 2017 (abstr 9056)",2,"GDKD","lung"
"Lung Cancer","EGFR","K757R, E746G(GoF)","response","erlotinib","case report","26773740",2,"GDKD","lung"
"Lung Cancer","ALK","EML4-ALK","Resistance","Erlotinib","C","23181703",2,"CIVIC","Lung Acinar Adenocarcinoma"
"Lung Cancer","EGFR","Exon 20 Insertion","Resistance","Erlotinib","C","22895145",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Afatinib","B","24439929",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","RIT1","MUTATION","Sensitivity/Response","Pictilisib,Selumetinib","D","24469055",3,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Osimertinib","C","26181354",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","RET","KIF5B-RET","Sensitivity/Response","Vandetanib","C","23584301",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Afatinib","B","22452895",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","RET","KIF5B-RET","Sensitivity/Response","Vandetanib+Everolimus","C","25982012",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","D770_N771insGT","Resistance","Erlotinib","C","23371856",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ALK","ALK Fusion G1202R","Resistance","Crizotinib","C","22277784",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","NRG1","SDC4-NRG1","Sensitivity/Response","Afatinib","C","28950338",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ERBB2","Kinase Domain Mutation","Sensitivity/Response","Trastuzumab","C","26598547",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Salirasib","B","21847063",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","STK11","Mutation","Resistance","Atezolizumab,Pembrolizumab,Nivolumab","B","29773717",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","PIK3CA","E545K","Resistance","Gefitinib","D","16906227",3,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","MET","Amplification","Sensitivity/Response","Crizotinib","C","25922291",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","MAP2K1","K57N","Sensitivity/Response","Selumetinib","D","18632602",3,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","C797S","Resistance","Osimertinib","C","26181354",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ERBB2","Y772_A775DUP","Sensitivity/Response","Afatinib","C","22325357",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Crizotinib","C","25922291",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","D770delinsGY","Resistance","Erlotinib","C","24353160",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","Ex19 del L858R","Sensitivity/Response","Erlotinib","B","22285168",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","AKT2","Amplification","Sensitivity/Response","Vandetanib+Everolimus","C","25982012",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","MET","EXON 14 SKIPPING MUTATION","Sensitivity/Response","Crizotinib","C","25769807",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ROS1","REARRANGEMENT","Sensitivity/Response","Ceritinib","C","26917690",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Afatinib","B","22452895",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","MET","EXON 14 SKIPPING MUTATION","Sensitivity/Response","Crizotinib","C","25971939",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","Exon 20 Insertion","Resistance","Afatinib","B","26051236",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Afatinib","B","23816960",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","E746_T751>I","Sensitivity/Response","Gefitinib","C","15329413",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Afatinib","B","24439929",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","KRAS","G12A","Resistance","Gefitinib,Erlotinib","B","19794967",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Erlotinib","D","27102076",3,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ERBB2","Y772_A775DUP","Sensitivity/Response","Trastuzumab Emtansine","C","25789838",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","L747_S752delinsQ","Sensitivity/Response","Erlotinib","C","15329413",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ROS1","CD74-ROS1 G2032R","Resistance","Crizotinib","C","23724914",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","D770_N771insGL","Resistance","Erlotinib","C","24353160",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Gefitinib","B","22370314",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Afatinib","B","25589191",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Afatinib","B","23816960",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","MET","Amplification","Sensitivity/Response","Crizotinib","C","26724472",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","NTRK1","Fusion","Sensitivity/Response","Larotrectinib,Crizotinib,Lestaurtinib","D","24162815",3,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Erlotinib","C","27566387",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ROS1","REARRANGEMENT","Sensitivity/Response","Crizotinib","C","25922291",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Gefitinib","B","27022112",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","Rare Mutation","Sensitivity/Response","Gefitinib","C","27022112",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ERBB2","Kinase Domain Mutation","Sensitivity/Response","Afatinib","C","22325357",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Gefitinib","B","27022112",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ROS1","G2032R","Resistance","Crizotinib","C","23724914",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","P772_V774insPHV","Sensitivity/Response","Erlotinib","C","24353160",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","PIK3CA","E545K","Resistance","Erlotinib,Afatinib,Gefitinib","B","27304188",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Osimertinib","C","26269204",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","H773_V774insNPH","Resistance","Erlotinib","C","24353160",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","S768I","Sensitivity/Response","Gefitinib","C","20522446",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","A767_V769dupASV","Resistance","Erlotinib","C","24353160",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","EGFR-RAD51","Sensitivity/Response","Erlotinib","C","29290255",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ERBB2","Amplification","Resistance","Gefitinib,Erlotinib","C","23470965",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","S768I","Sensitivity/Response","Erlotinib","C","25521405",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","T790M","Resistance","Erlotinib,Gefitinib","B","23470965",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","E746G","Sensitivity/Response","Erlotinib","C","26773740",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","MET","EXON 14 SKIPPING MUTATION","Sensitivity/Response","Capmatinib","C","25971938",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","S768I","Resistance","Erlotinib","C","22895145",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","TYMS","Amplification","Resistance","Pemetrexed","B","23645741",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","GATA2","EXPRESSION","Sensitivity/Response","Bortezomib+Fasudil","D","22541434",3,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","EGFR-RAD51","Sensitivity/Response","Icotinib","C","31064887",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ERBB2","P780INS","Sensitivity/Response","Dacomitinib","C","25899785",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Gefitinib","C","15329413",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","MET","Amplification","Resistance","Erlotinib,Gefitinib","C","23470965",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","POLD1","C284Y","Sensitivity/Response","Pembrolizumab","C","25765070",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ERBB2","G776L","Sensitivity/Response","Afatinib","C","22325357",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Cetuximab","D","27102076",3,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Erlotinib","B","27032107",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","MET","EXON 14 SKIPPING MUTATION","Sensitivity/Response","Crizotinib","C","26845194",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","G719","Sensitivity/Response","Erlotinib","B","26773740",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","RICTOR","AMPLIFICATION","Sensitivity/Response","Sapanisertib,Onatasertib","C","26370156",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ERBB2","Y772_A775DUP","Sensitivity/Response","Afatinib","C","26559459",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","PIK3CA","H1047R","Sensitivity/Response","Dactolisib","D","19029981",3,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Gefitinib","B","22370314",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","MET","EXON 14 SKIPPING MUTATION","Sensitivity/Response","Crizotinib","C","26729443",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","V769_770insASV","Sensitivity/Response","Erlotinib","C","26773740",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","S720","Resistance","Erlotinib","C","26773740",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","ERBB2","G778_P780DUP","Sensitivity/Response","Afatinib","C","22325357",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","EGFR","K757R","Sensitivity/Response","Erlotinib","C","26773740",2,"CIVIC","Lung Adenocarcinoma"
"Lung Cancer","KRAS","G12D","Resistance","Gefitinib","B","17409929",2,"CIVIC","Lung Cancer"
"Lung Cancer","FGFR1","Expression","Sensitivity/Response","Ponatinib","D","24771645",3,"CIVIC","Lung Cancer"
"Lung Cancer","NQO1","EXPRESSION","Resistance","Amrubicin","D","21964527",3,"CIVIC","Lung Cancer"
"Lung Cancer","KRAS","G12A","Resistance","Gefitinib","B","17409929",2,"CIVIC","Lung Cancer"
"Lung Cancer","KRAS","G12V","Resistance","Gefitinib","C","17409929",2,"CIVIC","Lung Cancer"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Gefitinib","B","17409929",2,"CIVIC","Lung Cancer"
"Lung Cancer","KRAS","G12S","Resistance","Gefitinib","B","17409929",2,"CIVIC","Lung Cancer"
"Lung Cancer","EGFR","T790M","Resistance","Multikinase Inhibitor AEE788>Gefitinib","D","18227510",3,"CIVIC","Lung Cancer"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Erlotinib","B","22025157",2,"CIVIC","Lung Cancer"
"Lung Cancer","KRAS","G12C","Resistance","Gefitinib","B","17409929",2,"CIVIC","Lung Cancer"
"Lung Cancer","NQO1","P187S","Sensitivity/Response","Amrubicin","D","21964527",3,"CIVIC","Lung Cancer"
"Lung Cancer","PDCD4","EXPRESSION","Sensitivity/Response","Paclitaxel","B","25928036",2,"CIVIC","Lung Cancer"
"Lung Cancer","ERBB2","Y772_A775DUP","Sensitivity/Response","Afatinib","D","19122144",3,"CIVIC","Lung Carcinoma"
"Lung Cancer","BRAF","V600E","Resistance","Dabrafenib","C","23524406",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK G1269A","Resistance","Crizotinib","C","22235099",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Docetaxel+Selumetinib","B","23200175",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L747_P753delinsS","Sensitivity/Response","Erlotinib","D","19147750",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Pemetrexed+Erlotinib","C","24636847",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Gefitinib","B","20038723",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","F1174L","Resistance","Crizotinib","D","21030459",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","TYMS","Underexpression","Sensitivity/Response","Pemetrexed","B","21367480",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","NRG1","Expression","Sensitivity/Response","Carboplatin,Paclitaxel,Cisplatin,Gemcitabine","D","23390248",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L861Q","Sensitivity/Response","Gefitinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","G719S","Sensitivity/Response","Gefitinib","D","15118125",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","BRAF","V600E","Sensitivity/Response","Trametinib+Dabrafenib","A","27283860",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Gefitinib,Erlotinib","B","24457318",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Gefitinib,Erlotinib","B","16818686",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Resistance","Selumetinib+Docetaxel","A","28492898",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Gefitinib","D","15118125",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T847I","Sensitivity/Response","Gefitinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","E746_A750del","Sensitivity/Response","Gefitinib","D","24893891",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Gefitinib","D","16730237",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","G719D","Sensitivity/Response","Erlotinib,Gefitinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion G1202R","Resistance","Crizotinib","D","22277784",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Mutation","Sensitivity/Response","Ceritinib","B","24670165",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Resistance","MEK Inhibitor RO4987655","B","24947927",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK and Amplification","Resistance","Crizotinib","D","22277784",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","XRCC1","R194W","Sensitivity/Response","Gemcitabine,Vinorelbine,Docetaxel","B","19157633",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Gefitinib","B","20022809",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 L2026M","Sensitivity/Response","Foretinib","D","25688157",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK S1206Y","Resistance","Crizotinib","D","22277784",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion I1171","Sensitivity/Response","Ceritinib","C","25736571",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Exon 18 Overexpression","Sensitivity/Response","Erlotinib+Bevacizumab","B","24039832",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Ceritinib","B","26973324",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Trametinib","B","22805291",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","CD274","Expression","Sensitivity/Response","Nivolumab,Pembrolizumab","B","26086854",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Erlotinib","B","15329413",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","A763_Y764insFQEA","Sensitivity/Response","Erlotinib","D","24353160",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK e6-e20","Sensitivity/Response","TAE684","D","18451166",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK L1196M","Sensitivity/Response","Alectinib","D","21575866",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","TYMS","Overexpression","Resistance","Pemetrexed","B","23060591",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ETS2","RS461155","Sensitivity/Response","Paclitaxel+Cisplatin","B","26893365",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","HIP1-ALK I1171N","Resistance","Alectinib>Crizotinib","C","25393796",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Rociletinib","B","25923550",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","AURKA","Overexpression","Resistance","Cisplatin","B","25082261",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","M766_A767insASV","Sensitivity/Response","Erlotinib","C","24353160",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion I1171","Resistance","Alectinib","C","25736571",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Gefitinib","B","20038723",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK C1156Y","Resistance","Crizotinib","C","20979473",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK L1196M","Resistance","Crizotinib","C","20979473",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","NRG1","Expression","Sensitivity/Response","Patritumab","B","26137564",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","REARRANGEMENT","Sensitivity/Response","Crizotinib","B","25667280",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Afatinib","A","23982599",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK","Sensitivity/Response","Crizotinib","C","20979469",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 G2032R","Sensitivity/Response","Lorlatinib","D","25733882",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Erlotinib","B","21783417",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Alectinib","A","28586279",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab","B","14679114",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","PIK3CA","E545K","Sensitivity/Response","PI103","D","19513541",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Ceritinib","A","28602779",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","DDR2","L239R","Sensitivity/Response","Dasatinib","D","22328973",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","RARE Exon 18-21 Mutation","Sensitivity/Response","Gefitinib,Erlotinib","B","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","DDR2","L63V","Sensitivity/Response","Dasatinib","D","22328973",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","GNAS","c.393T>C","Resistance","Gefitinib,Erlotinib","B","24758907",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Erlotinib,Docetaxel","B","26209642",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK","Sensitivity/Response","Lorlatinib","D","26554404",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","RET","Fusion","Sensitivity/Response","Cabozantinib","B","27825636",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","FGFR1","Amplification","Sensitivity/Response","Dovitinib","B","27315356",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK L1196M","Resistance","Crizotinib","D","22277784",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","G719A","Sensitivity/Response","Gefitinib","C","20038723",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","D770_N771insNPG","Sensitivity/Response","Gefitinib,Afatinib","D","24353160",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Erlotinib","D","18408761",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion F1245C","Resistance","Crizotinib","C","26775591",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab","B","14967075",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Lorlatinib","B","30413378",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Gain-of-function","Sensitivity/Response","Gefitinib","B","15118073",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","N826S","Resistance","Erlotinib","D","19147750",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK e6-e20","Sensitivity/Response","Crizotinib","C","20979469",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ERCC2","K751Q","Sensitivity/Response","Carboplatin+Paclitaxel","B","19470925",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK C1156Y","Resistance","Crizotinib","D","24675041",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","BRAF","V600E","Sensitivity/Response","Vemurafenib","B","29320312",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","AREG","Expression","Resistance","Crizotinib","D","21791641",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ERBB2","Amplification","Sensitivity/Response","Dacomitinib","B","25899785",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Wildtype","Resistance","Gefitinib","B","19692680",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","S768I","Sensitivity/Response","Erlotinib","C","27211795",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Crizotinib","A","23724913",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ERBB2","M774DELINSWLV","Sensitivity/Response","Dacomitinib","C","25899785",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","DDR2","I638F","Sensitivity/Response","Dasatinib","D","22328973",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ABCB1","I1145I","Sensitivity/Response","Cisplatin,Carboplatin","B","22296372",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ARAF","S214C","Sensitivity/Response","Sorafenib","C","24569458",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","DDR2","S768R","Sensitivity/Response","Dasatinib+Erlotinib","C","22328973",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Erlotinib","A","24868098",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK e20-e20","Sensitivity/Response","Alvespimycin+Crizotinib","D","22912387",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Afatinib","A","23982599",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","REARRANGEMENT","Sensitivity/Response","Crizotinib","A","29596029",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MET","D1228V","Resistance","Savolitinib","C","27694386",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L747P","Sensitivity/Response","Gefitinib,Erlotinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Gefitinib,Erlotinib","B","24736073",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 L2026M","Resistance","Crizotinib","D","25688157",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 G2032R","Sensitivity/Response","Foretinib","D","25688157",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","Fusion","Sensitivity/Response","Crizotinib","A","30980071",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L838P","Sensitivity/Response","Gefitinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Retaspimycin Hydrochloride","C","20940188",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Brigatinib","B","28475456",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","PDGFRA","Amplification","Sensitivity/Response","Sunitinib","D","19366796",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Amplification","Sensitivity/Response","Gefitinib,Erlotinib","B","20826716",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","V851I","Sensitivity/Response","Gefitinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Rociletinib","D","24065731",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Alectinib","B","23639470",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L861R","Sensitivity/Response","Gefitinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK e6-e20","Sensitivity/Response","Ceritinib","D","24675041",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","G12/G13","Resistance","Gefitinib,Erlotinib","B","15696205",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MET","MET-ATXN7L1","Sensitivity/Response","Crizotinib","C","30339198",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Resistance","Erlotinib,Gefitinib","B","21258250",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Alectinib","A","26708155",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Erlotinib,Gefitinib","B","21258250",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","RET","Fusion","Sensitivity/Response","Selpercatinib","B","32846060",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","SMARCA4","LOSS","Sensitivity/Response","Abemaciclib,Palbociclib","D","30718506",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion G1202R","Resistance","Ceritinib","D","24675041",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK  V1180L","Resistance","Crizotinib","D","25228534",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KIT","L576P","Sensitivity/Response","Dasatinib,Nilotinib,Imatinib","D","17372901",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MET","Amplification","Resistance","Gefitinib","D","17463250",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","G12D","Sensitivity/Response","Dactolisib+Selumetinib","D","19029981",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L861","Sensitivity/Response","Gefitinib,Erlotinib","B","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion G1202R","Sensitivity/Response","Tanespimycin","D","22277784",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MET","Amplification","Sensitivity/Response","Crizotinib","D","21716144",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","NRAS","Q61K","Sensitivity/Response","Selumetinib,Trametinib","D","23515407",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ABL1","R351W","Sensitivity/Response","Dasatinib","D","26758680",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","G12C","Sensitivity/Response","Docetaxel+Selumetinib","B","26125448",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 G2032R","Sensitivity/Response","Cabozantinib","D","25351743",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK","Sensitivity/Response","Retaspimycin Hydrochloride+Crizotinib","D","21258415",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK e6-e20","Sensitivity/Response","Alvespimycin","D","22912387",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","JAK1","OVEREXPRESSION","Sensitivity/Response","Enzastaurin","D","22333600",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK","Sensitivity/Response","Alvespimycin+Crizotinib","D","22912387",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","TSC1","FRAMESHIFT TRUNCATION","Sensitivity/Response","Sirolimus","D","19966866",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Resistance","Afatinib","B","24035188",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Crizotinib","B","26466010",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","CDKN2A","Loss","Resistance","Palbociclib","B","174591",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Staurosporine","E","24658966",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","K806E","Sensitivity/Response","Gefitinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","V834I","Sensitivity/Response","Gefitinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Selumetinib+B-Raf/VEGFR-2 Inhibitor RAF265","D","25199829",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Trametinib+Afatinib","D","24685132",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Gefitinib","B","15329413",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","N842S","Sensitivity/Response","Gefitinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Resistance","Erlotinib","A","25668228",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","IGF1R","EXPRESSION","Resistance","Gefitinib","D","23619944",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Resistance","Dacomitinib","B","21430269",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Amplification","Sensitivity/Response","Gefitinib,Erlotinib","B","27664271",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","NTRK1","SQSTM1-NTRK1","Sensitivity/Response","Entrectinib","C","28183697",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","D770_N771insSVD","Resistance","Erlotinib","D","24353160",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK and Amplification","Resistance","Crizotinib","C","23344087",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","BCL2L11","DELETION POLYMORPHISM","Resistance","Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor","B","22426421",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L838V","Resistance","Erlotinib","D","19147750",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ERBB2","Y772_A775DUP","Sensitivity/Response","Dacomitinib","B","25899785",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK L1196M","Sensitivity/Response","Ceritinib","D","24675041",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion I1171","Sensitivity/Response","TAE684","D","25228534",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Ex19 del L858R","Sensitivity/Response","Erlotinib,Gefitinib","B","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Afatinib","B","27083334",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion I1171","Sensitivity/Response","Ceritinib","D","24675041",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ARAF","S214C","Sensitivity/Response","Sorafenib","D","24569458",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Gefitinib","B","18509184",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","CD274","Expression","Sensitivity/Response","Pembrolizumab","B","27718847",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK","Sensitivity/Response","Crizotinib","C","20979473",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Resistance","Gefitinib","C","17020982",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","DDR2","G253C","Sensitivity/Response","Dasatinib","D","22328973",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","DDR2","G505S","Sensitivity/Response","Dasatinib","D","22328973",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","DDR2","G774V","Sensitivity/Response","Dasatinib","D","22328973",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Overexpression","Sensitivity/Response","Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor","B","22056021",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","G719","Sensitivity/Response","Gefitinib,Erlotinib","B","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","STK11","LOSS","Sensitivity/Response","Sirolimus,Everolimus","D","26027660",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","A864T","Sensitivity/Response","Erlotinib","D","19147750",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","E746_A750del","Sensitivity/Response","Gefitinib","C","15329413",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Erlotinib","C","21969500",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Canertinib","D","18408761",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","M766_A767insAI","Resistance","Erlotinib","D","24353160",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK L1152R","Resistance","Crizotinib","C","21791641",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MET","D1228V","Sensitivity/Response","Cabozantinib","C","27694386",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","D761Y","Resistance","Erlotinib,Gefitinib","C","17085664",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 L2155S","Resistance","Foretinib,TAE684,Crizotinib","D","25688157",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","G12V","Sensitivity/Response","Palbociclib","D","20609353",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","V774M","Sensitivity/Response","Erlotinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","G719A","Sensitivity/Response","Erlotinib,Gefitinib","C","23749122",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","R705K","Sensitivity/Response","Gefitinib,Erlotinib","C","23749122",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ERBB2","Mutation","Sensitivity/Response","Pertuzumab+Trastuzumab","B","29320312",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 G2101A","Resistance","Crizotinib","D","25688157",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Docetaxel","B","20038723",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Amplification","Resistance","Rociletinib,Osimertinib","D","28202511",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Lapatinib","D","18408761",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK e6-e20","Sensitivity/Response","TAE684","D","18594010",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Neratinib","D","16818618",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK G1269A","Resistance","Crizotinib","C","23344087",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","H773_V774insH","Resistance","Erlotinib","D","24353160",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","PIK3CA","Mutation","Resistance","Gefitinib,Erlotinib","B","21258250",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Dacomitinib","B","28958502",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK I1171S","Resistance","Alectinib>Crizotinib","C","25393796",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","G12V","Sensitivity/Response","Selumetinib+Docetaxel","B","26125448",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Overexpression","Sensitivity/Response","Gefitinib","B","16707605",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","STK11","LOSS","Resistance","Selumetinib+Docetaxel","D","22425996",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK  V1180L","Resistance","Alectinib","D","25228534",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","TP53","Mutation","Sensitivity/Response","Docetaxel+Selumetinib","D","22425996",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","TP53","Mutation","Resistance","Docetaxel","D","22425996",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","V742A","Sensitivity/Response","Erlotinib","D","19147750",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Osimertinib","D","24893891",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Afatinib","D","25862853",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MET","EXON 14 SKIPPING MUTATION","Sensitivity/Response","Crizotinib","C","26892698",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MET","Amplification","Sensitivity/Response","Crizotinib","C","21623265",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Overexpression","Sensitivity/Response","Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor","B","26439803",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Afatinib","D","26515464",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Erlotinib","B","22285168",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Erlotinib","B","22285168",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","G719S","Sensitivity/Response","Erlotinib","D","19147750",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","BRAF","V600","Sensitivity/Response","Vemurafenib","B","26287849",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 G2032R","Sensitivity/Response","Cabozantinib,Foretinib","D","26372962",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Afatinib","D","21732342",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ABCB1","Overexpression","Resistance","Paclitaxel","D","21883677",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Dacomitinib","D","18089823",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Y764_V765insHH","Resistance","Erlotinib","D","24353160",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","V774A","Sensitivity/Response","Gefitinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","CD274","Expression","Sensitivity/Response","Avelumab,Nivolumab,Pembrolizumab,Atezolizumab","B","26918451",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Osimertinib","A","27959700",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","P772_H773insYNP","Resistance","Erlotinib","C","24353160",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","NTRK1","SQSTM1-NTRK1","Sensitivity/Response","Entrectinib","C","26565381",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","CD274","Expression","Sensitivity/Response","Atezolizumab","B","26970723",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 G2101A","Sensitivity/Response","Foretinib","D","25688157",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","BIRC5","NUCLEAR EXPRESSION","Sensitivity/Response","Taxane Compound+Platinum Compound","B","24961465",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Crizotinib","B","21933749",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab Emtansine","D","24898067",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion I1171","Resistance","Crizotinib","D","25228534",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","TP53","Deleterious Mutation","Sensitivity/Response","Adjuvant Chemotherapy","B","26899019",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","NTRK1","Fusion","Sensitivity/Response","Entrectinib","C","26565381",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Canertinib","D","18408761",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK T1151INST","Resistance","Crizotinib","C","22277784",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","RASA1","LOSS-OF-FUNCTION","Sensitivity/Response","Trametinib","D","29127119",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion F1245C","Sensitivity/Response","Ceritinib","C","26775591",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","RET","CCDC6-RET","Sensitivity/Response","Nintedanib","C","26787234",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion I1171","Resistance","Alectinib","C","25228534",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","RARE Exon 18-21 Mutation","Sensitivity/Response","Erlotinib,Gefitinib","B","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Dacomitinib","D","18089823",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Resistance","Crizotinib","C","22235099",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Erlotinib","D","24353160",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","WEE1","RS3910384","Sensitivity/Response","Platinum Compound+Gemcitabine","B","26057002",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 G2032R","Resistance","Brigatinib,AZD3463,Ceritinib,Crizotinib","D","26372962",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Ex19 del L858R","Sensitivity/Response","Gefitinib","C","24755888",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","POLD1","E374K","Sensitivity/Response","Pembrolizumab","C","25765070",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Y1092 PHOSPHORYLATION","Sensitivity/Response","Erlotinib,Gefitinib","B","22901364",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","RRM1","Underexpression","Sensitivity/Response","Gemcitabine+Cisplatin","B","24595080",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","BRAF","G596C","Sensitivity/Response","Dabrafenib+Trametinib","D","27577079",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Afatinib","D","26515464",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK C1156Y","Sensitivity/Response","Lorlatinib","C","26698910",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ABL1","G340L","Sensitivity/Response","Imatinib Mesylate,Dasatinib","D","26758680",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","N826Y","Sensitivity/Response","Gefitinib","C","21531810",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Amplification","Sensitivity/Response","Erlotinib,Gefitinib","B","26722081",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Erlotinib","A","24868098",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK","Sensitivity/Response","WHI-P154","D","17625570",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK e2-e20","Sensitivity/Response","Crizotinib","E","18927303",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Abemaciclib","B","27217383",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Resistance","Gefitinib","B","15728811",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 L2026M","Resistance","Crizotinib","D","25733882",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 G2032R","Resistance","Crizotinib","C","25688157",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MET","EXON 14 SKIPPING MUTATION","Sensitivity/Response","Tepotinib","B","160289",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","A146V","Sensitivity/Response","Abemaciclib","C","24836576",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK and Amplification","Resistance","Crizotinib","D","22235099",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Crizotinib","A","20979469",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion I1171","Sensitivity/Response","Ceritinib","C","25228534",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","RET","Fusion","Sensitivity/Response","Selpercatinib","B","161573",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Erlotinib","D","27612423",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Afatinib","D","18408761",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ERBB3","V855A","Sensitivity/Response","Pertuzumab,Afatinib","D","26689995",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ARAF","S214C","Sensitivity/Response","Trametinib","D","24569458",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Teprotumumab+Erlotinib","B","22025157",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Pemetrexed","B","21642865",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Amplification","Sensitivity/Response","Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor","B","20826716",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MET","D1228N","Resistance","Crizotinib","C","27343442",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MET","Amplification","Sensitivity/Response","Crizotinib","C","27664533",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK e6-e20","Sensitivity/Response","Crizotinib","D","22912387",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Crizotinib","A","25470694",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK C1156Y-L1198F","Resistance","Lorlatinib","C","26698910",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Crizotinib","B","24478318",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Neratinib","D","16818618",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Expression","Sensitivity/Response","Gefitinib","B","12748244",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Crizotinib,Alectinib","B","28586279",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK C1156Y-L1198F","Sensitivity/Response","Crizotinib","C","26698910",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Immune Checkpoint Inhibitor","E","28259530",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","HAVCR2","OVEREXPRESSION","Resistance","PD1 Inhibitor","C","26883990",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Resistance","Erlotinib,Gefitinib","C","15737014",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Osimertinib","B","26720284",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Osimertinib,Rociletinib","D","26515464",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","CD274","Expression","Sensitivity/Response","Atezolizumab,Durvalumab,Avelumab,Nivolumab,Pembrolizumab","B","28472902",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","RET","Fusion","Sensitivity/Response","Vandetanib","B","27825616",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ERBB2","G778_P780DUP","Sensitivity/Response","Dacomitinib","C","25899785",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","ALK Fusion G1269A","Sensitivity/Response","Ceritinib","D","24675041",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Dacomitinib","B","26768165",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Erlotinib,Dacomitinib","B","26768165",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Gefitinib","B","19692680",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Trametinib","B","25722381",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK T1151INST","Resistance","Alectinib","D","22277784",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK  V1180L","Sensitivity/Response","Ceritinib","D","25228534",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK e20-e20","Sensitivity/Response","Crizotinib","D","22912387",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MAPK1","AMPLIFICATION","Resistance","WZ4002","D","22961667",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","CD74-ROS1 L2026M","Sensitivity/Response","Lorlatinib","D","25733882",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","CD274","Expression","Sensitivity/Response","Pembrolizumab","B","25891174",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","G719S","Sensitivity/Response","Gefitinib,Erlotinib","B","26124334",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK C1156Y","Resistance","Ceritinib>Luminespib>Crizotinib","C","26698910",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Crizotinib","B","27022118",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","SMARCA4","UNDEREXPRESSION","Sensitivity/Response","Cisplatin+Vinorelbine","B","26671993",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","PBK","OVEREXPRESSION","Resistance","Gefitinib","D","26745678",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","RRM1","Underexpression","Sensitivity/Response","Gemcitabine,Docetaxel,Vinorelbine","B","24647522",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Alectinib","A","28501140",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Erlotinib","C","15329413",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ABL1","R351W","Sensitivity/Response","Imatinib","D","26758680",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK e6-e20","Sensitivity/Response","2,4-pyrimidinediamine","D","18593892",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Afatinib","D","18408761",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","RET","Fusion","Sensitivity/Response","Alectinib","C","27544060",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MET","EXON 14 MUTATION and AMPLIFICATION","Sensitivity/Response","Crizotinib","C","26729443",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Alectinib","B","25153538",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK e20-e20","Sensitivity/Response","Crizotinib","C","20979469",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK T1151INST","Sensitivity/Response","Tanespimycin","D","22277784",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ABCC10","Overexpression","Resistance","Paclitaxel","D","18445659",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK  V1180L","Sensitivity/Response","Brigatinib","D","25228534",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Resistance","Erlotinib","B","21969500",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ROS1","REARRANGEMENT","Sensitivity/Response","Crizotinib","B","25264305",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Resistance","Erlotinib","B","22025157",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Osimertinib","A","26729184",1,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Osimertinib","D","24893891",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","HAVCR2","OVEREXPRESSION","Sensitivity/Response","Anti-TIM-3 Monoclonal Antibody+PD1 Inhibitor","D","26883990",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Osimertinib","B","25923549",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Resistance","Lapatinib","D","18408761",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK T1151INST","Resistance","TAE684","D","22277784",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Nivolumab,Atezolizumab","B","28525386",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","EML4-ALK  V1180L","Sensitivity/Response","TAE684","D","25228534",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ALK","Fusion","Sensitivity/Response","Alectinib","C","26938871",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","RET","Fusion","Sensitivity/Response","Vandetanib","B","27803005",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Erlotinib+Selumetinib","B","26802155",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","FGFR1","Amplification","Sensitivity/Response","PD173074","D","21666749",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","C797S","Resistance","Osimertinib","B","25939061",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","TYMS","Overexpression","Resistance","Pemetrexed","B","26502926",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","ERBB2","Y772_A775DUP","Sensitivity/Response","Sirolimus+Afatinib","D","19122144",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Mutation","Sensitivity/Response","Afatinib","B","22452896",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","R776C","Sensitivity/Response","Erlotinib","D","19147750",3,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MET","EXON 14 SKIPPING MUTATION","Sensitivity/Response","Crizotinib","B","123413",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","TP53","Wildtype","Sensitivity/Response","Adjuvant Chemotherapy","B","26899019",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","RRM1","Underexpression","Sensitivity/Response","Vinorelbine,Paclitaxel,Gemcitabine","B","23038758",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","T790M","Resistance","Erlotinib,Gefitinib,Afatinib","B","27304188",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","EGFR","Exon 19 Deletion","Sensitivity/Response","Gefitinib","B","18509184",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","KRAS","Mutation","Sensitivity/Response","Trametinib+Pemetrexed+Docetaxel","B","27876675",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","AREG","Expression","Resistance","Crizotinib","B","23344087",2,"CIVIC","Lung Non-small Cell Carcinoma"
"Lung Cancer","MYC","Overexpression","Sensitivity/Response","Cisplatin+Olaparib+Prexasertib","D","28490518",3,"CIVIC","Lung Small Cell Carcinoma"
"Lung Cancer","RICTOR","AMPLIFICATION","Sensitivity/Response","Vistusertib","C","173496",2,"CIVIC","Lung Small Cell Carcinoma"
"Lung Cancer","RB1","MUTATION","Sensitivity/Response","Chemotherapy","B","26802149",2,"CIVIC","Lung Small Cell Carcinoma"
"Lung Cancer","CHEK1","Overexpression","Sensitivity/Response","Olaparib+Cisplatin+Prexasertib","D","28490518",3,"CIVIC","Lung Small Cell Carcinoma"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Erlotinib","D","24893891",3,"CIVIC","Lung Small Cell Carcinoma"
"Lung Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab+Irinotecan","C","25601188",2,"CIVIC","Lung Small Cell Carcinoma"
"Lung Cancer","MET","Amplification","Sensitivity/Response","Crizotinib","C","24192513",2,"CIVIC","Lung Squamous Cell Carcinoma"
"Lung Cancer","FGFR1","Amplification","Sensitivity/Response","AZD4547, BGJ398, Debio1347, Erdafitinib","3A","23082000, 27870574, 30745300",2,"OncoKB","Lung Squamous Cell Carcinoma"
"Lung Cancer","NFE2L2","MUTATION","Sensitivity/Response","Sapanisertib","B","174406",2,"CIVIC","Lung Squamous Cell Carcinoma"
"Lung Cancer","FGFR1","Amplification","Sensitivity/Response","Infigratinib","B","27870574",2,"CIVIC","Lung Squamous Cell Carcinoma"
"Lung Cancer","FGFR1","Amplification","Sensitivity/Response","PD173074","D","21160078",3,"CIVIC","Lung Squamous Cell Carcinoma"
"Lung Cancer","ARAF","S214C(GoF)","response","sorafenib","case report","24569458",2,"GDKD","lung_adeno"
"Lung Cancer","BRAF","rearrangement(GoF)","response","BRAF inhibitor + MEK inhibitor","case report","ASCO 2017 (abstr 9072)",2,"GDKD","lung_adeno"
"Lung Cancer","ROS1","S1986Y, S1986F(GoF)","response","lorlatinib","case report","27401242",2,"GDKD","lung_adeno"
"Lung Cancer","NRG1","rearrangement(GoF)","sensitivity","lapatinib","preclinical","24727320",3,"GDKD","lung_adeno"
"Lung Cancer","BRAF","G466V","sensitivity","dasatinib","preclinical","22649091",3,"GDKD","lung_adeno"
"Lung Cancer","EGFR","L798I(GoF)","resistance","rociletinib","case report","27283993",2,"GDKD","lung_adeno"
"Lung Cancer","ROS1","G2032R(GoF)","resistance","crizotinib","case report","23724914, 25688157",2,"GDKD","lung_adeno"
"Lung Cancer","NRG1","rearrangement(GoF)","response","afatinib","case report","AACR 2016 (abstr 2631)",2,"GDKD","lung_adeno"
"Lung Cancer","FGFR3","S249C, G691R(GoF)","sensitivity","FGFR inhibitors","preclinical","27998968",3,"GDKD","lung_adeno"
"Lung Cancer","BRAF","Y472C","response","dasatinib","case report","22649091",2,"GDKD","lung_adeno"
"Lung Cancer","RET","I788N(GoF)","resistance","ponatinib","preclinical","28615362",3,"GDKD","lung_adeno"
"Lung Cancer","ERBB2","proximal exon 20 p.775-881(GoF)","response","trastuzumab, lapatinib, afatinib, neratinib","early trials","26598547, ASCO 2017 (abstr 9071)",2,"GDKD","lung_adeno"
"Lung Cancer","ROS1","S1986Y, S1986F(GoF)","resistance","crizotinib, ceritinib","case report","27401242",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","C1156Y(GoF)","sensitivity","lorlatinib","preclinical","27401242",3,"GDKD","lung_adeno"
"Lung Cancer","ALK","F1174L(GoF)","sensitivity","novel ALK inhibiors","preclinical","24327273",3,"GDKD","lung_adeno"
"Lung Cancer","ROS1","G2032R(GoF)","sensitivity","cabozantinib","preclinical","25351743",3,"GDKD","lung_adeno"
"Lung Cancer","MET","D1228V(GoF)","resistance","MET inhibitor","case report","27694386",2,"GDKD","lung_adeno"
"Lung Cancer","BRAF","V600E(GoF)","response","dabrafenib","early trials","27080216",2,"GDKD","lung_adeno"
"Lung Cancer","MET","amplification(GoF)","response","crizotinib","early trials","ASCO 2014 (abstr 8001), ASCO 2015 (abstr 2595)",2,"GDKD","lung_adeno"
"Lung Cancer","NRAS","any(GoF)","sensitivity","MEK inhibitors","preclinical","23515407",3,"GDKD","lung_adeno"
"Lung Cancer","ALK","L1198F(GoF)","response","crizotinib","case report","26698910",2,"GDKD","lung_adeno"
"Lung Cancer","MET","amplification(GoF)","resistance","EGFR TKIs (EGFR mut disease)","early trials","ASCO 2015 (abstr 8089)",2,"GDKD","lung_adeno"
"Lung Cancer","BRAF","V600E(GoF)","response","dabrafenib + trametinib","FDA-approved","27283860",1,"GDKD","lung_adeno"
"Lung Cancer","ERBB2","V659E(GoF)","response","lapatinib","case report","23950206",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","L1198F(GoF)","resistance","lorlatinib","case report","26698910",2,"GDKD","lung_adeno"
"Lung Cancer","BRAF","rearrangement(GoF)","sensitivity","sorafenib, MEK inhibitors","preclinical","24727320",3,"GDKD","lung_adeno"
"Lung Cancer","NTRK1","rearrangement(GoF)","sensitivity","TRK inhibitors","preclinical","24162815",3,"GDKD","lung_adeno"
"Lung Cancer","ROS1","rearrangement(GoF)","response","cabozantinib","case report","27370605",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","C1156Y(GoF)","resistance","crizotinib","case report","22277784",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","L1196M(GoF)","response","brigatinib","case report","ASCO 2017 (abstr 9065)",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","E1408V(GoF)","response","brigatinib","case report","ASCO 2017 (abstr 9065)",2,"GDKD","lung_adeno"
"Lung Cancer","BRAF","V600E(GoF)","resistance","EGFR TKIs","case report","22773810",2,"GDKD","lung_adeno"
"Lung Cancer","IGF1R","amplification(GoF)","resistance","erlotinib","preclinical","24458568",3,"GDKD","lung_adeno"
"Lung Cancer","ALK","rearrangement(GoF)","sensitivity","ALK inhibitors + SRC inhibitors","preclinical","25394791",3,"GDKD","lung_adeno"
"Lung Cancer","ALK","rearrangement(GoF)","sensitivity","ALK inhibitors + MEK inhibitors","preclinical","26301689",3,"GDKD","lung_adeno"
"Lung Cancer","NTRK1","rearrangement(GoF)","response","crizotinib","case report","ASCO 2013 (abstr 8023)",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","1151Tins(GoF)","resistance","crizotinib","case report","22277784",2,"GDKD","lung_adeno"
"Lung Cancer","ROS1","rearrangement(GoF)","sensitivity","HSP90 inhibitors","preclinical","23533265",3,"GDKD","lung_adeno"
"Lung Cancer","ERBB2","G776L(GoF)","response","trastuzumab-based therapy","case report","16775247",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","amplification(GoF)","resistance","crizotinib","case report","22277784",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","F1174L(GoF)","resistance","crizotinib","case report","22277784",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","L1196M(GoF)","response","ceritinib","FDA-approved","24670165, 24327273",1,"GDKD","lung_adeno"
"Lung Cancer","ALK","1151Tins(GoF)","response","ceritinib","FDA-approved","24670165",1,"GDKD","lung_adeno"
"Lung Cancer","ALK","G1269A(GoF)","response","ceritinib","FDA-approved","24670165",1,"GDKD","lung_adeno"
"Lung Cancer","ALK","L1196M(GoF)","resistance","crizotinib","case report","22277784",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","amplification(GoF)","response","brigatinib","case report","ASCO 2017 (abstr 9065)",2,"GDKD","lung_adeno"
"Lung Cancer","RET","rearrangement(GoF)","response","cabozantinib, vandetanib, sunitinib","early trials","28447912",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","rearrangement(GoF)","response","crizotinib, ceritinib, alectinib","FDA-approved","FDA",1,"GDKD","lung_adeno"
"Lung Cancer","STK11","any/deletion(LoF)","resistance","PD1 blockade (if KRAS co-mutation)","early trials","ASCO 2017 (abstr 9016)",2,"GDKD","lung_adeno"
"Lung Cancer","STK11","any/deletion(LoF)","resistance","MEK inhibitors + docetaxel in KRAS mutant","preclinical","22425996",3,"GDKD","lung_adeno"
"Lung Cancer","STK11","any/deletion(LoF)","sensitivity","mTOR inhibitors","preclinical","19165201",3,"GDKD","lung_adeno"
"Lung Cancer","ALK","G1202R(GoF)","resistance","crizotinib","case report","22277784",2,"GDKD","lung_adeno"
"Lung Cancer","BRAF","V600E(GoF)","response","ERK inhibitors","early trials","ASCO 2017 (abstr 2508)",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","I1171T(GoF)","response","ceritinib","FDA-approved","25228534",1,"GDKD","lung_adeno"
"Lung Cancer","ALK","rearrangement(GoF)","sensitivity","ALK inhibitors + IGF1R inhibitors","preclinical","25173427",3,"GDKD","lung_adeno"
"Lung Cancer","ALK","L1152R(GoF)","resistance","crizotinib","case report","22277784",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","I1171T(GoF)","resistance","crizotinib, alectinib","case report","25228534",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","G1269A(GoF)","resistance","crizotinib","case report","22277784",2,"GDKD","lung_adeno"
"Lung Cancer","STK11","any/deletion(LoF)","sensitivity","MEK inhibitors","preclinical","19165201",3,"GDKD","lung_adeno"
"Lung Cancer","BRAF","G469A(GoF)","resistance","EGFR TKIs","case report","22773810",2,"GDKD","lung_adeno"
"Lung Cancer","RET","rearrangement(GoF)","response","nintedanib","case report","26787234",2,"GDKD","lung_adeno"
"Lung Cancer","STK11","any/deletion(LoF)","sensitivity","SRC inhibitors (in combination with PI3K/MEK inhibitors)","preclinical","20541700",3,"GDKD","lung_adeno"
"Lung Cancer","ROS1","rearrangement(GoF)","response","crizotinib","FDA-approved","FDA",1,"GDKD","lung_adeno"
"Lung Cancer","ALK","S1206Y(GoF)","response","ceritinib","FDA-approved","24670165",1,"GDKD","lung_adeno"
"Lung Cancer","BRAF","G469A(GoF)","sensitivity","EGFR TKIs + MEK inhibitors in EGFR mutant","preclinical","22773810",3,"GDKD","lung_adeno"
"Lung Cancer","ALK","rearrangement(GoF)","response","novel ALK inhibitors","early trials","23639470",2,"GDKD","lung_adeno"
"Lung Cancer","BRAF","V600E(GoF)","response","vemurafenib","case report","22743296",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","rearrangement(GoF)","response","HSP90 inhibitors","early trials","23553849",2,"GDKD","lung_adeno"
"Lung Cancer","ALK","S1206Y(GoF)","resistance","crizotinib","case report","22277784",2,"GDKD","lung_adeno"
"Lung Cancer","ERBB4","rearrangement(GoF)","sensitivity","lapatinib, afatinib","preclinical","24727320",3,"GDKD","lung_adeno"
"Lung Cancer","STK11","any/deletion(LoF)","sensitivity","phenformin","preclinical","23352126",3,"GDKD","lung_adeno"
"Lung Cancer","MLL2","mut(LoF)","sensitivity","bicalutamide","preclinical","27397505",3,"GDKD","lung_squamous"
"Lung Cancer","DDR2","S768R(GoF)","response","dasatinib + erlotinib","case report","22328973",2,"GDKD","lung_squamous"
"Lung Cancer","FGFR2","S320C(GoF)","sensitivity","FGFR inhibitors","preclinical","23786770",3,"GDKD","lung_squamous"
"Lung Cancer","DDR2","L239R(GoF)","sensitivity","dasatinib","preclinical","22328973",3,"GDKD","lung_squamous"
"Lung Cancer","FGFR2","W290C(GoF)","sensitivity","FGFR inhibitors","preclinical","23786770",3,"GDKD","lung_squamous"
"Lung Cancer","FGFR2","K660N(GoF)","sensitivity","FGFR inhibitors","preclinical","25035393",3,"GDKD","lung_squamous"
"Lung Cancer","FGFR1","amplification(GoF)","response","FGFR inhibitors","case report","27870574",2,"GDKD","lung_squamous"
"Lung Cancer","DDR2","L63V(GoF)","sensitivity","dasatinib","preclinical","22328973",3,"GDKD","lung_squamous"
"Lung Cancer","DDR2","I638F(GoF)","sensitivity","dasatinib","preclinical","22328973",3,"GDKD","lung_squamous"
"Lung Cancer","DDR2","G505S(GoF)","sensitivity","dasatinib","preclinical","22328973",3,"GDKD","lung_squamous"
"Lung Cancer","DDR2","G253C(GoF)","sensitivity","dasatinib","preclinical","22328973",3,"GDKD","lung_squamous"
"Lung Cancer","DDR2","S768R(GoF)","sensitivity","dasatinib","preclinical","22328973",3,"GDKD","lung_squamous"
"Lung Cancer","EPHA2","G391R(GoF)","sensitivity","mTOR inhibitors, dasatinib","preclinical","20360610",3,"GDKD","lung_squamous"
"Lung Cancer","DDR2","G774V(GoF)","sensitivity","dasatinib","preclinical","22328973",3,"GDKD","lung_squamous"
"Rare Lung Disease","TSC2","any/deletion(LoF)","sensitivity","SRC inhibitors","preclinical","24691995",3,"GDKD","lymphangioleiomyomatosis"
"Lymphoma","JAK3","A572V(GoF)","sensitivity","JAK inhibitors","preclinical","22705984",3,"GDKD","lymphoma"
"Lymphoma","EZH2","Y641F(GoF)","sensitivity","EZH2 inhibitor","preclinical","24563539",3,"GDKD","lymphoma"
"Lymphoma","ATM","any/deletion(LoF)","sensitivity","DNA-PKc inhibitors","preclinical","23761041",3,"GDKD","lymphoma"
"Lymphoma","EZH2","A677(GoF)","sensitivity","EZH2 inhibitor","preclinical","23023262",3,"GDKD","lymphoma"
"Lymphoma","BCL2","amplification(GoF)","sensitivity","BCL2 inhibitors","preclinical","22649144",3,"GDKD","lymphoma"
"Lymphoma","ALK","rearrangement(GoF)","response","crizotinib","early trials","24491302",2,"GDKD","lymphoma"
"Lymphoma","SOCS1","any(LoF)","sensitivity","JAK inhibitors","preclinical","22025331",3,"GDKD","lymphoma"
"Lymphoma","MYD88","L265P(GoF)","response","ibrutinib","case report","26244327",2,"GDKD","lymphoma"
"Lymphoma","JAK3","A573V(GoF)","sensitivity","JAK inhibitors","preclinical","22705984",3,"GDKD","lymphoma"
"Lymphoma","MYD88","L265P(GoF)","sensitivity","JAK inhibitors","preclinical","21179087",3,"GDKD","lymphoma"
"Melanoma","KIT","Internal Duplication","Sensitivity/Response","Imatinib","C","18421059",2,"CIVIC","Malignant Anus Melanoma"
"Glioma","ATRX","Underexpression","Sensitivity/Response","PCV Regimen,Temozolomide","B","23904111",2,"CIVIC","Malignant Astrocytoma"
"Mesothelioma","EGFR","W731L","Sensitivity/Response","Erlotinib","D","20942962",3,"CIVIC","Malignant Mesothelioma"
"Mesothelioma","EGFR","E734Q","Sensitivity/Response","Erlotinib","D","20942962",3,"CIVIC","Malignant Mesothelioma"
"Mesothelioma","EGFR","C797Y","Sensitivity/Response","Erlotinib","D","20942962",3,"CIVIC","Malignant Mesothelioma"
"Mesothelioma","EGFR","E868G","Sensitivity/Response","Erlotinib","D","20942962",3,"CIVIC","Malignant Mesothelioma"
"Mesothelioma","BAP1","Mutation","Sensitivity/Response","Vorinostat,Mocetinostat,MC1568","E","25970771",3,"CIVIC","Malignant Mesothelioma"
"Mesothelioma","EGFR","Y801H","Sensitivity/Response","Erlotinib","D","20942962",3,"CIVIC","Malignant Mesothelioma"
"Mesothelioma","EGFR","R831H","Sensitivity/Response","Erlotinib","D","20942962",3,"CIVIC","Malignant Mesothelioma"
"Mesothelioma","BAP1","ALTERNATIVE TRANSCRIPT (ATI)","Sensitivity/Response","Olaparib+Apitolisib","D","28389374",3,"CIVIC","Malignant Mesothelioma"
"Mesothelioma","BRCA1","Expression","Sensitivity/Response","Vinorelbine","D","22190288",3,"CIVIC","Malignant Mesothelioma"
"Mesothelioma","EGFR","T785A","Sensitivity/Response","Erlotinib","D","20942962",3,"CIVIC","Malignant Mesothelioma"
"Sarcoma","NF1","Loss","Sensitivity/Response","JQ1 Compound","D","24373973",3,"CIVIC","Malignant Peripheral Nerve Sheath Tumor"
"Sarcoma","PARP1","OVEREXPRESSION","Sensitivity/Response","Olaparib","D","26650448",3,"CIVIC","Malignant Peripheral Nerve Sheath Tumor"
"Mesothelioma","MDM2","EXPRESSION","Resistance","Cisplatin+Pemetrexed","B","25668009",2,"CIVIC","Malignant Pleural Mesothelioma"
"Sarcoma","NF1","any/deletion(LoF)","sensitivity","mTOR inhibitors + HSP90 inhibitors","preclinical","21907929",3,"GDKD","malignant_peripheral_nerve_sheat_tumor"
"Sarcoma","NF1","any/deletion(LoF)","no response","everolimus + bevacizumab","early trials","ASCO 2016 (abstr 11053)",2,"GDKD","malignant_peripheral_nerve_sheat_tumor"
"Sarcoma","NF1","any/deletion(LoF)","sensitivity","mTOR inhibitors","preclinical","18483311, 20505189, 24509877",3,"GDKD","malignant_peripheral_nerve_sheat_tumor"
"Sarcoma","NF1","any/deletion(LoF)","sensitivity","MEK inhibitors","preclinical","23221341",3,"GDKD","malignant_peripheral_nerve_sheat_tumor"
"Sarcoma","INI1","any/deletion(LoF)","response","EZH2 inhibitor","case report","ENA 2014 (abstr 6LBA), ESMO 2015 (abstract 302)",2,"GDKD","malignant_rhabdoid_tumor"
"Sarcoma","SMARCB1","mut(LoF)","sensitivity","HDAC inhibitors","preclinical","26920892",3,"GDKD","malignant_rhabdoid_tumor"
"Lymphoma","ATM","Mutation","Sensitivity/Response","Olaparib","D","20124459",3,"CIVIC","Mantle Cell Lymphoma"
"Lymphoma","ZEB1","Expression","Sensitivity/Response","Salinomycin+Doxorubicin","D","24013721",3,"CIVIC","Mantle Cell Lymphoma"
"Lymphoma","CCND1","Overexpression","Sensitivity/Response","Palbociclib","D","16690963",3,"CIVIC","Mantle Cell Lymphoma"
"Lymphoma","ZEB1","Expression","Resistance","Cytarabine,Gemcitabine,Doxorubicin","D","24013721",3,"CIVIC","Mantle Cell Lymphoma"
"Lymphoma","CCND1","Overexpression","Sensitivity/Response","Palbociclib","B","22383795",2,"CIVIC","Mantle Cell Lymphoma"
"Lymphoma","BTK","C481(GoF)","resistance","ibrutinib","case report","25082755",2,"GDKD","mantle_cell_lymphoma"
"Lymphoma","SYK","amplification(GoF)","sensitivity","SYK inhibitors","preclinical","16409295, 19549911",3,"GDKD","mantle_cell_lymphoma"
"Lymphoma","NOTCH1","any(GoF)","sensitivity","Gamma secretase inhibitors","preclinical","22210878",3,"GDKD","mantle_cell_lymphoma"
"Blood Disorder","KIT","D816","Sensitivity/Response","Avapritinib","3A","29233825, 30274985",2,"OncoKB","Mastocytosis"
"Thyroid Cancer","RET","Oncogenic Mutations","Sensitivity/Response","BLU-667, LOXO-292","3A","29657135, 29912274",2,"OncoKB","Medullary Thyroid Cancer"
"Blastoma","SMO","D473H(GoF)","resistance","vismodegib","case report","19726788, 25759019",2,"GDKD","medulloblastoma"
"Blastoma","PTCH1","any(LoF)","sensitivity","foretinib","preclinical","25391241",3,"GDKD","medulloblastoma"
"Blastoma","PTCH1","any(LoF)","response","vismodegib","FDA-approved","19726761",2,"GDKD","medulloblastoma"
"Blastoma","PTCH1","MUTATION","Sensitivity/Response","Sonidegib","B","24651015",2,"CIVIC","Medulloblastoma"
"Blastoma","SMO","D473H","Sensitivity/Response","Patidegib","D","22550175",3,"CIVIC","Medulloblastoma"
"Blastoma","SMO","D473H","Resistance","Vismodegib","C","19726788",2,"CIVIC","Medulloblastoma"
"Blastoma","PTCH1","LOH","Sensitivity/Response","Vismodegib","B","26169613",2,"CIVIC","Medulloblastoma"
"Leukemia","JAK3","I87T(GoF)","sensitivity","JAK inhibitors","preclinical","18397343",3,"GDKD","megakaryoblastic_leukemia"
"Leukemia","JAK3","Q501H(GoF)","sensitivity","JAK inhibitors","preclinical","18397343",3,"GDKD","megakaryoblastic_leukemia"
"Leukemia","JAK3","R657Q(GoF)","sensitivity","JAK inhibitors","preclinical","18397343",3,"GDKD","megakaryoblastic_leukemia"
"Melanoma","KIT","D820Y(GoF)","response","nilotinib","case report","25695690",2,"GDKD","melanoma"
"Melanoma","BRAF","V600K(GoF)","response","vemurafenib","late trials","22356324",2,"GDKD","melanoma"
"Melanoma","BRAF","V600E(GoF)","sensitivity","BRAF inhibitors + CDK2/4 inhibitors","preclinical","22997239",3,"GDKD","melanoma"
"Melanoma","NRAS","any(GoF)","response","MEK inhibitors","early trials","18390968, 22761467",2,"GDKD","melanoma"
"Melanoma","BRAF","L597R(GoF)","response","trametinib, MEK inhibitors","case report","22805292, 22798288",2,"GDKD","melanoma"
"Melanoma","MAP2K2","V35M, L46F, N126D, C125S(GoF)","sensitivity","ERK inhibitors","preclinical","24265153",3,"GDKD","melanoma"
"Melanoma","MAP2K1","P124(GoF)","resistance","BRAF inhibitors","early trials","25370473",2,"GDKD","melanoma"
"Melanoma","BRAF","V600E(GoF)","sensitivity","ERK inhibitors","preclinical","23614898, 22997239",3,"GDKD","melanoma"
"Melanoma","NRAS","any(GoF)","response","MEK inhibitors","late trials","23414587, ASCO 2016 (abstr 9500)",2,"GDKD","melanoma"
"Melanoma","BRAF","rearrangement(GoF)","sensitivity","MEK inhibitors","preclinical","24345920",3,"GDKD","melanoma"
"Melanoma","NRAS","any(GoF)","response","MEK inhibitors + CDK4/6 inhibitors","early trials","ASCO 2014 (abstr 9009)",2,"GDKD","melanoma"
"Melanoma","BRAF","L597R(GoF)","response","BRAF inhibitors","case report","23715574",2,"GDKD","melanoma"
"Melanoma","CCND1","amplification(GoF)","response","CDK4/6 inhibitors","case report","ASCO 2014 (abstr 2528^)",2,"GDKD","melanoma"
"Melanoma","BRAF","V600R(GoF)","response","MEK inhibitors","case report","23248257",2,"GDKD","melanoma"
"Melanoma","BRAF","V600K(GoF)","response","trametinib, dabrafenib + trametinib, vemurafenib + cobimetinib","FDA-approved","FDA",1,"GDKD","melanoma"
"Melanoma","MAP2K1","P124L(GoF)","resistance","BRAF inhibitors, MEK inhibitors","case report","19915144",2,"GDKD","melanoma"
"Melanoma","CDKN2A","any/deletion(LoF)","response","CDK4/6 inhibitors","case report","ASCO 2013 (abstr 2500)",2,"GDKD","melanoma"
"Melanoma","MAP2K1","K57E(GoF)","resistance","vemurafenib","case report","23569304",2,"GDKD","melanoma"
"Melanoma","BRAF","K601R(GoF)","response","MEK inhibitors","case report","23248257",2,"GDKD","melanoma"
"Melanoma","SERPINB3","mut(LoF)","response","anti-CTLA4 mAbs","early trials","27668655",2,"GDKD","melanoma"
"Melanoma","GNAQ","Q209(GoF)","sensitivity","HDAC inhibitors","preclinical","NCT01587352",3,"GDKD","melanoma"
"Melanoma","BRAF","V600E(GoF)","sensitivity","BRAF inhibitors + PI3K pathway inhibitors","preclinical","22389471, 21156289",3,"GDKD","melanoma"
"Melanoma","BRAF","G469E(GoF)","sensitivity","sorafenib","preclinical","18794803",3,"GDKD","melanoma"
"Melanoma","PDGFRA","V658A(GoF)","resistance","imatinib","preclinical","24132921",3,"GDKD","melanoma"
"Melanoma","BRAF","V600E(GoF)","sensitivity","BRAF inhibitors + HSP90 inhibitors","preclinical","22351686",3,"GDKD","melanoma"
"Melanoma","MAP2K2","Q60P(GoF)","sensitivity","ERK inhibitors","preclinical","24265154",3,"GDKD","melanoma"
"Melanoma","MAP2K1","P124S(GoF)","response","BRAF inhibitors in BRAF mutant tumor","case report","22588879",2,"GDKD","melanoma"
"Melanoma","KIT","D820Y(GoF)","response","imatinib","case report","23775962",2,"GDKD","melanoma"
"Melanoma","GNA11","Q209L(GoF)","sensitivity","PI3K pathway inhibitors + MEK inhibitors","preclinical","22733540, 22808163",3,"GDKD","melanoma"
"Melanoma","MAP2K1","I111S(GoF)","response","BRAF inhibitors in BRAF mutant tumor","case report","22588879",2,"GDKD","melanoma"
"Melanoma","GNA11","Q209L(GoF)","response","selumetinib","early trials","ASCO 2013 (abstr CRA9003)",2,"GDKD","melanoma"
"Melanoma","BRAF","D594G(GoF)","sensitivity","sorafenib","preclinical","18794803",3,"GDKD","melanoma"
"Melanoma","BRAF","rearrangement(GoF)","sensitivity","sorafenib","preclinical","238900088",3,"GDKD","melanoma"
"Melanoma","BRAF","V600E(GoF)","response","vemurafenib, dabrafenib, trametinib, dabrafenib + trametinib, vemurafenib + cobimetinib","FDA-approved","FDA",1,"GDKD","melanoma"
"Melanoma","PDGFRA","V658A(GoF)","sensitivity","crenolanib","preclinical","24132921",3,"GDKD","melanoma"
"Melanoma","GNAQ","Q209(GoF)","sensitivity","PKC inhibitor","preclinical","22653968, 22253748",3,"GDKD","melanoma"
"Melanoma","MAP2K1","Q56P(GoF)","resistance","vemurafenib","case report","23569304",2,"GDKD","melanoma"
"Melanoma","ERBB4","E452K(GoF)","sensitivity","lapatinib","preclinical","19718025",3,"GDKD","melanoma"
"Melanoma","ERBB4","E317K(GoF)","sensitivity","lapatinib","preclinical","19718025",3,"GDKD","melanoma"
"Melanoma","MAP2K2","Q60P(GoF)","resistance","BRAF + MEK inhibitors","case report","24265154",2,"GDKD","melanoma"
"Melanoma","PAK1","amplification(GoF)","sensitivity","PAK inhibitors","preclinical","23535073",3,"GDKD","melanoma"
"Melanoma","MAP2K1","P124(GoF)","sensitivity","MEK inhibitors, ERK inhibitors","preclinical","25370473",3,"GDKD","melanoma"
"Melanoma","KIT","exon 17 p.788-828, exon 18 p.829-860(GoF)","response","sorafenib","case report","20372153",2,"GDKD","melanoma"
"Melanoma","RAC1","P29S(GoF)","resistance","BRAF inhibitors in BRAF mutant tumors","case report","25056119",2,"GDKD","melanoma"
"Melanoma","NF1","any/deletion(LoF)","response","PD1 blockade","early trials","ASCO 2016 (abstr 105)",2,"GDKD","melanoma"
"Melanoma","MAP2K1","C121S(GoF)","resistance","BRAF inhibitors, MEK inhibitors","case report","21383288",2,"GDKD","melanoma"
"Melanoma","MAP2K1","C121S(GoF)","sensitivity","novel MEK inhibitors","preclinical","24448821",3,"GDKD","melanoma"
"Melanoma","KIT","amplification(GoF)","no response","imatinib","early trials","23775962",2,"GDKD","melanoma"
"Melanoma","BRAF","V600E(GoF)","response","pan-RAF inhibitors","early trials","ESMO 2015 (abstract 300), AACR 2016 (abstr CT005), AACR 2017 (abstr  CT002)",2,"GDKD","melanoma"
"Melanoma","PDGFRA","P577S, R841K, H845Y, G853D(GoF)","sensitivity","imatinib, crenolanib","preclinical","24132921",3,"GDKD","melanoma"
"Melanoma","NRAS","any(GoF)","response","ERK inhibitors","case report","ASCO 2017 (abstr 2508)",2,"GDKD","melanoma"
"Melanoma","MITF","amplification(GoF)","resistance","BRAF inhibitors","case report","24265153",2,"GDKD","melanoma"
"Melanoma","NRAS","any(GoF)","resistance","BRAF inhibitors","early trials","23569304, 24265153",2,"GDKD","melanoma"
"Melanoma","ERBB4","R544W(GoF)","sensitivity","lapatinib","preclinical","19718025",3,"GDKD","melanoma"
"Melanoma","ERBB4","E872K(GoF)","sensitivity","lapatinib","preclinical","19718025",3,"GDKD","melanoma"
"Melanoma","MAP2K2","V35M, L46F, N126D, C125S(GoF)","resistance","BRAF inhibitors, MEK inhibitors","preclinical","24265153",3,"GDKD","melanoma"
"Melanoma","ERBB4","R393W(GoF)","sensitivity","lapatinib","preclinical","19718025",3,"GDKD","melanoma"
"Melanoma","BRAF","V600R(GoF)","response","BRAF inhibitors","early trials","23237741",2,"GDKD","melanoma"
"Melanoma","MAP2K1","K57N(GoF)","resistance","MEK inhibitors","case report","23444215",2,"GDKD","melanoma"
"Melanoma","GNA11","Q209P(GoF)","response","selumetinib","early trials","ASCO 2013 (abstr CRA9003)",2,"GDKD","melanoma"
"Melanoma","MAP2K1","E203K(GoF)","resistance","vemurafenib","case report","23569304",2,"GDKD","melanoma"
"Melanoma","KIT","exon 11 p.550-592, exon 13 p.627-664(GoF)","response","nilotinib","early trials","22068222, 25695690",2,"GDKD","melanoma"
"Melanoma","MAP2K1","E203K(GoF)","resistance","BRAF inhibitors, MEK inhibitors","preclinical","19915144",3,"GDKD","melanoma"
"Melanoma","GNAQ","Q209(GoF)","response","selumetinib","early trials","ASCO 2013 (abstr CRA9003)",2,"GDKD","melanoma"
"Melanoma","BAP1","any/deletion(LoF)","sensitivity","HDAC inhibitors","preclinical","22038994",3,"GDKD","melanoma"
"Melanoma","KIT","exon 17 p.788-828, exon 18 p.829-860(GoF)","resistance","imatinib","early trials","21690468, 21642685",2,"GDKD","melanoma"
"Melanoma","KIT","amplification(GoF)","no response","sunitinib","early trials","22261812",2,"GDKD","melanoma"
"Melanoma","JAK2","any(LoF)","resistance","PD1 blockade","case report","27433843",2,"GDKD","melanoma"
"Melanoma","BRCA2","any(LoF)","response","PD1 blockade","case report","26997480",2,"GDKD","melanoma"
"Melanoma","BRAF","V600D,V600K,V600M,V600G,V600R(GoF)","response","vemurafenib","NCCN guidelines","NCCN",1,"GDKD","melanoma"
"Melanoma","GNA11","Q209P(GoF)","sensitivity","vorinostat","preclinical","NCT01587352",3,"GDKD","melanoma"
"Melanoma","JAK1","any(LoF)","resistance","PD1 blockade","case report","27433843",2,"GDKD","melanoma"
"Melanoma","GNA11","Q209L(GoF)","sensitivity","vorinostat","preclinical","NCT01587352",3,"GDKD","melanoma"
"Melanoma","GNA11","Q209P(GoF)","sensitivity","PI3K pathway inhibitors + MEK inhibitors","preclinical","22733540, 22808163",3,"GDKD","melanoma"
"Melanoma","PTEN","any/deletion(LoF)","resistance","MEK inhibitors in BRAF mutant tumors","preclinical","23039341",3,"GDKD","melanoma"
"Melanoma","NF1","any/deletion(LoF)","resistance","selumetinib in BRAF mutant tumors","case report","23444215, 23288408",2,"GDKD","melanoma"
"Melanoma","B2M","any(LoF)","resistance","PD1 blockade","case report","27433843",2,"GDKD","melanoma"
"Melanoma","GNAQ","Q209(GoF)","sensitivity","PI3K pathway inhibitors + MEK inhibitors","preclinical","22733540, 22808163",3,"GDKD","melanoma"
"Melanoma","ERBB4","E542K(GoF)","sensitivity","lapatinib","preclinical","19718025",3,"GDKD","melanoma"
"Melanoma","NF1","any/deletion(LoF)","resistance","BRAF inhibitors in BRAF mutant tumor","preclinical","23288408, 24576830",3,"GDKD","melanoma"
"Melanoma","PTEN","any/deletion(LoF)","resistance","BRAF inhibitors in BRAF mutant tumor","early trials","http://ascopubs.org/doi/abs/10.1200/PO.16.00054",2,"GDKD","melanoma"
"Melanoma","AKT1","Q79K(GoF)","resistance","BRAF inhibitors","preclinical","24265152",3,"GDKD","melanoma"
"Melanoma","NF1","any/deletion(LoF)","sensitivity","trametinib","preclinical","24576830",3,"GDKD","melanoma"
"Melanoma","RAF1","G361A(GoF)","resistance","BRAF inhibitors in BRAF mutant tumors","preclinical","23737487",3,"GDKD","melanoma"
"Melanoma","KIT","exon 11 p.550-592, exon 13 p.627-664(GoF)","response","dasatinib","case report","19671763",2,"GDKD","melanoma"
"Melanoma","PTEN","any/deletion(LoF)","resistance","PD1 inhibitors","early trials","26645196",2,"GDKD","melanoma"
"Melanoma","NRAS","any(GoF)","sensitivity","HSP90 inhibitors","preclinical","23538902",3,"GDKD","melanoma"
"Melanoma","KIT","exon 11 p.550-592, exon 13 p.627-664(GoF)","response","imatinib","NCCN guidelines","NCCN",1,"GDKD","melanoma"
"Melanoma","NRAS","any(GoF)","response","pan-RAF inhibitors","case report","ESMO 2015 (abstract 300), AACR 2017 (abstr CT002)",2,"GDKD","melanoma"
"Melanoma","KIT","exon 11 p.550-592, exon 13 p.627-664(GoF)","response","sorafenib","case report","18936790",2,"GDKD","melanoma"
"Melanoma","RAF1","P261P(GoF)","resistance","BRAF inhibitors in BRAF mutant tumors","preclinical","23737487",3,"GDKD","melanoma"
"Melanoma","RAF1","S257P(GoF)","resistance","BRAF inhibitors in BRAF mutant tumors","preclinical","23737487",3,"GDKD","melanoma"
"Melanoma","KIT","exon 11 p.550-592, exon 13 p.627-664(GoF)","response","imatinib, sunitinib","late trials","18421059, 21642685, 21690468, 22261812",2,"GDKD","melanoma"
"Melanoma","PIK3CA","E545G","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","KIT","K642E","Sensitivity/Response","Dasatinib","C","21523734",2,"CIVIC","Melanoma"
"Melanoma","BRAF","L505H","Resistance","Vemurafenib","B","25515853",2,"CIVIC","Melanoma"
"Melanoma","KIT","Exon 11 Mutation","Sensitivity/Response","Sunitinib","C","22261812",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600K","Sensitivity/Response","Trametinib+Dabrafenib","B","25265494",2,"CIVIC","Melanoma"
"Melanoma","KIT","V654A","Sensitivity/Response","Imatinib","2A","21642685, 23775962",1,"OncoKB","Melanoma"
"Melanoma","BRAF","L505H","Resistance","Vemurafenib","D","24112705",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Pictilisib","C","25370471",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600","Sensitivity/Response","Dabrafenib","B","22608338",2,"CIVIC","Melanoma"
"Melanoma","NRAS","Mutation","Resistance","MEK Inhibitor RO4987655","C","24947927",2,"CIVIC","Melanoma"
"Melanoma","NRAS","G13D","Sensitivity/Response","Tanespimycin","C","18375819",2,"CIVIC","Melanoma"
"Melanoma","NRAS","Q61L","Sensitivity/Response","Temozolomide","C","21576590",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Vemurafenib","B","24508103",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600D","Sensitivity/Response","BRAF Inhibitor","C","31580757",2,"CIVIC","Melanoma"
"Melanoma","PDGFRA","P577S","Sensitivity/Response","Crenolanib,Imatinib","D","24132921",3,"CIVIC","Melanoma"
"Melanoma","PDGFRA","H845Y","Sensitivity/Response","Crenolanib,Imatinib","D","24132921",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600","Sensitivity/Response","Vemurafenib+Cobimetinib","B","25037139",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600","Sensitivity/Response","Cobimetinib+Vemurafenib","B","25265494",2,"CIVIC","Melanoma"
"Melanoma","BRAF","A598V","Sensitivity/Response","Mitogen-Activated Protein Kinase Kinase Inhibitor+BRAF Inhibitor","C","31580757",2,"CIVIC","Melanoma"
"Melanoma","PDGFRA","R841K","Sensitivity/Response","Crenolanib,Imatinib","D","24132921",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600K","Sensitivity/Response","Dabrafenib + Trametinib, Encorafenib + Binimetinib, Trametinib, Vemurafenib + Cobimetinib","1","22663011, 23020132, 25265492, 25265494, 25287827, 25399551, 27480103, 28891408, 28991513, 29361468, 29573941",1,"OncoKB","Melanoma"
"Melanoma","NTRK1","NTRK1-DDR2","Sensitivity/Response","Larotrectinib","E","29683819",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600K","Sensitivity/Response","Vemurafenib","B","25524477",2,"CIVIC","Melanoma"
"Melanoma","PREX2","R172I","Resistance","Vemurafenib","C","24265155",2,"CIVIC","Melanoma"
"Melanoma","BRAF","AGK-BRAF","Resistance","Vemurafenib","D","23890088",3,"CIVIC","Melanoma"
"Melanoma","NRAS","Mutation","Resistance","Vemurafenib,Dabrafenib","B","24265155",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600D","Sensitivity/Response","Vemurafenib","D","18287029",3,"CIVIC","Melanoma"
"Melanoma","KIT","S628N","Sensitivity/Response","Imatinib","C","25317746",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Trametinib+Dabrafenib","B","23020132",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Cobimetinib+Vemurafenib","B","25265494",2,"CIVIC","Melanoma"
"Melanoma","KIT","L576P","Sensitivity/Response","Dasatinib","D","19671763",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Resistance","Mirdametinib,Trametinib","D","24576830",3,"CIVIC","Melanoma"
"Melanoma","KIT","Oncogenic Mutations","Sensitivity/Response","Imatinib","2A","21642685, 23775962",1,"OncoKB","Melanoma"
"Melanoma","AKT1","Q79K","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Vemurafenib","B","20818844",2,"CIVIC","Melanoma"
"Melanoma","CD274","Expression","Sensitivity/Response","Nivolumab,Pembrolizumab","B","26086854",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Trametinib+Dabrafenib","B","28891408",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600","Sensitivity/Response","Dabrafenib+Trametinib","B","28891408",2,"CIVIC","Melanoma"
"Melanoma","BRAF","intron 9 rearrangement","Resistance","Vemurafenib,Dabrafenib","B","24265155",2,"CIVIC","Melanoma"
"Melanoma","PTEN","Loss","Sensitivity/Response","Uprosertib","D","24735930",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Dabrafenib+Trametinib","B","24583796",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600","Sensitivity/Response","Encorafenib+Binimetinib","A","29573941",1,"CIVIC","Melanoma"
"Melanoma","BRAF","V600D","Sensitivity/Response","BRAF Inhibitor+Mitogen-Activated Protein Kinase Kinase Inhibitor","C","31580757",2,"CIVIC","Melanoma"
"Melanoma","NRAS","Mutation","Sensitivity/Response","Binimetinib","D","24588908",3,"CIVIC","Melanoma"
"Melanoma","MTOR","H1968Y","Sensitivity/Response","Capivasertib,PI3K/BET Inhibitor LY294002","D","26490311",3,"CIVIC","Melanoma"
"Melanoma","KIT","MUTATION","Sensitivity/Response","Imatinib","B","21690468",2,"CIVIC","Melanoma"
"Melanoma","PDGFRA","G853D","Sensitivity/Response","Imatinib,Crenolanib","D","24132921",3,"CIVIC","Melanoma"
"Melanoma","PIK3CA","E545K","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","NRAS","Q61R","Sensitivity/Response","Temozolomide","C","21576590",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600","Resistance","Refametinib","C","23434733",2,"CIVIC","Melanoma"
"Melanoma","TBK1","OVEREXPRESSION","Sensitivity/Response","AZ909+Selumetinib","D","24962318",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600","Sensitivity/Response","Dabrafenib+Trametinib","B","23020132",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E/K and Amplification","Resistance","Vemurafenib,Dabrafenib","B","24265155",2,"CIVIC","Melanoma"
"Melanoma","ATM","Mutation","Sensitivity/Response","Temozolomide","D","23960094",3,"CIVIC","Melanoma"
"Melanoma","PIK3R2","OVEREXPRESSION","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","CTNNB1","Activating Mutation","Resistance","Anti-CTLA-4 Monoclonal Antibody,Anti-PD-L1 Monoclonal Antibody","D","25970248",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Resistance","MEK Inhibitor RO4987655","B","24947927",2,"CIVIC","Melanoma"
"Melanoma","BRAF","G469","Sensitivity/Response","Mitogen-Activated Protein Kinase Kinase Inhibitor+BRAF Inhibitor","B","31580757",2,"CIVIC","Melanoma"
"Melanoma","PTEN","Loss","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","KIT","C788_N828mut","Sensitivity/Response","Imatinib","2A","21642685, 23775962",1,"OncoKB","Melanoma"
"Melanoma","KIT","T670I","Sensitivity/Response","Imatinib","2A","21642685, 23775962",1,"OncoKB","Melanoma"
"Melanoma","BRAF","V600","Sensitivity/Response","Vemurafenib+Cobimetinib","A","27480103",1,"CIVIC","Melanoma"
"Melanoma","NTRK1","NTRK1-TRIM63","Sensitivity/Response","Larotrectinib","E","29683819",3,"CIVIC","Melanoma"
"Melanoma","PIK3R2","N561D","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","MAP2K1","C121S","Resistance","Vemurafenib","C","21383288",2,"CIVIC","Melanoma"
"Melanoma","KIT","Exon 11 Mutation","Sensitivity/Response","Imatinib","B","23775962",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E and V600M","Sensitivity/Response","Dabrafenib","C","23031422",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600D","Sensitivity/Response","Vemurafenib","D","20551065",3,"CIVIC","Melanoma"
"Melanoma","NRAS","Q61","Resistance","Vemurafenib","B","23569304",2,"CIVIC","Melanoma"
"Melanoma","MERTK","OVEREXPRESSION","Sensitivity/Response","UNC1062","D","23585477",3,"CIVIC","Melanoma"
"Melanoma","KIT","D816","Sensitivity/Response","Imatinib","2A","21642685, 23775962",1,"OncoKB","Melanoma"
"Melanoma","BRAF","TRIM24-BRAF","Sensitivity/Response","Trametinib","D","24345920",3,"CIVIC","Melanoma"
"Melanoma","KRAS","Amplification","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","BRAF","WILD TYPE","Resistance","MEK Inhibitor RO4987655","B","24947927",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Dabrafenib, Dabrafenib + Trametinib, Encorafenib + Binimetinib, Trametinib, Vemurafenib, Vemurafenib + Cobimetinib","1","22608338, 22663011, 22735384, 23020132, 23051966, 24508103, 25265492, 25265494, 25287827, 25399551, 27480103, 28891408, 28961848, 28991513, 29361468, 29573941",1,"OncoKB","Melanoma"
"Melanoma","BRAF","V600E","Resistance","Vemurafenib","D","24576830",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600K","Sensitivity/Response","Trametinib","B","22663011",2,"CIVIC","Melanoma"
"Melanoma","CD274","Expression","Sensitivity/Response","Ipilimumab+Nivolumab","B","23724867",2,"CIVIC","Melanoma"
"Melanoma","AKT1","E17K","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600D","Sensitivity/Response","Dabrafenib","B","23463675",2,"CIVIC","Melanoma"
"Melanoma","MAP2K1","Q56P","Resistance","Selumetinib","D","19915144",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Selumetinib+Dactolisib","D","26678033",3,"CIVIC","Melanoma"
"Melanoma","KIT","D820Y","Resistance","Imatinib","C","21642685",2,"CIVIC","Melanoma"
"Melanoma","AKT1","Q79K","Resistance","Vemurafenib","D","24265152",3,"CIVIC","Melanoma"
"Melanoma","BRAF","PAPSS1-BRAF","Sensitivity/Response","Trametinib","D","24345920",3,"CIVIC","Melanoma"
"Melanoma","BRAF","ZKSCAN1-BRAF","Sensitivity/Response","Trametinib","C","26314551",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Trametinib","B","22663011",2,"CIVIC","Melanoma"
"Melanoma","BRAF","L597R","Sensitivity/Response","Vemurafenib","C","23715574",2,"CIVIC","Melanoma"
"Melanoma","RAC1","P29S","Resistance","Vemurafenib,Dabrafenib","D","25056119",3,"CIVIC","Melanoma"
"Melanoma","SOX10","LOSS","Resistance","Vemurafenib","D","24670642",3,"CIVIC","Melanoma"
"Melanoma","KIT","L576P","Resistance","Nilotinib,Imatinib,Sorafenib","D","19671763",3,"CIVIC","Melanoma"
"Melanoma","AKT3","OVEREXPRESSION","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","MAP2K1","Oncogenic Mutations","Sensitivity/Response","Cobimetinib, Trametinib","3A","25351745, 25370473, 26324360, 26566875, 30867592",2,"OncoKB","Melanoma"
"Melanoma","MTOR","P2213S","Sensitivity/Response","PI3K/BET Inhibitor LY294002+Capivasertib","D","26490311",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Vemurafenib","B","25524477",2,"CIVIC","Melanoma"
"Melanoma","KRAS","G12D","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600_K601>E","Sensitivity/Response","BRAF Inhibitor+Mitogen-Activated Protein Kinase Kinase Inhibitor","C","31580757",2,"CIVIC","Melanoma"
"Melanoma","BRAF","Amplification","Resistance","Trametinib+Dabrafenib","C","25452114",2,"CIVIC","Melanoma"
"Melanoma","KIT","D820Y","Sensitivity/Response","Sunitinib","D","19035443",3,"CIVIC","Melanoma"
"Melanoma","STAG3","UNDEREXPRESSION","Resistance","Vemurafenib","D","27500726",3,"CIVIC","Melanoma"
"Melanoma","PIK3CA","D350G","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600K","Sensitivity/Response","Vemurafenib","B","24508103",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600K","Sensitivity/Response","Dabrafenib","B","21343559",2,"CIVIC","Melanoma"
"Melanoma","NTRK1","NTRK1-GON4L","Sensitivity/Response","Larotrectinib","E","29683819",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Dabrafenib+Trametinib","B","25265492",2,"CIVIC","Melanoma"
"Melanoma","NRAS","Oncogenic Mutations","Sensitivity/Response","Binimetinib, Binimetinib + Ribociclib","3A","16273091, 22983396, 28284557",2,"OncoKB","Melanoma"
"Melanoma","BRAF","V600K","Sensitivity/Response","Vemurafenib","C","26989536",2,"CIVIC","Melanoma"
"Melanoma","MAP2K1","P124S","Resistance","Selumetinib","D","19915144",3,"CIVIC","Melanoma"
"Melanoma","STAG2","UNDEREXPRESSION","Resistance","Vemurafenib","D","27500726",3,"CIVIC","Melanoma"
"Melanoma","AKT3","E17K","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600K","Sensitivity/Response","Trametinib+Dabrafenib","B","28891408",2,"CIVIC","Melanoma"
"Melanoma","KRAS","Mutation","Resistance","Vemurafenib,Dabrafenib","B","24265155",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600","Sensitivity/Response","Trametinib","B","22663011",2,"CIVIC","Melanoma"
"Melanoma","BRAF","intron 10 rearrangement","Resistance","Vemurafenib,Dabrafenib","B","24265155",2,"CIVIC","Melanoma"
"Melanoma","BRAF","PAPSS1-BRAF","Resistance","Vemurafenib","D","24345920",3,"CIVIC","Melanoma"
"Melanoma","BRAF","AGK-BRAF","Sensitivity/Response","Sorafenib","C","23890088",2,"CIVIC","Melanoma"
"Melanoma","ERBB4","MUTATION","Sensitivity/Response","Lapatinib","D","19718025",3,"CIVIC","Melanoma"
"Melanoma","NRAS","Mutation","Sensitivity/Response","Omipalisib+Trametinib","D","23431193",3,"CIVIC","Melanoma"
"Melanoma","BRAF","V600","Sensitivity/Response","Trametinib+Dabrafenib","B","25265492",2,"CIVIC","Melanoma"
"Melanoma","AKT1","E17K","Sensitivity/Response","Uprosertib","D","24735930",3,"CIVIC","Melanoma"
"Melanoma","NRAS","Mutation","Sensitivity/Response","Trametinib","B","22805292",2,"CIVIC","Melanoma"
"Melanoma","BRAF","K601","Sensitivity/Response","Trametinib","3A","22798288, 23248257, 24933606, 28344857, 29903896",2,"OncoKB","Melanoma"
"Melanoma","BRAF","Fusions","Sensitivity/Response","Cobimetinib, Trametinib","3A","23890088, 24345920, 26072686, 26314551",2,"OncoKB","Melanoma"
"Melanoma","AKT1","Q79K","Resistance","Dabrafenib","C","24265155",2,"CIVIC","Melanoma"
"Melanoma","PIK3CA","Amplification","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Melanoma","BRAF","L597","Sensitivity/Response","Trametinib","3A","22798288, 24933606, 29903896",2,"OncoKB","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Vemurafenib","B","26557775",2,"CIVIC","Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Vemurafenib","B","23569304",2,"CIVIC","Melanoma"
"Melanoma","JAK2","Splice Site (c.1641+2T>G)","Resistance","Pembrolizumab","C","27433843",2,"CIVIC","Melanoma"
"Melanoma","AKT1","Overexpression","Resistance","Vemurafenib","D","24265155",3,"CIVIC","Melanoma"
"Brain Tumor","NF2","any/deletion(LoF)","sensitivity","mTOR inhibitors","preclinical","19451225, 22426462, 22927055",3,"GDKD","meningioma"
"Skin Cancer","CD274","Expression","Sensitivity/Response","Pembrolizumab","B","27093365",2,"CIVIC","Merkel Cell Carcinoma"
"Skin Cancer","PIK3CA","P471L","Sensitivity/Response","Idelalisib","C","26466009",2,"CIVIC","Merkel Cell Carcinoma"
"Mesothelioma","BAP1","any/deletion(LoF)","sensitivity","EZH2 inhibitor","preclinical","26437366",3,"GDKD","mesothelioma"
"Mesothelioma","NF2","any/deletion(LoF)","response","FAK inhibitors","early trials","ENA 2012 (abstr 610)",2,"GDKD","mesothelioma"
"Adenocarcinoma","NRG1","Fusion","Sensitivity/Response","Afatinib","C","29610121",2,"CIVIC","Mucinous Adenocarcinoma"
"Melanoma","KIT","Amplification","Resistance","Imatinib","B","23775962",2,"CIVIC","Mucosal Melanoma"
"Melanoma","ALK","Alternative Transcript (ATI)","Sensitivity/Response","Entrectinib","C","29054983",2,"CIVIC","Mucosal Melanoma"
"Melanoma","KIT","K642E","Sensitivity/Response","Imatinib","C","18510589",2,"CIVIC","Mucosal Melanoma"
"Myeloma","KRAS","G12D","Resistance","Melphalan","D","11050000",3,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12C","Resistance","Melphalan","D","16497971",3,"CIVIC","Multiple Myeloma"
"Myeloma","CTAG2","Overexpression","Sensitivity/Response","Letetresgene Autoleucel","B","26193344",2,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12A","Resistance","Melphalan","B","19284554",2,"CIVIC","Multiple Myeloma"
"Myeloma","MYCL","EXPRESSION","Sensitivity/Response","I-BET151,JQ1","D","27276402",3,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12C","Resistance","Melphalan","B","19284554",2,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12D","Resistance","Melphalan","B","19284554",2,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12D","Resistance","Melphalan","D","12483530",3,"CIVIC","Multiple Myeloma"
"Myeloma","BRAF","V600E","Sensitivity/Response","Vemurafenib","C","24997557",2,"CIVIC","Multiple Myeloma"
"Myeloma","CTAG1B","Overexpression","Sensitivity/Response","Letetresgene Autoleucel","B","26193344",2,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12S","Resistance","Melphalan","B","19284554",2,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12C","Resistance","Melphalan","D","12483530",3,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12D","Resistance","Melphalan","D","16497971",3,"CIVIC","Multiple Myeloma"
"Myeloma","CRBN","MUTATION","Resistance","Lenalidomide,Pomalidomide","C","23480694",2,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12S","Resistance","Melphalan","D","16497971",3,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12A","Resistance","Melphalan","D","12483530",3,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12S","Resistance","Melphalan","D","12483530",3,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12C","Resistance","Melphalan","D","11050000",3,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12S","Resistance","Melphalan","D","11050000",3,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12A","Resistance","Melphalan","D","16497971",3,"CIVIC","Multiple Myeloma"
"Myeloma","KRAS","G12A","Resistance","Melphalan","D","11050000",3,"CIVIC","Multiple Myeloma"
"Myeloma","MYC","Overexpression","Sensitivity/Response","JQ-1","D","21889194",3,"CIVIC","Multiple Myeloma"
"Blood Cancer","TP53","mut(LoF)","response","decitabine","early trials","27959731",2,"GDKD","myelodisplastic_syndrome"
"Blood Cancer","SF3B1","Oncogenic Mutations","Sensitivity/Response","H3B-8800","4","29457796",3,"OncoKB","Myelodysplastic Syndromes"
"Blood Cancer","ZRSR2","Oncogenic Mutations","Sensitivity/Response","H3B-8800","4","29457796",3,"OncoKB","Myelodysplastic Syndromes"
"Blood Cancer","U2AF1","Oncogenic Mutations","Sensitivity/Response","H3B-8800","4","29457796",3,"OncoKB","Myelodysplastic Syndromes"
"Blood Cancer","SRSF2","Oncogenic Mutations","Sensitivity/Response","H3B-8800","4","29457796",3,"OncoKB","Myelodysplastic Syndromes"
"Blood Cancer","PDGFRB","Fusions","Sensitivity/Response","Imatinib","1","12181402, 12676775, 14504092, 1516603, 16960151, 18950453, 22897847, 24687085, 26355392",1,"OncoKB","Myelodysplastic/Myeloproliferative Neoplasms"
"Blood Cancer","PDGFRA","Fusions","Sensitivity/Response","Imatinib","1","12660384, 12944919, 14504092, 15034867, 16498388, 16845659, 17555450, 18950453",1,"OncoKB","Myelodysplastic/Myeloproliferative Neoplasms"
"Blood Cancer","JAK2","V617F(GoF)","response","ruxolitinib","FDA-approved","FDA",1,"GDKD","myelofibrosis"
"Blood Cancer","PDGFRA","FIP1L1-PDGFRA T674I","Resistance","Imatinib","C","12660384",2,"CIVIC","Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA/PDGFRB/FGFR1"
"Blood Cancer","PDGFRA","FIP1L1-PDGFRA T674I","Sensitivity/Response","Ponatinib","D","24407160",3,"CIVIC","Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA/PDGFRB/FGFR1"
"Blood Cancer","PDGFRA","FIP1L1-PDGFRA","Sensitivity/Response","Imatinib","B","14504092",2,"CIVIC","Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA/PDGFRB/FGFR1"
"Blood Cancer","PDGFRA","FIP1L1-PDGFRA T674I","Resistance","Imatinib","C","21818111",2,"CIVIC","Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA/PDGFRB/FGFR1"
"Blood Cancer","PDGFRA","FIP1L1-PDGFRA","Sensitivity/Response","Imatinib","A","12660384",1,"CIVIC","Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA/PDGFRB/FGFR1"
"Blood Cancer","PDGFRA","FIP1L1-PDGFRA","Sensitivity/Response","Imatinib","C","24456122",2,"CIVIC","Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA/PDGFRB/FGFR1"
"Blood Cancer","PDGFRA","FIP1L1-PDGFRA","Sensitivity/Response","Ponatinib","D","24407160",3,"CIVIC","Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA/PDGFRB/FGFR1"
"Blood Cancer","PDGFRA","TNKS2-PDGFRA","Sensitivity/Response","Imatinib","C","25658984",2,"CIVIC","Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA/PDGFRB/FGFR1"
"Myeloma","FGFR3","V555M(GoF)","resistance","FGFR inhibitors","preclinical","22869148",3,"GDKD","myeloma"
"Myeloma","FGFR3","Y373C(GoF)","sensitivity","FGFR inhibitors","preclinical","22869148",3,"GDKD","myeloma"
"Myeloma","NRAS","any(GoF)","sensitivity","PI3K pathway inhibitors + MEK inhibitors","preclinical","22985491",3,"GDKD","myeloma"
"Myeloma","FGFR3","Y373C(GoF)","resistance","bortezomib","preclinical","19331127, 21273588",3,"GDKD","myeloma"
"Myeloma","KRAS","any(GoF)","sensitivity","PI3K pathway inhibitors + MEK inhibitors","preclinical","22985491",3,"GDKD","myeloma"
"Myeloma","BRAF","V600E(GoF)","response","vemurafenib","case report","23612012",2,"GDKD","myeloma"
"Myeloma","FGFR3","K650(GoF)","sensitivity","FGFR inhibitors","preclinical","16091734, 20439987",3,"GDKD","myeloma"
"Myeloma","FGFR3","K650(GoF)","sensitivity","bortezomib","preclinical","19331127, 21273588",3,"GDKD","myeloma"
"Myeloma","MYC","amplification(GoF)","sensitivity","BET inhibitors","preclinical","21889194",3,"GDKD","myeloma"
"Blood Cancer","PDGFRB","Fusion","Sensitivity/Response","Imatinib","A","16960151",1,"CIVIC","Myeloproliferative Neoplasm"
"Blood Cancer","FGFR1","ZNF198-FGFR1","Sensitivity/Response","Midostaurin","C","15448205",2,"CIVIC","Myeloproliferative Neoplasm"
"Blood Cancer","CALR","EXON 9 FRAMESHIFT","Sensitivity/Response","Peginterferon Alfa-2a","B","26486786",2,"CIVIC","Myeloproliferative Neoplasm"
"Blood Cancer","PDGFRA","rearrangement(GoF)","response","imatinib","FDA-approved","FDA",1,"GDKD","myeloproliferative_neoplasm"
"Blood Cancer","CBL","Y371H(GoF)","sensitivity","JAK inhibitors, dasatinib","preclinical","23696637",3,"GDKD","myeloproliferative_neoplasm"
"Blood Cancer","CBL","C384R(GoF)","sensitivity","JAK inhibitors, dasatinib","preclinical","23696637",3,"GDKD","myeloproliferative_neoplasm"
"Blood Cancer","SH2B3","any/deletion(LoF)","sensitivity","JAK inhibitors","preclinical","20404132",3,"GDKD","myeloproliferative_neoplasm"
"Blood Cancer","CSF1R","Y571D(GoF)","sensitivity","imatinib","preclinical","18971950",3,"GDKD","myeloproliferative_neoplasm"
"Blood Cancer","MPL","W515F(GoF)","sensitivity","JAK inhibitors","preclinical","16834459",3,"GDKD","myeloproliferative_neoplasm"
"Blastoma","MYC","amplification(GoF)","sensitivity","BET inhibitors","preclinical","23430699",3,"GDKD","neuroblastoma"
"Blastoma","MYC","amplification(GoF)","sensitivity","FACT inhibitor","preclinical","26537256",3,"GDKD","neuroblastoma"
"Blastoma","MYC","amplification(GoF)","sensitivity","CDK7 inhibitors","preclinical","25416950",3,"GDKD","neuroblastoma"
"Blastoma","ALK","F1174L","Sensitivity/Response","Alectinib","D","21575866",3,"CIVIC","Neuroblastoma"
"Blastoma","ALK","F1245C","Resistance","Crizotinib","C","23598171",2,"CIVIC","Neuroblastoma"
"Blastoma","ALK","R1275Q","Sensitivity/Response","TAE684","D","18923525",3,"CIVIC","Neuroblastoma"
"Blastoma","ALK","R1275Q","Resistance","TAE684","D","18923525",3,"CIVIC","Neuroblastoma"
"Blastoma","MYCN","Amplification","Sensitivity/Response","JQ1+Panobinostat","D","26733615",3,"CIVIC","Neuroblastoma"
"Blastoma","ALK","R1275Q","Sensitivity/Response","Lorlatinib","D","26554404",3,"CIVIC","Neuroblastoma"
"Blastoma","ALK","Exon 4-11 Deletion","Sensitivity/Response","Brigatinib","D","27049722",3,"CIVIC","Neuroblastoma"
"Blastoma","ALK","R1275Q","Sensitivity/Response","Crizotinib","D","22072639",3,"CIVIC","Neuroblastoma"
"Blastoma","ALK","R1275Q","Sensitivity/Response","Crizotinib","C","23598171",2,"CIVIC","Neuroblastoma"
"Blastoma","NRAS","Q61K","Sensitivity/Response","Binimetinib+Everolimus","D","26821351",3,"CIVIC","Neuroblastoma"
"Blastoma","ALK","F1174L","Sensitivity/Response","AZD3463","D","26786851",3,"CIVIC","Neuroblastoma"
"Blastoma","ALK","F1174L","Sensitivity/Response","Crizotinib","C","23598171",2,"CIVIC","Neuroblastoma"
"Blastoma","ALK","F1174L","Sensitivity/Response","Lorlatinib","D","26554404",3,"CIVIC","Neuroblastoma"
"Blastoma","ALK","F1245C","Sensitivity/Response","Lorlatinib","D","26554404",3,"CIVIC","Neuroblastoma"
"Blastoma","ALK","I1171T","Sensitivity/Response","Ceritinib","C","29907598",2,"CIVIC","Neuroblastoma"
"Blastoma","ALK","F1174L","Sensitivity/Response","Crizotinib","D","21948233",3,"CIVIC","Neuroblastoma"
"Blastoma","ALK","F1245V","Sensitivity/Response","Entrectinib","C","28183697",2,"CIVIC","Neuroblastoma"
"Blastoma","ALK","F1174L","Resistance","Crizotinib","D","22072639",3,"CIVIC","Neuroblastoma"
"Blastoma","ALK","F1174L","Sensitivity/Response","TAE684","D","18923525",3,"CIVIC","Neuroblastoma"
"Blastoma","MYCN","Amplification","Sensitivity/Response","FACT Complex-targeting Curaxin CBL0137","D","26537256",3,"CIVIC","Neuroblastoma"
"Neuroendocrine Tumor","BRAF","V600E(GoF)","response","dabrafenib + trametinib","case report","27048246",2,"GDKD","neuroendocrine"
"Neuroendocrine Tumor","MGMT","Underexpression","Sensitivity/Response","Temozolomide","B","19118063",2,"CIVIC","Neuroendocrine Tumor"
"Skin Cancer","PTCH1","Truncating Mutations","Sensitivity/Response","Sonidegib, Vismodegib","3A","22670903, 22670904, 24523439, 24900187, 29320312",2,"OncoKB","Non-Melanoma"
"Lung Cancer","EGFR","762_823ins","Resistance","Afatinib, Erlotinib, Gefitinib","R1","15897572, 17686547, 1867676, 18676761, 19536777, 21764376, 23328547, 23371856, 24065731, 24353160, 24893891",4,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","963_1010splice","Sensitivity/Response","Crizotinib","2A","21623265, 25971939, 26729443",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","Y1003C","Sensitivity/Response","Crizotinib","2A","21623265, 25971939, 26729443",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","T790M","Resistance","Afatinib, Erlotinib, Gefitinib","R1","23816963, 24478319, 26051236",4,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","L833V","Sensitivity/Response","Afatinib, Erlotinib, Gefitinib","1","20808254, 21422421, 21949883, 23912954, 25130612",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","D1010Y","Sensitivity/Response","Cabozantinib, Capmatinib","3A","21918175, 25971938, 25971939, 27693535",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","Y1003F","Sensitivity/Response","Crizotinib","2A","21623265, 25971939, 26729443",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","963_1010del","Sensitivity/Response","Cabozantinib, Capmatinib","3A","21918175, 25971938, 25971939, 27693535",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","D761Y","Resistance","Gefitinib","R2","17085664, 17192902, 22052230, 28424065",4,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","M277E","Sensitivity/Response","Afatinib, Erlotinib, Gefitinib","1","28979142",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","BRAF","V600E","Sensitivity/Response","Dabrafenib + Trametinib","1","27283860, 28919011",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","T790M","Sensitivity/Response","Osimertinib","1","25923549, 27751847, 29151359, 30059262",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","963_1010splice","Sensitivity/Response","Cabozantinib, Capmatinib","3A","21918175, 25971938, 25971939, 27693535",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","D1010N","Sensitivity/Response","Crizotinib","2A","21623265, 25971939, 26729443",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","A750P","Sensitivity/Response","Afatinib, Erlotinib, Gefitinib","1","15737014, 19625781, 25179728, 28336552",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","963_1010del","Sensitivity/Response","Crizotinib","2A","21623265, 25971939, 26729443",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","729_761del","Sensitivity/Response","Afatinib, Dacomitinib, Erlotinib, Gefitinib, Osimertinib","1","19692680, 20022809, 20573926, 21670455, 22285168, 22370314, 22452895, 23816960, 25589191, 27987585, 28958502, 29151359, 29864379, 30659024",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","ALK","L1196M","Resistance","Crizotinib","R2","22235099, 22277784, 23344087, 23434628, 24675041, 27432227, 28434515",4,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","Kinase Domain Duplication","Sensitivity/Response","Afatinib, Erlotinib, Gefitinib","1","26286086, 28336552",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","C797S","Resistance","Osimertinib","R2","25939061, 26181354, 26749488, 28625641",4,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","Y1003F","Sensitivity/Response","Cabozantinib, Capmatinib","3A","21918175, 25971938, 25971939, 27693535",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","L858R","Sensitivity/Response","Afatinib, Dacomitinib, Erlotinib, Gefitinib, Osimertinib","1","19692680, 20022809, 20573926, 21670455, 22285168, 22370314, 22452895, 23816960, 25589191, 27987585, 28958502, 29151359, 29864379, 30659024",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","L861","Sensitivity/Response","Afatinib, Erlotinib, Gefitinib","1","21531810, 26051236, 28336552",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","S768I","Sensitivity/Response","Afatinib, Erlotinib, Gefitinib","1","17285735, 25521405, 26051236, 28336552",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","D1010Y","Sensitivity/Response","Crizotinib","2A","21623265, 25971939, 26729443",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","E709K","Sensitivity/Response","Afatinib, Erlotinib, Gefitinib","1","15710947, 18000506, 23566546, 23749122, 25130612, 25179728, 28336552",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","A763_Y764insFQEA","Sensitivity/Response","Afatinib, Erlotinib, Gefitinib","1","23371856, 23969006, 24353160",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","E709_T710delinsD","Sensitivity/Response","Afatinib, Erlotinib, Gefitinib","1","21531810, 26206867, 28336552",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","Y1003C","Sensitivity/Response","Cabozantinib, Capmatinib","3A","21918175, 25971938, 25971939, 27693535",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","ALK","I1171N","Resistance","Alectinib","R2","23239810, 25393796, 25393798, 25736571, 27565911, 29376144, 29650534",4,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","D1010N","Sensitivity/Response","Cabozantinib, Capmatinib","3A","21918175, 25971938, 25971939, 27693535",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","C797G","Resistance","Osimertinib","R2","27086175, 29713646",4,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","Y1003N","Sensitivity/Response","Cabozantinib, Capmatinib","3A","21918175, 25971938, 25971939, 27693535",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","ARAF","Oncogenic Mutations","Sensitivity/Response","Sorafenib","3A","24569458",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","L747P","Sensitivity/Response","Afatinib, Erlotinib, Gefitinib","1","22190593, 28336552",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","Y1003N","Sensitivity/Response","Crizotinib","2A","21623265, 25971939, 26729443",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","RET","Fusions","Sensitivity/Response","BLU-667, LOXO-292","3A","29657135, 29912274",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","ALK","Fusions","Sensitivity/Response","Alectinib, Ceritinib, Crizotinib","1","23724913, 28126333, 28586279, 29596029, 29668860, 30215676",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","Amplification","Sensitivity/Response","Crizotinib","2A","21623265, 25971939, 26729443",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","D1010H","Sensitivity/Response","Crizotinib","2A","21623265, 25971939, 26729443",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","762_823ins","Sensitivity/Response","Poziotinib","3A","27188206, 29686424",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","G719","Sensitivity/Response","Afatinib, Erlotinib, Gefitinib","1","15118073, 16011858, 20573926, 21531810, 21670455, 24285021, 26051236, 28336552",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","ALK","Oncogenic Mutations","Sensitivity/Response","Brigatinib, Lorlatinib","1","27432227, 28475456, 29074098, 29768119, 30280657, 30413378",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","D761Y","Sensitivity/Response","Osimertinib","4","17085664, 28424065",3,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","D1010H","Sensitivity/Response","Cabozantinib, Capmatinib","3A","21918175, 25971938, 25971939, 27693535",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","ALK","C1156Y","Resistance","Crizotinib","R2","20979473, 22235099, 23434628, 24675041, 26144315, 26698910, 27045755",4,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","ROS1","Fusions","Sensitivity/Response","Crizotinib","1","25264305, 29596029, 30980071",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","ALK","G1269A","Resistance","Crizotinib","R2","22235099, 23344087, 23434628, 24675041, 27045755, 28434515",4,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","Y1230H","Resistance","Capmatinib, Crizotinib","R2","27666659, 27987579, 28396313, 28522754, 29128427",4,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","RET","Fusions","Sensitivity/Response","Cabozantinib, Vandetanib","2A","23533264, 27803005, 27825636, 28447912",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","EGFR","729_761ins","Sensitivity/Response","Afatinib, Erlotinib, Gefitinib","1","20075572, 21841502, 22190593, 24389445, 25279299, 28336552, 29340050",1,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","ALK","G1202R","Resistance","Alectinib","R2","24736079, 27130468, 27432227, 29373100, 29376144, 29650534",4,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","ERBB2","Oncogenic Mutations","Sensitivity/Response","Ado-Trastuzumab Emtansine, Neratinib","3A","23220880, 29420467, 29989854, 30206164",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MAP2K1","Oncogenic Mutations","Sensitivity/Response","Cobimetinib, Trametinib","3A","25351745, 25370473, 26324360, 26566875, 30867592",2,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","Amplification","Resistance","Erlotinib, Gefitinib, Osimertinib","R2","17463250, 18093943, 30073261, 30676858",4,"OncoKB","Non-Small Cell Lung Cancer"
"Lung Cancer","MET","D1228N","Resistance","Cabozantinib, Capmatinib, Crizotinib","R2","27343442, 27987579, 28396313, 28522754, 29128427",4,"OncoKB","Non-Small Cell Lung Cancer"
"Unspecified Cancer","JAK2","PCM1-JAK2 Fusion","Sensitivity/Response","Ruxolitinib","3A","22875628, 22899477, 23400675, 23630205, 25207766, 25260694, 25515960, 26202607",2,"OncoKB","NOS"
"Unspecified Cancer","PDGFRA","FIP1L1-PDGFRA Fusion","Sensitivity/Response","Imatinib","1","18950453",1,"OncoKB","NOS"
"Carcinoma","BRD4","BRD4-NUTM1","Sensitivity/Response","Birabresib","C","26976114",2,"CIVIC","NUT Midline Carcinoma"
"Carcinoma","BRD4","BRD4-NUTM1","Sensitivity/Response","JQ1","D","20871596",3,"CIVIC","NUT Midline Carcinoma"
"Carcinoma","BRD4","BRD4-NUT fusion(GoF)","response","BET inhibitors","case report","ENA 2015 (abstract A49)",2,"GDKD","NUT_midline_carcinoma"
"Glioma","MGMT","Underexpression","Sensitivity/Response","Temozolomide","B","16541434",2,"CIVIC","Oligodendroglioma"
"Glioma","IDH1","R132H","Sensitivity/Response","AGI-5198","D","23558169",3,"CIVIC","Oligodendroglioma"
"Head & Neck","CDKN2A","p16 Expression","Resistance","Cetuximab","B","26712222",2,"CIVIC","Oropharynx Cancer"
"Bone Cancer","ERCC2","K751Q","Resistance","Cisplatin","B","19434073",2,"CIVIC","Osteosarcoma"
"Bone Cancer","TP53","R273H","Resistance","Doxorubicin,Methotrexate","D","17363498",3,"CIVIC","Osteosarcoma"
"Ovarian Cancer","ERCC4","any(LoF)","sensitivity","cisplatin","preclinical","25634215",3,"GDKD","ovarian"
"Ovarian Cancer","BRCA1","deletion(LoF)","sensitivity","PARP inhibitors","preclinical","22392482",3,"GDKD","ovarian"
"Ovarian Cancer","CDK12","any/deletion(LoF)","sensitivity","PARP inhibitors","preclinical","24240700, 24554720",3,"GDKD","ovarian"
"Ovarian Cancer","PTEN","any/deletion(LoF)","sensitivity","PI3K pathway inhibitors","preclinical","21632463",3,"GDKD","ovarian"
"Ovarian Cancer","LRP1B","any/deletion(LoF)","resistance","liposomal doxorubicin","early trials","22896685",2,"GDKD","ovarian"
"Ovarian Cancer","PTEN","any/deletion(LoF)","sensitivity","PI3K pathway inhibitors + MEK inhibitors","preclinical","21632463",3,"GDKD","ovarian"
"Ovarian Cancer","TP53","any(GoF)","response","WEE1 inhibitors + carboplatin","early trials","ASCO2015 (abstr 2507)",2,"GDKD","ovarian"
"Ovarian Cancer","BRCA1","any(LoF)","response","olaparib, rucaparib","FDA-approved","FDA",1,"GDKD","ovarian"
"Ovarian Cancer","BRCA2","any(LoF)","response","olaparib, rucaparib","FDA-approved","FDA",1,"GDKD","ovarian"
"Ovarian Cancer","BRCA2","any(LoF)","response","PARP inhibitors + chemotherapy","early trials","22307137, ASCO 2012 (abstr 1009)",2,"GDKD","ovarian"
"Ovarian Cancer","BRAF","rearrangement(GoF)","response","MEK inhibitors","case report","26324360",2,"GDKD","ovarian"
"Ovarian Cancer","KRAS","any(GoF)","sensitivity","MEK inhibitors","preclinical","19018267",3,"GDKD","ovarian"
"Ovarian Cancer","ERBB2","amplification(GoF)","response","trastuzumab","early trials","20003286, 12525520",2,"GDKD","ovarian"
"Ovarian Cancer","KRAS","any(GoF)","response","PI3K pathway inhibitors + MEK inhibitors","early trials","25500057, 25516890",2,"GDKD","ovarian"
"Ovarian Cancer","BRAF","V600E(GoF)","sensitivity","MEK inhibitors","preclinical","19018267",3,"GDKD","ovarian"
"Ovarian Cancer","ERCC6","any(LoF)","sensitivity","cisplatin","preclinical","25634215",3,"GDKD","ovarian"
"Ovarian Cancer","BRCA2","any(LoF)","response","platinum agents","late trials","22406760, 22711857",2,"GDKD","ovarian"
"Ovarian Cancer","KRAS","any(GoF)","sensitivity","decitabine + BCL2 inhibitors","preclinical","25968887",3,"GDKD","ovarian"
"Ovarian Cancer","BRAF","V600E(GoF)","response","BRAF inhibitors","case report","22608338",2,"GDKD","ovarian"
"Ovarian Cancer","MAP2K1","Q56_V60del(GoF)","response","MEK inhibitors","case report","26324360",2,"GDKD","ovarian"
"Ovarian Cancer","BRCA1","any(LoF)","response","PARP inhibitors + chemotherapy","early trials","22307137, ASCO 2012 (abstr 1009)",2,"GDKD","ovarian"
"Ovarian Cancer","PIK3CA","any(GoF)","response","PI3K pathway inhibitors","early trials","22271473, AACR 2013 (abstr LB-66), 25231405",2,"GDKD","ovarian"
"Ovarian Cancer","ARID1A","any(LoF)","sensitivity","EZH2 inhibitor","preclinical","25686104",3,"GDKD","ovarian"
"Ovarian Cancer","BRCA2","deletion(LoF)","sensitivity","PARP inhibitors","preclinical","22392482",3,"GDKD","ovarian"
"Ovarian Cancer","BRCA1","any(LoF)","response","platinum agents","late trials","22406760, 22711857",2,"GDKD","ovarian"
"Ovarian Cancer","RAD51C","any(LoF)","response","PARP inhibitors","early trials","ASCO 2015 (abstr 5508)",2,"GDKD","ovarian"
"Ovarian Cancer","BRCA1","Loss-of-function","Sensitivity/Response","Talazoparib","B","28242752",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA1","Mutation","Sensitivity/Response","Olaparib","B","21862407",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","KRAS","G12D","Resistance","Cetuximab","D","22246397",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","Oncogenic Mutations","Sensitivity/Response","Niraparib, Rucaparib","1","27717299, 28882436, 28916367, 30425037, 30948273",1,"OncoKB","Ovarian Cancer"
"Ovarian Cancer","BRCA1","Mutation","Sensitivity/Response","Rucaparib","B","27908594",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","SYK","OVEREXPRESSION","Resistance","Paclitaxel","D","26096845",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","TP53","R273L","Resistance","Cisplatin,Carboplatin","C","11595686",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","NRG1","Expression","Sensitivity/Response","Seribantumab","D","20227043",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","V211I","Sensitivity/Response","Rucaparib","C","27908594",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","TP53","Overexpression","Resistance","Carboplatin,Cisplatin","B","11595686",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","R2336P","Sensitivity/Response","Rucaparib","C","27908594",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","KRAS","Mutation","Sensitivity/Response","Decitabine","D","25968887",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","Oncogenic Mutations","Sensitivity/Response","Olaparib","2A","24882434, 25366685, 30285518, 30345884",1,"OncoKB","Ovarian Cancer"
"Ovarian Cancer","TOP1","EXPRESSION","Sensitivity/Response","Carboplatin+Topotecan+Cyclophosphamide","B","19648970",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA1","Underexpression","Sensitivity/Response","Platinum Compound+Taxane Compound","B","21920589",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","ABCB1","S893T","Sensitivity/Response","Paclitaxel","B","16467099",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","PTEN","Loss","Resistance","Cisplatin","D","15790433",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA1","Loss-of-function","Sensitivity/Response","Olaparib","B","23346317",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA1","Mutation","Sensitivity/Response","Cediranib+Olaparib","B","25218906",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA1","Oncogenic Mutations","Sensitivity/Response","Niraparib, Rucaparib","1","27717299, 28882436, 28916367, 30425037, 30948273",1,"OncoKB","Ovarian Cancer"
"Ovarian Cancer","ASNS","AMPLIFICATION","Resistance","Asparaginase","D","17088436",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","M1R","Sensitivity/Response","Rucaparib","C","27908594",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","ASS1","LOSS","Resistance","Platinum Compound","D","19533750",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","DNMT1","EXPRESSION","Sensitivity/Response","Decitabine","D","25968887",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","CCND1","Amplification","Sensitivity/Response","Palbociclib","D","21278246",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","Loss-of-function","Sensitivity/Response","Olaparib","B","23346317",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","Mutation","Sensitivity/Response","Cediranib+Olaparib","B","25218906",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","AKT1","E17K","Sensitivity/Response","AZD5363","3A","22294718, 23394218, 26351323, 28489509",2,"OncoKB","Ovarian Cancer"
"Ovarian Cancer","BRCA2","Mutation","Sensitivity/Response","Olaparib","B","21862407",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRAF","Fusions","Sensitivity/Response","Cobimetinib, Trametinib","3A","23890088, 24345920, 26324360",2,"OncoKB","Ovarian Cancer"
"Ovarian Cancer","BRAF","V600E","Sensitivity/Response","Vemurafenib","B","29320312",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","V211L","Sensitivity/Response","Rucaparib","C","27908594",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","M1I","Sensitivity/Response","Rucaparib","C","27908594",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","Loss-of-function","Sensitivity/Response","Talazoparib","B","28242752",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","V159M","Sensitivity/Response","Rucaparib","C","27908594",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","LRP1B","EXON 12-22 DELETION","Resistance","Doxorubicin","D","22896685",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","FNTB","RS11623866","Resistance","Lonafarnib","B","26033044",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","Mutation","Sensitivity/Response","Rucaparib","B","27908594",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA1","Oncogenic Mutations","Sensitivity/Response","Olaparib","2A","24882434, 25366685, 30285518, 30345884",1,"OncoKB","Ovarian Cancer"
"Ovarian Cancer","VPS37A","UNDEREXPRESSION","Resistance","Cetuximab","D","22016507",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","TP53","ALTERATION","Resistance","Carboplatin,Cisplatin","B","11595686",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","CDKN2A","Loss","Sensitivity/Response","Palbociclib","D","21278246",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","CCNE1","Overexpression","Sensitivity/Response","CDK Inhibitor SNS-032","D","26204491",3,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","TP53","Y234C","Resistance","Cisplatin,Carboplatin","C","11595686",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA1","Q1467*","Sensitivity/Response","Rucaparib","C","27908594",2,"CIVIC","Ovarian Cancer"
"Ovarian Cancer","BRCA2","Mutation","Sensitivity/Response","Platinum Compound","B","24240112",2,"CIVIC","Ovarian Carcinoma"
"Ovarian Cancer","BRCA1","Mutation","Sensitivity/Response","Platinum Compound","B","24240112",2,"CIVIC","Ovarian Carcinoma"
"Ovarian Cancer","GSTP1","DELETION","Sensitivity/Response","Cisplatin,Carboplatin,Paclitaxel","D","25010864",3,"CIVIC","Ovarian Carcinoma"
"Ovarian Cancer","ARID1A","Q456*","Sensitivity/Response","Dasatinib","D","27364904",3,"CIVIC","Ovarian Clear Cell Carcinoma"
"Ovarian Cancer","ARID1A","LOSS-OF-FUNCTION","Sensitivity/Response","GSK126","D","25686104",3,"CIVIC","Ovarian Clear Cell Carcinoma"
"Ovarian Cancer","ARID1A","LOSS-OF-FUNCTION","Sensitivity/Response","Dasatinib","D","27364904",3,"CIVIC","Ovarian Clear Cell Carcinoma"
"Ovarian Cancer","ARID1A","P1175FS*5","Sensitivity/Response","Dasatinib","D","27364904",3,"CIVIC","Ovarian Clear Cell Carcinoma"
"Ovarian Cancer","CDK12","LOSS-OF-FUNCTION","Sensitivity/Response","Olaparib","D","24240700",3,"CIVIC","Ovarian Serous Carcinoma"
"Ovarian Cancer","BRAF","BRAF-CUL1","Sensitivity/Response","Mitogen-Activated Protein Kinase Kinase Inhibitor","C","26324360",2,"CIVIC","Ovarian Serous Carcinoma"
"Ovarian Cancer","MAP2K1","Q56_V60del","Sensitivity/Response","Selumetinib","C","26324360",2,"CIVIC","Ovarian Serous Carcinoma"
"Ovarian Cancer","BRAF","V600E","Sensitivity/Response","Vemurafenib","C","26490654",2,"CIVIC","Ovarian Serous Carcinoma"
"Ovarian Cancer","AURKA","Overexpression","Resistance","Platinum Compound","B","27209210",2,"CIVIC","Ovarian Serous Carcinoma"
"Ovarian Cancer","CCNE1","Amplification","Sensitivity/Response","Dinaciclib+Akt Inhibitor MK2206","D","27663592",3,"CIVIC","Ovarian Serous Cystadenocarcinoma"
"Ovarian Cancer","SMARCA4","any/deletion(LoF)","response","EZH2 inhibitor","case report","ESMO 2015 (abstract 302)",2,"GDKD","ovarian_rhabdoid_tumor"
"Ovarian","NRAS","Q61K","Sensitivity/Response","Trametinib","C","30809568",2,"CIVIC","Ovary Serous Adenocarcinoma"
"Ovarian","KRAS","Mutation","Sensitivity/Response","Binimetinib","B","32822286",2,"CIVIC","Ovary Serous Adenocarcinoma"
"Pancreatic Cancer","BRCA1","any(LoF)","response","PARP inhibitors","case report","25366685, 25719666",2,"GDKD","pancreatic"
"Pancreatic Cancer","KRAS","any(GoF)","no response","PI3K pathway inhibitors + MEK inhibitor","early trials","ASCO 2015 (abstr 4119)",2,"GDKD","pancreatic"
"Pancreatic Cancer","PALB2","any/deletion(LoF)","response","Mytomycin C","case report","21135251",2,"GDKD","pancreatic"
"Pancreatic Cancer","PTEN","any/deletion(LoF)","response","AKT inhibitors","case report","22025163",2,"GDKD","pancreatic"
"Pancreatic Cancer","PALB2","any/deletion(LoF)","response","platinum","case report","25719666",2,"GDKD","pancreatic"
"Pancreatic Cancer","STK11","D194E(LoF)","response","everolimus","case report","21189378",2,"GDKD","pancreatic"
"Pancreatic Cancer","RNF43","any(GoF)","sensitivity","FZD5 antibodies","preclinical","27869803",3,"GDKD","pancreatic"
"Pancreatic Cancer","PALB2","any/deletion(LoF)","sensitivity","PARP inhibitors","preclinical","25263539, NCT01585805",3,"GDKD","pancreatic"
"Pancreatic Cancer","KRAS","any(GoF)","response","gemcitabine + MEK inhibitors","early trials","23583440",2,"GDKD","pancreatic"
"Pancreatic Cancer","BRCA2","any(LoF)","response","platinum","case report","25719666",2,"GDKD","pancreatic"
"Pancreatic Cancer","KRAS","G12/G13","Resistance","Gemcitabine+Trametinib","B","24915778",2,"CIVIC","Pancreatic Adenocarcinoma"
"Pancreatic Cancer","KRAS","G12/G13","Sensitivity/Response","Trametinib","B","24915778",2,"CIVIC","Pancreatic Adenocarcinoma"
"Pancreatic Cancer","ERBB2","Amplification","Sensitivity/Response","Afatinib","D","26668065",3,"CIVIC","Pancreatic Adenocarcinoma"
"Pancreatic Cancer","RB1","OVEREXPRESSION","Resistance","Fluorouracil,Mitomycin,Gemcitabine,Doxorubicin","D","11792751",3,"CIVIC","Pancreatic Adenocarcinoma"
"Pancreatic Cancer","KRAS","Mutation","Sensitivity/Response","PI3Kbeta Inhibitor AZD8186+SCH772984","D","26725216",3,"CIVIC","Pancreatic Adenocarcinoma"
"Pancreatic Cancer","NRG1","Fusion","Sensitivity/Response","Afatinib","C","29802158",2,"CIVIC","Pancreatic Adenocarcinoma"
"Pancreatic Cancer","BRCA2","Mutation","Sensitivity/Response","Platinum Compound","B","25072261",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","FANCC","LOSS-OF-FUNCTION","Sensitivity/Response","Cisplatin,Chlorambucil,Melphalan,Mitomycin,Gemcitabine","D","16243825",3,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","ERBB2","Overexpression","Sensitivity/Response","Capecitabine+Trastuzumab","B","22374460",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","BRCA1","Mutation","Sensitivity/Response","Olaparib","B","25366685",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","BRCA2","Mutation","Sensitivity/Response","Veliparib","B","29223478",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","RRM2","OVEREXPRESSION","Resistance","Gemcitabine","D","17224927",3,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","RRM1","Underexpression","Sensitivity/Response","Gemcitabine","B","19543324",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","PALB2","Biallelic Inactivation","Sensitivity/Response","Mitomycin","C","21135251",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","ERBB2","Overexpression","Sensitivity/Response","Gemcitabine+Trastuzumab","B","15581051",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","BRAF","N486_P490del","Sensitivity/Response","Trametinib","C","29903880",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","RRM1","Overexpression","Resistance","Gemcitabine","D","17224927",3,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","CDKN2A","Mutation","Sensitivity/Response","Palbociclib","B","158598",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","BRAF","CUX1-BRAF","Sensitivity/Response","Vemurafenib","C","29320312",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","ERBB2","Amplification","Sensitivity/Response","Pertuzumab+Trastuzumab","B","29320312",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","STK11","D194E","Sensitivity/Response","Everolimus","C","21189378",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","BRCA1","Mutation","Sensitivity/Response","Veliparib","B","29223478",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","BRCA2","Mutation","Sensitivity/Response","Iniparib","C","21508395",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","BRCA2","Mutation","Sensitivity/Response","Veliparib+Cisplatin+Gemcitabine","B","29338080",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","BRCA1","Mutation","Sensitivity/Response","Oxaliplatin,Cisplatin","B","25072261",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","KRAS","Exon 2 Mutation","Resistance","Gemcitabine+Erlotinib","B","21862683",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","SIRT1","OVEREXPRESSION","Resistance","Niacinamide","D","24088390",3,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","BRCA1","Mutation","Sensitivity/Response","Gemcitabine+Veliparib+Cisplatin","B","29338080",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","RRM1","Underexpression","Sensitivity/Response","Gemcitabine","B","17131328",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","BRCA2","Mutation","Sensitivity/Response","Olaparib","B","25366685",2,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","BRCA2","Loss-of-function","Sensitivity/Response","Mitomycin","D","16243825",3,"CIVIC","Pancreatic Cancer"
"Pancreatic Cancer","PTEN","Loss","Sensitivity/Response","Akt Inhibitor MK2206","C","22025163",2,"CIVIC","Pancreatic Carcinoma"
"Pancreatic Cancer","KRAS","G12D","Sensitivity/Response","Akt Inhibitor MK2206","C","22025163",2,"CIVIC","Pancreatic Carcinoma"
"Pancreatic Cancer","KRAS","Exon 2 Mutation","Resistance","Erlotinib","B","23435671",2,"CIVIC","Pancreatic Carcinoma"
"Pancreatic Cancer","NRG1","ATP1B1-NRG1","Sensitivity/Response","Afatinib","C","31068372",2,"CIVIC","Pancreatic Ductal Adenocarcinoma"
"Pancreatic Cancer","ERBB3","EXPRESSION","Sensitivity/Response","Pertuzumab+9F7-F11","D","25216528",3,"CIVIC","Pancreatic Ductal Adenocarcinoma"
"Pancreatic Cancer","HSPB1","EXPRESSION","Sensitivity/Response","Gemcitabine","D","22004109",3,"CIVIC","Pancreatic Ductal Adenocarcinoma"
"Pancreatic Cancer","NRG1","APP-NRG1","Sensitivity/Response","Afatinib","C","31068372",2,"CIVIC","Pancreatic Ductal Adenocarcinoma"
"Pancreatic Cancer","CIP2A","UNDEREXPRESSION","Sensitivity/Response","Gemcitabine","D","26894380",3,"CIVIC","Pancreatic Ductal Adenocarcinoma"
"Pancreatic Cancer","IDH1","R132H","Sensitivity/Response","Ivosidenib","C","27466707",2,"CIVIC","Pancreatic Ductal Adenocarcinoma"
"Adenocarcinoma","RET","Overexpression","Sensitivity/Response","Sunitinib","C","20696054",2,"CIVIC","Papillary Adenocarcinoma"
"Kidney Cancer","MET","Mutation","Sensitivity/Response","Foretinib","B","23213094",2,"CIVIC","Papillary Renal Cell Carcinoma"
"Soft Tissue Sarcoma","NF2","any/deletion(LoF)","sensitivity","mTOR inhibitors","preclinical","19451225, 22426462, 22927055",3,"GDKD","PEComa"
"Soft Tissue Sarcoma","TSC1","any(LoF)","response","mTOR inhibitors","early trials","23312829, 21525172, 20048174",2,"GDKD","PEComa"
"Soft Tissue Sarcoma","TSC2","any(LoF)","response","mTOR inhibitors","early trials","23312829, 21525172, 20048174",2,"GDKD","PEComa"
"Mesothelioma","EGFR","Mutation","Sensitivity/Response","Hyperthermic Intraperitoneal Chemotherapy+Cytoreductive Surgery","B","20942962",2,"CIVIC","Peritoneal Mesothelioma"
"Mesothelioma","NF2","Y177fs","Resistance","Cisplatin,Carboplatin","C","25798586",2,"CIVIC","Peritoneal Mesothelioma"
"Peritoneal Cancer","BRCA1","Oncogenic Mutations","Sensitivity/Response","Olaparib","2A","24882434, 25366685, 30285518, 30345884",1,"OncoKB","Peritoneal Serous Carcinoma"
"Peritoneal Cancer","BRCA2","Oncogenic Mutations","Sensitivity/Response","Niraparib, Rucaparib","1","27717299, 28882436, 28916367, 30425037, 30948273",1,"OncoKB","Peritoneal Serous Carcinoma"
"Peritoneal Cancer","BRCA2","Oncogenic Mutations","Sensitivity/Response","Olaparib","2A","24882434, 25366685, 30285518, 30345884",1,"OncoKB","Peritoneal Serous Carcinoma"
"Peritoneal Cancer","BRCA1","Oncogenic Mutations","Sensitivity/Response","Niraparib, Rucaparib","1","27717299, 28882436, 28916367, 30425037, 30948273",1,"OncoKB","Peritoneal Serous Carcinoma"
"Genetic Syndrome","STK11","LOSS","Sensitivity/Response","Sirolimus","D","18281551",3,"CIVIC","Peutz-Jeghers Syndrome"
"Genetic Syndrome","STK11","LOSS","Sensitivity/Response","Sirolimus","D","19541609",3,"CIVIC","Peutz-Jeghers Syndrome"
"Nerve Tumor","NF1","Mutation","Sensitivity/Response","Selumetinib","B","28029918",2,"CIVIC","Plexiform Neurofibroma"
"Blood Cancer","JAK2","V617F","Sensitivity/Response","Fedratinib","D","18394554",3,"CIVIC","Polycythemia Vera"
"Prostate Cancer","FANCA","any/deletion(LoF)","response","PARP inhibitors","early trials","26510020",2,"GDKD","prostate"
"Prostate Cancer","PTEN","any/deletion(LoF)","response","everolimus","early trials","23582881",2,"GDKD","prostate"
"Prostate Cancer","AR","T877A(GoF)","resistance","flutamide","case report","2260966",2,"GDKD","prostate"
"Prostate Cancer","AR","F876L (GoF)","resistance","enzalutamide, ARN-509","case report","23779130",2,"GDKD","prostate"
"Prostate Cancer","ATM","any(LoF)","response","PARP inhibitors","early trials","26510020",2,"GDKD","prostate"
"Prostate Cancer","AR","F877L/T878A coexisting(GoF)","sensitivity","enzalutamide","preclinical","27196756",3,"GDKD","prostate"
"Prostate Cancer","TMPRSS2","rearrangement(GoF)","sensitivity","DNA-PKc inhibitors","preclinical","21575865",3,"GDKD","prostate"
"Prostate Cancer","CHEK2","any/deletion(LoF)","response","PARP inhibitors","early trials","AACR 2015 (abstr CT322), 26510020",2,"GDKD","prostate"
"Prostate Cancer","TMPRSS2","rearrangement(GoF)","sensitivity","PARP inhibitors","preclinical","21575865",3,"GDKD","prostate"
"Prostate Cancer","HDAC2","any/deletion(LoF)","response","PARP inhibitors","early trials","26510020",2,"GDKD","prostate"
"Prostate Cancer","AR","amplification(GoF)","sensitivity","next-generation AR antagonists","preclinical","23589709, 21859989",3,"GDKD","prostate"
"Prostate Cancer","AR","T877A(GoF)","sensitivity","enzalutamide, ARN-509","preclinical","23779130",3,"GDKD","prostate"
"Prostate Cancer","AR","L702H(GoF)","resistance","abiraterone","early trials","26537258",2,"GDKD","prostate"
"Prostate Cancer","MYC","amplification(GoF)","sensitivity","PIM inhibitors","preclinical","25505253",3,"GDKD","prostate"
"Prostate Cancer","AR","T878A(GoF)","resistance","abiraterone","early trials","26537258",2,"GDKD","prostate"
"Prostate Cancer","AR-V7","splice variant mRNA(GoF)","resistance","enzalutamide, abiraterone","early trials","25184630",2,"GDKD","prostate"
"Prostate Cancer","BRAF","rearrangement(GoF)","sensitivity","sorafenib, MEK inhibitors","preclinical","20526349",3,"GDKD","prostate"
"Prostate Cancer","AR","W741(GoF)","resistance","bicalutamide","preclinical","12517791",3,"GDKD","prostate"
"Prostate Cancer","PTEN","any/deletion(LoF)","sensitivity","PI3K pathway inhibitors + AR antagonists","preclinical","21575859",3,"GDKD","prostate"
"Prostate Cancer","BRCA1","any(LoF)","response","PARP inhibitors","early trials","19553641, 25366685, 26510020",2,"GDKD","prostate"
"Prostate Cancer","AR","W741(GoF)","sensitivity","enzalutamide, ARN-509","preclinical","23779130",3,"GDKD","prostate"
"Prostate Cancer","AR","amplification(GoF)","resistance","abiraterone","early trials","26537258",2,"GDKD","prostate"
"Prostate Cancer","PTEN","any/deletion(LoF)","response","PI3K beta inhibitor","case report","ASCO 2014 (abstr 2514^)",2,"GDKD","prostate"
"Prostate Cancer","RAF1","rearrangement(GoF)","sensitivity","sorafenib, MEK inhibitors","preclinical","20526349",3,"GDKD","prostate"
"Prostate Cancer","AURKA","amplification(GoF)","sensitivity","AURK inhibitors","preclinical","22389870",3,"GDKD","prostate"
"Prostate Cancer","BRCA2","any(LoF)","response","PARP inhibitors","early trials","26510020",2,"GDKD","prostate"
"Prostate Cancer","PALB2","any/deletion(LoF)","response","PARP inhibitors","early trials","AACR 2015 (abstr CT322), 26510020",2,"GDKD","prostate"
"Prostate Cancer","MRE11","FRAMESHIFT MUTATION","Sensitivity/Response","Olaparib","B","26510020",2,"CIVIC","Prostate Cancer"
"Prostate Cancer","GAS6","EXPRESSION","Resistance","Docetaxel","D","27153245",3,"CIVIC","Prostate Cancer"
"Prostate Cancer","PTEN","Mutation","Sensitivity/Response","Alpelisib+Enzalutamide+PI3Kbeta Inhibitor AZD8186","D","25544636",3,"CIVIC","Prostate Cancer"
"Prostate Cancer","PTEN","Loss","Sensitivity/Response","Temsirolimus","D","11504908",3,"CIVIC","Prostate Cancer"
"Prostate Cancer","BRCA2","Loss-of-function","Sensitivity/Response","Olaparib","B","26510020",2,"CIVIC","Prostate Cancer"
"Prostate Cancer","AR","MUTATION","Resistance","Flutamide,Cyproterone Acetate,Nilutamide,Bicalutamide","B","26000489",2,"CIVIC","Prostate Cancer"
"Prostate Cancer","IGF2","Overexpression","Sensitivity/Response","Linsitinib,Docetaxel,Cabazitaxel","D","25670080",3,"CIVIC","Prostate Cancer"
"Prostate Cancer","STK11","UNDEREXPRESSION","Sensitivity/Response","SB202190","D","26391455",3,"CIVIC","Prostate Cancer"
"Prostate Cancer","AR","F877L","Resistance","Apalutamide,Enzalutamide","D","23779130",3,"CIVIC","Prostate Cancer"
"Prostate Cancer","BRCA1","Loss-of-function","Sensitivity/Response","Olaparib","C","26510020",2,"CIVIC","Prostate Cancer"
"Prostate Cancer","PTEN","Deletion","Sensitivity/Response","Everolimus","B","23582881",2,"CIVIC","Prostate Cancer"
"Prostate Cancer","ATM","Mutation","Sensitivity/Response","Olaparib","C","26510020",2,"CIVIC","Prostate Cancer"
"Prostate Cancer","CFLAR","EXPRESSION","Resistance","Bicalutamide","D","22623731",3,"CIVIC","Prostate Cancer"
"Prostate Cancer","PALB2","Biallelic Inactivation","Sensitivity/Response","Olaparib","C","26510020",2,"CIVIC","Prostate Cancer"
"Prostate Cancer","ATM","N2875H","Sensitivity/Response","Olaparib","C","26510020",2,"CIVIC","Prostate Cancer"
"Prostate Cancer","IGF2","Overexpression","N/A","Linsitinib","D","25670080",3,"CIVIC","Prostate Cancer"
"Prostate Cancer","AR","V7 EXPRESSION","Resistance","Enzalutamide,Abiraterone","B","25184630",2,"CIVIC","Prostate Cancer"
"Prostate Cancer","TYMS","Underexpression","Sensitivity/Response","Pemetrexed","C","24782778",2,"CIVIC","Prostate Cancer"
"Prostate Cancer","ATM","S2289*","Sensitivity/Response","Olaparib","C","26510020",2,"CIVIC","Prostate Cancer"
"Prostate Cancer","DEFA1","EXPRESSION","Sensitivity/Response","Docetaxel","B","26261420",2,"CIVIC","Prostate Cancer"
"Prostate Cancer","AR","W742","Resistance","Bicalutamide","D","12517791",3,"CIVIC","Prostate Carcinoma"
"Colon and Rectal Cancer","MTHFR","A222V","Sensitivity/Response","Fluorouracil","B","26693073",2,"CIVIC","Rectum Cancer"
"Kidney Cancer","MET","M1268T(GoF)","response","MET inhibitors","case report","23610116",2,"GDKD","renal"
"Kidney Cancer","BAP1","any/deletion(LoF)","sensitivity","PARP inhibitors","preclinical","22683710",3,"GDKD","renal"
"Kidney Cancer","TSC1","any/deletion(LoF)","response","everolimus","case report","24622468, 26859683, ASCO 2015 (abstr 11010), ASCO 2015 (abstr 4519)",2,"GDKD","renal"
"Kidney Cancer","MTOR","Q2223K(GoF)","response","everolimus","case report","24622468",2,"GDKD","renal"
"Kidney Cancer","MET","amplification(GoF)","response","MET inhibitors","early trials","23213094, AACR 2016 (abstr CT2006)",2,"GDKD","renal"
"Kidney Cancer","MET","exon 16-19 p.1132-1330(GoF)","response","crizotinib","early trials","AACR 2016 (abstr CT2006)",2,"GDKD","renal"
"Kidney Cancer","MET","kinase domain(GoF)","response","MET inhibitor savolitinib","early trials","28644771",2,"GDKD","renal"
"Kidney Cancer","MET","H1094R(GoF)","response","MET inhibitors","early trials","23213094",2,"GDKD","renal"
"Kidney Cancer","FLCN","any/deletion(LoF)","response","everolimus","case report","23995526",2,"GDKD","renal"
"Kidney Cancer","MTOR","I1973F(GoF)","response","everolimus","case report","26859683",2,"GDKD","renal"
"Kidney Cancer","VHL","LOSS","Sensitivity/Response","Temsirolimus","D","16341243",3,"CIVIC","Renal Carcinoma"
"Kidney Cancer","EPAS1","OVEREXPRESSION","Sensitivity/Response","Pazopanib","B","23881929",2,"CIVIC","Renal Cell Carcinoma"
"Kidney Cancer","VHL","MUTATION","Sensitivity/Response","Pazopanib","B","23881929",2,"CIVIC","Renal Cell Carcinoma"
"Kidney Cancer","FBXW7","LOSS-OF-FUNCTION","Sensitivity/Response","Everolimus","E","24253377",3,"CIVIC","Renal Cell Carcinoma"
"Kidney Cancer","VHL","LOSS","Sensitivity/Response","Anti-VEGF Monoclonal Antibody","B","28103578",2,"CIVIC","Renal Cell Carcinoma"
"Kidney Cancer","VHL","MUTATION","Resistance","Anti-VEGF Monoclonal Antibody","B","28103578",2,"CIVIC","Renal Cell Carcinoma"
"Kidney Cancer","HMOX1","EXPRESSION","Resistance","Sunitinib,Sorafenib","B","26309414",2,"CIVIC","Renal Cell Carcinoma"
"Kidney Cancer","MTOR","L2209V","Sensitivity/Response","Temsirolimus","3A","26831717",2,"OncoKB","Renal Cell Carcinoma"
"Kidney Cancer","MTOR","L1460P","Sensitivity/Response","Temsirolimus","3A","26831717",2,"OncoKB","Renal Cell Carcinoma"
"Kidney Cancer","CDKN2A","Loss","Sensitivity/Response","Palbociclib","D","23898052",3,"CIVIC","Renal Cell Carcinoma"
"Kidney Cancer","CCND1","Amplification","Sensitivity/Response","Palbociclib","D","23898052",3,"CIVIC","Renal Cell Carcinoma"
"Kidney Cancer","HIF1A","EXPRESSION","Sensitivity/Response","Pazopanib","B","23881929",2,"CIVIC","Renal Cell Carcinoma"
"Kidney Cancer","MTOR","Q2223K","Sensitivity/Response","Everolimus","3A","24622468",2,"OncoKB","Renal Cell Carcinoma"
"Kidney Cancer","VHL","MUTATION","Sensitivity/Response","Everolimus","B","26951309",2,"CIVIC","Renal Cell Carcinoma"
"Kidney Cancer","MET","Amplification","Sensitivity/Response","Cabozantinib","2A","27279544, 27462141",1,"OncoKB","Renal Cell Carcinoma"
"Kidney Cancer","MTOR","L2427Q","Sensitivity/Response","Temsirolimus","3A","26831717",2,"OncoKB","Renal Cell Carcinoma"
"Kidney Cancer","TSC1","Oncogenic Mutations","Sensitivity/Response","Everolimus","2A","26831717, 30327302",1,"OncoKB","Renal Cell Carcinoma"
"Kidney Cancer","TSC2","Oncogenic Mutations","Sensitivity/Response","Everolimus","2A","26831717, 30327302",1,"OncoKB","Renal Cell Carcinoma"
"Kidney Cancer","FLT3","T227M","Adverse Response","Sunitinib","B","19667267",2,"CIVIC","Renal Cell Carcinoma"
"Kidney Cancer","CDKN2B","LOSS","Sensitivity/Response","Palbociclib","D","23898052",3,"CIVIC","Renal Cell Carcinoma"
"Kidney Cancer","BAP1","Mutation","Resistance","Sunitinib>Everolimus","B","27751729",2,"CIVIC","Renal Cell Carcinoma"
"Blastoma","RB1","any/deletion(LoF)","sensitivity","MDM2/MDMX inhibitors","preclinical","17080083, 21515735",3,"GDKD","retinoblastoma"
"Blastoma","RB1","any/deletion(LoF)","sensitivity","HDAC inhibitors","preclinical","18483379",3,"GDKD","retinoblastoma"
"Sarcoma","SMARCB1","DELETION","Sensitivity/Response","Tazemetostat","D","23620515",3,"CIVIC","Rhabdoid Cancer"
"Sarcoma","FGFR4","V550(GoF)","sensitivity","FGFR inhibitors","preclinical","19809159, 24124571",3,"GDKD","rhabdomyosarcoma"
"Sarcoma","FGFR4","N535(GoF)","sensitivity","FGFR inhibitors","preclinical","19809159, 24124571",3,"GDKD","rhabdomyosarcoma"
"Sarcoma","IL6","Overexpression","Resistance","Bazedoxifene","D","28672024",3,"CIVIC","Rhabdomyosarcoma"
"Sarcoma","PDGFRA","Overexpression","Sensitivity/Response","Sunitinib","D","19366796",3,"CIVIC","Rhabdomyosarcoma"
"Salivary Gland Cancer","ERBB2","Overexpression","Sensitivity/Response","Paclitaxel+Trastuzumab","C","23826550",2,"CIVIC","Salivary Gland Cancer"
"Salivary Gland Cancer","ERBB2","Overexpression","Sensitivity/Response","Capecitabine+Trastuzumab+Zoledronic Acid","C","20504363",2,"CIVIC","Salivary Gland Cancer"
"Salivary Gland Cancer","NTRK3","ETV6-NTRK3","Sensitivity/Response","Entrectinib","C","26884591",2,"CIVIC","Salivary Gland Carcinoma"
"Salivary Gland Cancer","NTRK3","ETV6-NTRK3","Sensitivity/Response","Crizotinib","C","26884591",2,"CIVIC","Salivary Gland Carcinoma"
"Salivary Gland Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab+Pertuzumab","B","29320312",2,"CIVIC","Salivary Gland Carcinoma"
"Sarcoma","PTPRD","mut(GoF)","response","IGF-1R antibodies","case report","23800680",2,"GDKD","sarcoma"
"Sarcoma","TSC1","any(LoF)","response","everolimus","case report","26859683",2,"GDKD","sarcoma"
"Sarcoma","MDM4","amplification(GoF)","sensitivity","MDM2/MDMX inhibitors","preclinical","24336067",3,"GDKD","sarcoma"
"Sarcoma","IGF1R","NUCLEAR EXPRESSION","Sensitivity/Response","IGF1R Monoclonal Antibody","B","22682017",2,"CIVIC","Sarcoma"
"Sarcoma","NTRK2","STRN-NTRK2","Sensitivity/Response","Larotrectinib","C","29606586",2,"CIVIC","Sarcoma"
"Sarcoma","BRAF","KIAA1549-BRAF","Sensitivity/Response","Bevacizumab+Temsirolimus+Sorafenib","C","24422672",2,"CIVIC","Sarcoma"
"Sarcoma","NTRK1","Fusion","Sensitivity/Response","Larotrectinib","B","29606586",2,"CIVIC","Sarcoma"
"Sarcoma","NTRK1","PDE4DIP-NTRK1","Sensitivity/Response","Larotrectinib","C","29606586",2,"CIVIC","Sarcoma"
"Sarcoma","FGFR1","Expression","Sensitivity/Response","FGF/VEGF Receptor Tyrosine Kinase Inhibitor, PD173074,Infigratinib,FGFR Inhibitor AZD4547","D","27535980",3,"CIVIC","Sarcoma"
"Sarcoma","TP53","Deleterious Mutation","Sensitivity/Response","Pazopanib","B","26646755",2,"CIVIC","Sarcoma"
"Sarcoma","CDK4","EXPRESSION","Sensitivity/Response","Palbociclib","D","26528855",3,"CIVIC","Sarcoma"
"Sarcoma","NTRK1","PDE4DIP-NTRK1","Sensitivity/Response","Larotrectinib","C","30204247",2,"CIVIC","Sarcoma"
"Sarcoma","NTRK1","TPM3-NTRK1","Sensitivity/Response","Larotrectinib","C","29606586",2,"CIVIC","Sarcoma"
"Sarcoma","NTRK1","LMNA-NTRK1","Sensitivity/Response","Larotrectinib","C","29606586",2,"CIVIC","Sarcoma"
"Sarcoma","NTRK1","LMNA-NTRK1 e2-e11","Sensitivity/Response","Larotrectinib","C","26216294",2,"CIVIC","Sarcoma"
"Sarcoma","ASS1","LOSS","Sensitivity/Response","Pegargiminase+Chloroquine","D","27735949",3,"CIVIC","Sarcoma"
"Sarcoma","RAD23B","EXPRESSION","Sensitivity/Response","Vorinostat","D","27499916",3,"CIVIC","Sarcoma"
"Nerve Tumor","NF2","any/deletion(LoF)","sensitivity","PAK inhibitors","preclinical","23960073",3,"GDKD","schwannoma"
"Nerve Tumor","NF2","any/deletion(LoF)","response","everolimus","early trials","25567352",2,"GDKD","schwannoma"
"Nerve Tumor","NF2","any(LoF)","response","lapatinib","early trials","22844108",2,"GDKD","schwannoma"
"Nerve Tumor","NF2","any(LoF)","response","bevacizumab","early trials","22805104",2,"GDKD","schwannoma"
"Skin Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab","C","25692060",2,"CIVIC","Scrotum Paget's Disease"
"Lymphoma","CTLA4","CTLA4-CD28","Sensitivity/Response","Ipilimumab","C","25802883",2,"CIVIC","Sezary's Disease"
"Skin Cancer","PTCH1","Truncating Mutations","Sensitivity/Response","Sonidegib, Vismodegib","3A","22670903, 22670904, 24523439, 24900187, 29320312",2,"OncoKB","Skin Cancer"
"Melanoma","NRAS","Mutation","Sensitivity/Response","Docetaxel+Trametinib","B","25542057",2,"CIVIC","Skin Melanoma"
"Melanoma","JAK2","c.1641+1dup","Resistance","Pembrolizumab","C","27433843",2,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","L597S","Sensitivity/Response","MEK Inhibitor TAK-733","C","22798288",2,"CIVIC","Skin Melanoma"
"Melanoma","B2M","S14FS","Resistance","Pembrolizumab","C","27433843",2,"CIVIC","Skin Melanoma"
"Melanoma","GNAQ","Q209P","Resistance","Vemurafenib","C","24504448",2,"CIVIC","Skin Melanoma"
"Melanoma","NRAS","Q61K","Resistance","Vemurafenib","D","22194965",3,"CIVIC","Skin Melanoma"
"Melanoma","MET","Overexpression","Resistance","Vemurafenib","B","23802768",2,"CIVIC","Skin Melanoma"
"Melanoma","NRAS","Q61K","Sensitivity/Response","Selumetinib","D","22194965",3,"CIVIC","Skin Melanoma"
"Melanoma","CCND1","Amplification","Sensitivity/Response","Paclitaxel+Carboplatin+Sorafenib","B","26307133",2,"CIVIC","Skin Melanoma"
"Melanoma","CDK4","R24C","Sensitivity/Response","Palbociclib","D","24495407",3,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","D594V","Sensitivity/Response","Trametinib,Sorafenib","E","20141835",3,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","V600K","Sensitivity/Response","Dabrafenib+Trametinib","B","25399551",2,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Vemurafenib","B","22356324",2,"CIVIC","Skin Melanoma"
"Melanoma","MET","Overexpression","Resistance","Vemurafenib","B","26359985",2,"CIVIC","Skin Melanoma"
"Melanoma","PTEN","V317FS","Sensitivity/Response","MEK Inhibitor CI-1040+Akt Inhibitor MK2206","D","24504448",3,"CIVIC","Skin Melanoma"
"Melanoma","JAK1","Q503*","Resistance","Pembrolizumab","C","27433843",2,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","K601E","Sensitivity/Response","Trametinib,Vemurafenib","D","22798288",3,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","KIAA1549-BRAF","Sensitivity/Response","Trametinib","C","26072686",2,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","L597V","Sensitivity/Response","Trametinib","C","22805292",2,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","L597R","Sensitivity/Response","Trametinib,Vemurafenib","D","22798288",3,"CIVIC","Skin Melanoma"
"Melanoma","CDKN2A","Loss","Sensitivity/Response","Alvocidib","D","12777976",3,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","G469E","Resistance","U0126","D","18794803",3,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","D594G","Resistance","U0126","D","18794803",3,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","K483M","Sensitivity/Response","Mitogen-Activated Protein Kinase Kinase Inhibitor,Sorafenib","E","20141835",3,"CIVIC","Skin Melanoma"
"Melanoma","HLA-DRA","EXPRESSION","Sensitivity/Response","Nivolumab,Atezolizumab,Pembrolizumab","B","26822383",2,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","D594A","Sensitivity/Response","Mitogen-Activated Protein Kinase Kinase Inhibitor,Sorafenib","E","20141835",3,"CIVIC","Skin Melanoma"
"Melanoma","NRAS","Mutation","Sensitivity/Response","Ribociclib+Binimetinib","B","26987942",2,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","L597Q","Sensitivity/Response","Trametinib","C","24933606",2,"CIVIC","Skin Melanoma"
"Melanoma","NF1","Mutation","Sensitivity/Response","AZ628,VTX-11e","D","23288408",3,"CIVIC","Skin Melanoma"
"Melanoma","NRAS","Q61","Sensitivity/Response","Selumetinib","C","18390968",2,"CIVIC","Skin Melanoma"
"Melanoma","NRAS","Mutation","Sensitivity/Response","Binimetinib","B","23414587",2,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Dabrafenib+Trametinib","B","25399551",2,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","L597Q","Sensitivity/Response","Trametinib,Vemurafenib","D","22798288",3,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","G469E","Sensitivity/Response","Sorafenib","D","18794803",3,"CIVIC","Skin Melanoma"
"Melanoma","ALK","Alternative Transcript (ATI)","Sensitivity/Response","Crizotinib","C","26444240",2,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","D594G","Sensitivity/Response","Sorafenib","D","18794803",3,"CIVIC","Skin Melanoma"
"Melanoma","NRAS","Mutation","Sensitivity/Response","Amuvatinib","D","24950457",3,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","V600","Sensitivity/Response","Dabrafenib+Trametinib","A","25399551",1,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","TRIM24-BRAF","Resistance","Vemurafenib","D","24345920",3,"CIVIC","Skin Melanoma"
"Melanoma","RAF1","AMPLIFICATION","Sensitivity/Response","Paclitaxel+Carboplatin+Sorafenib","B","26307133",2,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","V600E","Sensitivity/Response","Vemurafenib","A","21639808",1,"CIVIC","Skin Melanoma"
"Melanoma","NF1","Mutation","Sensitivity/Response","Sirolimus+Mirdametinib","D","23171796",3,"CIVIC","Skin Melanoma"
"Melanoma","NRAS","Q61","Sensitivity/Response","Binimetinib","B","23414587",2,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","L597S","Sensitivity/Response","Vemurafenib,Trametinib","D","22798288",3,"CIVIC","Skin Melanoma"
"Melanoma","NF1","Mutation","Resistance","Vemurafenib","D","23171796",3,"CIVIC","Skin Melanoma"
"Melanoma","EZH2","Y646","Sensitivity/Response","GSK126","D","26304929",3,"CIVIC","Skin Melanoma"
"Melanoma","BRAF","PPFIBP2-BRAF","Sensitivity/Response","Trametinib","C","26072686",2,"CIVIC","Skin Melanoma"
"Melanoma","CDKN2A","Loss","Sensitivity/Response","Palbociclib","D","24495407",3,"CIVIC","Skin Melanoma"
"Melanoma","NF1","Mutation","Resistance","Vemurafenib","C","23288408",2,"CIVIC","Skin Melanoma"
"Melanoma","NRAS","Mutation","Sensitivity/Response","Binimetinib","B","28284557",2,"CIVIC","Skin Melanoma"
"Melanoma","KRAS","Amplification","Sensitivity/Response","Docetaxel+Carboplatin+Sorafenib","B","26307133",2,"CIVIC","Skin Melanoma"
"Melanoma","GNAQ","Q209P","Resistance","PLX4720","D","24504448",3,"CIVIC","Skin Melanoma"
"Skin Cancer","EGFR","P753S","Sensitivity/Response","Sirolimus+Cetuximab","C","24934779",2,"CIVIC","Skin Squamous Cell Carcinoma"
"Skin Cancer","HRAS","G13D","Resistance","Vemurafenib","C","22256804",2,"CIVIC","Skin Squamous Cell Carcinoma"
"General Cancer","BRAF","Non-V600","Sensitivity/Response","Trametinib","B","31924734",2,"CIVIC","Solid Tumor"
"General Cancer","NTRK3","ETV6-NTRK3","Sensitivity/Response","Larotrectinib","A","30624546",1,"CIVIC","Solid Tumor"
"General Cancer","PTEN","Loss","Sensitivity/Response","Paclitaxel+Carboplatin+Buparlisib","B","28281183",2,"CIVIC","Solid Tumor"
"General Cancer","NTRK3","Fusion","Sensitivity/Response","Larotrectinib","A","29466156",1,"CIVIC","Solid Tumor"
"General Cancer","BRAF","G466V","Sensitivity/Response","Vemurafenib","D","28783719",3,"CIVIC","Solid Tumor"
"Sarcoma","NTRK1","TPM3-NTRK1","Sensitivity/Response","Larotrectinib","C","30204247",2,"CIVIC","Spindle Cell Sarcoma"
"Gastric Cancer","MTHFR","A222V","Sensitivity/Response","Fluorouracil","B","18704422",2,"CIVIC","Stomach Cancer"
"Gastric Cancer","PTEN","Loss","Sensitivity/Response","Capivasertib+Docetaxel","D","24088382",3,"CIVIC","Stomach Cancer"
"Gastric Cancer","PIK3CA","Mutation","Sensitivity/Response","Capivasertib","D","24088382",3,"CIVIC","Stomach Cancer"
"Gastric Cancer","ATM","Underexpression","Sensitivity/Response","Paclitaxel+Olaparib","B","26282658",2,"CIVIC","Stomach Cancer"
"Gastric Cancer","TP53","Overexpression","Sensitivity/Response","Etoposide+Mitomycin+Cisplatin","B","14514923",2,"CIVIC","Stomach Cancer"
"Gastric Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab Deruxtecan","B","31047804",2,"CIVIC","Stomach Cancer"
"Gastric Cancer","TP53","Y220C","Sensitivity/Response","Etoposide+Cisplatin+Mitomycin","C","14514923",2,"CIVIC","Stomach Carcinoma"
"Gastric Cancer","TP53","Mutation","Sensitivity/Response","Etoposide+Cisplatin+Doxorubicin","C","14514923",2,"CIVIC","Stomach Carcinoma"
"Gastric Cancer","TP53","R213P","Sensitivity/Response","EAP Protocol","C","14514923",2,"CIVIC","Stomach Carcinoma"
"Gastric Cancer","MET","Overexpression","Sensitivity/Response","Rilotumumab","B","28958504",2,"CIVIC","Stomach Carcinoma"
"Gastric Cancer","FGFR2","Amplification","Sensitivity/Response","FGFR Inhibitor AZD4547","B","27179038",2,"CIVIC","Stomach Carcinoma"
"Gastric Cancer","PIK3CA","Amplification","Sensitivity/Response","Alpelisib","D","24608574",3,"CIVIC","Stomach Carcinoma"
"Gastric Cancer","MLH1","METHYLATION","Resistance","Oxaliplatin","B","24748501",2,"CIVIC","Stomach Carcinoma"
"Gastric Cancer","TP53","R273C","Sensitivity/Response","Etoposide+Cisplatin+Mitomycin","C","14514923",2,"CIVIC","Stomach Carcinoma"
"Gastric Cancer","TP53","R282L","Sensitivity/Response","EAP Protocol","C","14514923",2,"CIVIC","Stomach Carcinoma"
"Gastric Cancer","PTEN","Loss","Resistance","Chemotherapy","B","15900596",2,"CIVIC","Stomach Carcinoma"
"Gastric Cancer","ERBB2","T862A","Sensitivity/Response","Lapatinib","D","22046346",3,"CIVIC","Stomach Carcinoma"
"Gastric Cancer","TP53","R175H","Sensitivity/Response","EAP Protocol","C","14514923",2,"CIVIC","Stomach Carcinoma"
"Sarcoma","SMARCB1","UNDEREXPRESSION","Sensitivity/Response","Tazemetostat","D","27391784",3,"CIVIC","Synovial Sarcoma"
"Blood Cancer","KIT","D816V","Sensitivity/Response","Midostaurin","B","27355533",2,"CIVIC","Systemic Mastocytosis"
"Blood Cancer","KIT","D816V(GoF)","response","dasatinib","early trials","18559612",2,"GDKD","systemic_mastocytosis"
"Leukemia","NT5C2","R367Q","Resistance","Mercaptopurine,Thioguanine","D","23377281",3,"CIVIC","T-cell Acute Lymphoblastic Leukemia"
"Leukemia","NT5C2","K359Q","Resistance","Mercaptopurine,Thioguanine","D","23377281",3,"CIVIC","T-cell Acute Lymphoblastic Leukemia"
"Leukemia","NT5C2","D407A","Resistance","Nelarabine,Arabinosylguanine","D","23377281",3,"CIVIC","T-cell Acute Lymphoblastic Leukemia"
"Leukemia","NT5C2","D407A","Resistance","Mercaptopurine,Thioguanine","D","23377281",3,"CIVIC","T-cell Acute Lymphoblastic Leukemia"
"Leukemia","NT5C2","K359Q","Resistance","Nelarabine,Arabinosylguanine","D","23377281",3,"CIVIC","T-cell Acute Lymphoblastic Leukemia"
"Leukemia","NT5C2","R367Q","Resistance","Nelarabine,Arabinosylguanine","D","23377281",3,"CIVIC","T-cell Acute Lymphoblastic Leukemia"
"Leukemia","MTOR","C1483Y","Sensitivity/Response","Sirolimus","D","24631838",3,"CIVIC","T-cell Acute Lymphoblastic Leukemia"
"Lymphoma","CCND3","LOSS","Sensitivity/Response","Palbociclib","D","23079656",3,"CIVIC","T-cell Lymphoblastic Leukemia/lymphoma"
"Leukemia","CCND3","LOSS","Sensitivity/Response","Palbociclib","D","23079656",3,"CIVIC","T-cell Lymphoblastic Leukemia/lymphoma"
"Thymus Cancer","KIT","D820E(GoF)","response","sorafenib","case report","19461405",2,"GDKD","thymic"
"Thymus Cancer","KIT","del577-578–579(GoF)","response","sorafenib","case report","20970876",2,"GDKD","thymic"
"Thymus Cancer","KIT","V560del(GoF)","response","imatinib","case report","15201427",2,"GDKD","thymic"
"Thymus Cancer","KIT","H697Y(GoF)","sensitivity","sunitinib","preclinical","19861435",3,"GDKD","thymic"
"Thymus Cancer","KIT","Y553N(GoF)","response","sunitinib","case report","23375402",2,"GDKD","thymic"
"Thymus Cancer","KIT","Y553N(GoF)","response","imatinib","case report","21969494",2,"GDKD","thymic"
"Thymus Cancer","KIT","V560DEL","Sensitivity/Response","Imatinib","C","15201427",2,"CIVIC","Thymic Carcinoma"
"Thymus Cancer","KIT","T670I","Sensitivity/Response","Sorafenib, Sunitinib","2A","14991904, 19461405, 20571495, 25592632",1,"OncoKB","Thymic Tumor"
"Thymus Cancer","KIT","V654A","Sensitivity/Response","Sorafenib, Sunitinib","2A","14991904, 19461405, 20571495, 25592632",1,"OncoKB","Thymic Tumor"
"Thymus Cancer","KIT","C788_N828mut","Sensitivity/Response","Sorafenib, Sunitinib","2A","14991904, 19461405, 20571495, 25592632",1,"OncoKB","Thymic Tumor"
"Thymus Cancer","KIT","D816","Sensitivity/Response","Sorafenib, Sunitinib","2A","14991904, 19461405, 20571495, 25592632",1,"OncoKB","Thymic Tumor"
"Thymus Cancer","KIT","Oncogenic Mutations","Sensitivity/Response","Sorafenib, Sunitinib","2A","14991904, 19461405, 20571495, 25592632",1,"OncoKB","Thymic Tumor"
"Lymphoma","TP53","any(LoF)","sensitivity","pramlintide","preclinical","25409149",3,"GDKD","thymic_lymphoma"
"Thyroid Cancer","PTC1","rearrangement(GoF) RET-PTC1","sensitivity","cabozantinib, vandetanib, sunitinib","preclinical","21470995",3,"GDKD","thyroid"
"Thyroid Cancer","RET","C634W(GoF)","response","vandetanib","FDA-approved","20065189, 22025146",1,"GDKD","thyroid"
"Thyroid Cancer","RET","C634W(GoF)","sensitivity","RET inhibitors","preclinical","23056499",3,"GDKD","thyroid"
"Thyroid Cancer","RET","M918T(GoF)","sensitivity","cabozantinib, sunitinib","preclinical","21470995",3,"GDKD","thyroid"
"Thyroid Cancer","RET","rearrangement(GoF) RET-PTC1","sensitivity","RET inhibitors","preclinical","23056499",3,"GDKD","thyroid"
"Thyroid Cancer","RET","rearrangement(GoF) RET-PTC1","sensitivity","cabozantinib, vandetanib, sunitinib","preclinical","21470995",3,"GDKD","thyroid"
"Thyroid Cancer","ALK","rearrangement(GoF)","response","crizotinib","case report","24687827",2,"GDKD","thyroid"
"Thyroid Cancer","PTEN","any/deletion(LoF)","sensitivity","PI3K pathway inhibitors","preclinical","21289267",3,"GDKD","thyroid"
"Thyroid Cancer","PTC1","rearrangement(GoF) RET-PTC1","sensitivity","RET inhibitors","preclinical","23056499",3,"GDKD","thyroid"
"Thyroid Cancer","RET","M918T(GoF)","response","vandetanib","FDA-approved","20065189, 22025146",1,"GDKD","thyroid"
"Thyroid Cancer","RET","M918T(GoF)","sensitivity","RET inhibitors","preclinical","23056499",3,"GDKD","thyroid"
"Thyroid Cancer","RET","codon 618, 620, 634, 768, 791, 891, 918(GoF)","response","vandetanib","FDA-approved","20065189, 22025146",1,"GDKD","thyroid"
"Thyroid Cancer","BRAF","V600E(GoF)","response","pan-RAF inhibitors","early trials","AACR 2016 (abstr CT005)",2,"GDKD","thyroid"
"Thyroid Cancer","RET","C634W(GoF)","sensitivity","cabozantinib, sunitinib","preclinical","21470995",3,"GDKD","thyroid"
"Thyroid Cancer","FLCN","any/deletion(LoF)","response","everolimus","case report","25295501",2,"GDKD","thyroid"
"Thyroid Cancer","BRAF","V600E(GoF)","response","vemurafenib, dabrafenib","early trials","22608338, 20818844, 23489023, 27460442",2,"GDKD","thyroid"
"Thyroid Cancer","BRAF","V600E(GoF)","response","MEK inhibitors","early trials","22241789",2,"GDKD","thyroid"
"Thyroid Cancer","PIK3CA","any(GoF)","sensitivity","PI3K pathway inhibitors","preclinical","21289267",3,"GDKD","thyroid"
"Thyroid Cancer","BRAF","V600E(GoF)","response","BRAF inhibitors + MEK inhibitors","early trials","ASCO 2013 (abstr 9029)",2,"GDKD","thyroid"
"Thyroid Cancer","TSC2","any(LoF)","response","everolimus","case report","25295501",2,"GDKD","thyroid"
"Thyroid Cancer","BRAF","V600E(GoF)","response","MEK-inhibitor enhanced radioiodine uptake","early trials","23406027",2,"GDKD","thyroid"
"Thyroid Cancer","NRAS","Oncogenic Mutations","Sensitivity/Response","Iodine I 131-6-Beta-Iodomethyl-19-Norcholesterol + Selumetinib","3A","22105174, 23406027",2,"OncoKB","Thyroid Cancer"
"Thyroid Cancer","BRAF","V600E","Sensitivity/Response","Pertuzumab+Vemurafenib","C","29320312",2,"CIVIC","Thyroid Gland Anaplastic Carcinoma"
"Thyroid Cancer","ALK","Fusion","Sensitivity/Response","Crizotinib","C","24687827",2,"CIVIC","Thyroid Gland Anaplastic Carcinoma"
"Thyroid Cancer","BRAF","V600E","Sensitivity/Response","Trametinib+Dabrafenib","B","29072975",2,"CIVIC","Thyroid Gland Anaplastic Carcinoma"
"Thyroid Cancer","BRAF","V600E","Sensitivity/Response","Vemurafenib","B","26287849",2,"CIVIC","Thyroid Gland Anaplastic Carcinoma"
"Thyroid Cancer","PTEN","R130*","Sensitivity/Response","Perifosine,Temsirolimus","D","19706758",3,"CIVIC","Thyroid Gland Cancer"
"Thyroid Cancer","PIK3CA","E542K","Sensitivity/Response","Perifosine,Temsirolimus","D","19706758",3,"CIVIC","Thyroid Gland Cancer"
"Thyroid Cancer","PIK3CA","H1047R","Sensitivity/Response","Perifosine,Temsirolimus","D","19706758",3,"CIVIC","Thyroid Gland Cancer"
"Thyroid Cancer","TSC2","Q1178*","Sensitivity/Response","Everolimus","C","25295501",2,"CIVIC","Thyroid Gland Carcinoma"
"Thyroid Cancer","MTOR","F2108L","Resistance","Everolimus","C","25295501",2,"CIVIC","Thyroid Gland Carcinoma"
"Thyroid Cancer","NF2","Loss","Sensitivity/Response","Selumetinib","D","26359368",3,"CIVIC","Thyroid Gland Carcinoma"
"Thyroid Cancer","GNAS","R201H","Sensitivity/Response","Radioactive Iodine","C","26788326",2,"CIVIC","Thyroid Gland Follicular Carcinoma"
"Thyroid Cancer","RET","M918T","Sensitivity/Response","Sorafenib","B","20368568",2,"CIVIC","Thyroid Gland Medullary Carcinoma"
"Thyroid Cancer","RET","M918T","Resistance","Motesanib","D","21422803",3,"CIVIC","Thyroid Gland Medullary Carcinoma"
"Thyroid Cancer","RET","M918T","Sensitivity/Response","Cabozantinib","B","27525386",2,"CIVIC","Thyroid Gland Medullary Carcinoma"
"Thyroid Cancer","RET","M918T","Sensitivity/Response","JAK2 Inhibitor AZD1480","D","23056499",3,"CIVIC","Thyroid Gland Medullary Carcinoma"
"Thyroid Cancer","RET","C634W","Resistance","Motesanib","D","21422803",3,"CIVIC","Thyroid Gland Medullary Carcinoma"
"Thyroid Cancer","BRAF","V600E","Sensitivity/Response","Vemurafenib","B","27460442",2,"CIVIC","Thyroid Gland Papillary Carcinoma"
"Thyroid Cancer","BRAF","V600E","Sensitivity/Response","Vemurafenib","C","24987354",2,"CIVIC","Thyroid Gland Papillary Carcinoma"
"Urothelial Carcinoma","ERBB3","V104M","Sensitivity/Response","Afatinib","B","27044931",2,"CIVIC","Transitional Cell Carcinoma"
"Urothelial Carcinoma","FGFR3","S249C","Sensitivity/Response","Pazopanib","C","25766722",2,"CIVIC","Transitional Cell Carcinoma"
"Urothelial Carcinoma","FGFR2","FGFR2-BICC1","Sensitivity/Response","Erdafitinib","C","26324363",2,"CIVIC","Transitional Cell Carcinoma"
"Urothelial Carcinoma","FGFR3","Mutation","Sensitivity/Response","Erdafitinib","A","31340094",1,"CIVIC","Transitional Cell Carcinoma"
"Urothelial Carcinoma","ERBB3","R103G","Sensitivity/Response","Afatinib","B","27044931",2,"CIVIC","Transitional Cell Carcinoma"
"Urothelial Carcinoma","BRAF","NRF1-BRAF","Sensitivity/Response","Trametinib","C","31010895",2,"CIVIC","Transitional Cell Carcinoma"
"Urothelial Carcinoma","MTOR","E2014K and E2419K","Sensitivity/Response","Pazopanib+Everolimus","C","24625776",2,"CIVIC","Transitional Cell Carcinoma"
"Urothelial Carcinoma","FGFR3","FGFR3-TACC3","Sensitivity/Response","Infigratinib","C","29848605",2,"CIVIC","Transitional Cell Carcinoma"
"Urothelial Carcinoma","MSH2","LOSS","Sensitivity/Response","Durvalumab+Anti-PD-1 Monoclonal Antibody MEDI0680","C","26674132",2,"CIVIC","Transitional Cell Carcinoma"
"Urothelial Carcinoma","MSH6","LOSS","Sensitivity/Response","Anti-PD-1 Monoclonal Antibody MEDI0680+Durvalumab","C","26674132",2,"CIVIC","Transitional Cell Carcinoma"
"Urothelial Carcinoma","ERBB3","G284R","Sensitivity/Response","Afatinib","B","27044931",2,"CIVIC","Transitional Cell Carcinoma"
"Urothelial Carcinoma","FGFR3","S249C","Resistance","Cisplatin","D","31316618",3,"CIVIC","Transitional Cell Carcinoma"
"Breast Cancer","BRCA1","Mutation","Resistance","Olaparib","B","21862407",2,"CIVIC","Triple-receptor Negative Breast Cancer"
"Breast Cancer","BRCA2","Mutation","Sensitivity/Response","Olaparib","B","21862407",2,"CIVIC","Triple-receptor Negative Breast Cancer"
"Breast Cancer","BRCA2","Mutation","Sensitivity/Response","Cisplatin,Carboplatin","B","25847936",2,"CIVIC","Triple-receptor Negative Breast Cancer"
"Breast Cancer","AKT3","OVEREXPRESSION","Sensitivity/Response","Pan-AKT Kinase Inhibitor GSK690693","E","24335962",3,"CIVIC","Triple-receptor Negative Breast Cancer"
"Breast Cancer","BRCA1","Mutation","Sensitivity/Response","Cisplatin,Carboplatin","B","25847936",2,"CIVIC","Triple-receptor Negative Breast Cancer"
"Urothelial Carcinoma","RAD50","L1237F","Sensitivity/Response","Checkpoint Kinase Inhibitor AZD7762+Irinotecan","C","24934408",2,"CIVIC","Ureter Small Cell Carcinoma"
"Bladder Cancer","FGFR3","Mutation","Sensitivity/Response","Gemcitabine+Cisplatin","B","29941343",2,"CIVIC","Urinary Bladder Cancer"
"Uterine Cancer","ERBB2","Amplification","Sensitivity/Response","Trastuzumab+Pertuzumab","B","29320312",2,"CIVIC","Uterine Cancer"
"Endometrial Cancer","ERBB2","Amplification","Sensitivity/Response","Afatinib","D","25268372",3,"CIVIC","Uterine Corpus Endometrial Carcinoma"
"Uterine Cancer","ERBB2","Amplification","Sensitivity/Response","Carboplatin-Taxol Regimen + Trastuzumab","2A","29584549",1,"OncoKB","Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma"
"Melanoma","GNAQ","MUTATION","Sensitivity/Response","Trametinib","B","22805292",2,"CIVIC","Uveal Melanoma"
"Melanoma","GNA11","MUTATION","Sensitivity/Response","Cabozantinib","B","28103611",2,"CIVIC","Uveal Melanoma"
"Melanoma","BAP1","Mutation","Sensitivity/Response","Panobinostat,Valproic Acid,Vorinostat,Trichostatin A","D","22038994",3,"CIVIC","Uveal Melanoma"
"Melanoma","GNAQ","MUTATION","Sensitivity/Response","Cabozantinib","B","28103611",2,"CIVIC","Uveal Melanoma"
"Melanoma","GNAQ","Q209","Sensitivity/Response","Refametinib","C","23434733",2,"CIVIC","Uveal Melanoma"
"Melanoma","GNAQ","MUTATION","Sensitivity/Response","Sotrastaurin Acetate+Mirdametinib","D","24141786",3,"CIVIC","Uveal Melanoma"
"Melanoma","GNA11","MUTATION","Sensitivity/Response","Sotrastaurin Acetate+Mirdametinib","D","24141786",3,"CIVIC","Uveal Melanoma"
"Melanoma","DDX43","OVEREXPRESSION","Resistance","Mirdametinib,Selumetinib,Trametinib","D","24899684",3,"CIVIC","Uveal Melanoma"
"Melanoma","GNA11","MUTATION","Sensitivity/Response","JQ1","D","26397223",3,"CIVIC","Uveal Melanoma"
"Melanoma","MET","Overexpression","Resistance","Selumetinib,Trametinib","D","25952648",3,"CIVIC","Uveal Melanoma"
"Melanoma","MET","Overexpression","Sensitivity/Response","Crizotinib","D","24140933",3,"CIVIC","Uveal Melanoma"
"Melanoma","GNA11","Q209","Sensitivity/Response","Selumetinib","B","24938562",2,"CIVIC","Uveal Melanoma"
"Melanoma","GNAQ","MUTATION","Sensitivity/Response","JQ1","D","26397223",3,"CIVIC","Uveal Melanoma"
"Melanoma","GNA11","MUTATION","Sensitivity/Response","Trametinib","C","22805292",2,"CIVIC","Uveal Melanoma"
"Melanoma","GNAQ","Q209","Sensitivity/Response","Selumetinib","B","24938562",2,"CIVIC","Uveal Melanoma"
"Sarcoma","ALK","Fusion","Sensitivity/Response","Crizotinib","C","26942346",2,"CIVIC","Vagina Sarcoma"
"Lymphoma","MYD88","L265P","Sensitivity/Response","IMG-2005-5,IRAK-1/4 Inhibitor","D","22931316",3,"CIVIC","Waldenstroem's Macroglobulinemia"
"Lymphoma","MYD88","L265P","Sensitivity/Response","Ibrutinib","B","25853747",2,"CIVIC","Waldenstroem's Macroglobulinemia"
"Lymphoma","MYD88","L265P(GoF)","response","ibrutinib","FDA-approved","25853747",2,"GDKD","waldenstrom macroglobulinemia"
"Sarcoma","CDK4","Amplification","Sensitivity/Response","Abemaciclib, Palbociclib","2A","23569312, 27124835",1,"OncoKB","Well-Differentiated Liposarcoma"
